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Abstract 
The concept of Lewis base activation of Lewis acid has been successfully applied to the 
enantioselective sulfenoamination of olefins. The unreactive, achiral Lewis acidic sulfenylating 
agent, N-arylthiophthalimide, is activated by the coordination of a chiral Lewis base, binaphthyl-
derived selenophosphoramide, in presence of a Brønsted acid as a co-catalyst. The Lewis base-
acid adduct exhibits a strong sulfenylating ability towards various olefins with formation of 
enantioenriched thiiranium ion intermediates. These configurationally stable thiiranium ions are 
stereospecifically captured by amines and anilines to afford nitrogen-containing heterocycles, 
such as piperidines, azepanes, and tetrahydroquinolines. 
In the course of developing an enantioselective carbosulfenylation of alkenes, a 
seemingly contradicting phenomenon of a catalyst inhibiting a stoichiometric reaction was 
observed. In the absence of catalyst, the background reaction rates were comparable to or greater 
than the catalyzed process, despite the observation of highly enantioenriched product when a 
chiral, nonracemic catalyst was employed. Detailed kinetic and spectroscopic studies revealed 
that the conversion of the Lewis base pre-catalyst to the catalytically active species was 
responsible for the observed comparable reactivity. Specifically, the equimolar formation of the 
byproducts of the catalyst activation, sulfonate ion and phthalimide, buffered the Brønsted acid, 
resulting in inhibition of the uncatalyzed racemic pathway. Therefore, the operating background 
reaction under catalytic conditions cannot be represented by simply omitting the catalyst. 
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CHAPTER 1: Introduction 
1.1 General Considerations 
1.1.1 Lewis Definition of Acids and Bases 
Acids and bases are one of the most fundamental concepts in chemistry that is required 
for understanding the reactivities of molecules. The first modern definition of acids and bases 
was formulated by Svante Arrhenius in 1896.
1
 His definition, an acids and bases are substances 
that dissociate hydrogen ions or hydroxide ions in aqueous solutions, clearly showed its 
limitation for it being only applicable to aqueous solutions. In 1923, Johannes Brønsted and 
Martin Lowry devised an improved definition of acids and bases, focusing on the ability to 
donate and accept the hydrogen ions. While this definition removed the restriction of aqueous 
solutions, it still required a hydrogen atom to be present in the molecule to qualify as a Brønsted 
acid. Interestingly, in the same year of 1923, Gilbert N. Lewis stated, “…we may say that a basic 
substance is one which has a lone pair of electrons which may be used to complete the stable 
group of another atom and that an acid substance is one which can employ a lone pair from 
another molecule in completing the stable group of one of its own atoms. In other words, the 
basic substance furnishes a pair of electrons for a chemical bond; the acid substance accepts 
such a pair.”2 
The true impact of Lewis‟s definition is that each molecule‟s affinity towards electrons is 
the only factor considered for categorizing and explaining acidic and basic substances. That is, in 
simple words, a Lewis base is an electron-pair donor, and a Lewis acid is an electron-pair 
acceptor. This pioneering, revolutionary concept for acid and base has become the basis for 
understanding chemical reactivity in modern organic chemistry
3
 
2 
 
The interaction of a Lewis base with a Lewis acid is manifested by the octet rule. This 
rule describes that an atom is in a thermodynamically most stable “noble state” when its valence 
shell is fully occupied with electrons. As supported by many examples,
4
 Lewis bases interact 
with acids to form more stable adduct, which the process is driven by fulfilling the noble state of 
both donor and acceptor. However, formation of a thermodynamically stable Lewis base-acid 
adduct does not necessarily mean reduction in reactivity.
5
 
1.1.2 Jensen’s Orbital Analysis of Lewis Base-Lewis Acid Adducts 
Lewis acids and bases can influence reactions in various ways, such as by activating the 
substrates, or by modulating its electrochemical properties. To better understand the fundamental 
details of how reactions are influenced by Lewis acids and bases, Jensen classified the types of 
Lewis base-acid bonding interactions (Table 1).
3
 
Table 1. Jensen’s Orbital Analysis of Lewis Base-Lewis Acid Adducts. 
Acceptor 
Donor 
n* σ* π* 
n n-n* n-σ* n-π* 
σ σ-n* σ-σ* σ-π* 
π π-n* π-σ* π-π* 
Overall 9 types of Lewis base-acid bonding interactions were proposed based on the 
available combination of three kinds of each of donor and acceptor orbitals. Among the possible 
donor-acceptor orbital interactions, only three orbital combinations are classified as important 
interactions that can increase chemical reactivity. Those three are interactions of non-bonding 
orbital (n) with: (1) anti-bonding π orbitals (n-π*) (2) anti-bonding σ orbitals (n-σ*), and (3) 
vacant non-bonding orbitals (n-n*). 
3 
 
Among the three orbital interactions mentioned above, the combination of the 
nonbonding electron pair of a Lewis base with an anti-bonding  orbital (n-*) is the most 
common interaction that results with increased reactivity.
6
 The Morita-Baylis-Hillman reaction is 
a good representative example of this type of activation (Scheme 1).
7
 Conjugate addition of a 
phosphine (Lewis base, n) to α,β-unsaturated enone (Lewis acid, *) generates zwitterionic 
enolate, which undergoes nucleophilic attack to the second carbonyl unit. Effectively, the enolate 
intermediate is activated by addition of a Lewis base, possessing an increased nucleophilic 
character at the α-carbon. 
Scheme 1 
 
The n-σ* and n-n* activation modes are the other two orbital interactions that can 
positively influence the reactivities. While these types of orbital interactions more exotic and 
exhibit a simultaneous increase in both nucleophilic and electrophilic character of the adduct, it 
requires the acceptor (Lewis acid) to be capable of forming a hypervalent species. This intriguing 
reactivity enhancement of the hypervalent adducts are best explained by Gutmann‟s analysis on 
Lewis base-acid interactions.
5
 
1.1.3 Gutmann’s Analysis 
When a Lewis base (donor) interacts with a Lewis acid (acceptor), the electron density is 
transferred from the donor to the acid moiety. As a result, the overall electron density of the acid 
is increased and a stronger nucleophilicity is expected. However, enhancement of electrophilicity 
4 
 
of the adduct is simultaneously observed in some reactions. In 1978, Gutmann proposed an 
explanation for this counter-intuitive phenomenon, by identifying the uneven distribution of the 
electron density during the formation of the Lewis base-acid adduct (Figure 1).
5c 
 
Figure 1. Structural redistribution of the donor-acceptor pair. 
Gutmann formulated four rules from the empirical analyses of X-ray structures:
5c
 (1) The 
smaller the intramolecular distance between the donor atom (D) and the acceptor atom (A), the 
greater the induced lengthening of the peripheral bonds (A–X), (2) the longer the bond between 
D and A, the greater the degree of polarization of electron density across the intramolecular bond, 
(3) as the coordination number of an atom increases, so do the lengths of all the bonds 
originating from that coordination center, and (4) the bonds adjacent to D and A will either 
contract or elongate to compensate for the changes in electron density at D and A. Described as 
the “spill-over” effect, the electron density is redistributed to the more electronegative 
substituent atoms. Consequently, the Lewis acidic central atom becomes more electrophilic 
compared to the parent Lewis acid, while the peripheral atoms are rendered more nucleophilic. 
5 
 
Upon treatment of a Lewis acid with a Lewis base, elongation of the bond between the 
central atom A and peripheral atom X is observed in the X-ray structure (Scheme 2). For 
example, the Lewis base-acid complex resulting from tetrachloroethylene carbonate with 
antimony pentachloride shows elongated Sb–Cl bond.5c Similarly, binding of Lewis base 
selenophosphoramide to Lewis acid iodine forms a complex with a significant lengthening of the 
I–I bond by 25 pm.8 
Scheme 2 
 
1.1.4 Hypervalent Bonding Analysis 
The Lewis base-acid adducts form by n-σ* type interactions exhibit unusual properties 
that cannot be classified with conventional bonding structures. The newly formed bond between 
the donor (D) and the acceptor (A) is structurally identified as three-center four-electron (3c-4e) 
bondings, which are are highly electron-rich hypervalent bonds.
6,9
 The characteristic feature of 
these 3c-4e bonds is that the both terminal atoms D, X are electron-rich, and the center atom A is 
electron-deprived. This can be better explained by analysis of a molecular orbital diagram of the 
hypervalent bond, obtained from combination of the three atomic orbitals D, A, and X (Figure 2). 
Whereas the bonding orbital (Ψ1) equally shares electrons for all three atoms, the non-bonding 
orbital (Ψ2) contains a node at the center atom A with increased electron density at terminal 
atoms. This means that the electron density is polarized toward the terminal atoms D and X. The 
energy gap between the Ψ1 and Ψ2 orbitals increases as the strength of donor increase.  
6 
 
 
Figure 2. MO diagram of 3-center-4-electron hybrid bonding. 
1.2 Lewis Base Catalysis 
These laboratories have been focusing on reaction development employing n-σ* type 
Lewis base activation of a variety of Lewis acids including silicon(IV),
10
 selenium(II),
11
 and 
sulfur(II) reagents.
12
 
Scheme 3 
 
In the Lewis base-catalyzed aldol reactions, Group 14 Lewis acid SiCl4 is activated by 
chelation of bisphosphoramide 1 (Scheme 3). This generates highly activated chiral [SiCl4LB2] 
7 
 
complex,
10a
 which binds to the carbonyl and enhances the electrophilic character towards 
incoming nucleophiles. An extensive scope of nucleophiles have been employed for the 
enantioselective, catalytic aldol reactions, such as silyl enol ethers, isocyanides, silyl ketene 
imines and many more.
10b
  
Scheme 4 
 
More recently, selenofunctionalization reactions were developed by applying n-σ* type 
activation to Group 16 elements (Scheme 4).
11
 Interaction of protonated arylselenyl succinimide 
3 (Lewis acid) with chiral thiophosphoramide 4 (Lewis base) generates highly activated adduct, 
which is the in situ formed key chiral sulfenylating agent. Effectively, the arylselenium group is 
transferred from succinimide to thiophosphoramide 4 to generate the activated chiral selenylating 
species. This aryl selenium group is then subsequently delivered to the alkene 2 to form an 
enantioenriched seleniranium ion intermediate. This seleniranium ion is captured by pendant 
hydroxyl group to yield 3-selenotetrahydropyrans 5. Configurational stability of the seleniranium 
ion was increased by installing an electron withdrawing nitro group on the S-aryl moiety, which 
resulted in enhanced enantiomeric composition of the cyclized product.  
8 
 
The n-σ* activation to Group 16 elements have been expanded to electrophilic sulfurs 
reagents for enantioselective oxysulfenylation of olefins (Scheme 5).
12
 In a similar manner to 
selenofunctionalizations, the catalytically active complex [R3P=Se-SPh]
+
 was generated by 
interaction of selenophosphoramide 7 (Lewis base) with protonated N-phenylthiophthalimide 6 
(Lewis acid). Various unactivated disubstituted olefins successfully afforded 3-sulfenylated 
tetrahydropyrans in high yields and enantioselectivities.  
Scheme 5 
 
1.3 Dissertation Objectives 
In past years, the concept of Lewis base activation of acids has been successfully applied 
to the aforementioned reactions with good to excellent selectivities. While 
sulfenofunctionalization reactions have some more opportunity for improvement in 
enantioselectivity, it has not yet been explored with nitrogen-based nucleophiles for access of 
azaheterocycles. The objectives for this study is (1) to design Lewis base catalyzed, 
enantioselective sulfenoamination reactions with various nitrogen-based nucleophiles, (2) to 
engineer the Lewis base catalyst for selectivity enhancement, and (3) to explore mechanistic 
details of the sulfenofunctionalization reactions.  
9 
 
CHAPTER 2: Lewis Base Catalyzed, Enantioselective, 
Intramolecular Sulfenoamination of Olefins
13
 
2.1 Introduction  
2.1.1 Piperidines 
Piperidines are one of the most common subunits found in biologically important natural 
products and pharmaceutical compounds.
14,15
 For example, both (S)-coniine (9),
15a
 a poisonous 
alkaloid that disrupts human nerve systems found in hemlock, and (S)-anabasine (10),
15b
 an 
insecticide found in tree tobacco plant, are simple natural products which contain a piperidine 
moiety (Scheme 6a). Miglitol (11),
15c
 an FDA approved drug for type II diabetes, and nocaine 
(12),
15d
 a stimulant drug developed to as a treatment for cocaine addiction, are non-natural 
compounds that have piperidine subunits (Scheme 6b). Interestingly, while investigating nocaine 
analogues 13, the enantiomers of one set of analogues were shown to possess entirely different 
inhibitory potencies against targets (Scheme 6c).
15d
 While the (+)-trans analogue was shown to 
selectively inhibit against the dopamine/norepinephrine transporter, the (–)-trans analogue 
inhibited serotonin transporter. These interesting regulation abilities has implications on the 
treatment of psychological conditions such as depression, or Parkinson‟s disease.16 
Scheme 6 
 
10 
 
Due to the prevalence of stereodefined piperidine moieties in biologically and 
pharmaceutically active compounds, numerous strategies have been developed to generate 
piperidines chemo-, regio-, and stereoselectively for various types of substitutions.
14 
For instance, 
enantioselective lithiation-cyclization of Boc-protected chlorobutylcinnamylamine 14 gave 
enantioenriched piperidines 16 by employing (–)-sparteine 15 as a chiral ligand (Scheme 7a).17 
In another example, an asymmetric Diels-Alder reaction of imines 20 with dienes 19 was 
developed to generate enantioenriched piperidinones 22, which are common precursors to 
functionalized piperidines (Scheme 7b).
18  
The development of general, efficient methods to 
produce enantiomerically enriched piperidine compounds would be significantly important to the 
pharmaceutical industry. In this Chapter, the development of a catalytic enantioselective 
sulfenoamination reaction as an effective route to synthesize 2,3-functionalized piperidines is 
described. 
Scheme 7 
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2.1.2 Sulfenoamination of Olefins 
Sulfenofunctionalization of alkenes with electrophilic sulfur reagents has been known 
since 1960s in the context of thiiranium ion chemistry.
19
 Among them, sulfenoamination reaction, 
which involves incorporation of nitrogen and sulfur atoms into olefins in a stereodefined manner, 
provides access to the stereoselective synthesis of sulfenofunctionalized N-containing 
compounds.
20
 In 1982, Trost and coworkers reported the first sulfenoamination of olefins with 
dimethyl(methylthio)sulfonium fluoroborate (DMTSF, 24) and either ammonia, amine, azide, or 
nitrite as a nucleophile (Scheme 8).
21
 Although the mechanism was not elucidated, the reactions 
were thought to proceed via olefin adducts of DMTSF because anti-Markovnikov products were 
obtained.
22
 
Scheme 8 
 
In 1984, Spagnolo and coworkers illustrated the anti addition of sulfenanilides PhSNHAr 
to olefins in presence of BF3∙etherate (Scheme 9).
23
 For these reactions, exclusive formation of 
the anti adduct suggested a thiiranium ion as a probable intermediate. In the same year, 
Brownbridge reported a sulfenoamidination reaction as an interesting extension of this method.
24
 
The author proposed that the reaction proceeds via the formation of a thiiranium ion due to the 
exclusive formation of trans products. The thiiranium ion is captured by the nitrogen atom of the 
12 
 
nitrile nucleophile and the corresponding nitrilium ion is subsequently captured with liberated 
amine generating the sulfenoamidine product. 
Scheme 9 
 
An intramolecular electrophilic sulfenoamination of β-alkenylamines by a 5-endo-trig 
closure constructing the pyrrolizidine ring was described by Kametani and coworkers (Scheme 
10).
25
 This sulfenoamination process was applied in a synthesis of pyrrolizidine-based natural 
products retronecine (32) and turneforcidine (33). The authors considered two possibilities (5-
endo-trig and 4-exo-trig) for the ring closure (vide infra). Treatment of the terminal olefin 34 
with benzenethiochloride (PhSCl) and an aniline nucleophile afforded two chlorosulfenylated 
intermediates 35, and subsequent treatment of the mixture with K2CO3 and NaI afforded the 
pyrrolidine ring 36 as a single product. The reaction was proposed to proceed via a thiiranium 
ion based on the observation that both chlorosulfenylated intermediates lead to a single product.  
Scheme 10 
 
13 
 
Another interesting example of intramolecular sulfenoamination is an application in the 
synthesis of β-lactam antibiotics (Scheme 11).26 The reaction proceeds analogously to the above 
example, giving a mixture of two isomers 39 prior to intramolecular cyclization. Interestingly, 
the observed product 40 arose from a 5-exo cyclization instead of a 6-endo, indicating the 
formation of 5-membered rings is favored over 4- and 6-membed rings for terminal olefins. 
Scheme 11 
 
 Catalytic, asymmetric variants of sulfenoamination have been developed by 
Cordova and coworkers (Scheme 12).
27
 The reaction affords Michael-type adducts by employing 
a stoichiometric amount of the electrophilic sulfenylating reagent 42 with a catalytic amount of 
chiral prolinol-based organocatalyst 43. α,β-Unsaturated aldehydes 41 reacts with prolinols 43 to 
generate iminium ion intermediate which is followed by vinylogous addition of succinimide at 
the β-position. Resulting enamine attacks electrophilic sulfur source 42 and releases succinimide 
to re-enter the catalytic cycle. The substitute pattern on the olefin is fairly broad with various aryl 
and alkyl substitutents proceeding with excellent enantioselectivity. However, reaction scope is 
limited to enals because of the enantiotopic facial discrimination of the olefin is believed to be 
achieved by formation of the iminium intermediate.  
Scheme 12 
 
14 
 
Given the amount of research performed in this field, the asymmetric sulfenoamination of 
unactivated olefins still remains underdeveloped. To date, only two examples of enantioselective 
sulfenylation reactions of unactivated olefins have been reported (Scheme 13).
28 ,29  
In 1994, 
Pasquato and coworkers disclosed an enantioselective sulfenoamination of trans-3-hexene 45 by 
employing a binaphthyl-derived sulfenylating agent 46 as a stoichiometric reagent.
28
 
Subsequently, intermolecular capture of the thiiranium ions by acetonitrile in presence of water 
in a Ritter-type fashion afforded highly enantioenriched thioacetamides 47. Generation of the 
thiiranium ions at lower temperatures (–78 oC) led to formation of the products with higher 
enantiomeric purities, which is consistent with temperature dependence on the configurational 
stability. Rayner reported the intramolecular capture of thiiranium ions generated from a chiral 
methylthiosulfonium salt 49 to afford benzoxazines 50.
29
 While the reaction proceeded cleanly 
with high yield, it only gave marginal stereoselection at –20 oC. 
Scheme 13 
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Foregoing studies from these laboratories have described the first examples of the 
catalytic, enantioselective sulfenofunctionalization of unactivated olefins with oxygen-,
12
 and 
carbon-based
30
 nucleophiles (scheme 14). These reactions employ chiral Lewis base catalysts 
and proceed with high selectivities and to provide access to tetrahydropyrans, and tetralins, 
respectively. While terminal alkenes and trans-disubstituted alkenes showed high reactivities and 
enantioselectivities, trisubstituted alkenes and electron deficient alkenes and were found to react 
sluggishly. Unlike the work of Pasquato, which required stoichiometric amount of the 
sulfenylating agent, this reaction system was capable of generating a reactive chiral sulfenylating 
species in situ using a catalytic amount of BINAM-based chiral Lewis bases (7 and 53). 
Successful nucleophilic capture of the thiiranium ions with a pendant alcohol or aryl carbon 
afforded sulfenofunctionalized products with high enantioselectivities. 
Scheme 14 
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2.1.3 The Intermediacy of Thiiranium Ions 
Thiiranium ions (also called episulfonium ions) are analogous to epoxides and 
aziridinium ions in their ability to undergo ring opening with a variety of nucleophiles to install 
stereogenic centers (Scheme 15).
31
 Thiiranium ions are typically generated from reaction of 
alkenes with electrophilic sulfur reagents, such as sulfenyl halides, thiosulfonium salts, and 
disulfides.
19,32
 Despite the high reactivity of thiiranium ions, they are configurationally stable at 
low temperature and undergo stereospecific SN2 ring opening by nucleophiles, thus leading to 
anti-sulfenofunctionalized products.
33
 
Scheme 15 
 
The electrophilic addition reaction of an olefin to a sulfur-based electrophile reagent is 
believed to proceed through formation of a thiiranium intermediate.
34
 Subsequent nucleophilic 
attack at one of the carbon atoms of this intermediate leads to the desired 
sulfenofunctionalization. For this system to function both catalytically and enantioselectively, 
three criteria must be met: (1) the two enantiotopic faces of the olefin generate an 
enantioenriched chiral thiiranium ion, (2) the thiiranium ion must be configurationally stable, and 
(3) the capture of the thiiranium ion must occur selectively at the carbon atom. 
For the first criterion, the formation of the activated chiral sulfenylating complex is 
critical (Figure 3).
33
 Because the thiiranium ions are generated by electrophilic addition of the 
alkenes to the sulfur electrophile, the sulfenylating complex must exist in a chiral environment. 
17 
 
The resulting chiral sulfenylating complex can potentially interact favorably with one of the two 
enantiotopic faces of the alkene. 
 
Figure 3. Formation of the activated chiral sulfenylating complex. 
Secondly, racemization of the thiiranium ion intermediate needs to be avoided because 
racemization after the enantioselective formation of the thiiranium ion would lead to a loss of 
configuration homogeneity. The thiiranium ion can racemize via two pathways (Figure 4): (1) 
nucleophilic attack at the sulfur atom,
35
 or (2) olefin-to-olefin transfer.
36
 
 
Figure 4. Potential racemization pathways of thiiranium ions. 
Nucleophilic attack at the sulfur atom will produce an achiral sulfenylating reagent, 
which would lead to racemization of thiiranium ions upon delivery to olefins. Alternatively, 
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olefinic substrates present under catalytic condition could potentially lead to racemization via 
direct “olefin-to-olefin” transfer of the thiiranium moiety. Studies have shown that while the 
seleniranium ions are configurationally instable at –20 oC, S-phenyl thiiranium ions are stable 
and therefore preserve the configurational identity by the catalyst (Scheme 16).
33,36
  
Scheme 16 
 
Lastly, the nucleophile must open up the thiiranium ion by attacking the carbon atom 
(Figure 5). Attack at the sulfur atom not only promotes racemization as mentioned above, but 
also represents an unproductive pathway. To produce the desired sulfenofunctionalization 
product, nucleophilic attack at the carbon atom of the thiiranium ion is essential. Indeed, it was 
demonstrated experimentally that nucleophilic attack occurs preferentially at the carbon atom 
compared to the sulfur atom on the thiiranium moiety with stronger nucleophiles.
35
  
 
Figure 5. Two possible ways of capturing the thiiranium ion. 
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2.1.4 Project Design 
Investigation of mechanistic details on the intermediate thiiranium ions proved their 
configurational stability at low temperatures.
33,36
 Moreover, successful sulfenofunctionalization 
of alkenes with oxygen-
12
 and carbon-based nucleophiles
30
 encouraged to expand the scope of 
functionalization with nitrogen-based nucleophiles. The overall goal of this research project is to 
develop a catalytic method for the asymmetric sulfenoamination of olefins using an achiral 
sulfenylating reagent in presence of a chiral Lewis base catalyst (Scheme 17). 
Scheme 17 
 
Several key insights from the previous study on the oxysulfenylation
12
 were important in 
the initial design of this reaction system (see Scheme 15 in Section 2.1.2). The weak achiral 
sulfur electrophile was activated with a chiral Lewis base to generate the reactive chiral 
sulfenylating species in situ. This kinetically activated sulfenylating complex was able to 
distinguish the two enantiotopic faces of the olefin to stereoselectively form a chiral thiiranium 
ion, which was found to be configurationally stable at low temperature
 33,36
 Nucleophilic capture 
of this thiiranium ion at a carbon atom with a pendant alcoholic nucleophile afforded 
enantioenriched sulfenofunctionalized products. 
In addition to the oxysulfenylation reaction, very recent work in these laboratories has led 
to a catalytic enantioselective carbosulfenylation reaction employing an electron rich aromatic 
moiety as the nucleophile (see Scheme 14 in Section 2.1.2).
30
 In terms of catalyst design, it is 
interesting to note that diisobutylamine substituted-BINAM catalyst (S)-53 was found to give 
better enantioselectivity than the catalyst (S)-7 which used in oxysulfenylation reactions. This 
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finding implied that steric bulk around the amino group of the catalyst may play an important 
role in the selective formation of cyclized products. On the basis of these previous findings, 
efforts have been made to develop a catalytic enantioselective aminosulfenylation of olefins via 
cyclization with a pendant amine.  
 
2.2 Results 
2.2.1 Selecting a Suitable Nucleophile for Sulfenoamination 
In the initial stage of the project, it was important to select an appropriate nitrogen-based 
nucleophile with good reactivity. In the previous sulfenofunctionalization studies, a Brønsted 
acid co-activator was required for these types of reactions.
12,30
 As a result, the present reaction 
required a nucleophile that remained active in acidic media. That is, the nitrogen must be 
sufficiently nucleophilic to form the C-N bond, but also sufficiently non-basic to avoid 
protonation. Therefore, several protected amines were selected as candidates for nucleophiles: 
sulfonamides, benzamides, carbamates, and phosphinic amides (Chart 1).
37
  
Chart 1 
 
2.2.1.1 Synthesis of Protected Amines Substrates 
The model substrates 56-62 were designed to have a pendant amine so that it can undergo 
intramolecular cyclization, which can have an entropic advantage for reactivity and site-
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selectivity on thiiranium ion capture. The model candidate substrates were prepared from the 
precursor amine 67, which was prepared by modification of the methods developed for the 
formation for the corresponding alcohol by Breit and coworkers (Scheme 18).
38
 
Scheme 18 
 
Addition of vinylmagnesium bromide to benzaldehyde 63 afforded a secondary allylic 
alcohol 64, which was then combined with excess triethylorthoacetate in the presence of a 
catalytic amount of acid to afford the corresponding ester 65 via the Johnson-Claisen 
rearrangement.
38,39
 The ester was transformed into the precursor amine 67 in two steps, by 
treatment with trimethylaluminum and ammonium chloride to afford amide 66,
40
 followed by 
reduction with lithium aluminum hydride.
41
 Amine 67 was then converted to the targeted 
substrates 56-62 with respective protecting groups following literature procedures.
42
 All of seven 
amine-protected substrates were prepared in good yields.  
2.2.1.2 Reactivity Investigation of Protected Amines 
To examine the reactivities of the various protected amine substrates, the initial reaction 
condition was adopted from the preceding sulfenofunctionalization reactions. Although many 
Lewis basic catalysts exist, tetrahydrothiophene (THT, 68), which has been used in previous 
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studies, was chosen for its robust Lewis base reactivity.
12,30,33
 THT (68) is a suitable catalyst that 
is active under the acidic reaction conditions, exhibiting both strong Lewis basicity and weak 
Brønsted basicity.
43
 For the electrophile, N-(phenylthio)phthalimide (PhthSPh, 6) was employed 
for its stability and commercial availability.
44
 
To evaluate the reactivity of the nucleophiles, each of the substrates was initially 
subjected to the reaction conditions developed for the oxysulfenylation reaction both with and 
without THT (68) (Table 2).
12
 Preliminary evaluation of the protected amine substrates 56-62 
with sulfenylating agent 6 (1 equiv) in presence of an achiral Lewis base catalyst 68 (0.1 equiv) 
and a Brønsted acid (MsOH, 1.0 equiv) at room temperature showed that sulfonamide substrates 
56-58 rapidly formed piperidines in good yields (entries 1, 3, and 5). The structure of the product 
determined to be piperidines (See Section 2.2.2.2 for details). 
Table 2. Survey of the Nucleophiles. 
 
entry substrate (R) THT (equiv) time
a
 yield, %
d
 
1 56 (Ts) 0.1 5 min
b
 93 
2 56 (Ts) 0 48 h
c
 4 
3 57 (Ns) 0.1 5 min
b
 95 
4 57 (Ns) 0 48 h
c
 11 
5 58 (Tris) 0.1 5 min
b
 84 
6 58 (Tris) 0 48 h
c
 2 
7 59 (Bz) 0.1 48 h
b
 86 
8 60 (Cbz) 0.1 48 h
b
 81 
9 61 (Boc) 0.1 -
e
 -
e
 
10 62 (DPP) 0.1 -
e
 -
e
 
a Conversion monitored by TLC. b The time full conversion observed. c The time 
reaction was quenched. d Isolated yields. e Decomposed under the reaction condition. 
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For sulfonamide substrates 56-58, the high rate of reaction was visibly apparent with 
immediate precipitation of phthalimide observed upon addition of MsOH. Although both 
tosylamide 56 and nosylamide 57 displayed excellent reactivity in the presence of THT (68), 
tosylamide 56 possessed a slower lower background rate when the Lewis base was omitted 
(entries 2 and 4). In contrast to the sulfonamides, cyclization of benzamide 59 (entry 7) and 
benzyl carbamate 60 (entry 8) were found to be slow under the reaction conditions such that 48 h 
was required to reach high conversions. Unsurprisingly, the t-butylcarbamate substrate 61 (entry 
9) and the diphenylphosphinic amide 62 (entry 10) decomposed under the strongly acidic 
conditions. Only trace conversion was observed in the absence of the Lewis base at room 
temperature, indicating that cyclization via simple acid-catalysis was negligible. On the basis of 
these results, 4-toluenesulfonylamides were chosen as the nucleophiles for exploration of 
substrate scope.  
2.2.2 Isomerization of Sulfenoamination Product Under Acidic Conditions 
2.2.2.1 Control Experiments 
Interestingly, whereas the sulfonamide substrates gave full conversion to a single product 
within a short period of time, a side-product was observed when the reaction was allowed to run 
for an extended period of time (Scheme 19). This conversion of “initially” formed product 69 to 
“converted” constitutional isomer 70, demanded attention because this indicated that the product 
could be unstable under the reaction conditions. Specifically, treatment of tosylamide 56 with 
THT and MsOH (1.0 equiv) afforded piperidine 69 quantitatively within 5 min at room 
temperature. However, piperidine 69 isomerized into a 1:2.8 mixture of 69 and pyrrolidine 70 by 
allowing the mixture to stir for 12 h. 
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Scheme 19 
 
To further understand the proposed isomerization, initial product 69 and converted 
product 70 were isolated and individually treated with 1.0 equiv of MsOH in CDCl3 (Scheme 20). 
Independent treatment of either 69 or 70 resulted in the establishment of an equilibrium reaching 
a thermodynamic mixture of 1:2.8 (initial:converted) was observed by 
1
H NMR at room 
temperature over 12 h. The isomerization of 69 to 70 is driven by alleviation of the steric 
interactions between the N-tosyl group and the 2-phenyl group in piperidine 69.
45
  
Scheme 20 
 
2.2.2.2 Structural Determination of the Cyclized Product 
Compounds 69 and 70 were speculated to be the 6- and 5- membered cyclized products, 
respectively, with neither being reported in the chemical literature. Chemical shift comparisons 
between tosyl and nosyl products, 69 and 71, provided some information regarding product 
identity (Figure 6). Because nosyl is a stronger electron withdrawing group than tosyl, the 
protons that are α-to the nitrogen atom should be more deshielded than the protons at the β-
positions. In the case of 6-membered rings 69 and 71 the H
1
 proton should be more deshielded 
than H
2
, and in case of 5-membered rings 70 and 72, the H
2
 proton should be affected more than 
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H
1
. Unfortunately, this logic was not applicable to the spectral data comparison for determination 
of the structure, because one set of chemical shifts shifted 0.02 ppm upfield while the other set 
shifted 0.02 ppm downfield.  
         
Figure 6. Comparison of 
1
H NMR spectra for between “initial” products 69 / 71 (or 70 / 72). 
The next attempt to determine the structure of these products was to remove the 
phenylthio group from the cyclized compounds by treatment with nickel boride
46
 to generate 
known compound 73 (Scheme 21).
47
 Desulfurization of C-S bond from the initially observed 
compound 69 afforded a desulfurized product, which after comparison with the literature (
1
H and 
13
C NMR spectroscopic data) was found to be N-tosylpiperidine 73.
47
 To rule out the possibility 
of isomerization during the sulfide reduction, a 1:2.8 mixture (initially cyclized 69 : isomerized 
70) of the products was subjected to the nickel boride reaction. This experiment afforded a 
mixture with a conserved ratio of the 2-substituted piperidine 73 and 2-substituted pyrrolidine 74, 
where 74 is also a known compound reported in literature.
47, 48
 These experiments 
unambiguously determined the initially formed product to be the 2,3-substituted N-
tosylpiperidine 69, and isomerized product to be 2-substituted N-tosylpyrrolidine 70. 
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Scheme 21 
 
2.2.3 Optimization of Reaction Conditions 
Previous research in these laboratories explored a broad range of known achiral Lewis 
base catalysts oxysulfenylation reactions.
12
 In these studies, THT 68, dimethylpropylene urea 
(DMPU), triphenylphosphine (Ph3P), tricyclohexylphosphine (Cy3P), hexamethylphosphoramide 
(HMPA), hexamethylthiophosphoramide (HMPA=S), and hexamethylselenophosphoramide 
(HMPA=Se) were examined with Brønsted acids (methanesulfonic acid (MsOH), trifluoroacidic 
acid (TFA)). 
Chart 2 
 
Among the Lewis base catalysts surveyed, THT 68, phosphines Ph3P, Cy3P and 
HMPA=Se were shown to give the best conversion. However, in the oxysulfenylation of alcohol 
2, chiral analogues of THT, e.g. sulfide 75 and phosphine 76 gave poor enantiomeric ratios of 
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product 8 (Chart 2). On the other hand, improved enantioselectivity was observed with the 
BINAM-based chiral selenophosphoramide derivatives 77, 78, and 7. 
On the basis of these studies, to initially probe the impact of catalyst structure on reaction 
rate, the cyclization of tosylamide 56 to N-tosylpiperidine was monitored by 
1
H NMR 
spectroscopy (Chart 3). For these studies, catalyst (R)-7 and (S)-53, which were shown to be 
successful in the previous oxysulfenylation
12
 and carbosulfenylation
30
 reactions, were selected. 
1
H NMR spectroscopy showed that with catalyst (R)-7, the reaction reached full conversion after 
43 hours at –20 oC, while with catalyst (S)-53, the reaction reached >95% conversion after 72 
hours at –20 oC. On the basis of these results, the reactions for the catalyst screen (vide infra) 
were allowed to run for 72 hours at –20 oC. 
Chart 3 
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2.2.3.1 Investigation of Chiral Lewis Bases 
After confirming the reactivity of selenophosphoramide catalyst (R)-7 and (S)-53 in 
sulfenoamination reaction at –20 oC, a number of BINAM-based selenophosphoramides 79-8330 
with different amine substituents were investigated (Chart 4). Initial evaluations were performed 
with substrate 56 (63 μmol), PhthSPh 6 (1.0 equiv), catalysts 79-83 (0.1 equiv), and MsOH (1.0 
equiv) in CH2Cl2 for 72 h at –20 
o
C. After aqueous work up, cyclized product 69 was isolated to 
compare yields and enantiomeric ratios. 
Chart 4 
 
The azapane substituted catalyst (R)-7 was examined first because it gave the best result 
in the analogous oxylsulfenylation reaction.
12
 For the reaction at –20 oC, catalyst (R)-7 generated 
the product with 89:11 e.r. (Table 3, entry 1). Interestingly, diisobutylamine substituted catalyst 
(S)-53, which was the most effective catalyst in the carbosulfenylation reaction,
30
 showed slower 
conversion than (R)-7, but with no improvement in enantioselectivity 89:11 e.r. (entry 2). As 
expected, the Lewis base catalyst derived from the opposite enantiomers of BINAM gave the 
opposite sense of enantioselectivity. Di-n-butylamine-substituted catalyst (S)-79 and n-
29 
 
butylethylamine substituted catalyst (S)-80 gave lower yield and selectivity than (R)-7 (entries 3, 
and 4). Azocane substituted catalyst (S)-81 and diisopentylamine substituted catalyst (S)-82 
afforded the product in slightly lower yield but improved the enantioselectivity to 91:9 and 93:7 
e.r., respectively (entries 5, and 6). The best enantioselectivity, 95:5 e.r., was achieved with 
diisopropylamine substituted catalyst (S)-83 (entry 7). 
Table 3. Survey of Chiral Lewis Bases. 
 
entry catalyst, R2 yield, %
a
 e.r.
b
 
1 (R)-7, (CH2)6 90 11.5 : 88.5 
2 (S)-53, (i-Bu)2 88 89.4 : 10.6 
3 (S)-79, (n-Bu)2 29 85.8 : 14.2 
4 (S)-80, n-Bu, Et 79 88.1 : 11.9 
5 (S)-81, (CH2)7 67 91.4 : 8.6 
6 (S)-82, (i-amyl)2 82 92.8 : 7.2 
7 (S)-83, (i-Pr)2 75 94.6 : 5.4 
a Isolated yields. b The enantiomeric ratio was determined by CSP-SFC 
analysis. 
2.2.3.2 Synthesis of Chiral Lewis Base (S)-83 
Chiral Lewis base (S)-83 was initially prepared from the precursor N,N’-dimethyl-
BINAM 84
49
 by applying an established procedure for synthesis of other selenophosphoramide 
catalysts 79-83.
50 
The typical procedure for synthesis of Lewis base catalysts 7, 53, and 79-83 
was to treat precursor 84 with PCl3, and Et3N in CH2Cl2 which affords the phosphorus(III) 
intermediate 85. This intermediate 85 was then subsequently treated with corresponding 
secondary amines, followed by oxidation with selenium to afford selenophosphoramides 7, 53, 
and 79-83 (Scheme 22).
12,50
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Scheme 22 
 
Unfortunately, applying the established protocol for Lewis base catalysts to did not 
furnish 83, the most selective catalyst, in synthetically useful yields (21% yield) (Scheme 23). 
Moreover, many side-products made purification challenging. As a result, development of an 
improved route to (S)-83 was required. The main difference between catalysts 7-82 and catalyst 
83 is that selenophosphoramide catalysts 7-82 contain an amine with two primary alkyl 
substituents, whereas the diisopropylamine substituted catalyst 83 has an amine with two 
secondary alkyl groups.
51
 Therefore, the steric congestion originating from diisopropylamine is 
impeding the nucleophilic addition to phosphorus (III) intermediate 85 in the final step. 
Scheme 23 
 
To overcome this problem, the P-N bond between the phosphorus and diisopropylamine 
was formed before the reacting with BINAM 84. Following the procedure reported by Nurminen, 
N,N-diisopropylphosphoramidodichloridite reagent 86 was prepared  (Scheme 24).
52
 
Scheme 24 
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The reaction intermediates were monitored by 
31
P NMR spectroscopy for optimization 
(Scheme 25). The 
31
P NMR chemical shifts for dichlorophosphoramidite 86, and intermediate 
(S)-87 show up at 170 ppm and 137 ppm, respectively. In the initial attempt, the reaction 
employing triethylamine reached only 50% conversion after refluxing for 43 h. With extended 
reaction time for high conversion, a decomposition of the intermediate 87 into other unidentified 
phosphorus species was observed. After the treatment with elemental selenium powder, the 
target product 83 was obtained with its characteristic broad 
31
P NMR singlet around 80 ppm.
51
 
Scheme 25 
 
In contrast, when n-BuLi was employed as a base for deprotonation, a fast conversion to 
the intermediate (S)-87 was observed reaching 65% within 10 min at –78 oC (Scheme 26). By 
elevating the temperature after addition of phosphoramidite 86 to room temperature, full 
conversion to the intermediate (S)-87 was achieved within 30 min. Oxidization of the resulting 
intermediate (S)-87 with selenium gave clean conversion to the target selenophosphoramide (S)-
83 with within 30 min. Repeating the reaction in larger scale afforded desired Lewis base 
catalyst (S)-83 in 79% yield after chromatography and recrystallization. 
Scheme 26 
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Scheme 26 (cont.) 
 
2.2.3.3 Optimization of Temperature 
With the parent substrate and optimum catalyst (S)-83 in hand, the impact of temperature 
on reactivity and selectivity was investigated. Experiments at a five different temperatures 
ranging from –20 oC to 20 oC were performed (Table 4). Experiments were set up with substrate 
56 (63 μmol), PhthSPh 6 (1.0 equiv), catalyst (S)-83 (0.1 equiv), MsOH (1.0 equiv) in CDCl3 at 
five temperatures (–20, –10, 0, 5, and 20 oC) and was monitored by 1H NMR to check 
completion. The reactions were quenched upon completion, however, 72 h was set as maximum 
time frame to be a practical method. After aqueous work up, cyclized product 69 was isolated to 
compare yields and enantiomeric ratios. 
Table 4. Investigation of Effects on Temperature. 
 
entry temp (
o
C) time (h) yield, %
b
 e.r.
c
 
1 20 72
a
 73 94.6 : 5.4 
2 10 72
a
 85 93.9 : 6.1 
3 0 48 95 93.6 : 6.4 
4 5 48 95 93.0 : 7.0 
5 20 6 96 91.5 : 8.5 
a The reaction was incomplete. b Isolated yield. c The enantiomeric ratio was 
determined by CSP-SFC analysis. 
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Increasing the temperature from –20 oC to 0 oC (entries 1, 2, and 3), gave increased 
reaction rate with full conversion at 0 
o
C after 48 h. Importantly, enantioselectivity was 
maintained. In fact, reactions performed at room temperature proceeded to completion with only 
a small decrease in enantioselectivity (entry 5). Taking into account reaction time and 
enantioselectivity, 48 h at 0 
o
C was considered to be optimal. 
2.2.3.4 Examination of Acid Concentration 
Another important component of this reaction system is the Brønsted acid. 
Methanesulfonic acid (MsOH), which is a strong Brønsted acid (pKa = 1.6 in DMSO),
43c
 has 
showen superior reactivity over trifluoroacetic acid (TFA) in oxysulfenylation reactions.
12
 Given 
the similarity between the two reaction systems, MsOH was initially examined, and gave 
satisfying results. However, since MsOH-induced product isomerization, additional optimization 
was required to find the optimal acid loading for the sulfenoamination reaction (Table 5). 
Table 5. Survey of Acid Loadings. 
 
entry MsOH (equiv) conv, %
a,b
 endo:exo
b
 e.r.
c
 
1 1.00 100 85.7:14.3 91.6 : 8.4 
2 0.75 100 98.9:1.1 92.9 : 7.1 
3 0.50 100 99.2:0.8 93.5 : 6.5 
4 0.25 98 99.4:0.6 93.6 : 6.4 
5 0.10 69 99.5:0.5 93.9 : 6.1 
a The conversion was monitored by 1H NMR spectroscopy (6 h, 12 h, and 24 h). b 
Determined by 1H NMR spectroscopy of the crude mixture. c The enantiomeric ratio 
was determined by CSP-SFC analysis. 
With 1.0 equiv of MsOH at 0 
o
C, isomerization of 69 to 70 was observed. Interestingly, 
using less than 1.0 equiv of MsOH greatly reduced the amount of product isomerization. 
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Whereas reactions with loadings of 0.5 and 0.75 equivs of MsOH afforded comparable results 
(entries 2 and 3), 0.5 equivs led to slightly higher enantioselectivity. The reaction with 0.25 
equiv of MsOH displayed slightly slower reaction rate, reaching full conversion at 24 h (entry 4). 
Although the reaction with 0.10 equivalents gave high e.r., the reaction rate was unacceptably 
slow (entry 5). 
2.2.3.5 Determination of Absolute Configuration of 69 
The absolute configuration of the product 69 was determined via desulfurization,
46
 using 
the method outlined in Section 2.2.2.2. Desulfurization from the enantioenriched cyclized 
product 69 gave 2-phenyl-N-tosylpiperidine 73 with optical rotation [α]D = +54.8 (CHCl3, c 0.65) 
(Scheme 27). Comparison of this data to known optical rotation data reported in the literature for 
(R)-2-phenyl-N-tosylpiperidine ([α]D = +70.3 (CHCl3, c 1.01, >99% e.e.))
47
 gave 89:11 e.r. 
which is in agreement with the e.r. of the initial cyclized product 69. 
Scheme 27 
 
2.2.4 Synthesis of Substrates 
Having the optimum reaction conditions established, in terms of yield, rate, and 
enantioselectivity, the scope of olefins was investigated. The majority of the trans olefin 
substrates were synthesized from the corresponding esters and alcohols, which were prepared via 
a Johnson-Claisen rearrangement
38,39
 of the allylic alcohols (Scheme 28).  The most important 
reason for selecting this route was because [3,3] rearrangement afforded exclusively trans olefins 
(see Chapter 5: Experimental Section for detailed reaction conditions). Substrates 56, and 88-91 
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was synthesized by mesylation of the corresponding alcohols, followed by nucleophilic addition 
of tosylamide.
42c
 Substrates 92-94 were prepared in a similar route, converting the corresponding 
alcohol to the tosylamide through two step sequence. 
Scheme 28 
 
 
 
Various nitriles were synthesized to access α,α-dimethyl substrate 95 and longer-tethered 
substrates 96-97 (Scheme 29). Mesylates were treated with sodium cyanides to afford the nitrile 
intermediates. Addition of methyl organocerium reagent to 4-phenyl-3-butenyl nitrile gave α,α-
dimethylamine in quantitative yield.
53
 Protection of the free amine with tosyl chloride afforded 
α,α-dimethyl substrate 95 in 84% yield. Substrates having extended tethers were prepared by a 
four-step sequence from the one-carbon shorter alcohols. The alcohols were mesylated, then 
treated with cyanides, and the resulting nitriles were reduced to primary amines by LiAlH4 
reduction, which were followed by subsequent tosyl protection of the amine groups. 
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Scheme 29 
 
β,β-Dimethyl substrate 99 was synthesized by following a reported procedure (Scheme 
30).
42b
 Addition of isopropyl nitrile to cinnamyl bromide generated β,β-disubstituted nitrile, and 
subsequent LiAlH4 reduction and tosyl protection afforded 99.
 
Lastly, carboxamide 100 was 
prepared in one-step from 5-phenyl-4-pentenoic acid by treating with tosyl isocyanate.
54
 
Scheme 30 
 
2.2.5 Survey of Substrate Scope 
Above 14 substrates were evaluated in terms of reactivity and stereoselectivity. Reactions 
were monitored by TLC every 12 h, and quenched with saturated NaHCO3 aqueous solution at 0 
o
C when full conversion was observed. The endo:exo ratio was determined by 
1
H NMR 
spectroscopy of crude product after aqueous work up, prior to purification. 
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2.2.5.1 Influence of Electron Density of the Alkene 
Olefins with varying electron density were tested to examine the influence of the 
electronic properties of the alkene on reaction rate and stereoselectivity. Substrate 88 with a 4-
anisyl-substituted double bond possessing greater electron density than 56, showed comparable 
reactivity with a slight drop in enantioselectivity (Table 6, entry 1). In contrast, substrate 89, 
bearing a strongly electron withdrawing 4-trifluoro-methylphenyl substituent, afforded only a 39% 
yield after 48 h (54% conv., entry 3). Interestingly, the observed e.r. (91.9:8.1) for 102 was 
comparable to that for 101. It is important to note that substrates 56, 88, and 89 (entries 1, 2, and 
3) afforded piperidines, as established by 
1
H NMR spectroscopy.  
Table 6. Investigation of the Effects of Olefin Electron Density. 
  
entry substrate product time yield, %a endo:exob e.r.c 
1 
 
 
24 h 93 >99 : 1 93.6 : 6.4 
2 
 
24 h 91 46 : 1 91.8 : 8.2 
3 
 
48 h 39d 27 : 1 91.9 : 8.1 
a Isolated yields of analytically pure material. b Constitutional selectivity determined by 1H NMR 
spectroscopy of the crude mixture.  c The enantiomeric ratio of the major constitutional isomer was 
determined by CSP-SFC analysis, and the absolute configurations of the products were assigned by 
analogy to 69. d Incomplete conversion on quenching at 48 h. 
2.2.5.2 Influence of Steric Factors 
Substrate 90 bearing a non-conjugated, dialkylsubstituted olefin afforded a mixture of 
endo and exo products in 1:3 ratio in 91% yield with excellent e.r.s (Table 7, entry 1). The 
reduced endo to exo ratio is likely due to the less-biased electron density of the alkene. In 
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contrast, isopropyl-substituted olefin 91 showed a highly improved exo selectivity (with high 
yield and e.r. preserved), thus implicating an important role for the steric bulk around the alkene 
environment (entry 2). To examine the proximal effect of steric bulk on the reaction outcome, 
substrate bearing geminal dimethyl groups on the tether were tested. Interestingly, reaction of 
alkene 99, a substate containing a dimethyl moiety at 2-position of the tether, afforded high yield 
with retention of excellent enantioselectivity (entry 3). However, when the dimethyl moiety was 
further moved to 1-position, slightly diminished enantioselectivity was observed (entry 4).  
Table 7. Investigation of the Effects of Steric Parameters. 
 
entry substrate product time yield, %a endo:exob e.r.c 
1 
 
 
24 h 91 1 : 3 
95.9 : 4.1(exo) 
95.8 : 4.2(endo) 
2 
 
48 h 89 1 : 15 96.8 : 3.2 
3 
 
 
24 h 91 80 : 1 96.3 : 3.7 
4 
  
24 h 93 20 : 1 91.8 : 8.2 
a Isolated yields of analytically pure material. b Constitutional selectivity determined by 1H NMR spectroscopy 
of the crude mixture.  c The enantiomeric ratio of the major constitutional isomer was determined by CSP-SFC 
analysis, and the absolute configurations of the products were assigned by analogy to 69. d Incomplete 
conversion on quenching at 48 h. 
2.2.5.3 Influence of Olefin Geometry 
Other olefins with different substitution patterns were also investigated (Scheme 31). 
Contrary to its trans counterpart 56, cis olefin 92 reacted very slowly (75% conv. in 48 h) with 
moderate endo:exo ratio and poor enantioselectivity (62.8:37.2). Remarkably, the reaction of 
terminal olefin 93 gave good yield and high enantioselectivity of 92.5:7.5 with exclusive exo 
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cyclization. This result was very promising considering the fact that distinguishing the two 
enantiotopic faces of terminal olefins is known to be difficult.
55
 
Scheme 31 
 
2.2.5.4 Influence of Internal Carbonyl Group 
To extend the scope of accessible product scaffolds, carboxamide 100 was tested 
(Scheme 32). Cyclization of carboxamide substrate 100 afforded δ-lactam 109 in high yield with 
high constitutional selectivity, but with diminished enantiomeric ratio of 88:12. Presumably, 
protonation of the carbonyl group attenuates the nucleophilicity of the nitrogen and prevents 
rapid capture of the intermediate thiiranium ion, thus allowing racemization. 
Scheme 32 
 
2.2.5.5 Influence of Carbon Tether Length 
Since piperidine scaffold was the predominant product in most cases of 3-carbon tethered 
substrates, the following question arose: What would be the major product for substrates with 
shorter or longer chains? To address this question, substrates with different tether lengths were 
prepared and examined (Table 8). Using the same reaction protocol, two carbon-tethered 
40 
 
substrate 94 cyclized to pyrrolidine 110 in 86% yield and 91.3:8.7 e.r. with complete endo 
selectivity (entry 1). Interestingly, four carbon-tethered substrate 96 showed the impact of 
conjugation on biasing the two olefinic carbons by affording exclusively azepane 110 (entry 2). 
The structure and the absolute configuration of 110 were established by X-ray crystallography.
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In contrast, the non-conjugated substrates 97 and 98 afforded only piperidine products 112 and 
113 via exo cyclization, indicating the preference to form the 6-membered rings for dialkyl-
substituted olefins. Additionally, reactions with both 97 and 98 gave the products in good yields 
and excellent enantioselectivities. 
Table 8. Survey on Length of the Tether. 
  
entry substrate product time yield, %
a
 endo:exo
b
 e.r.
c
 
1 
 
 
36 h 86 >99 : 1 91.3 : 8.7 
2 
 
 
36 h 84 >99 : 1 92.7 : 7.3 
3 
 
 
48 h 87 1 : >99 95.4 : 4.6 
4 
 
48 h 91 1 : >99 97.4 : 2.6 
a Isolated yields of analytically pure material. b Constitutional selectivity determined by 1H NMR spectroscopy 
of the crude mixture.  c The enantiomeric ratio of the major constitutional isomer was determined by CSP-SFC 
analysis, and the absolute configurations of the products were assigned by analogy to 69. d Incomplete 
conversion on quenching at 48 h. 
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2.3 Discussion 
2.3.1 Selection of Nucleophile 
The survey of nucleophiles revealed that sulfonamides performed well as nucleophiles 
for the sulfenoamination reaction. However, benzamide- and benzylcarbamate-protected 
nucleophiles were much less reactive. The basicity of benzenesulfonamine (pKa = 16.1 in DMSO) 
is lower when compared to benzamide (pKa = 23.3 in DMSO) or benzylcarbamate (pKa = 24.2 in 
DMSO).
43c
 In this reaction system, nucleophiles with higher pKa values will be more readily 
protonated resulting in lower reactivity. 
2.3.2 Reaction Condition Optimization 
During the initial planning of this project, the stability of the product 69 in acidic media 
was considered. While the achiral Lewis base (THT) demonstrated excellent catalytic activity 
under acidic conditions, chiral catalyst had slower reaction rates and as a result product 
isomerization was a potential complication. Surprisingly, no isomerization was observed during 
the examination of chiral Lewis base catalysts. These results were perplexing until the purity of 
MsOH was investigated (see Section 2.3.5). Repeating the reaction with the purified MsOH gave 
a mixture of isomerized products. This problem will be discussed in more detail in Section 2.3.5. 
Investigation of the Lewis bases showed that the diisopropylamine substituted catalyst 83 
was the best catalyst for the sulfenoamination reaction of parent olefin 56; 95% isolated yield of 
69 was obtained giving 93:7 e.r. at 0 
o
C after 48 h. Based on the results from catalyst screen, the 
steric bulk around the monodentate amine is considered to be playing a major role in the 
catalyst‟s ability to discriminate between the two enantiotopic faces. This hypothesis will be 
more closely investigated and discussed with other substrates in the following Section 2.3.3. 
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While the impact of temperature on enantioselectivity was small, the range from 94:6 at  
–20 oC to 92:8 at room temperature is significantly smaller than the temperature dependence of 
oxysulfenylation reactions (84:16 at 23 
o
C to 91:9 at –20 oC). This observation indicates a shorter 
life time of thiiranium ion; a species known to be unstable at elevated temperatures.
28,36
 That is, 
after the formation of the thiiranium ion, its capture with a pendant tosylamine nucleophile is 
apparently faster than an alcoholic nucleophile.  
2.3.3 Sufenoamination 
On the basis of these experimental results, trans substituted olefins were determined to be 
competent substrates for this system affording products in good yields with high endo:exo ratio 
and enantioselectivities. The consistently high enantiomeric composition of the product 
throughout most of the substrate scope indicates that the described reactions proceed through a 
common intermediate. Thiiranium ions are the common intermediates for these electrophilic 
sulfenylation reactions, and formations of these ions are typically known as the 
enantiodetermining step (discussed in Section 2.3.4.3).  
However, some exceptions with diminished enantiomeric ratio were observed. The cis 
olefin substrate 92 showed a significant drop in enantioselectivity. This observation is in 
agreement with the oxysulfenylation reactions
12
 and carbosulfenylation reactions.
30
 It suggests 
that the interaction between the trans olefin and activated catalytic complex is quite different 
from the cis olefin. This hypothesis is illustrated in Figure 7. As the olefin approaches the 
electrophilic sulfur atom (Figure 7a) the steric bulk of the binding pocket-like surroundings 
around the sulfur atom leads to specific orientation of the olefin substrate. While the trans 
conformation has only one favored binding orientation possible, the cis conformation has two 
(Figure 7b). In addition, the survey of substrates with different degrees of steric hindrance 
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(Section 2.2.5.2) supports the importance of steric congestion near the olefin, and suggests a 
pivotal role in aiding the catalyst to differentiate the two enantiotopic faces. This hypothesis is 
further supported by the results from the chiral Lewis base survey (Section 2.2.3.1). That is, 
diisopropylamine-substituted BINAM selenophosphoramide (S)-83, which is the most sterically 
encumbered catalyst of the screening pool, showed the best enantioselectivity. 
 
Figure 7. Suggested interaction between the olefin and the catalytically active complex. 
To further rationalize the observed relationship between the steric hindrance and the 
enantiotopic facial selectivity of the olefin, the interaction between nucleophilic π-orbital of 
olefin and the electron deficient σ*-orbital of S-Se can be considered (Figure 7a). To maximize 
the interaction between olefin and the active complex, the orbital overlap between the π-orbital 
of olefin and σ*-orbital of S-Se should be maximized. That is, the olefin must be on the 
trajectory of the σ*-orbital of S-Se.57 Due to the bulky isopropyl substituent and binaphthyl 
backbone, the orientation of the sulfenium is locked in transition state 114 (B3LYP/6-31G*) as 
illustrated in Figure 6a. Considering four quadrants around the σ*-orbital trajectory of S-Se, N-
methyl group occupies one quadrant (Figure 7b). 
Previous researches on the impact of catalyst structure show that these methyl 
substituents were critical experimentally. Replacement of methyl with either smaller (H) or 
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larger groups (Et, Bn) afforded lower stereoselectivity.
58
 Additionally, by analogy to oxirane 
formation,
59
 stabilizing interaction of a sulfur lone pair with π*-orbital of the olefin makes the 
spiro transition state favored over the planar transition state (Figure 7c).
30b
   
2.3.4 Mechanistic Details 
2.3.4.1 Proposed Catalytic Cycle  
Based on the experimental observations for this reaction and known mechanistic studies 
for electrophilic addition reactions of olefins, the catalytic cycle for sulfenoamination is 
proposed in Figure 8.
12,60
  
 
Figure 8. Proposed catalytic cycle for the asymmetric sulfenoamination. 
The proposed catalytic cycle begins with the activation of the unactivated sulfenylating 
agent (PhthSPh, 6) by a Brønsted acid (MsOH). Upon reaction with the chiral Lewis base 
catalyst 83, the active catalytic complex i is formed which is thought to be the resting state in the 
catalytic cycle based on the fact that 
31
P NMR signal for the complex i shifts from 82.2 ppm to 
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59.8 ppm immediately under the reaction conditions. This upfield shift is can be rationalized by 
the electron density of the phosphorus atom being removed with the formation of the Se-S bond. 
Transfer of the sulfenium ion from the activated complex i to the olefin substrate furnishes the 
enantioenriched chiral thiiranium ion intermediate ii. Lastly, subsequent capture of the 
thiiranium ion ii with the pendant tosylamine affords the enantioenriched product. 
2.3.4.2 Rate-Determining Step 
In the course of evaluating substrate scope, trifluoromethylphenyl substituted substrate 89 
showed a significant reduction in reactivity (Section 2.2.5.1). This observation indicates that a 
change on the electron density of the olefin impacts the rate-determining step. Formation of the 
activated catalytic complex i, which is believed to be the resting state, occurs significantly faster 
compared to the overall reaction time. Moreover, isomerization of the cyclized products which 
was observed for several substrates implies the possibility of reversible capture of the thiiranium 
ion. Taken together, these data suggest the formation of the thiiranium ion to be the rate-
determining step. 
Comparison of the rate between two analogous systems, such as oxysulfenylation
12
 and 
sulfenoamination, may provide additional evidence for the determination of the rate-determining 
step. The reaction of olefins with different pendant nucleophiles, ROH and RNHTs should give 
the same rate if formation of the thiiranium ion is rate-limiting. However, a full rate study to 
determine the reaction orders of the components is required to obtain a complete mechanistic 
profile for this reaction system. 
2.3.4.3 Enantiodetermining Step 
For hyper-reactive thiiranium ions, there is no analytical method currently available to 
monitor their configurational stability directly and accurately.
33
 As a result, it is difficult to 
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directly monitor the enantiopurity of the thiiranium ions being formed during the reaction. 
However, in theory, two possibilities may be considered as the enantiodetermining step: (1) 
formation of the thiiranium ion, or (2) the capture of the thiiranium ion. In the first case, chiral 
complex i distinguishes two enantiotopic faces of the olefin and produces enantio-enriched 
thiiranium ion ii, which is captured by the nitrogen nucleophile to produce the cyclized product. 
In the second case, both enantiomers of the thiiranium ions are formed, while thiiranium ions are 
still bound to chiral Lewis base catalyst. Then, the nucleophile selectively captures one 
diastereomer of the two thiiranium-Lewis base complexes ii-LB* to produce enantioenriched 
product. Mechanistically, for this catalytic cycle to make to full turnover, the second route 
requires formation of ii-LB* to be reversible.  
Experiments evaluating the effects of tether lengths (Section 2.2.5.5) provides useful 
information for identifying the enantiodetermining step. By comparing the substrates 56/94/96, 
and 91/97, which gave results with identical enantiomeric ratios regardless of the tether length, it 
is fair to suggest that the formation of the thiiranium ion rather than nucleophilic capture is the 
enantiodetermining step. 
The dependence of the enantioselectivity on reaction temperature (Section 2.2.3.3) may 
provide additional valuable information. The observation of cyclization at higher temperatures 
resulting in reduced enantioselectivity is in agreement with the instability of thiiranium ions at 
elevated temperatures. However, while these data support the proposed mechanistic hypothesis, 
more studies are required to conclude that formation of the thiiranium is the enantiodetermining 
step. One simple experiment that could be done is the treatment of the isolated racemic product 
with MsOH and enantioenriched Lewis base catalyst to form a mixture of constitutional isomers. 
As seen in Section 2.2.2, the piperidine product isomerizes into pyrrolidine in presence of a 
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Brønsted acid with no diastereomers being observed. This stereocontrol indicates that the 
isomerization undergoes through a thiiranium ion intermediate, which should be racemic. 
Therefore, examination of the enantiomeric ratio of these isomerized compounds will provide 
information on whether capture of thiiranium ion is the enantiodetermining step. If the capture of 
the thiiranium ion is indeed the enantiodetermining step, chiral Lewis base catalyst may re-
coordinate to the in situ generated thiiranium ion and induce some enantioenrichment of the 
constitutional isomers. However, if the both isomers remain as racemic, it would be hard to argue 
that the capture of the thiiranium ion is the enantiodetermining step. Therefore, this experiment 
can provide an additional piece of information to determine the enantiodetermining step. 
2.3.5 Impact of MsOH Purity on Reactions 
During the development of the current project, cyclization results from the earlier stage of 
the project were found to be irreproducible. Both faster conversion rate and faster isomerization 
from piperidine to pyrrolidine was observed for latter stage experiments. This disturbing result 
difference was consistently obtained after repetitive runs with the same protocol.  
Control experiments were performed to determine the discrepancy. Two 
sulfenoamination reactions were setup with olefin substrate 56, PhthSPh 6, catalyst (S)-83, and 
solvent, all taken from the same batch. Only MsOH was drawn from a different source, because 
the old bottle was running low. Eventually it was determined that the new MsOH was the caveat 
for the increased conversion rate and isomerization observed. Strictly speaking, the impure “wet” 
MsOH decelerated reaction rate and suppressed the isomerization. 
1
H NMR spectroscopic studies showed that the bottle of MsOH used in the reactions 
reported in the results section of this paper (Chart 5b) contained a significant amount of water. 
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This finding indicates that a lower loading of acid or a buffering effect of water (or both) could 
be responsible for the slower conversion rate and inhibition of isomerization. 
Chart 5 
1
H NMR spectra of (500 MHz, 0.1 M in CDCl3): (a) distilled MsOH, (b) the “wet” MsOH 
 
Serendipitously, critical insights were gained from this unintended incident. Whereas the 
conversion rate and isomerization rate were affected by the purity of acid, the enantioselectivity 
was maintained across MsOH sources. That is, both catalyst activation and stability of the 
cyclized products are dependent on the amount of acid or water, while the facial selectivity 
during the formation of the thiiranium ion is not affected with the water content in the reaction.  
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2.4 Future Directions  
2.4.1 Impact of the Acid in Sulfenofunctionalization Reactions 
As the amount of acid loaded, or pH of the reaction mixture, was found to be critical, the 
first goal for this project is to reestablish a general reaction protocol using a reliable source of 
MsOH which can be consistently used by this, and any other laboratory (See Chapter 3 for more 
details). Also, more thorough investigation is needed on amount of acid required for the 
formation of the catalytically active species i. Titration of the sulfenylating agent and the Lewis 
base catalyst with the purified MsOH may provide further mechanistic insight for 
sulfenofunctionalization reactions (See Chapter 3 for more details).  
2.4.2 Olefins with Higher Order Substitution 
For this sulfenoamination to be a general method for olefin functionalization, it is 
necessary to expand the scope to include higher order substituted olefin substrates. A variety of 
trisubstituted and tetrasubstituted olefins are to be examined. While these are more electron rich, 
it may decelerate the reaction rate due to the highly congested nature of the olefin. A simple way 
to get around this potential pitfall is to run at elevated temperatures. In this sulfenoamination 
studies, it was shown that the reactions run at higher temperatures could result in a minimal 
decrease in the enantiomeric ratio. Adjustment of the temperature may provide an opportunity to 
balance between a reasonable reaction time and acceptable enantioselectivity. Alternatively, 
employment of a novel electrophile with better activity may improve reaction rates. For example, 
nitro group, as seen in selenolactonization reactions, improved the enantiomeric composition of 
the lactones by effectively suppressing the racemization of the seleniranium ions. Also, isolation 
of the electrophile-catalyst complex i may provide a better understanding of the transition state 
and thus facilitate the design of a suitable catalyst for higher-order substituted olefins. 
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2.4.3 Application to a Synthesis of Natural Products 
There are a number of natural products and bioactive molecules that contain piperidine or 
azaheterocycle moieties (Chart 6).
15
 For example, (–)-adalinine (115) is one of the alkaloids 
found in defensive fluid emitted by ladybird beetles.
61
 It is a chiral molecule consisting of a δ-
lactam skeleton bearing two alkyl substituents on the 6-carbon. Using the developed method for 
sulfenoamination, cyclization of a trisubstituted olefin 119 with a four carbon tether may 
generate the 6,6-disubstituted-δ-lactam backbone 118 (Scheme 33a). Another interesting 
application would be the synthesis of bioactive molecule 116 which is a potential 
antidepressant.
62
 Asymmetric sulfenoamination can be applied in synthesis of this compound via 
121 as an intermediate followed by a radical-induced cyclization
63
 to afford the tricyclic core 120 
(Scheme 33b). 
Chart 6 
 
Scheme 33 
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2.4.4 Utility Demonstration of the Sulfenylated Products 
Due to the versatile nature of sulfur, subsequent reaction of the sulfenoaminated product 
can be envisioned. Besides the simple cleavage of the sulfide,
64
 oxidation and elimination of the 
sulfenoaminated products can be performed to give cyclic olefins
65
 or Pummerer rearrangement 
can be carried out to give a cyclic ketone (Scheme 34).
66
 
Scheme 34 
 
Also, as shown in the retrosynthesis example of potent antidepressant 116 (Section 2.4.3), 
sequential radical induced cyclization
63
 could be performed to afford complex polycyclic 
scaffolds. However, in all cases mentioned thus far, the stereochemical information of the C-S 
bond is lost. One potentially promising transformation of the sulfide moiety would to exploit it as 
a precursor for transition metal-catalyzed, cross-coupling reactions. While organonickel 
compounds have been shown to promote fast elimination of sulfides containing β-heteroatomic 
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substrates,
67
  cobalt(II) salts are able to cross-couple halides with β-heteroatomic groups.68 Based 
on these previous studies, it would be interesting to investigate reactions in which the C-S bond 
serves as a cross-coupling precursor. 
 
2.5 Conclusions 
The first catalytic enantioselective sulfenoamination of olefins has been demonstrated 
using a novel BINAM-derived diisopropylamino selenophosphoramide (S)-83 as the chiral 
Lewis base. The fundamental principle behind this reaction relies on the Lewis base activation of 
a Lewis acid. A survey of various nucleophiles revealed that tosylamides are excellent 
nucleophiles under the acidic reaction conditions. High yields and high enantioselectivities were 
obtained for a number of trans olefins. Interestingly, it was serendipitously found that the purity 
of methanesulfonic acid have influence on the isomerization rate of cyclized product and 
reactivity but not on enantioselectivity. Further investigations of the impact of acid on 
sulfenofunctionalization reaction conditions, as well as the application of this methodology to the 
synthesis of a natural product are underway. 
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CHAPTER 3: Mechanistic Aspects of Catalytic, 
Enantioselective, Intramolecular Carbosulfenylation 
of Olefins: A Remarkable Case of Negative Catalysis
69
 
3.1 Introduction  
3.1.1 Brønsted Acid−Lewis Base Co-Catalytic Carbosulfenylation of Alkenes 
Recently published studies from these laboratories detail the optimization and 
development of a catalytic, enantioselective carbosulfenylation of alkenes using electron-rich 
arenes as the nucleophilic partner (Scheme 35).
30
 In the course of optimization of this process, it 
was discovered that the enantioselectivity was not reliably reproduced from orienting 
experiments (0.2 mmol) to descriptive scale (1.0 mmol). Consideration of the experimental 
variables that could be responsible led to detailed reevaluation of the role of the Brønsted acid 
co-catalyst, methanesulfonic acid (MsOH). Foregoing studies in these laboratories on the related 
heterofunctionalization of alkenes revealed the need for a Brønsted acid co-catalyst to enable 
Lewis base activation of both Group 16 and Group 17 electrophiles.
11,12,34c
 However, in none of 
these previous studies was the Brønsted acid dependence found to be problematic and, in general, 
a full equivalent with respect to the substrate could be employed without affecting 
reproducibility. For the carbosulfenylation, empirical optimization outlined in the preceding 
studies
30
 led to the use of 0.75 equivs of ethanesulfonic acid (EtSO3H) for all preparative 
experiments. Satisfactory rates and reproducible enantioselectivities were found. 
Scheme 35 
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Despite the successful deployment of these conditions for the method, it was nonetheless 
of significant interest to elucidate the basis for the heightened sensitivity of this particular 
sulfenofunctionalization toward the Brønsted acid. In addition, as part of our general program in 
Lewis base activation of Lewis acids, we were interested in a more fundamental understanding 
of the role of all reaction components and the mechanistic underpinnings of this type of catalysis. 
3.1.2 Objectives of This Study 
The goal of this study was to provide a detailed understanding of the mechanism of 
catalysis of carbosulfenylation using the combination of chiral Lewis base (S)-53 and Brønsted 
acids MsOH and EtSO3H with 6 and substrate 52 (Scheme 35). To gain insight into this process, 
a number of different spectroscopic and kinetic studies were carried out to provide answers to the 
following questions: (1) What are the rates of the catalyzed and uncatalyzed reactions promoted 
by varying amounts of MsOH and EtSO3H? (2) What is the protonation state of the sulfenylating 
agent under catalytic conditions with MsOH and EtSO3H? (3) What is the resting state of (S)-53 
under catalytic conditions? (4) What is the structure of the catalytically active species? (5) What 
is the protonation state of the catalyst in the absence of sulfenylating agent 6? The answers to 
these questions are provided below and together provide a refined picture of the mechanism of 
catalysis and a striking illustration of how seemingly contradictory results can be understood in 
the light of thorough mechanistic analysis. 
3.2 Results 
3.2.1 Rates of Catalyzed and Uncatalyzed Reactions 
To establish the rates of the Lewis base catalyzed cyclization and the uncatalyzed 
cyclization in the presence of both Brønsted acids, MsOH and EtSO3H, NMR kinetic analysis 
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with an internal standard was performed at −20 °C for the reaction of alkene 3 to produce 4. 
Reactions were carried out at 0.2 M concentrations.
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3.2.1.1 Observations on the Purity of Alkylsulfonic Acids 
As part of the optimization experiments designed to elucidate the origin of the variable 
enantioselectivity, the purity (i.e., hydration level) of the sulfonic acids was investigated. The 
hydration level of the highly hygroscopic alkylsulfonic acids could be specified by integration of 
the OH signal in the 
1
H NMR spectra in CDCl3. It was found that the hydration level 
significantly influenced the rate and enantioselectivity of the cyclization such that high hydration 
levels (e.g., 20 mol % water) led to slower, but more selective reactions. Accordingly, to 
vouchsafe the quality of the sulfonic acid for reproducibility, both MsOH and EtSO3H were 
rigorously dried by established procedures (see Chapter 5: Experimental for details), and the 
hydration levels were checked by 
1
H NMR integration on a regular basis. All of the experiments 
described below were performed with MsOH and EtSO3H of specified purity. 
3.2.1.2 Reaction Rates at 0.2 M 
The time course for the catalyzed reaction with MsOH at the preparative reaction 
concentration (Figure 9a) reveals clean and high-yielding conversion of 52 to 54, reaching 
completion in 12 h.
71
 Surprisingly, the uncatalyzed reaction is significantly faster than the 
catalyzed process and follows apparent zeroth-order kinetic behavior (Figure 9b). Curiously, the 
formation of 54 was accompanied by formation of 123, the product of proton-initiated 
cyclization (ca. 15%). Thus, the competitive production of racemic 54 at a rate comparable to 
that of the catalyzed process clearly reveals the problems associated with irreproducible 
enantioselectivity in the presence of MsOH. 
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Figure 9. Reactions with MsOH (1.0 equiv). (a) Rate profile for catalyzed cyclization with 0.1 
equiv of (S)-53. (b) Rate profile for uncatalyzed cyclization. 
The time courses for the corresponding reactions in the presence of EtSO3H are similar to 
those in the presence of MsOH. The catalyzed cyclizations at various loadings of EtSO3H 
(Figure 10a) display normal first-order kinetic behavior, but in this case, the initial rates of the 
reaction at all loadings of EtSO3H are similar. Interestingly, the enantiomeric composition of 54 
eroded only slightly at higher loadings of EtSO3H.
72
 
 
 
 
57 
 
 
 
Figure 10. Reactions with EtSO3H (X equiv). (a) Rate profile for catalyzed cyclization with 0.1 
equiv of (S)-53. (b) Rate profile for formation of 54 in the uncatalyzed cyclization. (c) Rate 
profile for formation of 123 in the uncatalyzed cyclization. 
The uncatalyzed reactions of 52 in the presence of varying amounts of EtSO3H (Figure 
10b,c) mimic the results obtained with MsOH. Interestingly, with 1.00 equiv of EtSO3H, the rate 
of formation of 54 was comparable to that in the presence of (S)-53 and again displayed zeroth-
order kinetic behavior. Here again, 123, the product of proton-initiated cyclization, was formed 
in minor amounts. 
Four critical insights were gained from the low-temperature NMR kinetic studies: (1) 
Both MsOH and EtSO3H are competent Brønsted acids for both the catalyzed and the 
uncatalyzed carbosulfenylations. (2) Proton-initiated cyclization to form 123 was observed in the 
absence of catalyst (S)-53 but not in its presence. (3) Overall first-order kinetic behavior was 
observed under catalysis by (S)-53. (4) Overall zeroth-order kinetic behavior was observed for 
the formation of 54 in the absence of (S)-53.
70
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In addition to these important insights, the kinetic analysis also raises interesting 
questions: (1) How is it possible to obtain enantiomerically enriched 54 if the background, 
uncatalyzed, racemic reaction is comparable to (EtSO3H) or faster than (MsOH) the reaction 
catalyzed by chiral Lewis base (S)-53? (2) How can the formation of 123 in the background 
reaction be reconciled with its absence in the catalyzed reactions? Answers to these questions 
require a better understanding of what actually constitutes the background reaction and will be 
addressed in the following sections. 
3.2.2 Catalyst Resting State and Titration Studies 
3.2.2.1 Identifying and Quantifying the Catalytically Active Species 
Foregoing studies with (S)-53 established that the catalytically active sulfenylating agent 
is formed by sulfenyl group transfer from 6 to the selenophosphoramide mediated by a Brønsted 
acid. In view of the unusual dependence of the rate of catalyzed carbosulfenylation on acid 
loading (Figure 10a), it was of interest to establish the magnitude of the pre-equilibrium 
formation of that species. Thus, low-temperature NMR experiments were undertaken under 
catalytic conditions without substrate (6/(S)-53, 10.0:1.0) with varying amounts of EtSO3H at 
−20 °C (8.3 μM in (S)-53). At this temperature, the exchange between (S)-53 and catalytically 
active species i was too fast to allow accurate integration, so the experiments were repeated at 
−50 °C (Table 9).73 Under these conditions, both species could be detected simultaneously, and 
this revealed that the catalyst becomes saturated as complex i somewhere between 2.5 and 5.0 
equiv of EtSO3H (with respect to (S)-53). 
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Table 9. Determination of Equilibrium for Formation of Complex i at 8.3 μM in (S)-53. 
 
reagents (equiv)  
31
P NMR (δ, ppm) 
i-Bu cat. 53 PhthSPh 6 EtSO3H  at –20 
oC at –50 oC 
1.0 10.0 0.0  95.0 – 
1.0 10.0 1.0  94.9 (br) 95.2 (br) 
1.0 10.0 2.5  94.3 (br), 64.7 (br) 95.4 (br), 63.9 (br) (ratio=1.00:0.91) 
1.0 10.0 5.0  63.7 (br) 64.0 
1.0 10.0 7.5  63.7 64.0 
1.0 10.0 10.0  63.6 63.9 
Repeating the titration experiments at −57 °C and at higher concentration (25 μM in (S)-
53) allowed a more accurate determination of the saturation point (Table 10).
73
 Thus, 
approximately 4.0 equiv of EtSO3H was needed to convert ca. 98% of (S)-53 into complex i, 
whereas with 2.5 equiv of EtSO3H only 65% of (S)-53 was converted.  
Table 10. Determination of Equilibrium for Formation of Complex i at 25 μM in (S)-53. 
reagents (equiv) ratio of 
31
P NMR signals at 95 ppm and 64 ppm 
(–57 oC) i-Bu cat. 53 PhthSPh 6 EtSO3H 
1.0 10.0 1.0 3.12:1.00 
1.0 10.0 2.5 1.00:1.86 
1.0 10.0 3.0 1.00:4.07 
1.0 10.0 3.5 1.00:24.88 
1.0 10.0 4.0 1.00:54.49 
3.2.2.2 Calculation of Equilibrium Constants (Keq) 
Equilibrium constants were calculated for the two preceding experiments both at the 2.5 
equiv data points. Calculations were carried out assuming that the catalytically active species i 
exists either as a solvent-separated ion pair (Figure 11) or as an intimate ion pair (Figure 12). 
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Solving the equations at two concentrations for the tight ion pair afforded the same equilibrium 
constant, whereas solving for the solvent-separated ion pair did not. Thus, it can be safely (and 
logically) concluded that complex i is a tight ion pair in dichloromethane under the reaction 
conditions. 
 
Figure 11. Calculation of Keq for complex i assuming solvent-separated ion pair structure. 
 
Figure 12. Calculation of Keq for complex i assuming intimate ion pair structure. 
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3.2.2.3 Protonation State of Phenylsulfenophthalimide (6) and the Catalyst ((S)-53) 
 To gain insight into the curious behavior of noncatalyzed cyclizations, the protonation 
states of (S)-53 and 6 were determined by VT-NMR experiments. The exchange rate between 6 
and 6·H
+
RSO3
−
 was sufficiently rapid at −20 °C (125 MHz 13C) to allow observation of a sharp 
singlet for the carbonyl groups that shifted from 167.8 ppm (no RSO3H) to 168.9 ppm 
(10.0−15.0 equiv of RSO3H, Figure 13a). 
 
Figure 13. Titration curves for protonation of PhthSPh 6 with MsOH and EtSO3H. 
These data were fitted to a curve with nonlinear regression (single-site total binding 
model). Extrapolation of the curve for MsOH gave 169.2 ppm as the chemical shift of 
6·H
+
RSO3
−
, whereas doing the same for EtSO3H gave 169.0 ppm. These extrapolated values 
lead to a single, apparent Keq = 3.63 M
−1
 for MsOH and Keq = 2.05 M
−1
 for EtSO3H (Kd = 0.276 
± 0.018 M for MsOH and Kd = 0.488 ± 0.049 M for EtSO3H). As expected, the Keq value for 
MsOH is larger than that for EtSO3H, because the ability of MsOH to protonate 6 is greater than 
that of EtSO3H. By using the average of the extrapolated chemical shifts of 6·H
+
RSO3
−
, the mole 
fraction of 6·H
+
RSO3
−
 present at various loadings of acid could be calculated (Figure 13b); at 
62 
 
1.00 equiv of acid, 6·H
+
RSO3
−
 is present at 41 mol % with MsOH and 26 mol % with EtSO3H. 
These numbers represent a significant amount of an active, achiral sulfenylating agent that is 
responsible for the background reaction. However, given the high enantioselectivities observed, 
the actual amount of 6·H
+
RSO3
−
 must be significantly less, the reason for which is addressed 
below. 
The protonation of catalyst (S)-53 was examined briefly. Addition of 1.0 equiv of 
EtSO3H to a 0.1 mM solution of (S)-53 in CHCl3 had no effect on the 
31
P NMR chemical shift, 
indicating a negligible degree of protonation. 
3.2.3 Effect of the Presence of Sulfonate Anion on the Rate of the Uncatalyzed 
Reaction 
The realization that (1) formation of catalytically active species i is quantitative under the 
catalytic reaction conditions, (2) sulfenylating agent 6 is partially protonated under these 
conditions, and (3) both of these species carry sulfonate counterions led to the recognition that 
the action of the remaining Brønsted acid could be attenuated by the buffering effect of the 
sulfonate. Thus, a modified version of the background reaction was formulated in which the 
amounts of complex i and protonated 6 formed under catalytic conditions were mimicked by 
adding varying amounts of tetrabutylammonium mesylate (Bu4N
+
OMs
−
) (Figure 14). 
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Figure 14. Reactions with MsOH (1.0 equiv) and Bu4N
+
OMs
−
. (a) Rate profile for formation of 
54 in the uncatalyzed cyclization. (b) Rate profile for formation of 123 in the uncatalyzed 
cyclization. 
The results were striking: whereas 0.1 equiv of Bu4N
+
OMs
−
 slows the formation of 54 
(but not 123), 0.2 equiv of Bu4N
+
OMs
−
 was able to almost completely shut down the formation 
of 54 and 123 in the presence of 1.0 equiv of MsOH. This observation implies that the actual 
background reaction operating under catalytic conditions is not accurately represented by simply 
omitting the catalyst. Moreover, reconsideration of the components present under catalytic 
conditions reveals that the actual amount of MsOH available is only 0.9 equiv and that 0.1 equiv 
of phthalimide is also present, both as a consequence of the formation of complex i. Figure 15a 
shows the rate profile for the uncatalyzed reaction with 0.9 equiv of MsOH and 0.1 equiv of 
Bu4N
+
OMs
−
; Figure 15b shows the rate for the same uncatalyzed reaction but with also 0.1 equiv 
of phthalimide. Here again, suppression of the formation of 54 is striking, illustrating that both 
methanesulfonate and phthalimide are serving as buffers to attenuate the acidity of MsOH in the 
medium. Figure 15c shows the superposition of all of these experiments. 
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Figure 15. (a) Rate profile for the uncatalyzed reaction with 0.9 equiv of MsOH and 0.1 equiv of 
Bu4N
+
OMs
−
. (b) Rate profile for the uncatalyzed reaction with 0.9 equiv of MsOH, 0.1 equiv of 
Bu4N
+
OMs
−
, and 0.1 equiv of phthalimide. (c) Superposition of all reactions with MsOH; only 
formation of 54 is depicted. 
It is now easy to see how a catalyzed reaction (black line) can be slower than the 
corresponding uncatalyzed reaction (red line) and still give rise to high enantioselectivities. One 
must consider the circumstances under which the uncatalyzed reaction is proceeding under the 
conditions of the catalyzed process. Simply removing the catalyst is not sufficient to accurately 
mimic those conditions. 
The true background formation of 54 under “catalytic conditions” was significantly 
slower than assumed on the basis of the results shown in Figure 15c. In the time required for 
complete consumption of substrate 52 under catalytic conditions, only 8.6% of 54 is produced in 
the background reaction. Obviously, this amount would be considerably less in the catalyzed 
reaction because the concentration of 52 would be decreasing faster (and the amount of 
phthalimide would be increasing faster) as a result of the productive enantioselective pathway. 
However, the formation of byproduct 123, which is not observed in any of the catalytic reactions, 
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suggests that this experiment is still not perfectly mimicking the actual catalytic reaction 
conditions. 
3.3 Discussion 
3.3.1 Role of the Brønsted Acid 
The irreproducibility of the catalytic carbosulfenylations upon scale-up for descriptive 
purposes revealed a dramatic sensitivity to the Brønsted acid that was not seen in the preceding 
studies on oxysulfenylation reactions.
12
 Systematic reinvestigation of the effects of Brønsted acid 
loading on the rate and selectivity of the reactions, the formation of the catalytically active 
sulfenylating agent, and the protonation equilibria for 6 was highly informative and revealed a 
dramatic sensitivity of the reaction behavior to the stoichiometry of the acid and also overall 
concentration. 
3.3.1.1 Comparison of Methane- and Ethanesulfonic Acids 
The Brønsted acidity of sulfonic acids has been the subject of intense study for many 
years.
74
 Alkylsulfonic acids are classified as “moderately strong acids”, with pKa‟s between +2 
and −2, and as such are amenable to a variety of acidity determinations. In water, 
methanesulfonic acid has pKa = −1.92, whereas that of ethanesulfonic acid is −1.68. Similarly 
small differences have been found in DMSO and acetonitrile. The slightly weaker acidity of 
EtSO3H has been manifested in all of the experiments described above: both catalyzed and 
uncatalyzed cyclizations of 52 proceed more slowly with EtSO3H than with MsOH.
75
 The 
preparative advantage of EtSO3H that was used for all descriptive cyclizations arises from the 
slightly larger difference in the catalyzed and uncatalyzed reactions at lower loadings and also 
the lower melting point that allowed cold delivery of the acid. 
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3.3.1.2 Effect of Brønsted Acid on the Rate and Enantioselectivity of the 
Carbosulfenylation 
The use of MsOH (1.0 equiv) in the catalytic carbosulfenylation led to a rapid 
consumption of the alkene, leveling off at 98.5% conversion at 12 h to afford 54 with a 75:25 er 
(Figure 9a). In the absence of catalyst (S)-53, the reaction profile showed zeroth-order decay, 
leveling off at >99% conversion at 3 h.
76
 Under these conditions, the product composition was ca. 
91% 54 and 8% 123. 
The use of EtSO3H in varying stoichiometries led to very similar reaction profiles albeit 
at overall lower rates compared to MsOH. The carbosulfenylation of 52 proceeded with normal 
first-order kinetics to afford 54 with highly reproducible and higher enantioselectivities (ca. 
92.5:7.5 er) (Figure 10a). With 1.0 equiv of EtSO3H the rates of the catalyzed and uncatalyzed 
reactions are comparable, leveling off at 98.6% conversion of 52 at 24 h with (S)-53 and 99.3% 
conversion at 12 h without (S)-53. Here again, the uncatalyzed reaction is competitive at 1.00 
and 0.75 equiv of EtSO3H (Figure 10b).
77
 The reason for the difference between MsOH and 
EtSO3H will be discussed below in the section on protonation equilibria with 6. 
3.3.1.3 Effect of Brønsted Acid on the Resting State of the Catalyst 
The unusual similarity of the rate profiles for the catalyzed carbosulfenylation in the 
presence of various amounts of EtSO3H (Figure 10a) stimulated an investigation into the effect 
of the Brønsted acid on the conversion of catalyst (S)-53 into the catalytically active 
sulfenylating agent i. Low-temperature 
31
P NMR titration experiments revealed that catalyst (S)-
53 becomes saturated as i with ca. 4.0 equiv of EtSO3H and 10.0 equiv of 6 with respect to (S)-
53 (i.e., 0.40 equiv with respect to 6 and substrate 52 under catalytic conditions). Thus, the 
similarity of rates for 1.00, 0.75, and 0.50 equiv of EtSO3H and the lower rate for 0.25 equiv can 
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be readily understood from the amount of active sulfenylating agent i present. Above 0.4 equiv 
of EtSO3H, the catalyst is saturated, and thus the rate has reached a maximum. 
An additional insight into the nature of the active sulfenylating agent was secured by 
taking advantage of the fact that the equilibrium formation of i was measured at two different 
concentrations (Figures 11 and 12). The Keq was calculated at both concentrations (using data 
from 2.5 equiv of EtSO3H) assuming that i was either a solvent-separated ion pair (Figure 11, 
Method 1) or an intimate ion pair (Figure 12, Method 2). Interestingly, the solution for the two 
concentrations using Method 1 produced two different Keq‟s, whereas the solution using Method 
2 gave nearly identical Keq‟s. From these data, we assume that the catalytically active species is 
an intimate ion pair in dichloromethane. 
3.3.1.4 Protonation Equilibria for N-Phenylsulfenylphthalimide (6) 
Sulfenylating agent 6 was shown to be significantly protonated under standard reaction 
conditions (0.2 M, 1.00 equiv of RSO3H). The high rate of the uncatalyzed reaction (in the 
absence of (S)-53) can be ascribed to the reactivity and concentration of 6·H
+
RSO3
−
. The greater 
difference in the rates of the catalyzed and uncatalyzed reactions for EtSO3H compared to MsOH 
can be understood from the differing consequences of their acidities. The rates of the catalyzed 
reactions are very similar because these reactions are governed by the concentration of the active 
sulfenylating agent i, which reaches its (saturated) maximum in the presence of both acids at 
1.00 equiv loading. However, the weaker proton-donating strength of EtSO3H compared to 
MsOH, as illustrated in the measured Keq‟s of protonation of 6, has a greater rate-attenuating 
effect on the uncatalyzed reaction, thus leading to a larger “split” in the catalyzed/uncatalyzed 
rates, which leads to a better-behaved system for enantioselectivity. 
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The dramatic drop in the rate of the uncatalyzed reaction upon the addition of n-
Bu4N
+
OMs
−
 and phthalimide together with the attendant decrease in the amount of MsOH 
implies that the concentration of 6·H
+
RSO3
−
 must be substantially lower under the condition of 
the catalytic reaction for reasons described below. 
3.3.2 Role of Sulfonate Ions in the Uncatalyzed Cyclization: The Structure of Ion 
Pairs 
The counterintuitive observation that the cyclization of 52 in the absence of catalyst 
(“racemic background reaction”) proceeded with a rate comparable to that of the catalyzed 
cyclization of 52 (which afforded high enantioselectivity) demanded a reevaluation of the actual 
racemic background reaction that may intervene under catalytic conditions. As shown in Figures 
14 and 15, sulfonate ions and phthalimide (necessary consequences of the formation of the 
catalytically active species i) were effective inhibitors of the racemic background reaction. The 
results shown in Figure 15c were most informative. With as little as 0.1 equiv of n-Bu4N
+
OMs
−
, 
0.1 equiv of phthalimide, and 0.9 equiv of MsOH (the actual stoichiometries with respect to 52 at 
the beginning of the catalyzed reaction), the cyclization is extremely slow, reaching less than 10% 
conversion in the same time that the catalytic reaction would be complete. Thus, the apparent 
contradiction seen in Figures 9 and 10 is, in reality, a consequence of the incorrect assumption 
that the racemic background reaction is accurately represented by simply leaving out the 
catalyst. 
A possible explanation for the inhibition of the racemic background reaction under 
catalytic conditions may be found in the buffering effect of the sulfonate ion. The strong 
buffering effect of sulfonate ions on the acidity of sulfonic acids has in fact been studied in 
nonaqueous media, but not in chlorinated solvents. The self-association of acids with their 
conjugate bases, known as the “homoconjugation reaction”, has been studied for sulfonic acids 
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in dipolar aprotic solvents.
78
 In the conductometric titration of MsOH in benzonitrile (with Et3N), 
a large maximum is observed at one-third of the equivalence point. Such maxima are 
characteristic of the formation of triple ions
79
 according to the formula shown in Scheme 36. The 
maximum at one-third equivalence for MsOH is much larger than that for PhSO3H or TsOH 
because of its weaker acidity and corresponding greater basicity of MsO
−
, thus leading to a 
higher concentration of the triple ion. In the cyclization reactions, the base (B) is N-
phenylthiophthalimide (6). With 1.00 equiv of EtSO3H, 6 is ca. 25% protonated, leading to a 
significant concentration of the triple ion which sequesters two additional molecules of EtSO3H. 
Scheme 36 
 
An important issue that could well impact the understanding of this phenomenon is the 
actual structure of the ion pairs involved in the various stages of the reaction. Although the 
structure of the catalytically active species i could be established as an intimate ion pair in CHCl3, 
the structures of 6·H
+
RSO3
−
 and protonated phthalimide could not be established. Clearly, the 
buffering power (i.e., homoconjugation strength) will depend on the structure of the ion such that 
the more solvent-separated the ions, the greater their ability to bind to their conjugate acids.
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3.3.3 Mechanistic Rationale and Catalytic Cycles 
The formation of (racemic) 54 at a rate greater than that of the catalyzed reaction 
provided a compelling explanation for the variability of the enantioselectivities in preparative 
reactions, but also presented a conundrum: how can a catalytic reaction outcompete a faster 
stoichiometric reaction and produce enantiomerically enriched products? 
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The answer to this question has been found in a deeper understanding of the 
stoichiometry for generation of the catalytically active sulfenylating agent i and in the buffering 
effect of sulfonate ions and phthalimide formed under catalytic conditions. These phenomena 
result in the simultaneous operation of two catalytic cycles illustrated in Scheme 37. 
Scheme 37 
 
Initiation of both cycles begins with the pre-equilibrium protonation of 6 to form species 
iii. Under catalytic conditions (i.e., with 0.1 equiv of (S)-53) the catalyst is saturated as the 
kinetically active sulfenylating agent i with as little as 0.4 equiv of EtSO3H (with respect to 6). 
Once i is stoichiometrically generated, the catalytic cycle has no further need for EtSO3H (as was 
seen in the similarity of rates in Figure 10a). Any additional acid would be deleterious in 
promoting the uncatalyzed pathway, but the presence of MsO
−
 from both i and iii (6·H
+
RSO3
−
) 
serves to neutralize the excess acid and inhibit the racemic background reaction. First-order 
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kinetic behavior requires that the formation of episulfonium ion ii be the rate-determining step 
which is followed by rapid cyclization and rearomatization. 
The striking behavior of this catalytic system bears some resemblance to the inhibition of 
the asymmetric catalytic pathway in the Povarov reaction elegantly analyzed by Jacobsen.
81
 In 
that study a similar observation was made regarding the suppression of a Brønsted acid catalyzed 
racemic background reaction that they ascribed to “negative catalysis”.82 The high association 
constant of the chiral urea for the protonated imine resulted in the removal of the Brønsted acid 
from the reaction. In our system, this behavior is reflected in the formation of species i. However, 
Jacobsen et al. employed only half as much Brønsted acid as catalyst loading, whereas in our 
system the Brønsted acid is deployed in stoichiometric quantities with respect to substrate. Thus, 
consuming 0.1 equiv of EtSO3H in the formation of i is insufficient to explain the inhibition of 
the background reaction. Instead, we have identified the crucial role of the conjugate base 
EtSO3
−
 in sequestering the excess Brønsted acid through the homoconjugation reaction, which 
forms triple ions, as well as the buffering effect of the phthalimide generated from 6. 
Although not directly relevant to the focus of this study, the curious zeroth-order 
dependence for the formation of 54 in the absence of (S)-53 warrants comment (Figures 9b and 
9b). This unusual behavior implies that the rate of cyclization depends only on the Brønsted acid, 
whose concentration does not change over the course of the reaction (Scheme 37). This unique 
dependence would obtain if the cyclization becomes rate determining in the absence of the Lewis 
base catalyst. In this scenario, the resting state is the species iv, whose concentration is set by the 
amount of Brønsted acid employed. Since this step is an intramolecular reaction, it will exhibit 
zeroth-order kinetic dependence on 6 and substrate 52. The subsequent rearomatization step from 
v should be very fast. This hypothesis posits that intermediate iv should be observable under the 
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reaction conditions. However, NMR analysis of the uncatalyzed reactions revealed a consistently 
high mass balance (>98%) consisting of only 6, 52, and 54. 
Scheme 38 
 
An alternative explanation for zeroth-order behavior would be a rate-determining step 
outside of the catalytic cycle. If the protonated sulfenylating agent iii existed in an aggregated 
state (perhaps intermolecularly hydrogen bonded) which had to dissociate to form a catalytically 
competent agent, and all downstream reactions were faster than dissociation, overall zeroth-order 
behavior would be observed (Scheme 38). The amount of reactive monomer would be dependent 
on the amount of iii, which is dependent only on the amount of Brønsted acid. In the presence of 
(S)-53, either the monomer is rapidly intercepted to form i or the catalyst is capable of reacting 
with the aggregate in a rapid pre-equilibrium which (as was established above) is acid 
dependent.
83
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3.4 Conclusion 
Detailed kinetic and spectroscopic analysis of the enantioselective Lewis base/Brønsted 
acid co-catalyzed carbosulfenylation reaction has revealed a number of interesting features that 
explain previously observed, contradictory behavior. The unusual observation that the rate of the 
catalyzed reaction is similar to that of the uncatalyzed process, yet still affords high 
enantioselectivity, is now understood. The actual background reaction operating under catalytic 
conditions is not accurately mimicked by simply leaving out the catalyst. In the presence of the 
Lewis base catalyst, the active sulfenylating agent 6 is formed quantitatively. Two byproducts of 
this step conspire to inhibit the Brønsted acid catalyzed pathway, namely, equimolar amounts of 
a sulfonate and phthalimide. The sulfonate forms triple ions with the remaining sulfonic acid, 
thus sequestering twice its molar concentration, and the phthalimide serves as a buffer to 
neutralize additional amounts of the acid. The consequences of these observations on other 
Brønsted acid catalyzed reactions are currently under investigation. 
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CHAPTER 4: Catalytic, Enantioselective, Intra-
molecular Sulfenoamination of Alkenes with Anilines
84
 
4.1 Introduction  
4.1.1 Tetrahydroquinolines 
As an important member of the class of nitrogen-containing biologically-relevant motifs, 
the tetrahydroquinoline ring system is common to a wide range of natural and synthetic 
compounds that exhibit biological activities (Chart 7).
85
 These compounds display, inter alia 
antitumor, antiarrhytmic, antibiotic, antidepressant,
 
cardiovascular, antithrombotic, antiallergenic, 
antiheumatic, immunosuppressant, and antifertility activity.
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Chart 7 
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4.1.1.1 Synthesis of Tetrahydroquinolines 
Due to their diverse applications in pharmaceutical and medicinal chemistry, the 
development of novel strategies for the synthesis of tetrahydroquinolines has been an active area 
of research. Traditional approaches to the synthesis of the tetrahydroquinoline core can be 
classified into three categories: (1) construction of the tetrahydropyridine fragment, (2) 
construction of the aryl ring, and (3) reduction/hydrogenation of quinolines (Figure 16). Among 
these, the first strategy is the most common and involves the formation of C-C or C-N bonds 
with creation of stereogenic sp
3
 carbon centers. A few reports employ the second strategy of 
which the intramolecular Diels-Alder reaction of a furan followed by thermal aromatization is a 
representative example.
86
 On the other hand, the third strategy (partial hydrogenation of 
quinolines) is often more direct and can be accomplished enantioselectively. Indeed, many 
enantioselective hydrogenation methods have been developed for the synthesis of syn-2,3-
substituted tetrahydroquinolines.
87
 Of course, the preparation of the starting quinolines then 
becomes the challenge.
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Figure 16. Three strategies for the synthesis of tetrahydroquinolines. 
4.1.1.2 Enantioselective Syntheses of Tetrahydroquinolines 
Numerous strategies for the synthesis of the tetrahydropyridine fragment have been 
developed that target different bond disconnections and stereocontrol elements. The 
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enantioselective syntheses of the tetrahydropyridine ring can be further divided into two 
subcategories by the number of bonds formed in the key step. The first category is a cyclization 
that forms one bond, and the second is an annulation that forms two or more bonds. Most 
enantioselective methods leverage facile cyclization whereas only a few enantioselective variants 
of annulation processes have been reported.  
Enantioselective, intramolecular, one-bond construction of tetrahydroquinolines can be 
categorized into four types based on the bond that is formed: (1) N-C2, (2) C2-C3, (3) C3-C4, and 
(4) C4-C4a (Figure 17). Disconnection strategy of N-C8a is also well described and represented by 
transition metal catalyzed amination reactions,
88
 but they inherently cannot be enantioselective. 
 
Figure 17. Different connectivity-based approaches to tetrahydroquinoline ring construction. 
For disconnection (1), Hamada and coworkers reported an enantioselective amination of 
an allylic acetate catalyzed by Pd(dba)2 in the presence of a chiral phosphabicyclononane ligand 
(Scheme 39).
89
 The reaction is speculated to proceed through an intermediate chiral, π-allyl 
palladium complex. For disconnection (2), Davies and coworkers reported the addition of chiral 
lithium amides to α,β-unsaturated esters to furnish 2,3,4-functionalized tetrahydroquinoline 
derivatives.
90
 The lithium amide initiates a tandem conjugate addition/cyclization reaction 
connecting C2-C3 bond with excellent diastereo- and enantioselectivity. For disconnection (3), 
77 
 
Nishibayashi and coworkers reported a ruthenium-catalyzed enantioselective synthesis of 3,4-
functionalized tetrahydroquinolines with excellent enantioselectivity.
91
 In this process a 
propargylic alcohol undergoes an intramolecular ene reaction with a pendant allyl amine under 
catalysis by a thiolate-bridged diruthenium complex. Finally, for disconnection (4), Lu and 
coworkers reported an enantioselective Friedel-Crafts alkylation using a prolinol silyl ether 
catalyst.
92
 
Scheme 39 
 
Enantioselective, intermolecular tetrahydroquinoline syntheses involving multi-bond 
construction have also been developed (Scheme 40). Nenajdenko and coworkers reported 
synthesis of tetrahydroquinolines via a two-bond formation approach using a (S)-methoxymethyl 
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pyrrolidine chiral auxiliary.
93
 Tunge and coworkers reported the Pd-catalyzed synthesis of 
tetrahydroquinoline from benzoxazinanones and benzylidene malononitriles in the presence of 
chiral bidentate phosphine ligands.
94
 
Scheme 40 
 
Unfortunately, application of these methods to the construction of enantioenriched anti-
2,3-difunctionalized tetrahydroquinolines is not trival, with most existing methods requiring 
multiple steps. In 2013, Zhou and coworkers reported a two-step sequence of asymmetric 
transfer hydrogenation followed by epimerization to afford anti-2,3-difunctionalized 
tetrahydroquinoline with high enantioselectivity (Scheme 41).
95
 
Scheme 41 
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4.1.2 Sulfenofunctionalization Reactions 
4.1.2.1 Enantioselective Sulfenofunctionalization 
As mentioned earlier in Section 2.1.2, only two enantioselective sulfenofunctionalization 
reactions have been reported until recent development of Lewis base catalyzed variants 
(Schemes 13 and 14).
28,29
 Foregoing studies from these laboratories have described catalytic, 
enantioselective sulfenofunctionalizations of isolated alkenes with oxygen-,
12,96
 carbon-,
30,69
 and 
nitrogen-based
13,96
 nucleophiles (Scheme 42). These reactions employ chiral Lewis bases 7, 53, 
and 83 and proceed with high selectivities and to provide access to tetrahydropyrans, tetralins, 
and piperidines, respectively. 
Scheme 42 
 
Enantioselective α-sulfenylation of silyl enol ethers has also been developed using a 
saccharin-derived sulfenylating agent 126
97
 More recently, a sterically encumbered sulfenylating 
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agent (2,6-diisopropylphenyl)thiophthalimide (PhthSAryl, 124) has been introduced to provide 
improved enantioselectivities for these sulfenylation reactions.
96
 To recapitulate, in all of these 
reports on sulfenofunctionalization, selenophosphoramide catalysts showed superior selectivity 
on trans-disubstituted alkenes compared to cis-disubstituted or trisubstituted alkenes. 
 
Figure 18. Catalytic cycle for enantioselective sulfenofunctionalization reaction. 
4.1.2.2 Catalytic Cycle of Sulfenofunctionalization 
The mechanistic details of this process have been thoroughly investigated by kinetic, 
spectroscopic, crystallographic, and computational analysis.
69,96
 The catalytic cycle begins with 
the protonation of the Lewis acid 124 by a Brønsted acid (MsOH) (Figure 18). This step is 
followed by transfer of the arylsulfenium group to the chiral Lewis base catalyst to form the 
catalytically active complex i. This sulfenylated complex i is the resting state of the catalyst and 
has been characterized by NMR spectroscopy and X-ray crystallographic analysis.
96
 The 
complex i then transfers the sulfenium ion to the carbon-carbon double bond to generate the 
enantioenriched thiiranium ion intermediate ii. Lastly, capture of the thiiranium ion with a 
81 
 
tethered nucleophile forms the protonated species v with release of the catalyst; subsequent 
proton transfer affords the enantioenriched, sulfenofunctionalized product.  
4.1.3 Project Design 
Among the series of above mentioned sulfenofunctionalization reactions, the 
enantioselective sulfenoamination of alkenes have demonstrated the synthesis of anti-2,3-
disubstituted piperidines and azepanes with high enantioselectivity (See Chapter 2 for more 
details, Scheme 43).
13
 Therefore, it was logical that anti-2,3-disubstituted tetrahydroquinolines 
could be analogously accessed by substituting aniline nucleophiles in place of the established 
amines. Anilines are unique functional groups in both their steric and electronic properties when 
compared to the aliphatic amines. While the conformational restriction from the planar geometry 
of aniline influences the cyclization, variable substitution pattern allows evaluation of the 
electronic properties of the nucleophiles. Their utilization would expand the scope of the reaction 
for the construction of other chiral nitrogen-containing heterocycles as well, such as indolines 
and tetrahydrobenzazepines.  
Scheme 43 
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4.2 Results 
Previously, the influence of the electronic and steric properties of the alkenes on the rate, 
site-selectivity, and enantioselectivity of the enantioselective sulfenoamination reaction were 
investigated.
13
 The electron property of the amine was varied by installing different protecting 
groups on the amine. Also, the tether length between the alkene and amine was varied to 
examine the accessibility of medium-sized rings. In a similar manner, the following goals were 
set for this study to investigate the effect of: (1) the electronic properties of the aniline 
nucleophile, (2) the steric and electronic properties of the olefin, and (3) the tether length for the 
sulfenoamination reaction of olefins with anilines. 
4.2.1 Substrate Preparation 
To evaluate all of these structural parameters required efficient access to range of aniline-
containing substrates. These substrates were prepared by three main routes: (1) 3-aza-Cope 
rearrangement of N-allylic anilines, (2) metathesis of terminal olefins, and (3) Pd-catalyzed C-N 
coupling (Scheme 44).  
Scheme 44 
 
83 
 
2-Cinnamylaniline substrates were synthesized via 3-aza-Cope rearrangement of α-
substituted allylic anilines, which was especially attractive route due to its inherent high 
stereospecificity (Scheme 45).
98
 Imines were prepared by condensation of the appropriate 
anilines and aldehydes, and subsequent addition of vinylmagnesium chloride in the presence of 
zinc chloride afforded α-substituted allylic anilines.99 This 3-step sequence was very effective for 
synthesis of substrates 129-131. However, a modified Grignard addition method,
100
 developed by 
Katritzky, was required for the synthesis of substrate 133 due to the acidic α-proton on the imine. 
Scheme 45 
 
N-Tosyl-2-allylaniline 134 and N-tosyl-2-homoallylaniline 135 was prepared following a 
reported procedure (Scheme 46).
101 , 102
 N-Allylaniline was heated in the presence of boron 
trifluoride diethyl etherate to promote 3-aza-Cope rearrangement. Resulting 2-allylaniline was 
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subsequently protected with a tosyl group to furnish N-tosyl-2-allylaniline 135. N-Tosyl-2-
homoallylaniline was synthesized from 2-aminobenzyl alcohol in a 3-step sequence. Tosyl 
protection of the aniline followed by chlorination furnished benzyl chloride. Addition of allyl 
Grignard reagent to the benzyl chloride afforded desired substrate 135. 
Scheme 46 
 
2-Cinnamylaniline derivatives with substituents on the styrene ring 136-139 were 
prepared by cross-metathesis of olefins with Grubbs catalyst (Scheme 47).
103
 Grubbs 1st 
generation indenylidene catalyst showed strong cross-metathesis of 2-allylaniline 134 and 2-
homoallylaniline 135 with various styrenes. While metathesis with styrenes afforded the trans-
olefin exclusively, 1-pentene gave approximately a mixture of trans- and cis-disubstituted olefins.  
Scheme 47 
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Olefin metathesis with linear aliphatic alkenes resulted in poor geometrical selectivity, 
forcing the development of a different route (Scheme 48). Knoevenagel-Doebner condensation 
of malonic acid to 2-chlorophenylpropanal 140a cleanly afforded non-conjugated carboxylic acid 
140b.
104
 Reduction of the acid to the alcohol 140c, followed by mesylation and SN2 displacement 
with cyanide furnished the nitrile intermediate 140d for the aryl amination.
13
 The resulting 2-aryl 
chloride 140d was coupled with ammonium sulfate to form aniline 140e via Pd-catalyzed C-N 
coupling method developed by Hartwig and co-workers.
105
 Unfortunately, the desired product 
was generated in low yield with a significant amount of olefin-migrated side products. However, 
tosylation of the aniline afforded nitrile substrate 140. Nitrile group was reduced with LiAlH4 to 
the free amine,
13
 and subsequential tosyl protection of the amine furnished bistosylamide 141. 
Scheme 48 
 
As with single methylene tether substrate preparation, synthesis of the dialkyl olefin 
substrate was shown to be less trans selective via cross-metathesis. To achieve selective 
synthesis of the trans dialkyl substituted olefin, a Johnson-Claisen rearrangement was again 
employed as the key stereogenerating step for the construction of the main scaffold of 142 
(Scheme 49). Addition of vinyl Grignard reagent to aldehyde 142a afforded allylic alcohol 142b, 
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which was subsequently treated with triethylorthoacetate in the presence of catalytic acid and 
heat to promote [3,3] sigmatropic rearrangement.
106
 Reduction of the resulting ester 142c to 
alcohol 142d,
106
 followed by a two-step sequence of mesylation-hydride reduction afforded the 
aryl bromide 142e.
107
 The aryl bromide 142e was then subjected to the Hartwig‟s C-N coupling 
method.
105 
Gratifyingly, in contrast to the one methylene tethered system, no olefin migration 
was observed. Tosyl protection of the primary aniline furnished the target substrate 142. 
Scheme 49 
 
2-Pentenylanilines were prepared from 2-bromobenzyl bromide, by addition of butenyl 
Grignard with catalytic assistance of copper (I) iodide to afford 2-pentenylaryl bromide (Scheme 
50).
108
 Hartwig‟s C-N coupling methodology was then employed to install the amine moiety,105 
and the resulting primary aniline was protected with a tosyl group to furnish the target olefin 
substrate 143. 
Scheme 50 
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4.2.2 Optimization of the Sulfenoamination Reaction 
To investigate the properties of aniline substrates, reaction conditions were adapted from 
the previously reported enantioselective sulfenoamination reaction: PhthSAryl 124 was 
employed as the sulfenylating agent, MsOH as the Brønsted acid, and selenophosphoramide (S)-
83 as the Lewis base catalyst,
13
 at room temperature at 0.1 M in substrate.
96
  
Table 11. Optimization of the Sulfenoamination Reaction. 
 
entry 
catalyst loading 
(equiv) 
solvent 
(concentration, M) 
conditions 
temp (oC), time (h) 
conversion/yieldb, % erc 
1 0.1 CDCl3 (0.1) 20, 6 52/– – 
2 0.1 CDCl3 (0.1) 20, 12 77/– – 
3 0.1 CDCl3 (0.1) 20, 24 94/– – 
4 0.1 CDCl3 (0.1) 20, 48 100/82 90:10 
5 0 CDCl3 (0.1) 20, 48 no conversion – 
6 0.1 CH2Cl2 (0.1) 0 
oC, 48 80a/64 94:6 
7 0.1 CH2Cl2 (0.4) 0 
oC, 48 100a/80 93:7 
a Conversion and constitutional selectivity determined by 1H NMR spectroscopy of the crude mixture. b Yields 
of isolated purified compounds, low yields due to difficulty in separation from the residual starting materials in 
case of incomplete conversion. c The enantiomeric ratio of the major constitutional isomer was determined by 
CSP-HPLC analysis. 
2-Cinnamyl-N-tosylanisidine (129) was selected as the test substrate for reaction 
optimization. Initially, the reaction was carried out in NMR tubes to monitor the rate profile at 
room temperature over 2 days (Table 11, entries 1, 2, 3, and 4). The reaction reached full 
conversion after 48 hours under the above conditions to afford tetrahydroquinoline 144, favoring 
6-endo cyclization exclusively. However, the enantiomeric composition of the product was much 
lower than expected, 90:10 er. To ensure that no competing racemic pathway was operative, the 
reaction was carried out in absence of the selenophosphoramide catalyst (entry 5). No product 
88 
 
was formed suggesting that the attenuated selectivity arose from other factors. Therefore, the 
reaction was performed at a lower temperature (0 
o
C) to enhance the configurational stability of 
the thiiranium ion intermediate, which resulted in an improved enantiomeric ratio of 94:6 er 
(entry 6). However, the conversion over the monitored time dropped to 80%, comparable to the 
12 h time point at room temperature reaction.
 
To improve the conversion, the overall 
concentration was increased to 0.4 M (entry 7). Gratifyingly, the reaction showed full conversion 
to tetrahydroquinoline 144 with excellent endo selectivity and negligible enantiomeric erosion.  
4.2.3 Survey of Substrate Scope 
4.2.3.1 Sulfenoamination of Olefins with One-Methylene Tether 
Both indoline and tetrahydroquinoline scaffolds were accessible with single-methylene 
tethered substrates, depending on the mode of cyclization (5-exo vs 6-endo). To evaluate the 
influence of electronic properties of the aniline nucleophile on reaction outcome, a series of 
substrates with varying substitutions on the nucleophile was prepared. The model substrate, 
electron-rich anisidine 129 afforded 2,3-difunctionalized tetrahydroquinoline 144 with high site- 
and enantioselectivity (Table 12, entry 1). Electron-neutral anilines 136 and 130 both cyclized 
into tetrahydroquinolines 145 and 146 with comparable enantioselectivity to 144 (entries 2, 3). 
However, the cyclization of para-fluoro aniline 130 was much slower in contrast to anilines 129 
and 136, requiring 6 days to reach full conversion (compared to 2 days). Cyclization of naphthyl 
substrate 131 cleanly furnished tetrahydrobenzo[f]quinoline 131 with high enantioenrichment 
(entry 4). In all single-methylene tethered styrenyl cases, excellent site-selectivity was observed 
for 6-endo cyclization.  
The influences of the electronic properties of the olefin were also investigated. Styrenes 
with electron-donating substituents 137 and 138 afforded tetrahydroquinolines via endo 
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cyclization with high yields and enantioselectivities (entries 5, 6). The reaction times required for 
full conversion were comparable to the model substrate 129. Electron-deficient styrenes are 
known to exhibit poor reactivity and therefore not examined.
12,13,30
 
Table 12. Scope of the Sulfenoamination of Substrates with One-Methylene Tether. 
 
entry substrate major product yield, %
a
 endo : exo
b
 er
c
 
1 
 
 
87 >20 : 1 94 : 6 
2 92 >20 : 1 95 : 5 
3 86
d
 >20 : 1 96 : 4 
4 
  
93 >20 : 1 98 : 2 
5 
  
93 >20 : 1 96 : 4 
6 88 >20 : 1 97 : 3 
7 
  
86 1 : 4 86 : 14 
8 
  
85 1 : 12 98 : 2 
9 
  
90 >20 : 1 98 : 2 
10 
  
89 >20 : 1 88 : 12 
11 
  
70 1 : 4 95 : 5 
a Isolated yields of analytically pure material. b Constitutional selectivity determined by 1H NMR spectroscopy 
of the crude mixture. c The enantiomeric ratio of the major constitutional isomer was determined by CSP-HPLC 
analysis, and the absolute configurations of the products were assigned by comparison of their CD spectra with 
144. d Reaction time of 6 d.  
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Next, dialkyl-substituted olefins were tested to explore the steric influences of the olefin 
on the reaction outcome. Cyclization of the nitrile-appended aliphatic olefin 140 afforded a 4:1 
mixture of exo and endo cyclized products, with diminished enantiomeric ratio of 86:14 (entry 7). 
However, olefin 133, having a sterically demanding isopropyl group, cyclized with improved 
constitutional selectivity favoring 5-exo cyclization (exo:endo = 12:1) and excellent 
enantioselectivity (98:2 er) (entry 8).  
Olefins with different numbers of substitutions were also examined. In the previous 
sulfenofunctionalization studies, cyclizations of terminal olefins resulted in high 
enantioselectivities whereas cyclizations of trisubstituted olefins did not.
12,13,30
 Terminal olefin 
containing substrate 134 transformed cleanly into 2-substituted indoline 152 via 5-exo 
cyclization with excellent enantioselectivity (entry 9). In contrast, trisubstituted olefin substrate 
132 afforded 2,2-dimethyl substituted tetrahydroquinoline 153 via 6-endo cyclization with a 
reduced enantiomeric ratio (88:12 er) (entry 10). 
Lastly, a substrate was devised to compare the relative reactivity of the two different 
types of nucleophiles, amines and anilines, toward the capture of the thiiranium ion. Substrate 
141, containing competing aniline and amine nucleophiles afforded pyrrolidine 154 as the major 
product (entry 11). This result clearly shows the superior thiiranium ion capturing ability of the 
aliphatic amines.  
4.2.3.2 Sulfenoamination of Olefins with Longer Tethers 
Substrates with longer tethers were explored to gauge the potential to access larger N-
containing heterocycles such as tetrahydrobenzazepines. In Table 12, tetrahydroquinolines with 
2-aryl substituents were accessible from 2-cinnamyl anilines with excellent site-selectivity, while 
those with aliphatic substituents at the 2-position were generated with reduced site-selectivity. 
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To address this problem, substrates bearing longer tethers were examined. Specifically, dialkyl 
substituted olefin 142 cleanly afforded 2-alkyltetrahydroquinoline 155 by 6-exo cyclization with 
excellent enantioselectivity (98:2 er) (Table 13, entry 1). On the other hand, electronically biased 
styrenyl olefin substrate 139 furnished 2-phenyltetrahydrobenzazepine 156 via 7-endo 
cyclization with high site- and enantioselectivity (entry 2). 
Terminal olefins with longer tethers were also examined. Cyclization of 2-homoallyl 
aniline 135 furnished 2-alkyltetrahydroquinoline 157 also via 6-exo closure with excellent 
constitutional and enantioselectivity (entry 3). Lastly, aniline 143 bearing an ortho-4-pentenyl 
chain cyclized to form 2-alkyltetrahydrobenzazepine 158 via the 7-exo mode with high 
enantioselectivity (entry 4). 
Table 13. Scope of the Sulfenoamination of Substrates with Longer Tethers. 
 
entry substrate product yield, %
a
 endo : exo
b
 er
c
 
1 
  
93 1 : >20 98 : 2 
2 
  
91 >20 : 1 95 : 5 
3 
  
93 1 : >20 98 : 2 
4 
  
89 1 : >20 93 : 7 
a Isolated yields of analytically pure material. b Constitutional selectivity determined by 1H NMR 
spectroscopy of the crude mixture. c The enantiomeric ratio of the major constitutional isomer was 
determined by CSP-HPLC analysis, and the absolute configurations of the products were assigned by 
comparison of their CD spectra with 144. 
92 
 
4.2.4 Desulfurization of the Sulfenoamination Products 
In contrast to phenyl sulfides, which are easily cleaved with nickel boride under mild 
conditions,
109
 2,6-diisopropylphenyl sulfides required more forcing desulfurization conditions. 
The 2,6-diisopropyl sulfide moiety was cleanly reduced by lithium naphthalenide, along with the 
concomitant reductive cleavage of the tosyl protecting group (Scheme 51).
110
 The absolute 
configuration of the reduced product, 2-methylindoline (159), was compared to literature values 
and assigned the (R)-configuration.
111
 
Scheme 51 
 
4.3 Discussion 
The primary objective for this project was to expand the scope of the enantioselective, 
catalytic sulfenoamination of olefins to tethered aniline nucleophiles to synthesize 
enantioenriched benzannulated nitrogen-containing heterocycles, e.g. indolines, 
tetrahydroquinolines, and tetrahydrobenzazepines. The influence of nucleophile, alkene 
environment, and tether length on the rate, enantioselectivity and site-selectivity are discussed. 
4.3.1 Optimization of the Sulfenoamination Reaction 
4.3.1.1 Overall Concentration 
During the optimization surveys, the overall concentration was the only factor altered 
from the typical reaction condition, which was increased four-fold to 0.4 M from 0.1 M. The 
main concern with this alteration was that higher concentration could result in racemization via 
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“olefin-to-olefin” transfer of the sulfenium group.33 However, in contrast to the effects of 
elevated temperature, increased concentration showed enhanced conversion with no significant 
enantiomeric erosion, indicating that olefin-to-olefin transfer is disfavored at 0 
o
C. 
4.3.1.2 Catalyst and Brønsted Acid 
An extensive catalyst survey was unnecessary, having been performed in the preceding 
studies. The third generation, diisopropylamine substituted selenophosphoramide catalyst (S)-83 
provided the best selectivity for all O-,
112
 N-,
13
 and C-nucleophile
97
 sulfenofunctionalization 
reactions. The improved performance of the PhthSAryl 124 relative to other sulfenylating agents 
(e.g. PhthSPh 6) attributed to its enhanced steric environment that leads to the distortion of the 
catalyst for better differentiation of the two enantiotopic faces of the olefin, ultimately resulting 
in excellent enantioselectivies.
96
 
The Brønsted acid loading was adopted unchanged from the previous sulfenoamination 
reaction conditions. According to the titration studies, the catalytically active species i reached 
saturation above 4.0 equivs of Brønsted acid with respect to the catalyst (Figure 18).
69
 In this 
sulfenoamination study, 0.5 equivs of MsOH were sufficient for full activation of the 
catalytically active species i (
31
P NMR at 60 ppm), and showed anticipated reactivity for the 
cyclization. Therefore, the acid loading required no further optimization. 
4.3.2 Structural Effects on Rate and Selectivity 
4.3.2.1 Influence of the Nucleophile 
 Many factors can influence the rate, enantioselectivity, and site-selectivity of the 
sulfenoamination reaction, such as electronic and steric properties of the olefin and the 
nucleophile, or the length of the tether connecting them. Because these factors were also 
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explored in the preceding cyclization studies with aliphatic tosylamides, the results from this 
work will be compared to those previous results.  
4.3.2.1.1 Reaction Rate 
Anilines with electron donating (129) and withdrawing (130) substituents on the para-
position were both examined (Scheme 52). Whereas no noticeable enhancement on rate was 
observed with more electron rich nucleophile relative to the electron neutral substrate 136, the 
reaction slowed significantly with electron poor nucleophile 130 which required 6 days to reach 
full completion. 
Scheme 52 
 
This observation may be explained by a change in the turnover limiting step (TOLS) 
(Figure 19). 
 
Figure 19. Unified mechanistic scheme for different TOLS. 
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For sulfenofunctionalization reactions involving thiiranium ion intermediates, the 
formation of the thiiranium ion is typically considered to be turnover limiting.
96
 Therefore, 
electron-rich anilines do not enhance the reaction rate, because the formation of the thiiranium 
ion is not affected by the electronic character of the aniline ring. However, with a 4-fluoro 
substituent, which is π-donating but σ-withdrawing,113 the rate was substantially retarded. This 
outcome can be interpreted as an inductive effect of the 4-fluoro group, resulting in decreased 
nucleophilicity of the nitrogen atom and thus disfavored capture of the thiiranium ion. Since the 
thiiranium ion formation should not be affected by the electron withdrawing character of the 
aniline ring, the observed rate deceleration can be interpreted as a change of TOLS for 130, from 
thiiranium formation to nucleophilic capture. 
4.3.2.1.2 Enantioselectivity 
The enantiomeric compositions of the sulfenoamination products were consistently high 
and exhibited the same absolute configuration across a range of nucleophiles possessing varying 
electronic properties. This behavior is consistent with the formation of the thiiranium ion being 
the enantiodetermining step. However, the shift in the turnover limiting step implies an extended 
lifespan of the thiiranium ion species. As stated earlier in Section 2.1.3, S-phenyl thiiranium ions 
are known to be configurationally unstable at 0 
o
C toward “olefin-to-olefin” sulfenium group 
transfer.
33
 Therefore, decreased enantioselectivity would be expected for slow cyclizations 
implying a slow capture of the thiiranium ion. 
Scheme 53 
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However, for the cyclization of 4-fluoro aniline substrate 130, high enantioselectivity was 
observed despite the slow capture of the thiiranium ion (Scheme 53). This result implied that the 
S-2,6-diisopropylphenyl thiiranium ion preserved its enantioenrichment at 0 
o
C. Therefore, it 
may be safely argued that the configurational stability of the S-2,6-diisopropylphenyl thiiranium 
ion is much greater than that of S-phenyl thiiranium ion at 0 
o
C. 
4.3.2.1.3 Site-Selectivity 
The site-selectivity of the cyclization reaction is heavily dominated by the electronic 
properties of the alkenes. (E)-2-Cinnamylaniline derivatives 129, 136, 130, and 131 afforded 6-
endo cyclized products exclusively, regardless of the electronic properties of the nucleophile. 
Therefore, the variation on electron density of the nucleophile had no observable influence on 
the site-selectivity of sulfenoamination reaction. 
4.3.2.2 Influence of Alkene Substitution 
In the previous sulfenofunctionalization studies, the alkene environment had a profound 
influence on both rate and selectivity.
12,13,30
 The reaction rate is heavily dependent on the 
electron density of the olefin because the formation of the thiiranium ion is generally the TOLS, 
while the enantioselectivity is mainly governed by the geometrical and steric environment of the 
olefin. These properties dictate the affinity of the olefin for the catalytically active species i. On 
the basis of the assumption that the formation of the thiiranium ions is typically the TOLS, the 
overarching reactivity trend on the alkene for the sulfenofunctionalizations was established. 
Therefore, it seemed unnecessary to explore the individual rate of the each reaction; the reactions 
were set up for 48 h to reach completion by default based on the results from the initial reactivity 
optimization.  
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4.3.2.2.1 Enantioselectivity 
During the examination of substrate scope, the enantiomeric ratios of the cyclized 
products were mostly unaffected by the alkene environment, with the exception of nitrile 
substrates 140
114
and trisubstituted olefin 132. Various aryl- and alkyl-substituted trans-alkenes 
were sulfenoaminated with high (95:5 er) to excellent (98:2 er) enantioselectivities. The 
consistency of enantiomeric composition observed for the cyclized products implies that the 
sulfenoamination proceeds through a common, enantioenriched thiiranium ion intermediate. This 
is strong evidence for the current understanding of the thiiranium ion formation being the 
enantiodetermining step. 
In the case of the trisubstituted olefin 132, several hypotheses may account for the 
diminished enantioselectivity. The first possibility is the lower inherent facial-selectivity of the 
catalyst toward this class of olefin, and the second is the existence of a competitive racemic 
pathway. However, in contrast to the case of 132, high enantioselectivity has recently been 
obtained for oxysulfenylation of 2-prenylphenol employing (S)-83, PhthSAryl 124 and 0.25 
equivs of MsOH (Scheme 54),
112
 which strongly suggests that the first possibility is not likely. 
Scheme 54 
 
The disparity between these two similar trisubstituted substrates may be explained by pH-
dependent reactivity differences. During the optimization of oxysulfenylation reaction, 
comparable rates and enantioselectivities were observed employing 0.25, 0.50, and 0.75 equivs 
of MsOH, hence 0.25 equivs of MsOH was chosen as the optimal condition.
112
 However, the 
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optimization process of the sulfenoamination reaction with anisidine 124 showed that 0.5 equivs 
of MsOH was adequate without observing a background reaction. 
From a titration study, as mentioned earlier, it was found that 4.0 equivs of Brønsted acid 
with respect to the catalyst was required to fully generate the catalytically active species i.
69
 This 
implies that employing 5.0 equivs of Brønsted acid with respect to the catalyst (the amount of 
acid loading found to be operative from optimizations) leaves an extra 1.0 equiv of the acid as a 
free state. This excess free acid can increase the population of protonated, achiral sulfenylating 
species 124·H
+
.  
 
Figure 20. Two pathways for generation of the thiiranium ion intermediates.  
In the initial step of the catalytic cycle, PhthSAryl 124 is protonated under the acidic 
conditions (Figure 20). Typically these protonated sulfenylating species are not reactive enough 
to effect direct thiiranium ion formation with unactivated disubstituted olefins, evidenced by no 
conversion in absence of the Lewis base catalyst (Table 11, entry 5). However, trisubstituted 
alkenes are more electron-rich than disubstituted alkenes, and the subsequent transfer of the 
sulfenium group to the alkene could generate a racemic thiiranium ion intermediate. Therefore, 
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under stronger acidic conditions, a small quantity of racemic thiiranium ion may be generated 
from trisubstituted alkenes that may attenuate the observed enantioselectivity.  
4.3.2.2.2 Site-Selectivity 
Among the factors governing the site-selectivity of the nucleophilic attack, the electron 
density distribution in the alkene appears to be the most important. For example, styrenyl 
substrates 136 and 139 cyclized into tetrahydroquinoline 145 and tetrahydrobenzazepine 156, 
respectively, with complete endo selectivity. In contrast, aliphatic alkenes cyclized with exo 
selectivity. Steric factors seem to be less important than electronic factors, yet the influence of 
the olefin steric environment on site-selectivity is evident in highly-hindered substrates. 
Isopropyl substituted olefin 133 afforded an enhanced exo/endo ratio compared to other alkyl-
substituted olefins, possibly due to the increased steric repulsion between the olefin substituent 
and the incoming nucleophile. 2-Prenylaniline 132 cyclized to 2,2-dimethyltetrahydroquinoline 
153 via a 6-endo pathway demonstrating that the site-selectivity is governed by the electronic, 
not steric factors (Markovnikov rule). 
4.3.2.3 Influence of the Tether Length 
From previous studies on sulfenoamination reactions, influence of the tether length was 
found to be an important factor in controlling the site-selectivity (See Chapter 2 for details, 
Scheme 55).
13
 As is now commonly observed, the enantioselectivities are not affected by the 
tether length if the alkene substitution pattern is the same.  
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Scheme 55 
 
These trends were also observed in the sulfenoamination with aniline substrates. In the 
case of electronically and sterically unbiased, aliphatic olefins 140 and 142, indoline 150 (5-exo 
vs 6-endo) and tetrahydroquinoline 155 (6-exo vs 7-endo) are generated, respectively (Scheme 
56). Whereas 150 was generated in a 4:1 mixture of constitutional isomers favoring the exo 
approach, 155 was formed with exclusive exo selectivity. However, in terms of enantioselectivity 
comparison, substrate 140 was unfortunate choice of selection. Enantioselectivity for cyclization 
of 140 was much lower, presumably due to the interference of the nitrile moiety.
115
  
Scheme 56 
 
This difference in site-selectivity is likely attributed to higher activation entropy required 
for the formation of larger size rings. The site-selectivity for a cyclization of an electronically 
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non-biased alkene should be dependent on the size of the rings that are formed. The rates for the 
cyclization of N-tosylazacycloalkanes are known in the order of 5 > 6 > 7-membered rings.
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Therefore, the cyclization of 140 should favor the formation of an indoline over a 
tetrahydroquinoline via 5-exo closure. The cyclization of substrate 142 also shows good 
agreement with the reported rate (6-membered ring formation is 200 fold faster than 7-membered 
ring formation) affording only tetrahydroquinoline 155 via 6-exo closure. 
Electronically biased alkene substrates with different tethers were also investigated. Both 
cinnamyl substrates 136 and 139 afforded tetrahydroquinoline 145 and tetrahydrobenzazepine 
156 respectively, with a kinetic preference of endo cyclization (Scheme 57a). Similar to the trend 
observed in the previous studies, the enantioselectivities were comparable for both heterocyclic 
products. The alkenes in substrates 134, 135, and 143 bearing different length tethers are 
electronically biased in the opposite direction (Scheme 57b). All three terminal olefins cyclized 
via exo closure into indolines, tetrahydroquinolines, and tetrahydrobenzazepines with excellent 
site-selectivity. Both of the cinnamyl and terminal alkene substrates demonstrated that the site-
selectivity is governed by the Markovnikov rule. 
Scheme 57 
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4.4 Conclusion 
In conclusion, the catalytic, enantioselective sulfenoamination of olefins with aniline 
nucleophiles has been developed, using a chiral selenophosphoramide Lewis base catalyst. This 
method allows rapid access to highly enantioenriched N-heterocycles, including biologically-
relevant indolines, tetrahydroquinolines, and tetrahydrobenzazepines with excellent site-
selectivity. Systematic investigation of the nucleophile component and tether enabled to identify 
their influence on rate, enantioselectivity, and site-selectivity. Whereas rates on cyclizations of 
electron-neutral and -rich anilines were comparable, those of electron-deficient anilines were 
greatly decelerated, suggesting a change in the TOLS. Enantioselectivity was unaffected with 
modifications in nucleophile component or tether length. Excellent site-selectivity for styrenyl 
alkenes were observed, favoring nucleophilic capture at the benzylic carbon. Site-selectivity for 
cyclization of electronically non-biased alkenes was low for one-methylene tethers but high for 
longer tethers. The configurational stability of the thiiranium ions was increased by employing 
(2,6-diisopropylphenyl)thiophthalimide, leading to enhanced enantioselectivities. Utilization of 
the arylsulfenyl moiety of the product is currently under investigation. Also development of new 
catalyst designs suitable for the enantioselective sulfenofunctionalization of cis- and higher-order 
substituted alkenes are underway. 
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CHAPTER 5: Experimental Procedures 
5.1 General Experimental  
All reactions were performed in oven dried (140 °C) and/or flame dried glassware under 
an atmosphere of dry argon, unless noted. Internal temperatures of low temperature reactions 
were measured using Teflon coated thermocouples unless otherwise noted. A ThermoNesLab 
CC-100 or a ThermoNesLab IBC-4A cryocool with an attached cryotrol was used for reactions 
at subambient temperatures. 
 Boiling points for Kugelrohr distillations correspond to corrected air bath temperatures 
(ABT). Melting points (mp) were determined on a Thomas-Hoover capillary melting point 
apparatus in sealed tubes under vacuum and are corrected. Analytical thin-layer chromatography 
was performed on Merck silica gel plates with QF-254 indicator. Rf values reported were 
measured using a 10 × 2 cm TLC plate in a developing chamber containing the solvent system 
described. Visualization was accomplished with UV (254 nm), and/or potassium permanganate 
(KMnO4), or ceric ammonium molybdate (CAM). Column chromatography was performed using 
Merck silica 60 (40-63 μm particle size) gel purchased from Aldrich.  
Analytical chiral stationary phase supercritical fluid chromatography (CSP-SFC) was 
performed on an Agilent 1100 HPLC equipped with an Aurora Systems A-5 supercritical CO2 
adapter for supercritical fluid chromatography and a UV detector (220 nm or 254 nm) using 
Daicel Chiralcel OD, OJ, OB or Chiralpak AD, and AS columns as well as a Regis Whelk-O1 
column. Normal Phase HPLC was performed on an Agilent 1100 HPLC equipped with AD-H, 
OJ-H, IB-3, Naphtholeucine and R,R-Beta-Gem columns. Reverse-Phase HPLC was performed 
on an Agilent 1100 HPLC using a Chiralpak AD-RH or Chiralcel OJ-RH column. Optical 
rotations were measured using a Jasco DIP-360 digital polarimeter in Fischer spectranalyzed 
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grade CHCl3 containing approximately 0.75% EtOH as a preservative and are reported as 
follows: concentration (c = g/dL), and solvent.   
1
H and 
13
C NMR spectra were recorded on Varian Unity (400 MHz, 
1
H; 101 MHz, 
13
C) 
or Inova (500 MHz, 
1
H; 126 MHz, 
13
C) spectrometers. 
31
P NMR and 
19
F spectra were recorded 
on Inova (202 MHz) and Inova (470 MHz) spectrometers respectively.
1
H NMR Spectra and 
13
C 
NMR spectra were acquired in CDCl3 referenced to residual CHCl3 at 7.26 and 77.00 ppm 
respectively.  Assignments were obtained by reference to COSY, HSQC and HMBC correlations. 
Chemical shifts are reported in ppm, multiplicities are indicated by s (singlet), d (doublet), t 
(triplet), q (quartet), p (pentet), sext (sextet), sept (septet), m (multiplet) and br (broad).  
Coupling constants, J, are reported in Hertz, and integration is provided and assignments are 
indicated.  
Mass spectroscopy (MS) was performed by the University of Illinois Mass Spectrometry 
Center. ESI mass spectra were performed on a Waters or Micromass Q-Tof Ultima instrument. 
EI mass spectra were performed on a 70-VSE instrument. Data are reported in the form of (m/z) 
versus intensity. Infrared spectra (IR) were recorded on a Mattson Galaxy 5020 
spectrophotometer in KBr pellets or NaCl cells (film) or Perkin-Elmer FT-IR system. Peaks are 
reported in cm
-1
 with indicated relative intensities: s (strong, 67-100%); m (medium, 34-66%); w 
(weak, 0-33%). Elemental analyses were performed by the University of Illinois Microanalytical 
Service Laboratory and Robertson Microlit Laboratories, Inc.  
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5.2 Commercial Chemicals 
Reaction solvents tetrahydrofuran (Fisher, HPLC grade), diethyl ether (Fisher, BHT 
stabilized ACS grade), and CH2Cl2 (Fisher, unstabilized HPLC grade) were dried by passage 
through two columns of neutral alumina in a solvent dispensing system. Reaction solvents 
hexane (Fisher, OPTIMA grade) was dried by percolation through a column packed with neutral 
alumina and a column packed with Q5 reactant, a supported copper catalyst for scavenging 
oxygen, in a solvent dispensing system. Reaction solvent N,N-dimethylformamide (Fisher, 
HPLC grade) was dried by percolation through a column packed with molecular sieves in a 
solvent dispensing system. Solvents for chromatography, filtration and recrystallization were 
CH2Cl2 (Aldrich, ACS grade), ethyl acetate (Fisher, ACS grade), diethyl ether (Fisher, ACS 
grade), hexane (Fisher, Optima) and toluene (Aldrich, Optima) were used as received. 
Isopropylamine (Aldrich), triethylamine (Alfa-Aesar) and pyridine (Fisher) were freshly distilled 
from CaH2. Methanol (Fisher, ACS grade) was distilled from magnesium. “Brine” refers to a 
saturated aqueous solution of sodium chloride.  
 
5.3 Literature Preparations 
Literature Preparations for Chapter 2: 
Electrophile N-(phenylthio)-phthalimide 6
44
 was prepared according to a literature 
procedure. 
Chiral selenophosphoramide catalysts (R)-7,
12
 (S)-53,
30
 (S)-79,
30
 (S)-80,
30
 (S)-81,
30
 (S)-
82
30
 were prepared as described. 
Substrates and intermediates (E)-5-phenyl-4-penten-1-ol 2,
12
 (E)-N-(5-phenyl-4-penten-
1-yl)-4-toluenesulfonamide 56,
42c
 (E)-ethyl 5-phenyl-4-pentenoate 65,
117
 (Z)-N-(5-phenyl-4-
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penten-1-yl)-4-toluenesulfonamide 92,
42c
 N-(4-penten-1-yl)-4-toluenesulfonamide 93,
118
 (E)-N-
(4-phenyl-3-buten-1-yl)-4-toluenesulfonamide 94,
42a
 (E)-N-(2,2-dimethyl-5-phenyl-4-penten-1-
yl)-4-toluenesulfonamide 99,
42b
 (E)-5-(4-methoxyphenyl)-4-penten-1-ol 160,
119
 (E)-5-(4-
trifluoromethylphenyl)-4-penten-1-ol 161,
120
 (E)-7-phenyl-4-hepten-1-ol 162,
38
 (E)-6-methyl-4-
hepten-1-ol 163,
121
 (E)-5-phenyl-4-pentenenitrile 167,
42b
 (E)-5-phenyl-4-pentenoic acid 168
122
 
were prepared according to a literature procedure. 
 
Literature Preparations for Chapter 3: 
Substrate alkene 52
30
, N-(phenylthio)-phthalimide 6
44
, and chiral selenophosphoramide 
catalyst (S)-53
30
 was prepared according to literature procedures.  
 
Literature Preparations for Chapter 4: 
Intermediates and substrates 129b,
123a
 130b,
123b
 131b,
123c
 132,
124
 133b,
123d
 134,
101
 135,
102
 
140c,
125
 (E)-7-(2-bromophenyl)-4-hepten-1-ol 142d,
126
 1-bromo-2-(4-pentenyl)benzene 143b
127
 
were prepared according to a literature procedure. 
 
Caution! Sodium cyanide is extremely toxic and great care should be taken when 
handling these reagents. All reactions should be performed in a well-ventilated fume-hood and 
the appropriate protective clothing should be worn at all times.  
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5.4 Experimental Procedures for Chapter 2 
Preparation of Amines with Varying Protecting Groups (Chart1 and Scheme 18) 
Preparation of (E)-5-Phenylpent-4-enamide (66)
128
 (Scheme 18) [HMC1030] 
 
An oven-dried 250 mL Schlenk flask was equipped with a stir bar, septum and a positive 
argon inlet. Solid ammonium chloride (16.1 g, 302 mmol, 2.80 equiv) was loaded into the flask 
which was purged with argon. Anhydrous toluene was added via syringe to afford a suspension 
of ammonium chloride/toluene. The suspension was cooled in an ice-bath for five minutes. To 
the suspension was added a solution of trimethylaluminum (151 mL, 302 mmol, 2.0 M in toluene, 
2.80 equiv) dropwise via addition funnel over 1 h with observation of gas evolution. The mixture 
was allowed to stir at 0 
o
C for 1 h at it became homogeneous. Then the mixture was allowed to 
warm to room temperature and was stirred for an additional 30 min. The aluminum reagent 
mixture was then transferred via cannula over 1 h to a solution of the ester 65
117
 (22.0 g, 108 
mmol) in toluene (150 mL) in an oven-dried, argon purged 1000-mL, 3-necked round-bottomed-
flask. After addition, the mixture was heated at 55 
o
C under argon for 14 h. After completion, the 
reaction was quenched with slow addition of 1 M HCl (150 mL) at 0 
o
C. The mixture was diluted 
with water (250 mL) and ethyl acetate (250 mL) and phases were separated. The aqueous layer 
was extracted with ethyl acetate (300 mL x3) and the combined organic extracts were washed 
with brine (300 mL), dried over Na2SO4, filtered, and concentrated in vacuo (30 
o
C, 10 mmHg) 
to afford a white solid. Recrystallization of the solid with hot ethyl acetate (77 
o
C, 40 mL) 
afforded 11.1 g (76%) of 66 as white crystals. The spectroscopic data matched those reported in 
the literature.
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Data for 66: 
 mp:  132-133 
o
C (sealed tube) 
 1
H NMR: (500 MHz, CDCl3) 
  δ 7.40 – 7.18 (m, 5 H), 6.46 (d, J = 16.0 Hz, 1 H,), 6.23 (dt, J = 16.0, and 7.0 Hz, 1 
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H), 5.61 (brs, 1 H), 5.50 (brs, 1 H), 2.60 – 2.53 (m, 2 H), 2.42 – 2.37 (m, 2 H). 
 13
C NMR: (126 MHz, CDCl3) 
  δ 174.5, 137.2, 131.2, 128.5, 127.3, 126.1, 125.9, 35.4, 28.7. 
 MS: (ESI)  
117 (51), 159 (25), 176 (M+H, 100), 177 (14), 198 (10) 
 HRMS: calcd for C11H14NO: 176.1075, found: 176.1079 
 
Preparation of (E)-5-Phenylpent-4-enylamine (67) [HMC1033] 
 
An oven-dried, 500-mL Schlenk flask was equipped with a stir bar, was charged with a 
solution of amide 66 (10.0 g, 57.1 mmol) in anhydrous tetrahydrofuran (190 mL) at 0 
o
C. To the 
solution was added lithium aluminum hydride (3.25 g, 85.6 mmol, 1.50 equiv) in portions with 
caution. Then the mixture allowed to warm to room temperature and was 12 h. The standard 
Fieser and Fieser work up was used,
129
 adding 3.24 mL of water, 3.24 mL of 15% NaOH 
solution, and 9.75 mL of water in sequence under 0 
o
C. Then the mixture was allowed to warm 
to room temperature and stir for 15 min. To the mixture was added 5 g of MgSO4 and the 
resulting solids were filtered through a pad of Celite (5 g, 35 mm). The resulting solution was 
concentrated under concentrated in vacuo (30 
o
C, 10 mmHg) and purified by passing through a 
short pad of silica (SiO2, 5 g, 20 mm Ø , dichloromethane/methanol = 9:1, then 
dichloromethane/methanol = 9:1 with 1% triethylamine) to afford 7.3 g (79%) of the primary 
amine 67. The spectroscopic data matched those reported in the literature.
122 
 
Data for 67: 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.36 – 7.16 (m, 5 H), 6.40 (d, J = 15.5 Hz, 1 H), 6.22 (d, J = 16.0 Hz, 1 H), 2.77 (t, 
J = 7.0 Hz, 2 H), 2.27 (q, J = 7.5 Hz, 2 H), 1.87 (brs, 2 H), 1.64 (p, J = 7.5 Hz, 2 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 137.7, 130.2, 130.2, 128.4, 126.9, 125.9, 41.6, 33.1, 30.3. 
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Protection of Precursor Amine (Scheme 18) 
Preparation of (E)-N-(4-Toluenesulfonyl)-5-phenylpent-4-enylamine (56)
42a,b
 (Scheme 18) 
[HMC1072] 
 
To an oven-dried, 25-mL Schlenk flask equipped with a magnetic stir bar, purged with 
positive pressure of argon, were added a solution of parent amine 67 (500 mg, 3.10 mmol) in 
dichloromethane (4 mL) and a solution of triethylamine (864 L, 6.20 mmol, 2.00 equiv) in 
dichloromethane (3 mL). After equilibration at 0 
o
C (internal temperature), to the mixture was 
added a solution of tosyl chloride (621 mg, 3.26 mmol, 1.05 equiv) in dichloromethane (3 mL) 
portion wise. The resulting reaction mixture was allowed to warm to room temperature and was 
stirred for 4 h. The resulting mixture was diluted with 20 mL of dichloromethane and washed 
with 20 mL of 1 M HCl, 1 M NaOH, water and brine, respectively. The resulting organic layer 
was dried over Na2SO4, filtered, and concentrated in vacuo (30 
o
C, 10 mmHg) to afford the crude 
yellow liquid. Purification via silica gel flash column chromatography (SiO2, 15 g, 20 mm Ø , 
hexanes/EtOAc, 9:1 to 4:1) afforded 792 mg (81%) of 56, as a white solid. The spectroscopic 
data matched those reported in the literature.
42c
 
 
Data for 56: 
 mp:  59-60 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.76 (d, J = 8.5 Hz, 2 H), 7.35 – 7.16 (m, 7 H), 6.34 (dt, J = 16.0, and 1.5 Hz, 1 
H), 6.09 (dt, J = 16.0, and 7.0 Hz, 1 H), 4.46 (t, J = 6.5 Hz, 1 H), 3.01 (q, J = 7.0, 
and 6.5 Hz, 2 H), 2.42 (s, 3 H), 2.25 – 2.19 (m, 2 H), 1.66 (p, J = 7.0 Hz, 2 H) 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.3, 137.4, 136.9, 130.9, 129.7, 128.9, 128.4, 127.1, 127.0, 125.9, 42.5, 29.8, 
29.1, 21.4. 
 MS: (ESI)  
316 (M+H, 100), 317 (22), 333 (10), 338 (18) 
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 HRMS: calcd for C18H22NO2S: 316.1371, found: 316.1365 
 TLC: Rf 0.32 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
  
Preparation of (E)-N-(4-Nitrobenzenesulfonyl)-5-phenylpent-4-enylamine (57) (Scheme 18) 
[HMC1038] 
 
To an oven-dried, 25-mL round-bottomed-flask equipped with a magnetic stir bar, purged 
with positive pressure of argon, were added a solution of parent amine 67 (250 mg, 1.55 mmol) 
in dichloromethane (3 mL) and triethylamine (432 L, 3.10 mmol, 2.00 equiv). After 
equilibration at 0 
o
C (internal temperature), to the mixture was added a solution of p-
nitrobenzenesulfonyl chloride (361 mg, 1.63 mmol, 1.05 equiv) in dichloromethane (2 mL). The 
resulting reaction mixture was allowed to warm to room temperature and was stirred for 10 h. 
The resulting mixture was diluted with 10 mL of dichloromethane and washed with 10 mL of 1 
M HCl, 1 M NaOH, water and brine, respectively. The resulting organic layer was dried over 
Na2SO4, filtered, and concentrated in vacuo (30 
o
C, 10 mmHg) to afford the crude yellow liquid. 
Purification via silica gel flash column chromatography (SiO2, 15 g, 20 mm Ø , hexanes/EtOAc, 
9:1 to 4:1) afforded 445 mg (83%) of 57, as a white solid. The spectroscopic data matched those 
reported in the literature.
42d
 
 
Data for 57: 
 mp:  97-98 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 8.33 (d, J = 9.0 Hz, 2 H), 8.05 (d, J = 9.0 Hz, 2 H), 7.32 – 7.20(m, 5 H), 6.34 (d, J 
= 16.0 Hz, 1 H), 6.08 (dt, J = 16.0, 7.0 Hz, 1 H), 4.81 (t, J = 6.0 Hz, 1 H), 3.08 (q, J 
= 7.0 Hz, 2 H), 2.24 (q, J = 7.0 Hz, 2 H), 1.71 (p, J = 7.0 Hz, 2 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 150.0, 145.9, 137.1, 131.3, 128.6, 128.3, 128.2, 127.3, 125.9, 124.4, 42.7, 29.7, 
29.2. 
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 MS: (ESI)  
145 (24), 255 (14), 317 (18), 347 (M+H, 100), 348 (20), 364 (58), 369 (41), 385 
(15), 421 (26) 
 HRMS: calcd for C17H19N2O4S: 347.1066, found: 347.1063 
 TLC: Rf 0.27 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
 
Preparation of (E)-N-(2,4,6-Triisopropylbenzenesulfonyl)-5-phenylpent-4-enylamine (58) 
(Scheme 18) [HMC1055] 
 
To an oven-dried, 25-mL Schlenk flask equipped with a magnetic stir bar, purged with 
positive pressure of argon, were added a solution of parent amine 67 (250 mg, 1.55 mmol) in 
dichloromethane (2 mL) and a solution of triethylamine (432 L, 3.10 mmol, 2.00 equiv) in 
dichloromethane (1.5 mL). After equilibration at 0 
o
C (internal temperature), to the mixture was 
added a solution of trisyl chloride (470 mg, 1.55 mmol, 1.00 equiv) in dichloromethane (1.5 mL) 
portion wise. The resulting reaction mixture was allowed to warm to room temperature and was 
stirred for 12 h. The resulting mixture was diluted with 10 mL of dichloromethane and washed 
with 15 mL of 1 M HCl, 1 M NaOH, water and brine, respectively. The resulting organic layer 
was dried over Na2SO4, filtered, and concentrated in vacuo (30 
o
C, 10 mmHg) to afford the crude 
yellow liquid. Purification via silica gel flash column chromatography (SiO2, 15 g, 20 mm Ø , 
hexanes/EtOAc, 4:1) afforded 504 mg (76%) of 58, as a white solid. 
 
 Data for 58: 
 mp:  85-86 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.31 – 7.18 (m, 7 H), 6.35 (d, J = 16.0 Hz, 1 H), 6.12 (dt, J = 16.0, 7.0 Hz, 1H), 
4.47 (t, J = 6.0 Hz, 1 H), 4.24 – 4.34 (m, 2 H), 3.05 (app. q, J = 7.5, 7.0 Hz, 2H), 
2.96 – 2.88 (m, 1 H), 2.24 (app. q, J = 7.5, 7.0 Hz, 2 H), 1.70 (p, J = 7.0 Hz, 2 H), 
1.28 (t, J = 6.0 Hz, 18 H). 
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13
C NMR:  (126 Hz, CDCl3) 
  δ 152.6, 150.2, 137.3, 132.3, 130.9, 128.9, 128.4, 127.0, 125.9, 123.8, 42.3, 34.1, 
30.0, 29.6, 29.4, 24.8, 23.5. 
 MS: (ESI)  
428 (M+H, 100), 429 (35), 430 (17), 445 (13), 450 (11) 
 HRMS: calcd for C26H38NO2S: 428.2623, found: 428.2615 
 TLC: Rf 0.54 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
 
Preparation of (E)-N-Benzoyl-5-phenylpent-4-enylamine (59) (Scheme 18)
42e
 [HMC1040] 
 
To an oven-dried, 25-mL Schlenk flask equipped with a magnetic stir bar, purged with 
positive pressure of argon, were added a solution of parent amine 67 (250 mg, 1.55 mmol) in 
dichloromethane (2 mL) and a solution of triethylamine (432 L, 3.10 mmol, 2.00 equiv) in 
dichloromethane (1.5 mL). After equilibration at 0 
o
C (internal temperature), to the mixture was 
added a solution of benzoyl chloride (180 L, 1.55 mmol, 1.00 equiv) in dichloromethane (1.5 
mL) portion wise. The resulting reaction mixture was allowed to warm to room temperature and 
was stirred for 16 h. The resulting mixture was diluted with 15 mL of dichloromethane and 
washed with 20 mL of water, 1 M HCl, and sat. NaHCO3 aq. solution, respectively. The resulting 
organic layer was dried over Na2SO4, filtered, and concentrated in vacuo (30 
o
C, 10 mmHg) to 
afford the crude orange oil. Purification via silica gel flash column chromatography (SiO2, 15 g, 
20 mm Ø , hexanes/EtOAc, 4:1) afforded 304 mg (74%) of 59, as a white solid. The melting 
point data matched the literature value.
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Data for 59: 
 mp:  62-63 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.74 (d, J = 8.0 Hz, 2 H), 7.50 – 7.19 (m, 8 H), 6.44 (d, J = 16.0 Hz, 1 H), 6.32 
(brs, 1 H), 6.25 (dt, J = 16.0, and 7.0 Hz, 1 H), 3.53 (td, J = 7.0, and 7.0 Hz, 2 H), 
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2.33 (td, J = 7.0, and 7.0 Hz, 2 H), 1.82 (p, J = 7.0 Hz, 2 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 167.4, 137.4, 134.7, 131.3, 130.7, 129.7, 128.5, 128.5, 127.0, 126.8, 126.0, 39.8, 
30.7, 29.3.  
 MS: (ESI)  
105 (40), 122 (25), 145 (20), 266 (M+H, 100), 267 (23), 282 (15), 288 (22) 
 HRMS: calcd for C18H20NO: 266.1545, found: 266.1540 
 TLC: Rf 0.20 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
 
Preparation of Benzyl ((E)-5-phenylpent-4-enyl)carbamate (60) (Scheme 18)
42f
 [HMC1039] 
 
To an oven-dried, 25-mL Schlenk flask equipped with a magnetic stir bar, purged with 
positive pressure of argon, were added a solution of parent amine 67 (250 mg, 1.55 mmol) in 
THF (2 mL) and a solution of triethylamine (648 L, 4.65 mmol, 3.00 equiv) in THF (1.5 mL). 
After equilibration at 0 
o
C (internal temperature), to the mixture was added a solution of benzyl 
chloroformate (529 mg, 3.10 mmol, 2.00 equiv) in THF (1.5 mL) portion wise. The resulting 
reaction mixture was allowed to warm to room temperature and was stirred for 4 h. The resulting 
mixture was diluted with 10 mL of dichloromethane and was added 10 mL of 1 M HCl. The 
resulting biphasic mixture was extracted with dichloromethane (10 mL x 5) and was washed with 
30 mL of sat. NaHCO3 aq. solution, brine, respectively. The resulting organic layer was dried 
over Na2SO4, filtered, and concentrated in vacuo (30 
o
C, 10 mmHg) to afford a crude yellow 
liquid. Purification via silica gel flash column chromatography (SiO2, 15 g, 20 mm Ø , 
hexanes/EtOAc, 9:1) afforded 348 mg (76%) of 60, as a white solid. 
 
Data for 60: 
 mp:  50-51 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.40 – 7.16 (m, 10 H), 6.40 (d, J = 16.0 Hz, 1 H), 6.19 (dt, J = 16.0, and 7.0 Hz, 1 
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H), 5.10 (s, 2 H), 4.78 (brs, 1 H), 3.26 (q, J = 7.0, and 7.0 Hz, 2 H), 2.26 (q, J = 7.0, 
and 7.0 Hz, 2 H), 1.70 (p, J = 7.0 Hz, 2 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 156.4, 137.5, 136.6, 130.6, 129.5, 128.5, 128.5, 128.1, 127.0, 126.0, 66.6, 40.6, 
30.2, 29.6. 
 MS: (ESI)  
91 (19), 218 (17), 235 (26), 252 (100), 253 (26), 296 (M+H, 65), 297 (14), 313 (26), 
318 (34) 
 HRMS: calcd for C19H22NO2: 296.1651, found: 296.1651 
 TLC: Rf 0.38 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
 
Preparation of tert-Butyl ((E)-5-phenylpent-4-enyl)carbamate (61) (Scheme 18)
42g
 
[HMC1046] 
 
To an oven-dried, 25-mL Schlenk flask equipped with a magnetic stir bar, purged with 
positive pressure of argon, were added a solution of parent amine 67 (250 mg, 1.55 mmol) in 
dichloromethane (3 mL) and a solution of di-tert-butyl carbonate (372 mg, 1.71 mmol, 1.10 
equiv) in dichloromethane (2 mL) portion wise and the resulting reaction mixture was stirred for 
16 h at room temperature. The resulting mixture was diluted with 10 mL of dichloromethane and 
10 mL of water. The biphasic mixture was extracted with dichloromethane (10 mL x 3), and the 
combined organic layer was washed with sat. NaHCO3 aq. solution. The resulting organic layer 
was dried over Na2SO4, filtered, and concentrated in vacuo (30 
o
C, 10 mmHg) to afford the crude 
yellow solid. Purification via silica gel flash column chromatography (SiO2, 15 g, 20 mm Ø , 
hexanes/EtOAc, 9:1) afforded 380 mg (94%) of 61, as a white solid. The spectroscopic data 
matched those reported in the literature.
42 h 
 
 
Data for 61: 
 1
H NMR:  (500 MHz, CDCl3) 
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  δ 7.40 – 7.18 (m, 5 H), 6.41 (d, J = 16.0 Hz, 1 H), 6.21 (dt, J = 16.0, and 7.0 Hz, 1 
H), 4.58 (brs, 1 H), 3.23 – 3.15 (m, 2 H), 2.26 (app. q, 7.0 Hz, 2 H), 1.68 (p, J = 7.0 
Hz, 2 H), 1.46 (s, 9 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 155.9, 137.5, 130.5, 129.7, 128.4, 126.9, 125.9, 79.1, 40.2, 30.3, 29.7, 28.4.  
 
Preparation of P,P-Diphenyl-N-((E)-5-phenylpent-4-enyl)phosphinic amide (62) (Scheme 
18)
42i
 [HMC1041] 
 
To an oven-dried, 25-mL Schlenk flask equipped with a magnetic stir bar, purged with 
positive pressure of argon, were added a solution of parent amine 67 (250 mg, 1.55 mmol) in 
dichloromethane (2 mL) and a solution of N-methylmorpholine (341 L, 3.10 mmol, 2.00 equiv) 
in dichloromethane (1.5 mL). After equilibration at 0 
o
C (internal temperature), to the mixture 
was added a solution of diphenylphosphinic chloride (296 L, 1.55 mmol, 1.00 equiv) in 
dichloromethane (1.5 mL) portion wise. The resulting reaction mixture was allowed to warm to 
room temperature and was stirred for 5 h. The resulting mixture was diluted with 15 mL of 
dichloromethane and was added 5 mL of 1 M HCl. The resulting biphasic mixture was extracted 
with dichloromethane (15 mL x 3). The combined organic extracts were dried over Na2SO4, 
filtered, and concentrated in vacuo (30 
o
C, 10 mmHg) to afford the crude yellow oil. The product 
was purified via silica gel flash column chromatography (SiO2, 15 g, 20 mm Ø , hexanes/EtOAc, 
30:1) affording 375 mg (67%) of 62, as a white solid. 
 
Data for 62: 
 1
H NMR:  (400 MHz, CDCl3) 
  δ 7.90 – 7.81 (m, 4 H), 7.50 – 7.12 (m, 11 H), 6.34 (d, J = 16.0 Hz, 1 H), 6.12 (dt, J 
= 16.0, and 6.8 Hz, 1 H), 3.05 – 2.93 (m, 2 H), 2.87 (brs, 1 H), 2.23 (dt, J = 6.8, and 
6.8 Hz, 2 H), 1.73 (p, J = 6.8 Hz, 2 H). 
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13
C NMR:  (101 MHz, CDCl3) 
  δ 132.2, 132.1, 131.8, 131.7, 130.7, 129.7, 128.6, 128.5, 127.0, 126.0, 40.5, 31.8, 
30.2.  
 31
P NMR:  (202 MHz, CDCl3) 
  δ 24.36.  
 MS: (ESI)  
362 (M+H, 100), 363 (27), 364 (23), 378 (44), 379 (11) 
 HRMS: calcd for C23H25NOP: 362.1674, found: 362.1672 
 
 
General Procedure I: Survey of Amine Protecting Groups (Table 2) 
 An oven-dried, 4-mL vial equipped with a magnetic stir bar was charged with the 
protected amine substrate (56-62, 0.063 mmol), N-(phenylthio)phthalimide 6 (PhthSPh, 16.2 mg, 
0.063 mmol, 1.0 equiv), tetrahydrothiophene 68 (THT, none or 0.10 equiv), and CH2Cl2 (500 L, 
0.13 M) and capped with a septum cap. After stirring the mixture until a homogeneous solution 
was obtained, methanesulfonic acid (MsOH, none or 1.0 equiv) was added at room temperature. 
The reaction was monitored by TLC at 5 min, 1 h, 3 h, 12 h, 24 h, and 48 h time points until no 
amine substrate was detected. Upon completion, the reaction mixture was quenched by addition 
of 1 mL of sat. NaHCO3 aq solution and the biphasic mixture was extracted with CH2Cl2 (1 mL 
x 3). The combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo 
(30 
o
C, 10 mmHg) to afford the crude product. The product was purified via silica gel flash 
column chromatography. In case of incomplete reaction after 48 h, the reaction mixture was 
quenched following above method, and the crude product was analyzed by 
1
H NMR 
spectroscopy to assess conversion. 
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Table 2 Entry 1 [HMC1035] 
 
 Following General Procedure I, an oven-dried vial was charged with 56 (20 mg, 0.063 
mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), THT 68 (0.6 µL, 6.3 mol, 0.10 equiv), 
and CH2Cl2 (500 L). To the mixture MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the 
reaction was monitored by TLC. TLC analysis showed immediate full conversion to 69 at 5 min. 
The reaction was quenched at 5 min and the crude product was purified via silica gel flash 
column chromatography (SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 19:1) affording 25 mg (93%) of 
rac-69 as white solid. 
Data for rac-69: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.82 (dd, J = 6.5, and 2.0 Hz, 2 H, HC(18)), 7.51 – 7.46 (m, 2 H, HC(13)), 7.37 – 
7.18 (m, 10 H, HC(aryl)), 5.41 (s, 1 H, HC(2)), 3.92 (d, J = 2.5 Hz, 1 H, HC(3)), 
3.76 (dd, J = 13.5, and 2.5 Hz, 1 H, HC(6)), 3.23 (td, J = 13.0, and 3.0 Hz, 1 H, 
HC(6)), 2.43 (s, 3 H, HC(21)), 1.92 – 1.73 (m, 3 H, HC(4,5)), 1.44 – 1.37 (m, 1 H, 
HC(5)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.0 (C(20)), 138.8 (C(7)), 137.7 (C(17)), 135.1 (C(12)), 132.3 (C(13)), 129.2 
(C(19)), 129.2 (C(14)), 128.7 (C(9)), 127.7 (C(18)), 127.5 (C(15)), 127.1 (C(10)), 
126.8 (C(8)), 60.0 (C(2)), 49.7 (C(3)), 41.8 (C(6)), 24.1 (C(4)), 21.5 (C(21)), 19.9 
(C(5)).  
 MS: (ESI) 314 (100), 315 (23), 424 (M+H, 49), 425 (14), 441 (11), 446 (18), 462 (12) 
 HRMS: calcd for C24H26NO2S2: 424.1405, found: 424.1406 
 TLC: Rf 0.48 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
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 Table 2 Entry 2 (Background reaction) [HMC1054] 
 
 Following General Procedure I, an oven-dried vial was charged with 56 (20 mg, 0.063 
mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), and CH2Cl2 (500 L). To the mixture 
MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the reaction was monitored by TLC. The 
reaction was incomplete at 48 h. The reaction was quenched and worked up. The conversion to 
69 (4%) was determined by analysis of 
1
H NMR spectroscopy of the crude product. Conversion 
to product was measured by the appearance of the diagnostic 
1
H NMR resonance for the product 
69 at 5.41 ppm with respect to the substrate peaks at 6.34 ppm and 6.09 ppm.  
  
Table 2 Entry 3 [HMC1042] 
  
 Following General Procedure I, an oven-dried vial was charged with 57 (22 mg, 0.063 
mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), THT 68 (0.6 µL, 6.3 mol, 0.10 equiv), 
and CH2Cl2 (500 L). To the mixture MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the 
reaction was monitored by TLC. TLC analysis showed immediate full conversion to 42 at 5 min. 
The reaction was quenched at 5 min and the crude product was purified via silica gel flash 
column chromatography (SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 19:1) affording 25 mg (95%) of 
rac-160 as white solid. 
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Data for rac-160: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 8.29 (dt, J = 9.0, and 2.0 Hz, 2 H), 8.05 (dt, J = 9.0, and 2.0 Hz, 2 H), 7.44 – 7.19 
(m, 10 H), 5.39 (s, 1H), 3.95, (d, J = 2.0 Hz, 1 H), 3.88 (dd, J = 13.5, and 2.5 Hz, 1 
H), 3.30 (td, J = 12.0, and 3.0 Hz, 1 H), 1.90 – 1.75 (m, 3 H), 1.54 – 1.45 (m, 1 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 149.8, 146.3, 138.0, 134.5, 131.8, 129.4, 128.9, 128.7, 127.6, 127.6, 126.7, 123.9, 
60.6, 49.1, 42.3, 23.8, 19.9.  
 MS: (ESI) 
345 (100), 346 (21), 455 (M+H, 54), 456 (15), 471 (33), 472 (83), 473 (26), 474 
(14), 477 (11), 482 (12), 493 (12) 
 HRMS: calcd for C23H23N2O4S2: 455.1099, found: 455.1102 
 TLC: Rf 0.45 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
  
Table 2 Entry 4 (Background reaction) [HMC1053] 
 
Following General Procedure I, an oven-dried vial was charged with 57 (20 mg, 0.063 
mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), and CH2Cl2 (500 L). To the mixture 
MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the reaction was monitored by TLC. The 
reaction was incomplete at 48 h. The reaction was quenched and worked up. The conversion to 
160 (11%) was determined by analysis of 
1
H NMR spectroscopy of the crude product. 
Conversion to product was measured by the appearance of the diagnostic 
1
H NMR resonance for 
the product 160 at 5.39 ppm with respect to the substrate peaks at 6.34 ppm and 6.08 ppm. 
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Table 2 Entry 5 [HMC1056] 
 
 Following General Procedure I, an oven-dried vial was charged with 58 (27 mg, 0.063 
mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), THT 68 (0.6 µL, 6.3 mol, 0.10 equiv), 
and CH2Cl2 (500 L). To the mixture MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the 
reaction was monitored by TLC. TLC analysis showed immediate full conversion to 161 at 5 min. 
The reaction was quenched at 5 min and the crude product was purified via silica gel flash 
column chromatography (SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 19:1) affording 29 mg (84%) of 
rac-161 as white solid. 
Data for rac-161: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.35 – 7.09 (m, 12 H), 5.03 (s, 1 H), 4.00 – 3.85 (m, 3 H), 3.68 (d, J = 3.5 Hz, 1 
H), 3.60 (td, J = 12.0, and 3.0 Hz, 1H), 2.92 (sept, J = 7.0 Hz, 1 H), 2.10 – 1.82 (m, 
3 H), 1.70 – 1.58 (m, 1 H), 1.28 (d, J = 6.0 Hz, 6 H), 1.23 (d, J = 6.0 Hz, 6 H), 1.19 
(d, J = 6.0 Hz, 6 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 152.6, 151.4, 140.1, 132.7, 129.0, 128.2, 127.6, 127.4, 127.2, 126.4, 123.8, 123.0, 
60.6, 51.3, 42.2, 34.2, 29.8, 25.5, 25.2, 24.9, 23.6, 23.5, 21.2.  
 MS: (ESI)  
384 (22), 426 (11), 536 (M+H, 100), 537 (40), 538 (18), 558 (12) 
 HRMS: calcd for C32H42NO2S2: 536.2657, found: 536.2656 
 TLC: Rf 0.63 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
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Table 2 Entry 6 (Background reaction with no catalyst) [HMC1057] 
 
Following General Procedure I, an oven-dried vial was charged with 7 (27 mg, 0.063 
mmol), PhthSPh 2 (16.2 mg, 0.063 mmol, 1.0 equiv), and CH2Cl2 (500 L). To the mixture 
MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the reaction was monitored by TLC. The 
reaction was incomplete at 48 h. The reaction was quenched and worked up. The conversion to 
161 (2%) was determined by analysis of 
1
H NMR spectroscopy of the crude product. Conversion 
to product was measured by the appearance of the diagnostic 
1
H NMR resonance for the product 
161 at 5.03 ppm with respect to the substrate peaks at 6.35 ppm and 6.12 ppm. 
 
Table 2 Entry 7 [HMC1023] 
 
 Following General Procedure I, an oven-dried vial was charged with 59 (17 mg, 0.063 
mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), THT 68 (0.6 µL, 6.3 mol, 0.10 equiv), 
and CH2Cl2 (500 L). To the mixture MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the 
reaction was monitored by TLC. TLC analysis showed full conversion to 162 at 48 h. The 
reaction was quenched and the crude product was purified via silica gel flash column 
chromatography (SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 9:1) affording 20 mg (86%) of rac-162 as 
white solid. 
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Data for rac-162: 
 1
H NMR:  (500 MHz, CDCl3, –40 
o
C) 
  Major rotamer: δ 7.70 – 7.09 (m, 15 H), 5.11 (s, 1 H), 4.80 (d, J = 16.5 Hz, 1 H), 
4.10 (s, 1 H), 2.92 (td, J = 16.5, and 3.5 Hz, 1 H), 2.15 – 1.96 (m, 1 H), 1.92 – 1.78 
(m, 2 H), 1.50 (d, J = 16.5 Hz, 1 H). 
  Minor rotamer: δ 7.70 – 7.09 (m, 15 H), 6.05 (s, 1 H), 4.24, (s, 1 H), 3.65 (d, J = 
17.5 Hz, 1 H), 3.00 (t, J = 15.0 Hz, 1 H), 2.15 – 1.96 (m, 1 H), 1.92 – 1.78 (m, 2 H), 
1.36 (d, J = 8.5 Hz, 1 H).  
13
C NMR:  (126 MHz, CDCl3, –40 
o
C) 
  δ 172.8, 172.1, 137.6, 137.4, 136.1, 135.4, 134.6, 134.0, 133.6, 130.9, 129.6, 129.5, 
129.1, 129.0, 128.8, 128.5, 128.2, 127.9, 127.3, 127.0, 126.7, 126.4, 126.1, 61.1, 
54.5, 49.0, 48.3, 43.6, 38.3, 24.8, 24.7, 21.0, 20.0.  
 MS: (ESI)  
264 (100), 265 (21), 374 (M+H, 80), 375 (22), 396 (18) 
 HRMS: calcd for C24H24NOS: 374.1579, found: 374.1582 
 TLC: Rf 0.36 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
 
Table 2 Entry 8 [HMC1025] 
  
 Following General Procedure I, an oven-dried vial was charged with 60 (19 mg, 0.063 
mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), THT 68 (0.6 µL, 6.3 mol, 0.10 equiv), 
and CH2Cl2 (500 L). To the mixture MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the 
reaction was monitored by TLC. TLC analysis showed full conversion to 163 at 48 h. The 
reaction was quenched and the crude product was purified via silica gel flash column 
chromatography (SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 9:1) affording 21 mg (81%) of rac-163 as 
white solid. 
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Data for rac-163: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.52 – 7.14 (m, 15 H), 5.59 (s, 1 H), 5.24 (d, J = 12.0 Hz, 1 H), 5.18 (d, J = 12.0 
Hz, 1 H), 4.27 (d, J = 12.0 Hz, 1 H), 4.08 (d, 1 H), 4.92 (td, J = 13.0, and 3.0 Hz, 1 
H), 2.10 – 1.98 (m, 1 H), 1.96 – 1.83 (m, 2 H), 1.44 (d, J = 13.0 Hz, 1 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 156.6, 138.8, 136.8, 135.1, 132.5, 129.1, 128.8, 128.4, 127.8, 127.7, 127.4, 127.0, 
126.3, 67.4, 57.4, 48.3, 40.2, 24.5, 20.3. 
 MS: (ESI)  
160 (11), 204 (61), 250 (29), 294 (67), 295 (14), 404 (M+H, 100), 405 (30), 421 
(45), 426 (36), 442 (20) 
 HRMS: calcd for C25H26NO2S: 404.1684, found: 404.1689 
 TLC: Rf 0.53 (hexanes/EtOAc, 7:3) [UV/KMnO4] 
 
Table 2 Entry 9 [HMC1047] 
 Following General Procedure I, an oven-dried vial was charged with 61 (17 mg, 0.063 
mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), THT 68 (0.6 µL, 6.3 mol, 0.10 equiv), 
and CH2Cl2 (500 L). To the mixture MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the 
reaction was monitored by TLC. TLC analysis indicated partial consumption of the substrate. 
However, after quenching the reaction at 48 h, analysis of the crude mixture by 
1
H NMR 
spectroscopy gave a complex mixture. 
 
Table 2 Entry 10 [HMC1050] 
 Following General Procedure I, an oven-dried vial was charged with 62 (23 mg, 0.063 
mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), THT 68 (0.6 µL, 6.3 mol, 0.10 equiv), 
and CH2Cl2 (500 L). To the mixture MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added and the 
reaction was monitored by TLC. TLC analysis indicated partial consumption of the substrate. 
However, after quenching the reaction at 48 h, analysis of the crude mixture by 
1
H NMR 
spectroscopy gave a complex mixture. 
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Isomerization Study (Scheme 19) [HMC1032] 
  
An oven-dried, 5-mm NMR tube was charged with 56 (20 mg, 0.063 mmol), PhthSPh 6 
(16.2 mg, 0.063 mmol, 1.0 equiv), THT 68 (0.6 µL, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 
0.13 M) and capped with a rubber septum cap. After shaking the mixture well making a 
homogeneous solution, MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via syringe at room 
temperature. Conversion to product was measured by the appearance of the diagnostic 
1
H NMR 
resonance for the “initial” product (proposed to be 69) at 5.41 ppm and the “converted” product 
(proposed to be 70) at 4.07 ppm with respect to the substrate peaks at 6.34 ppm and 6.09 ppm. 
Generally, no other products were observed in the 
1
H NMR spectra. Formation of phthalimide 
byproduct was visually confirmed by the precipitation out of the solution. Full conversion was 
observed after 5 min by 
1
H NMR spectroscopy giving 69 as only product. However, after 12 h, a 
1:2.8 mixture of two products (“initial”:”converted”) was observed. 
Data for 69+70: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.82 (d, J = 8.0 Hz, 69), 7.68 (d, J = 8.0 Hz, 70) 7.60 – 7.44 (m, 69+70), 7.41 – 
7.10 (m, 69+70), 5.41 (s, 69), 5.05 (d, J = 3.5 Hz, 70), 4.10 – 4.05 (m, 70), 3.92 (s, 
69), 3.76 (d, J = 14.5 Hz, 69), 3.49 – 3.39 (m, 70), 3.23 (td, J = 12.0, 3.0 Hz, 69), 
2.43 (s, 69), 2.38 (s, 70), 2.15 – 2.03 (m, 70), 1.95 – 1.73 (m, 69+70), 1.70 – 1.55 
(m, 70), 1.44 – 1.30 (m, 69+70). 
 
 
 
 
125 
 
Isomerization on Under Acidic Media (Scheme 20) [HMC6084] 
 
An oven-dried, 5-mm NMR tube was charged with 69 (140 mg, 0.33 mmol), and CDCl3 
(1.0 mL, 0.33 M) and capped with a rubber septum cap. After shaking the mixture well making a 
homogeneous solution, MsOH (21.4 µL, 0.33 mmol, 1.0 equiv) was added via syringe at room 
temperature. Conversion between two compounds was measured by the appearance of the 
diagnostic 
1
H NMR resonance for the “initial” product (proposed to be 69) at 5.41 ppm and the 
“converted” product (proposed to be 70) at 4.07 ppm. No other products were observed in the 1H 
NMR spectra. 
1
H NMR spectra were recorded at 5 min, 10 min, 15 min, 20 min, and 12 h. 
Converted product 70 was already observed at 5 min, until it reached the equilibrium after 20 
min. At the equilibrium, 1:2.8 mixture of two products (“initial”:”converted”) was observed. 
 
Reverse Direction Isomerization on Under Acidic Media [HMC6086] 
 
 
From the above isomerization experiment, a pyrrolidine-enriched (69:69, 1:5.2) fraction 
was isolated by chromatotron (SiO2, 4 mm plate, hexanes/EtOAc, 9:1 to 6:1). An oven-dried, 5-
mm NMR tube was charged with the mixture of 69+70 (53.5 mg, 0.13 mmol), and CDCl3 (0.6 
mL, 0.21 M) and capped with a rubber septum cap. After shaking the mixture well making a 
homogeneous solution, MsOH (8.2 µL, 0.13 mmol, 1.0 equiv) was added via syringe at room 
temperature. Conversion between two compounds was measured by the diagnostic 
1
H NMR 
resonance for the “initial” product (proposed to be 69) at 5.41 ppm and the “converted” product 
(proposed to be 70) at 4.07 ppm. No other products were observed in the 
1
H NMR spectra. 
1
H 
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NMR spectra were recorded at 0 min (immediately after MsOH addition), 5 min, 10 min, 2 h, 
and 12 h. Conversion of pyrrolidine 70 to piperidine 69 was already observed at 0 min, until it 
reached the equilibrium after 12 h. At the equilibrium, 1:2.8 mixture of two products 
(“initial”:”converted”) was observed. 
 
General Procedure II:
46
 Determination of the Product Structure by Desulfurization 
An oven-dried, round-bottomed-flask equipped with a magnetic stir bar was charged with 
a solution of the sulfenyl compound (1 equiv) in methanol (0.005 M). To the solution was then 
added NiCl2∙6H2O (20 equiv), which turned into a green solution upon stirring. The suspension 
was cooled to 0 
o
C (internal temperature) and NaBH4 (60 equiv) was added slowly portion wise, 
in order to minimize the gas evolution. The black suspension was then allowed to warm to room 
temperature and thoroughly stirred for indicated time. After this time, water (3 mL) was added 
slowly at 0 
o
C and the black resulting mixture was passed through a short pad of Celite (5 g, 35 
mm) to remove the nickel salts. The resulting solution was concentrated in vacuo (40 
o
C, 10 
mmHg). To the resulting crude oil was added water (30 mL) and extracted with Et2O (30 mL x 
3). The combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo 
(23 
o
C, 10 mmHg). The crude product was purified via silica gel flash column chromatography 
afforded the desulfurized products. 
 
Desulfurization of 69 to 2-Phenyl-N-(4-toluenesulfonyl)piperidine (73) (Scheme 21) 
[HMC1044] 
 
Following General Procedure II, an oven-dried, 50-mL round-bottomed-flask was 
charged with a solution of the “initial” product 69 (36 mg, 0.086 mmol) in methanol (17 mL, 
0.005 M). To the solution was then added NiCl2∙6H2O (407 mg, 1.71 mmol, 20 equiv). The 
suspension was cooled to 0 
o
C and NaBH4 (194 mg, 5.14 mmol, 60 equiv) was added portion 
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wise. After 12 h of stirring at room temperature, the reaction was quenched and worked up. The 
crude product was purified via silica gel flash column chromatography (SiO2, 5 g, 10 mm Ø , 
hexanes/EtOAc, 9:1) affording 20 mg (74%) of 73 as white solid. The spectroscopic data 
matched those reported in the literature.
47
 
Data for 73: 
 mp:  138-139 °C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.76 (d, J = 8.5 Hz, 2 H), 7.40 – 7.23 (m, 7 H), 5.27 (d, J = 4.5 Hz, 1 H), 3.84 (d, 
J = 14.0 Hz, 1 H), 3.01 (td, J = 13.5, and 3.0 Hz, 1 H), 2.44 (s, 3 H), 2.21 (d, J = 
13.0 Hz, 1 H), 1.71 – 1.62 (m, 1 H), 1.54 – 1.47 (m, 1 H), 1.44 – 1.35 (m, 2 H), 
1.34 – 1.24 (m, 1 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.9, 138.9, 138.7, 129.6, 128.6, 127.00, 126.96, 126.8, 55.2, 41.8, 27.3, 24.3, 
21.5, 18.9. 
 MS: (EI) 315 (M+), 238 (100), 207 (19), 161 (18), 160 (81), 159 (52), 91 (65). 
  
Desulfurization of 69 and 70 mixture to 73 and 2-Benzyl-N-(4-toluenesulfonyl)pyrrolidine 
(74) (Scheme 21) [HMC1045] 
 
Following General Procedure II, an oven-dried, 500-mL round-bottomed-flask was 
charged with a solution of the mixture of “initial” product 69 and “converted” product 70 (230 
mg, 0.543 mmol) in methanol (109 mL, 0.005 M). To the solution was then added NiCl2∙6H2O 
(2.58 g, 10.9 mmol, 20 equiv). The suspension was cooled to 0 
o
C and NaBH4 (1.23 g, 32.6 
mmol, 60 equiv) was added portion wise. After 12 h of stirring at room temperature, the reaction 
was quenched and worked up. The crude product was purified via silica gel flash column 
chromatography (SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 19:1) affording 30 mg (18%) of 73 as a 
white solid and 91 mg (53%) of 74 as white solid (overall 71% yield). The spectroscopic data 
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matched those reported in the literature.
47,48
 
Data for 74: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.77 (d, J = 8.0 Hz, 2 H), 7.36 – 7. 20 (m, 7 H), 3.88 – 3.80 (m, 1 H), 3.44 – 3.38 
(m, 1 H), 3.26 (dd, J = 13.0, and 3.5 Hz, 1 H), 3.18 – 3.11 (m, 1 H), 2.77 (dd, J = 
13.0, and 10.0 Hz, 1 H), 2.43 (s, 3H), 1.71 – 1.60 (m, 2 H), 1.51 – 1.39 (m, 2 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.3, 138.5, 134.7, 129.6, 129.6, 128.4, 127.5, 126.4, 61.6, 49.2, 42.7, 29.9, 23.8, 
21.5. 
 
Optimization of Reaction Conditions 
Conversion study with (R)-17, (S)-18 catalysts at 20 oC (Chart 3) [HMC1064, HMC1066] 
 
An oven-dried, 5-mm NMR tube was charged with 56 (20 mg, 0.063 mmol), PhthSPh 6 
(16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst ((R)-7, 3.3 mg or (S)-53, 3.5 mg, 
6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped with a rubber septum cap. After 
shaking the mixture well making a homogeneous solution, the tube was cooled to 20 oC in a 
cryocool unit. After reaching equilibrium, MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via 
syringe. Conversion to product was measured by the appearance of the diagnostic 
1
H NMR 
resonance for the piperidine 69 at 5.41 ppm and the pyrrolidine 70 at 4.07 ppm with respect to 
the substrate peaks at 6.34 ppm and 6.09 ppm. Interestingly, no pyrrolidine products were 
observed by the 
1
H NMR spectra for neither (R)-7 nor (S)-53 catalysts. Formation of phthalimide 
byproduct was visually confirmed by the precipitation out of the solution. Monitoring by 
1
H 
NMR spectroscopy was done by freezing the NMR tube in a dewar flask with dry-ice/acetone 
bath (78 oC) while transferring to a pre-cooled (20 oC) NMR instrument. 
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Chart 3 (reproduced) 
 
 
General Procedure III: Survey of Chiral Lewis Base Catalysts 
An oven-dried, 4-mL vial equipped with a magnetic stir bar was charged with 56 (20 mg, 
0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (7, 53, 79-
83, 6.3 mol, 0.10 equiv), and solvent (CH2Cl2 or CDCl3, 500 L, 0.13 M) and capped with a 
septum cap. After stirring the mixture well making a homogeneous solution, the vial was cooled 
to –20 oC in a Cryocool unit. After reaching equilibrium, MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) 
was added via syringe. After indicated time, the reaction mixture was quenched by rapid addition 
of 1 mL of sat. NaHCO3 aq solution upon stirring and the biphasic mixture was extracted with 
CH2Cl2 (1 mL x 3). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated in vacuo (30 
o
C, 10 mmHg) to afford the crude product. The product was purified 
via silica gel flash column chromatography (SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 9:1) prior to 
SFC analysis.  
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Survey of Chiral Lewis Base Catalysts (Table 3) 
Table 3 Entry 1 [HMC1064] 
 
Following General Procedure III, an oven-dried NMR tube was charged with 56 (20 mg, 
0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (R)-7 (3.3 
mg, 6.3 mol, 0.10 equiv), and CH2Cl2 (500 L, 0.13 M) and capped. The vial was cooled to –20 
o
C and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via syringe. After 72 h, the reaction 
was quenched, and purified by flash chromatography afforded 24 mg (90%) of pure 69.  
 
SFC: (2S,3R)-69, tR 14.8 min (11.5%); (2R,3S)-69, tR 16.5 min (88.5%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C)   
 Table 3 Entry 2 [HMC1066] 
 
Following General Procedure III, an oven-dried NMR tube was charged with 56 (20 mg, 
0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (S)-53 (3.3 
mg, 6.3 mol, 0.10 equiv), and CH2Cl2 (500 L, 0.13 M) and capped. The vial was cooled to –20 
o
C and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via syringe. After 72 h, the reaction 
was quenched, and purified by flash chromatography afforded 24 mg (88%) of pure 69.  
 
SFC: (2S,3R)-69, tR 14.8 min (89.4%); (2R,3S)-69, tR 16.5 min (10.6%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
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 Table 3 Entry 3 [HMC1068] 
 
Following General Procedure III, an oven-dried NMR tube was charged with 56 (20 mg, 
0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (S)-79 (3.5 
mg, 6.3 mol, 0.10 equiv), and CH2Cl2 (500 L, 0.13 M) and capped. The vial was cooled to 
20 oC and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via syringe. After 72 h, the 
reaction was quenched, and purified by flash chromatography afforded 8 mg (29%) of pure 69.  
 SFC: (2S,3R)-69, tR 14.8 min (85.8%); (2R,3S)-69, tR 16.5 min (14.2%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
  
 Table 3 Entry 4 [HMC1071] 
 
Following General Procedure III, an oven-dried NMR tube was charged with 56 (20 mg, 
0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (S)-80 (3.4 
mg, 6.3 mol, 0.10 equiv), and CH2Cl2 (500 L, 0.13 M) and capped. The vial was cooled to –20 
o
C and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via syringe. After 72 h, the reaction 
was quenched, and purified by flash chromatography afforded 21 mg (79%) of pure 69.  
 
SFC: (2S,3R)-69, tR 14.8 min (88.1%); (2R,3S)-69, tR 16.5 min (11.9%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
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Table 3 Entry 5 [HMC1069] 
 
Following General Procedure III, an oven-dried NMR tube was charged with 56 (20 mg, 
0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (S)-81 (3.4 
mg, 6.3 mol, 0.10 equiv), and CH2Cl2 (500 L, 0.13 M) and capped. The vial was cooled to –20 
o
C and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via syringe. After 72 h, the reaction 
was quenched, and purified by flash chromatography afforded 18 mg (67%) of pure 69.  
 
SFC: (2S,3R)-69, tR 14.8 min (91.4%); (2R,3S)-69, tR 16.5 min (8.6%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 
Table 3 Entry 6 [HMC1070] 
 
Following General Procedure III, an oven-dried NMR tube was charged with 56 (20 mg, 
0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (S)-82 (3.7 
mg, 6.3 mol, 0.10 equiv), and CH2Cl2 (500 L, 0.13 M) and capped. The vial was cooled to –20 
o
C and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via syringe. After 72 h, the reaction 
was quenched, and purified by flash chromatography afforded 22 mg (82%) of pure 69.  
 
SFC: (2S,3R)-69, tR 14.8 min (92.8%); (2R,3S)-69, tR 16.5 min (7.2%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
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Table 3 Entry 7 [HMC1067] 
 
Following General Procedure III, an oven-dried NMR tube was charged with 56 (20 mg, 
0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (S)-83 (3.3 
mg, 6.3 mol, 0.10 equiv), and CH2Cl2 (500 L, 0.13 M) and capped. The vial was cooled to –20 
o
C and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via syringe. After 72 h, the reaction 
was quenched, and purified by flash chromatography afforded 20 mg (75%) of pure 69.  
 
SFC: (2S,3R)-69, tR 14.8 min (94.6%); (2R,3S)-69, tR 16.5 min (5.4%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 
Synthesis of P-N Reagent (Scheme 24) 
Preparation of N,N-Diisopropylphosphoramidodichloridite (86)
52
 [HMC3023] 
 
A flame-dried, 100-mL two-necked, round-bottomed-flask equipped with a magnetic stir 
bar, a septum, and a argon inlet was added a solution of PCl3 (2 mL, 22.9 mmol, 1 equiv) in 
hexanes (53 mL) via syringe under argon. The solution was cooled to 0 
o
C (internal temperature) 
and was added diisopropylamine (6 mL, 42.9 mmol, 1.87 equiv) dropwise, whereupon the 
solution turned immediately into a white suspension. After stirring for 1 h at room temperature, a 
Schlenk filter was connected and the white suspension was filtered to a flame-dried, 250-mL 
round-bottomed-flask under high vacuum (0.1 mmHg). Rinsing the original flask with hexanes 
(30 mL x 3) gave a turbid suspension, and excess hexane was evaporated in vacuo (23 
o
C, 10 
mmHg). Distillation of the resulting residue was through short-path distillation (115-116 
o
C at 30 
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mmHg) afforded 3.27 g (71%) of compound 86 as clear liquid which solidified in freezer. The 
spectroscopic data matched those reported in the literature.
52
 
 
Data for 86: 
 mp:  26-27 °C (upon standing) 
 bp: 115-116 
o
C, 30 mmHg 
 1
H NMR:  (500 MHz, CDCl3) 
  3.93 (brm, 2 H, HC(1)), 1.29 (d, 12 H, J = 7.0 Hz, HC(2)). 
13
C NMR:  (126 MHz, CDCl3) 
  48.1 (d, C(1)), 23.4 (br, C(2)). 
 31
P NMR:  (202 MHz, CDCl3) 
  170.2 (br). 
 
Synthesis of Chiral Lewis Base (S)-83 (Scheme 26) 
Preparation of (S)-4-(Diisopropylamino)-3,5-dimethyl-4,5-dihydro-3H-dinaphtho[2,1-
d:1’,2’-f][1,3,2]diazaphosphepine-4-selenide ((S)-83) [HMC3024] 
 
To a flame-dried, 100-mL Schlenk flask equipped with a magnetic stir bar was added (S)-
dimethyl BINAM (S)-84
49
 (1.56 g, 5.00 mmol) under argon and capped with a septum. To the 
flask was added anhydrous THF (33.3 mL, 0.15 M) via syringe under argon. After stirring for 30 
min at -74 
o
C (internal temperature) in a dry-ice/i-PrOH bath, to the homogeneous solution was 
added a solution of n-BuLi in hexanes (2.29 M, 4.37 mL, 10.0 mmol, 2.0 equiv) dropwise over 
10 min whereupon the solution turned to yellow-orange. The dry-ice/i-PrOH bath was removed 
after the addition and the solution was stirred for 30 min at room temperature as the color turned 
yellowish black. Then the flask was immersed back into the dry-ice/i-PrOH bath and was 
allowed to equilibrate for another 30 min. To the mixture was added a freshly prepared solution 
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of 86
52
 in THF (910 L in 8.3 mL of THF, 5.00 mmol, 1.0 equiv) dropwise over 10 min, 
whereupon the color of the solution turned to burgundy-red immediately. After warming to room 
temperature by removing the dry-ice/i-PrOH bath the solution turned to bright red then bright 
orange after stirring for 30 min. To the bright orange solution was added powdered selenium 
(1.18 g, 15.0 mmol, 3.0 equiv) at room temperature under gentle argon flow whereupon the color 
turned brown-black immediately. The mixture was stirred for an hour at an ambient temperature 
and the resulting heterogeneous mixture was filtered through a pad of Celite (10 g, 35 mm), 
which was rinsed with EtOAc (50 mL). The bright orange filtrate was concentrated in vacuo (40 
o
C, 10 mmHg) to afford an orange solid. Purification by Combiflash®  column chromatography 
(SiO2, 24 g Luknova column, hexanes/EtOAc, 100:0 to 20:1) afforded an off-white solid (2.24 g). 
Recrystallization of this solid with n-pentane (1.0 L, 36 
o
C) afforded 2.06 g (79%) of (S)-83 as an 
off-white, crystalline solid. 
 
Data for (S)-83: 
 mp:  148-150 °C (sealed tube) 
 1
H NMR:  (500 MHz, DMSO-d6, 80 
o
C, heating for sharpening diisopropyl region) 
  δ 8.05 (t, J = 10.0 Hz, 2 H, HC(4) and HC(4‟)), 7.99 (d, J = 8.0 Hz, 1 H, HC(6)), 
7.95 (d, J = 8.0 Hz, 1 H, HC(6‟)), 7.81 (d, J = 9.0 Hz, 1 H, HC(3)), 7.66 (d, J = 9.0 
Hz, 1 H, HC(6‟)), 7.43 (t, J = 7.5 Hz, 1 H, HC(7)), 7.39 (t, J = 7.5 Hz, 1 H, HC(7‟)), 
7.23 (t, J = 7.5 Hz, 1 H, HC(8)), 7.14 (t, J = 7.5 Hz, 1 H, HC(8‟)), 7.06 (d, J = 8.5 
Hz, 1 H, HC(9)), 6.83 (d, J = 8.5 Hz, 1 H, HC(9‟)), 3.64 – 3.50 (m, 2 H, HC(12) 
and HC(12‟)), 3.24 (d, J = 12.5 Hz, 3 H, H3C(11)), 3.03 (d, J = 14.0 Hz, 3 H, 
H3C(11‟)), 1.39 (d, J = 6.5 Hz, 6 H, H3C(13) and H3C(13‟)), 1.28 (d, J = 6.0 Hz, 6 
H, H3C(14) and H3C(14‟)) 
13
C NMR:  (126 MHz, DMSO-d6, 80 
o
C, heating for sharpening diisopropyl region) 
  δ 142.7 (d, J = 5.9 Hz, C(2)), 141.8 (C(2‟)), 131.6 (C(10)), 131.3 (C(10‟)), 130.6 (d, 
J = 2.0 Hz, C(5‟)), 130.0 (C(5)), 128.2 (C(4‟)), 128.1 (C(4)), 127.61 (C(6‟)), 127.57 
(C(C6)), 126.9 (C(9)), 126.8 (d, J = 3.8 Hz, C(1‟)), 126.21 (C(1)), 126.16 (C(9‟)), 
125.8 (C(8)), 125.4 (C(8‟)), 124.6 (C(7)), 124.4 (C(7‟)), 122.7 (C(3‟)), 122.6 (C(3)), 
47.4 (C(12) and C(12‟)), 36.8 (d, J = 11.8 Hz, C(11)), 36.0 (d, J = 5.9 Hz, C(11‟)), 
23.9 (C(13,13‟)), 21.9 (C(14,14‟)) 
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 31
P NMR:  (202 MHz, DMSO-d6, 80 
o
C) 
  81.07 (t, J = 414.7 Hz, Se satellite)  
 IR: (KBr) 
  3059 (w), 2961 (m), 1618 (w), 1590 (w), 1503 (m), 1465 (m), 1365 (m), 1330 (m), 
1271 (m), 1257 (m), 1174 (s), 1143 (m), 1084 (m), 980 (s), 928 (s), 848 (w), 810 (s), 
751 (s) 
 MS: (EI) 
55 (26), 57 (34), 67 (10), 68 (11), 69 (82), 70 (13), 71 (20), 81 (43), 83 (17), 84 (42), 
85 (14), 86 (28), 86 (10), 95 (16), 97 (13), 100 (22), 109 (10), 136 (11), 137 (15), 
281 (14), 341 (100), 342 (25), 521 (M+) 
 HRMS: calcd for C28H32N3PSe: 521.1499, found: 521.1502 
 TLC: Rf 0.41 (hexanes/EtOAc, 9:1) [CAM] 
 Opt Rot: [α] D
24
 438.9 (c = 1.01, CHCl3) [non-linear ORD] 
 SFC: (R)-83, tR, 7.9 min (0.2%); (S)-83, tR 9.3 min (99.8%) (Chiralcel OJ, Gradient 3% 
MeOH in CO2 to 8% MeOH in CO2, 2.5 mL/min, 220 nm.) 
 Analysis:  C28H32N3PSe (520.51) 
  Calcd:  C, 64.61;  H, 6.20% N, 8.07% 
   Found:  C, 64.36;  H, 6.22% N, 7.77% 
 
General Procedure IV: Optimization of Reaction Temperature 
An oven-dried, 5-mm NMR tube was charged with 5 (20 mg, 0.063 mmol), PhthSPh 6 
(16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (S)-83 (3.3 mg, 6.3 mol, 0.10 
equiv), and CDCl3 (500 L, 0.13 M) and capped with a rubber septum cap. After shaking the 
mixture well making a homogeneous solution, the NMR tube was set to an indicated temperature 
(external temperature) in a Cryocool unit or a cold room. After reaching equilibrium, MsOH (4.1 
µL, 0.063 mmol, 1.0 equiv) was added via syringe. Conversion to product was measured by the 
appearance of the diagnostic 
1
H NMR resonance for the piperidine 69 at 5.41 ppm and the 
pyrrolidine 70 at 4.07 ppm with respect to the substrate peaks at 6.34 ppm and 6.09 ppm. 
Generally, no other products were observed in the 
1
H NMR spectra. Formation of phthalimide 
byproduct was visually confirmed by the precipitation out of the solution. Monitoring by 
1
H 
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NMR spectroscopy was done at 30 min, 3 h, 6 h, 12 h, 24 h, 48 h, and 72 h, by freezing the NMR 
tube in a Dewar flask with dry-ice/acetone bath (78 oC) while transferring to a pre-cooled (20 
o
C) NMR instrument. Reactions were run until complete consumption of 5 was observed by 
1
H 
NMR spectroscopy or at 72 h. The reaction mixture was quenched by rapidly pouring into 1 mL 
of sat. NaHCO3 aq solution and the biphasic mixture was extracted with CH2Cl2 (1 mL x 3). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo (30 
o
C, 
10 mmHg) to afford the crude product. The product was purified via silica gel flash column 
chromatography (SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 9:1) prior to SFC analysis.  
 
Temperature Survey (Table 4) 
Table 4 Entry 1 (20 oC) [HMC1067] 
Following General Procedure IV, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was cooled to 20 oC in a Cryocool unit and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added 
via syringe. The reaction was incomplete at 72 h, whereupon the reaction mixture was quenched. 
Purification of the crude product via silica gel flash column chromatography (SiO2, 5 g, 10 mm 
Ø , hexanes/EtOAc, 9:1) afforded 20 mg (73%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (94.6%); (2R,3S)-69, tR 16.5 min (5.4%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 
Table 4 Entry 2 (10 oC) [HMC1081] 
Following General Procedure IV, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was cooled to 10 oC in a Cryocool unit and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added 
via syringe. The reaction was incomplete at 72 h, whereupon the reaction mixture was quenched. 
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Purification of the crude product via silica gel flash column chromatography (SiO2, 5 g, 10 mm 
Ø , hexanes/EtOAc, 9:1) afforded 23 mg (85%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (93.9%); (2R,3S)-69, tR 16.5 min (6.1%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 
Table 4 Entry 3 (0 
o
C) [HMC1098] 
Following General Procedure IV, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was cooled to 0 
o
C in a Cryocool unit and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via 
syringe. The reaction was complete at 48 h, whereupon the reaction mixture was quenched. 
Purification of the crude product via silica gel flash column chromatography (SiO2, 5 g, 10 mm 
Ø , hexanes/EtOAc, 9:1) afforded 25 mg (95%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (93.6%); (2R,3S)-69, tR 16.5 min (6.4%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
Table 4 Entry 4 ( oC) [HMC1091] 
Following General Procedure IV, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was cooled to 5 
o
C in a cold room and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via 
syringe. The reaction was complete at 48 h, whereupon the reaction mixture was quenched. 
Purification of the crude product via silica gel flash column chromatography (SiO2, 5 g, 10 mm 
Ø , hexanes/EtOAc, 9:1) afforded 26 mg (95%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (93.0%); (2R,3S)-69, tR 16.5 min (7.0%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
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Table 4 Entry 5 (20 
o
C) [HMC1096] 
Following General Procedure IV, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was allowed run at 20 
o
C (room temperature) in a water bath and MsOH (4.1 µL, 0.063 mmol, 
1.0 equiv) was added via syringe. The reaction was complete at 6 h, but the reaction mixture was 
quenched at 24 h. Purification of the crude product via silica gel flash column chromatography 
(SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 9:1) afforded 26 mg (96%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (91.5%); (2R,3S)-69, tR 16.5 min (8.5%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
General Procedure V: Survey of Acid Loadings 
An oven-dried, 5-mm NMR tube was charged with 56 (20 mg, 0.063 mmol), PhthSPh 6 
(16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst (S)-83 (3.3 mg, 6.3 mol, 0.10 
equiv), and CDCl3 (500 L, 0.13 M) and capped with a rubber septum cap. After shaking the 
mixture well making a homogeneous solution, the NMR tube was set to 0 
o
C in a Cryocool unit. 
After reaching equilibrium, indicated amount of MsOH was added via syringe. Conversion to 
product was measured by the appearance of the diagnostic 
1
H NMR resonance for the piperidine 
69 at 5.41 ppm and the pyrrolidine 70 at 4.07 ppm with respect to the substrate peaks at 6.34 
ppm and 6.09 ppm. Generally, no other products were observed in the 
1
H NMR spectra. 
Formation of phthalimide byproduct was visually confirmed by the precipitation out of the 
solution. Monitoring by 
1
H NMR spectroscopy was done at 6 h, 12 h, 24 h, and 72 h, by freezing 
the NMR tube in a Dewar flask with dry-ice/acetone bath (–78 oC) while transferring to a pre-
cooled (–20 oC) NMR instrument. After 48 h, the reaction mixture was quenched by rapidly 
pouring into 1 mL of sat. NaHCO3 aq solution and the biphasic mixture was extracted with 
CH2Cl2 (1 mL x 3). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated in vacuo (30 
o
C, 10 mmHg) to afford the crude product. The ratio of 69 to 70 was 
determined by analysis with 
1
H NMR spectroscopy of the reaction mixture and the crude product. 
The product was purified via silica gel flash column chromatography (SiO2, 5 g, 10 mm Ø , 
hexanes/EtOAc, 9:1) prior to SFC analysis.  
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Acid Loading Study (Table 5) 
Table 5 Entry 1 [HMC4069] 
Following General Procedure V, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was cooled to 0 
o
C in a Cryocool unit and MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) was added via 
syringe. The ratio of 69 to 70 of the reaction mixture were 97.5:2.5 (76.1% conversion, 6 h), 
94.4:5.6 (93.4% conversion, 12 h), 86.4:13.6 (full conversion at 24 h), and of the crude product 
was 85.7:14.3. Purification of the crude product via silica gel flash column chromatography 
(SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 9:1) gave 22 mg (82%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (91.6%); (2R,3S)-70, tR 16.5 min (8.4%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 
Table 5 Entry 2 [HMC4068] 
Following General Procedure V, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was cooled to 0 
o
C in a Cryocool unit and MsOH (3.1 µL, 0.048 mmol, 0.75 equiv) was added 
via syringe. The ratio of 69 to 70 of the reaction mixture were 99.2:0.8 (76.9% conversion, 6 h), 
99.3:0.7 (93.5% conversion, 12 h), 99.0:1.0 (full conversion at 24 h), and of the crude product 
was 98.9:1.1. Purification of the crude product via silica gel flash column chromatography (SiO2, 
5 g, 10 mm Ø , hexanes/EtOAc, 9:1) afforded 23 mg (84%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (92.9%); (2R,3S)-70, tR 16.5 min (7.1%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
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Table 5 Entry 3 [HMC4067] 
Following General Procedure V, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was cooled to 0 
o
C in a Cryocool unit and MsOH (2.1 µL, 0.032 mmol, 0.50 equiv) was added 
via syringe. The ratio of 69 to 70 of the reaction mixture were 99.3:0.7 (73.8% conversion, 6 h), 
99.3:0.7 (92.9% conversion, 12 h), 99.2:0.8 (full conversion at 24 h), and of the crude product 
was 99.2:0.8. Purification of the crude product via silica gel flash column chromatography (SiO2, 
5 g, 10 mm Ø , hexanes/EtOAc, 9:1) afforded 26 mg (96%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (93.5%); (2R,3S)-70, tR 16.5 min (6.5%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 
Table 5 Entry 4 [HMC4066] 
Following General Procedure V, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was cooled to 0 
o
C in a Cryocool unit and MsOH (1.0 µL, 0.016 mmol, 0.25 equiv) was added 
via syringe. The ratio of 69 to 70 of the reaction mixture were 99.4:0.6 (62.0% conversion, 6 h), 
99.4:0.6 (85.0% conversion, 12 h), 99.4:0.6 (97.9% conversion at 24 h), and of the crude product 
was 99.4:0.6. Purification of the crude product via silica gel flash column chromatography (SiO2, 
5 g, 10 mm Ø , hexanes/EtOAc, 9:1) gave 23 mg (87%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (93.6%); (2R,3S)-69, tR 16.5 min (6.4%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
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Table 5 Entry 5 [HMC4065] 
Following General Procedure V, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M) and capped. The NMR tube 
was cooled to 0 
o
C in a Cryocool unit and MsOH (0.4 µL, 0.0063 mmol, 0.10 equiv) was added 
via syringe. Since the reaction was incomplete at 24 h, the reaction mixture was quenched at 72 h. 
The ratio of 69 to 69 of the reaction mixture were (no data points at 6 h, and 12 h due to 
overlapping) 99.5:0.5 (68.7% conversion, 24 h), 99.3:0.7 (87.2% conversion, 72 h), and of the 
crude product was 99.3:0.7. Purification of the crude product via silica gel flash column 
chromatography (SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 9:1) gave 21 mg (79%) of 69. 
 SFC: (2S,3R)-69, tR 14.8 min (93.9%); (2R,3S)-69, tR 16.5 min (6.1%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 
Determination of the Absolute Configuration (Scheme 27) 
Preparation of (R)-2-Phenyl-N-(4-toluenesulfonyl)piperidine ((R)-48) [HMC1087] 
 
Following General Procedure II, an oven-dried, 50-mL round-bottomed-flask was 
charged with a solution of the “initial” product 69 (60 mg, 0.14 mmol) in methanol (28 mL, 
0.005 M). To the solution was then added NiCl2∙6H2O (673 mg, 2.83 mmol, 20 equiv). The 
suspension was cooled to 0 
o
C and NaBH4 (322 mg, 8.50 mmol, 60 equiv) was added portion 
wise. After 12 h of stirring at room temperature, the reaction was quenched and worked up. The 
crude product was purified via silica gel flash column chromatography (SiO2, 5 g, 10 mm Ø , 
hexanes/EtOAc, 9:1) affording 31 mg (69%) of (R)-73 as white solid. The spectroscopic data 
matched those reported in the literature.
47 
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Data for (R)-73: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.76 (d, J = 8.5 Hz, 2 H), 7.40 – 7.23 (m, 7 H), 5.27 (d, J = 4.5 Hz, 1 H), 3.84 (d, 
J = 14.0 Hz, 1 H), 3.01 (td, J = 13.5, and 3.0 Hz, 1 H), 2.44 (s, 3 H), 2.21 (d, J = 
13.0 Hz, 1 H), 1.71 – 1.62 (m, 1 H), 1.54 – 1.47 (m, 1 H), 1.44 – 1.35 (m, 2 H), 
1.34 – 1.24 (m, 2 H). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.9, 138.9, 138.7, 129.6, 128.5, 127.00, 126.96, 126.7, 55.2, 41.8, 27.2, 24.3, 
21.5, 18.9. 
 MS: (EI) 
315 (M+), 238 (100), 207 (19), 161 (18), 160 (81), 159 (52), 91 (65). 
 Opt Rot. : [α] D
24 
+54.8 (c = 0.65, CHCl3, 89:11 er.) 
 
 
Substrate Preparation (Scheme 28 – 30) 
Compounds 56,
42c
 92,
42c
 93,
118
 94,
42a
 and 99
42b 
were prepared according to literature 
procedures. 
Compounds 88, 89, 90, and 91 were prepared by following an established procedure for 
sequential mesylation and tosylamine substitution
42
 of the corresponding precursor alcohols 
160,
119
 161,
120
 162,
38
 and 163,
121
 respectively (See General Procedure VI). The corresponding 
alcohols were prepared according to literature procedures. 
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Compounds 96, 97, and 98 were prepared by sequential mesylation,
42
 nitrile 
substitution,
130
 reduction,
42
 and tosylation
42
 of the corresponding precursor alcohols 2,
120
 163,
121
 
and 162,
38
 respectively (See General Procedure VII). The corresponding alcohols were prepared 
according to literature procedures.  
 
 
General Procedure VI: Substrate Preparation I 
 
 An oven-dried, 50-mL Schlenk flask equipped with a magnetic stir bar, a septum, and a 
argon inlet were charged with a solution of alcohol (2.0 mmol, 1 equiv) in CH2Cl2 (20 mL), and 
Et3N (0.98 mL, 7.0 mmol, 3.5 equiv) dropwise via syringe. The solution was cooled to 0 
o
C 
(internal temperature), and to the flask was added methanesulfonyl chloride (232 L, 3.0 mmol, 
1.5 equiv) via syringe. After stirring for 1 h at 0 
o
C, the reaction solution was quenched by 
slowly addition of water (20 mL) over 5 min. The resulting biphasic mixture was extracted with 
CH2Cl2 (20 mL x 3). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated in vacuo (40 
o
C, 10 mmHg) to afford the crude mesylate. The crude mesylate was 
directly dissolved in DMF (20 mL) and transferred to an oven-dried, 50-mL round-bottomed-
flask. To the flask were added K2CO3 (1.93 g, 14.0 mmol, 7 equiv) and p-toluenesulfonamide 
(2.40 g, 14.0 mmol, 7 equiv) and equipped with a reflux condenser. The suspension was heated 
to 80 
o
C (internal temperature) and stirred for 12 h. Upon reaction completion monitored by TLC, 
the suspension was cooled to 0 
o
C (internal temperature) and quenched by adding 2 M HCl (20 
mL) dropwise. The resulting mixture was extracted with Et2O (20 mL x 5). The combined 
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organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo (80 
o
C, 10 mmHg) 
to afford the crude product. The crude product was purified via silica gel flash column 
chromatography (SiO2, 15 g, 20 mm Ø , toluene/EtOAc, 9:1 to 4:1). 
 
General Procedure VII: Substrate Preparation II 
 
 An oven-dried, 250-mL Schlenk flask equipped with a magnetic stir bar, a septum, and a 
argon inlet were charged with a solution of alcohol (10.0 mmol, 1 equiv) in CH2Cl2 (100 mL), 
and Et3N (4.88 mL, 35.0 mmol, 3.5 equiv) dropwise via syringe. The solution was cooled to 0 
o
C 
(internal temperature), to the flask was added methanesulfonyl chloride (1.16 mL, 15.0 mmol, 
1.5 equiv) via syringe. After stirring for 1 h at 0 
o
C, the reaction solution was quenched by 
slowly adding water (100 mL) over 10 min. The resulting biphasic mixture was extracted with 
CH2Cl2 (100 mL x 3). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated in vacuo (40 
o
C, 10 mmHg) to afford the crude product. Purification via silica gel 
flash column chromatography (SiO2, 30 g, 30 mm Ø , hexanes/EtOAc, 9:1) afforded mesylate as 
a colorless oil. Then to an oven-dried, 250-mL round-bottomed-flask were added a solution of 
the resulted mesylate (1 equiv) in DMF (100 mL) and NaCN (3 equiv) as a solid in one portion. 
The flask was equipped with a reflux condenser and heated to 90 
o
C (internal temperature) and 
stirred for 24 h. Upon reaction completion monitored by TLC, the suspension was cooled to 0 
o
C 
(internal temperature) and quenched by adding water pre-cooled to 0 
o
C (50 mL) dropwise. The 
resulting mixture was extracted with Et2O (100 mL x 5). The combined organic extracts were 
dried over Na2SO4, filtered, and concentrated in vacuo (80 
o
C, 10 mmHg) to afford the crude 
nitrile. Purification via silica gel flash column chromatography (SiO2, 30 g, 30 mm Ø , 
hexanes/EtOAc, 19:1) afforded nitrile. 
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An oven-dried, 100-mL Schlenk flask equipped with a magnetic stir bar was charged 
with LiAlH4 (285 mg, 7.5 mmol, 1.5 equiv) and capped with a septum under argon. The flask 
was immersed in an ice-bath and was added Et2O (10 mL). To the resulting suspension was 
added a solution of nitrile (5.0 mmol, 1 equiv) in Et2O (7 mL) via syringe over 10 min at 0 
o
C 
(internal temperature). After addition was complete, the suspension was warmed to room 
temperature and stirred for 2 h. Upon reaction completion monitored by TLC, the suspension 
was cooled to 0 
o
C (internal temperature) and quenched by slow addition of 1 M NaOH (5 mL) 
dropwise. The resulting slurry was filtered through a pad of Celite (5 g, 35 mm) and concentrated 
in vacuo (23 
o
C, 10 mmHg). The resulting amine was then acidified by addition of 2 M HCl in 
Et2O (2.5 mL, 5 mmol, 1 equiv) to afford the corresponding amine∙HCl salt, which was 
thoroughly dried in vacuo (23 
o
C, 0.1 mmHg). Then an oven-dried, 50-mL Schlenk flask 
equipped with a magnetic stir bar were charged with amine∙HCl salt (5.0 mmol, 1 equiv), CH2Cl2 
(10 mL), and Et3N (2.09 mL, 15.0 mmol, 3 equiv) and capped with a septum under argon. The 
solution was cooled to 0 
o
C (internal temperature) and was added a solution of p-toluenesulfonyl 
chloride (1.00 g, 5.25 mmol, 1.05 equiv) in CH2Cl2 (7 mL) via syringe. The solution was 
warmed to room temperature and was stirred for 4 h. Upon reaction completion monitored by 
TLC, the mixture was cooled to 0 
o
C (internal temperature) and quenched by adding 1 M HCl 
(15 mL) dropwise. The resulting biphasic mixture was extracted with CH2Cl2 (20 mL x 3). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo (23 
o
C, 
10 mmHg) to afford the crude product. Purification via silica gel flash column chromatography 
(SiO2, 15 g, 20 mm Ø , hexanes/EtOAc, 9:1 to 4:1) afforded the homologated tosylamine. 
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Preparation of (E)-N-(4-Toluenesulfonyl)-5-(4-methoxyphenyl)pent-4-enylamine (88) 
[HMC2023, HMC2024] 
 
Following General Procedure VI, an oven-dried, 50-mL Schlenk flask equipped with a 
magnetic stir bar, a septum, and a argon inlet were charged with a solution of alcohol 160
119
 (443 
mg, 2.3 mmol, 1 equiv) in CH2Cl2 (23 mL), and Et3N (1.12 mL, 8.07 mmol, 3.5 equiv). After 
cooled to 0 
o
C, to the flask was added methanesulfonyl chloride (268 L, 3.46 mmol, 1.5 equiv) 
via syringe. After stirring for 1 h at 0 
o
C, the reaction solution was quenched. After the work-up, 
the crude mesylate (604 mg, 2.23 mmol) was dissolved in DMF (22 mL) and transferred to an 
oven-dried, 50-mL round-bottomed-flask. To the flask were added K2CO3 (2.16 g, 15.6 mmol, 7 
equiv) and p-toluenesulfonamide (2.68 g, 15.6 mmol, 7 equiv) and equipped with a reflux 
condenser. The suspension was heated to 80 
o
C (internal temperature) and stirred for 12 h. Upon 
reaction completion, the suspension was cooled to 0 
o
C and quenched. Purification via silica gel 
flash column chromatography (SiO2, 15 g, 20 mm Ø , toluene/EtOAc, 9:1 to 4:1) afforded 664 
mg (86% over two steps from 160) of 88 as a white solid. 
 
Data for 88: 
 mp:  99-100 °C 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.76 (d, J = 8.0 Hz, 2 H, HC(13)), 7.31 (d, J = 8.5 Hz, 2 H, HC(14)), 7.24 (d, J = 
8.5 Hz, 2 H, (HC(7)), 6.85 (d, J = 8.5 Hz, 2 H, HC(8)), 6.29 (d, J = 16.0 Hz, 1 H, 
HC(5)), 5.95 (dt, J = 15.5, and 7.0 Hz, 1 H, HC(4)), 4.47 (br, 1 H, HN), 3.82 (s, 3 H, 
HC(11)), 3.01 (q, J = 7.0 Hz, 2 H, HC(1)), 2.44 (s, 3 H, HC(16)), 2.20 (q, J = 7.0 
Hz, 2 H, HC(3)), 1.66 (p, J = 7.0 Hz, 2 H, HC(2)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 158.8 (C(9)), 143.4 (C(12)), 136.9 (C(15)), 130.3 (C(5)), 130.1 (C(6)), 129.7 
(C(14)), 127.1 (C(7/13)), 126.6 (C(4)), 113.9 (C(8)), 55.3 (C(11)), 42.6 (C(1)), 29.8 
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(C(3)), 29.3 (C(2)), 21.5 (C(16)). 
 IR: (Neat) 
  3247 (w), 1605 (w), 1511 (m), 1436 (w), 1323 (m), 1305 (m), 1288 (w), 1247 (s), 
1166 (s), 1155 (s), 1095 (m), 1070 (m), 1059 (m), 1024 (m), 969 (s), 910 (m), 872 
(w), 834 (m), 815 (s), 797 (m), 762 (w). 
 MS: (ESI)  
175 (35), 346 (M+H, 100), 347 (25), 362 (12), 363 (25), 368 (17) 
 HRMS: (ESI) calcd for C19H24NO3S (M+H
+
): 346.1477, found: 346.1461 
 TLC: Rf 0.39 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
  Analysis: C19H23NO3S (345.46) 
  Calcd:  C, 66.06;  H, 6.71% N, 4.05% 
   Found:  C, 65.74;  H, 6.68% N, 4.03% 
 
 
Preparation of (E)-N-(4-Toluenesulfonyl)-5-(4-trifluoromethylphenyl)pent-4-enylamine (89) 
[HMC2031, HMC2032] 
  
Following General Procedure VI, an oven-dried, 50-mL Schlenk flask equipped with a 
magnetic stir bar, a septum, and a argon inlet were charged with a solution of alcohol 161
120
 (460 
mg, 2.0 mmol, 1 equiv) in CH2Cl2 (20 mL), and Et3N (0.98 mL, 7.0 mmol, 3.5 equiv). After 
cooled to 0 
o
C, to the flask was added methanesulfonyl chloride (232 L, 3.0 mmol, 1.5 equiv) 
via syringe. After stirring for 1 h at 0 
o
C, the reaction solution was quenched. After the work-up, 
the crude mesylate was dissolved in DMF (20 mL) and transferred to an oven-dried, 50-mL 
round-bottomed-flask. To the flask were added K2CO3 (1.93 g, 14.0 mmol, 7 equiv) and p-
toluenesulfonamide (2.40 g, 14.0 mmol, 7 equiv) and equipped with a reflux condenser. The 
suspension was heated to 80 
o
C (internal temperature) and stirred for 12 h. Upon reaction 
completion, the suspension was cooled to 0 
o
C and quenched. Purification via silica gel flash 
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column chromatography (SiO2, 15 g, 20 mm Ø , toluene/EtOAc, 9:1 to 4:1) afforded 659 mg (86% 
over two steps from 161) of 89 as a white solid. 
 
Data for 89: 
 mp:  116-117 °C 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.76 (d, J = 8.0 Hz, 2 H, HC(12)), 7.54 (d, J = 8.5 Hz, 2 H, HC(8)), 7.39 (d, J = 
8.0 Hz, 2 H, HC(7)), 7.30 (d, J = 8.5 Hz, 2 H, HC(13)), 6.38 (d, J = 16.0 Hz, 1 H, 
HC(5)), 6.21 (dt, J = 16.0, and 7.0 Hz, 1 H, HC(4)), 4.48 (t, J = 6.0 Hz, 1 H, HN), 
3.01 (q, J = 7.0 Hz, 2 H, HC(1)), 2.42 (s, 3 H, HC(15)), 2.26 (q, J = 7.0 Hz, 2 H, 
HC(3)), 1.69 (p, J = 7.0 Hz, 2 H, HC(2)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.4 (C(11)), 140.8 (C(6)), 136.9 (C(14)), 131.8 (C(4)), 129.8 (C(5)), 129.7 
(C(13)), 128.9 (q, J = 32 Hz, C(9)), 127.1 (C(12)), 126.1 (C(7)), 125.4 (q, J = 3.8 
Hz, C(8)), 124.2 (q, J = 272 Hz, C(10)), 42.5 (C(1)), 29.8 (C(3)), 29.0 (C(2)), 21.5 
(C(15)). 
 
 19
F NMR:  (470 MHz, CDCl3) 
  δ -62.90 
 IR: (Neat) 
  3237 (w), 1613 (w), 1416 (w), 1319 (s), 1305 (m), 1288 (m), 1156 (s), 1114 (s), 
1100 (s), 1068 (s), 1035 (m), 1016 (m), 971 (m), 910 (m), 871 (m), 851 (m), 833 
(m), 815 (s), 801 (m). 
 MS: (ESI)  
364 (28), 384 (M+H, 100), 385 (26), 401 (50), 406 (19) 
 HRMS: (ESI) calcd for C19H21F3NO2S (M+H
+
): 384.1245, found: 384.1236 
 TLC: Rf 0.43 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
  Analysis: C19H20F3NO2S (383.43) 
  Calcd:  C, 59.52;  H, 5.26% N, 3.65% 
   Found:  C, 59.80;  H, 5.32% N, 3.54% 
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Preparation of (E)-N-(4-Toluenesulfonyl)-7-phenylhept-4-enylamine (90) [HMC3028, 
HMC3029] 
 
Following General Procedure VI, an oven-dried, 50-mL Schlenk flask equipped with a 
magnetic stir bar, a septum, and a argon inlet were charged with a solution of alcohol 162
38
 (381 
mg, 2.0 mmol, 1 equiv) in CH2Cl2 (20 mL), and Et3N (0.98 mL, 7.0 mmol, 3.5 equiv). After 
cooled to 0 
o
C, to the flask was added methanesulfonyl chloride (232 L, 3.0 mmol, 1.5 equiv) 
via syringe. After stirring for 1 h at 0 
o
C, the reaction solution was quenched. After the work-up, 
the crude mesylate was dissolved in DMF (20 mL) and transferred to an oven-dried, 50-mL 
round-bottomed-flask. To the flask were added K2CO3 (1.93 g, 14.0 mmol, 7 equiv) and p-
toluenesulfonamide (2.40 g, 14.0 mmol, 7 equiv) and equipped with a reflux condenser. The 
suspension was heated to 80 
o
C (internal temperature) and stirred for 12 h. Upon reaction 
completion, the suspension was cooled to 0 
o
C and quenched. Purification via silica gel flash 
column chromatography (SiO2, 15 g, 20 mm Ø , toluene/EtOAc, 9:1 to 4:1) afforded 577 mg (84% 
over two steps from 162) of 90 as a colorless oil. 
 
Data for 90: 
 bp:  165 °C at 3 x 10
-5
 mm Hg 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.75 (d, J = 8.0 Hz, 2 H, HC(13)), 7.32 (d, J = 8.0 Hz, 2 H, HC(14)), 7.27 (t, J = 
7.5 Hz, 3 H, HC(10)), 7.19 (d, J = 7.0 Hz, 1 H, HC(11)), 7.16 (d, J = 7.0 Hz, 2 H, 
HC(9)), 5.41 (dt, J = 15.0, and 7.0 Hz, 1 H, HC(5)), 5.31 (dt, J = 15.0, and 7.0 Hz, 
1 H, HC(4)), 4.34 (brs, 1 H, HN), 2.91 (t, J = 7.0 Hz, 2 H, HC(1)), 2.64 (t, J = 7.5 
Hz, 2 H, HC(7)), 2.43 (s, 3 H, HC(16)), 2.28 (q, J = 7.5 Hz, 2 H, HC(6)), 1.97 (q, J 
= 7.0 Hz, 2 H, HC(3)), 1.51 (p, J = 7.0 Hz, 2 H, HC(2)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.3 (C(12)), 141.9 (C(8)), 137.0 (C(15)), 130.8 (C(5)), 129.7 (C(14)), 129.2 
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(C(4)), 128.4 (C(9)), 128.2 (C(10)), 127.1 (C(13)), 125.7 (C(11)), 42.6 (C(1)), 35.9 
(C(7)), 34.3 (C(6)), 29.4 (C(3)), 29.2 (C(2)), 21.5 (C(16)). 
 IR: 3289 (m), 2926 (m), 1496 (m), 1455 (s), 1430 (m), 1416 (m), 1337 (s), 1158 (m), 
1093 (m), 970 (m), 815 (m). 
 MS: (ESI) 
173 (45), 344 (M+H, 100), 345 (24), 361 (16), 366 (25), 382 (12) 
 HRMS: (ESI) calcd for C20H26NO2S (M+H
+
): 344.1684, found: 344.1676 
 TLC: Rf 0.50 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
  Analysis: C20H25NO2S (343.48) 
  Calcd:  C, 69.93;  H, 7.34% N, 4.08% 
   Found:  C, 69.90;  H, 7.42% N, 4.25% 
 
Preparation of (E)-N-(4-Toluenesulfonyl)-6-methylhept-4-enylamine (91) [HMC2058, 
HMC2059] 
 
Following General Procedure VI, an oven-dried, 100-mL Schlenk flask equipped with a 
magnetic stir bar, a septum, and a argon inlet were charged with a solution of alcohol 163
121
 (600 
mg, 4.68 mmol, 1 equiv) in CH2Cl2 (47 mL), and Et3N (2.28 mL, 16.4 mmol, 3.5 equiv). After 
cooled to 0 
o
C, to the flask was added methanesulfonyl chloride (543 L, 7.02 mmol, 1.5 equiv) 
via syringe. After stirring for 1 h at 0 
o
C, the reaction solution was quenched. After the work-up, 
the crude mesylate was dissolved in DMF (49 mL) and transferred to an oven-dried, 100-mL 
round-bottomed-flask. To the flask were added K2CO3 (4.34 g, 31.4 mmol, 7 equiv) and p-
toluenesulfonamide (5.38 g, 31.4 mmol, 7 equiv) and equipped with a reflux condenser. The 
suspension was heated to 80 
o
C (internal temperature) and stirred for 12 h. Upon reaction 
completion, the suspension was cooled to 0 
o
C and quenched. Purification via silica gel flash 
column chromatography (SiO2, 120 g, 35 mm Ø , toluene/EtOAc, 9:1 to 4:1) afforded 1.02 g (81% 
over two steps from 163) of 91 as a colorless oil. 
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Data for 91: 
 bp:  decomposed at 150 °C, 2.5 x 10
-5
 mm Hg 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.76 (d, J = 8.0 Hz, 2 H, HC(9)), 7.31 (d, J = 8.0 Hz, 2 H, HC(10)), 5.32 (dd, J = 
15.5, and 6.5 Hz, 1 H, HC(5)), 5.23 (dt, J = 15.5, and 6.5 Hz, 1 H, HC(4)), 4.74 (t, J 
= 6.0 Hz, 1 H, HN), 2.92 (q, J = 6.5 Hz, 2 H, HC(1)), 2.43 (s, 3 H, HC(12)), 2.18 
(hept, J = 7.0 Hz, 1 H, HC(6)), 1.95 (q, J = 7.0 Hz, 2 H, HC(3)), 1.52 (p, J = 7.0 Hz, 
2 H, HC(2)), 0.92 (d, J = 7.0 Hz, 6 H, HC(7)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.2 (C(8)), 138.9 (C(5)), 137.0 (C(11)), 129.6 (C(10)), 127.1 (C(9)), 125.3 
(C(4)), 42.6 (C(1)), 30.9 (C(6)), 29.4 (C(3)), 29.2 (C(2)), 22.5 (C(7)), 21.5 (C(12)). 
 IR: 3289 (m), 3024 (w), 2958 (m), 2869 (m), 1456 (m), 1324 (s), 1216 (w), 1159 (s), 
1094 (s), 971 (m), 814 (m), 757 (s). 
 MS: (ESI)  
184 (21), 224 (38), 238 (16), 280 (71), 282 (M+H, 100), 283 (22), 296 (14), 299 
(13), 304 (10), 331 (51), 336 (20) 
 HRMS: (ESI) calcd for C15H24NO2S (M+H
+
): 282.1528, found: 282.1520 
 TLC: Rf 0.53 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 
 
  Analysis: C15H23NO2S (281.41) 
  Calcd:  C, 64.02;  H, 8.24% N, 4.98% 
   Found:  C, 63.91;  H, 8.09% N, 4.94% 
 
Preparation of (E)-N-(4-Toluenesulfonyl)-1,1-dimethyl-5-phenylpent-4-enylamine (95) 
[HMC4080, HMC5023] 
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Following a reported procedure for addition of organocerium reagents to nitriles,
53
 an 
flame-dried, three-necked, 50-mL Schlenk flask equipped with a magnetic stir bar, two glass 
stopper, and a argon inlet was charged with finely ground CeCl3∙7H2O (4.02 g, 10.8 mmol, 3 
equiv). CeCl3∙7H2O was dried by following a reported process.
131
 After purging with argon, the 
flask was cooled to 0 
o
C (external temperature) and was added anhydrous THF (21 mL). The 
white suspension was warmed to room temperature and stirred for 2 h. The suspension was 
cooled to -72 
o
C (internal temperature) in a dry-ice/i-PrOH bath and was added a solution of 
MeLi (1.61 M in Et2O, 6.68 mL, 10.8 mmol, 3 equiv), whereupon the suspension turned yellow. 
After stirring for 30 min at -72 
o
C, the flask was transferred to a cold bath (-65 
o
C), controlled 
with a Cryocool unit. To the flask was added a solution of nitrile 167
42b
 (565 mg, 3.6 mmol, 1 
equiv, pre-cooled to -65 
o
C) in THF (6 mL) via cannula at -65 
o
C (internal temperature). After 4 
h, the reaction was complete, and the reaction solution was quenched by adding concentrated 
NH4OH solution (6.5 mL) dropwise at -65 
o
C. The resulting mixture was warmed to room 
temperature and was filtered through a pad of Celite (5 g, 35 mm), rinsed thoroughly with 
CH2Cl2 (50 mL). The filtrate was dried over NaSO4, filtered, and concentrated in vacuo (50 
o
C, 
10 mmHg) to afford crude oil. The crude oil was dissolved in toluene (20 mL) and was added a 
solution of H3PO4 (3%, 20 mL) and was stirred for 15 min. The organic layer was separated from 
the aqueous layer, and was added concentrated NH4OH solution (20 mL). The biphasic mixture 
was extracted with CH2Cl2 (20 mL x 5), dried over NaSO4, filtered, and concentrated in vacuo 
(70 
o
C, 10 mmHg) to afford crude amine. Then an oven-dried, 50-mL Schlenk flask equipped 
with a magnetic stir bar were charged with the amine (680 mg, 3.59 mmol, 1 equiv), CH2Cl2 (12 
mL), and Et3N (1.75 mL, 12.6 mmol, 3.5 equiv) and capped with a septum under argon. The 
solution was cooled to 0 
o
C (internal temperature) and was added a solution of p-toluenesulfonyl 
chloride (754 mg, 3.95 mmol, 1.1 equiv) in CH2Cl2 (2 mL) via syringe. The solution was 
warmed to room temperature and was stirred for 24 h. Upon reaction completion monitored by 
TLC, the solution was cooled to 0 
o
C (internal temperature) and quenched by adding 1 M HCl 
(10 mL) dropwise. The resulting biphasic mixture was extracted with CH2Cl2 (10 mL x 3). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo (23 
o
C, 
10 mmHg) to afford the crude product. Purification via silica gel flash column chromatography 
(SiO2, 15 g, 20 mm Ø , hexanes/EtOAc, 9:1 to 4:1) afforded 1.04 g (84%) the tosylamine 95 as 
white solid. 
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Data for 95: 
 mp:  111-112 °C 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.80 (d, J = 8.5 Hz, 2 H, HC(12)), 7.32 – 7.27 (m, 6 H, HC(7,8,13)), 7.24 – 7.18 
(m, 1 H, HC(9)), 6.32 (d, J = 16.0 Hz, 1 H, HC(5)), 6.08 (dt, J = 16.0, and 7.0 Hz, 1 
H, HC(4)), 4.64 (brs, 1 H, HN), 2.42 (s, 3 H, HC(15)), 2.23 – 2.17 (m, 2 H, HC(3)), 
1.70 – 1.65 (m, 2 H, HC(2)), 1.23 (s, 6 H, HC(10)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.9 (C(11)), 140.5 (C(14)), 137.6 (C(6)), 137.2 (C(5)), 129.8 (C(4)), 129.5 
(C(13)), 128.5 (C(8)), 127.0 (C(12)), 126.9 (C(9)), 125.9 (C(7)), 57.0 (C(1)), 42.2 
(C(2)), 27.8 (C(10)), 27.6 (C(3)), 21.5 (C(15)). 
 IR: (Neat) 
  3296 (w), 2920 (w), 1426 (w), 1321 (m), 1220 (w), 1149 (s), 1089 (m), 1019 (w), 
991 (m), 966 (m), 867 (w), 847 (w), 819 (m), 742 (m). 
 MS: (ESI) 
117 (14), 173 (82), 174 (16), 344 (M+H, 100), 345 (25), 361 (100), 362 (27), 366 
(18) 
 HRMS: (ESI) calcd for C20H26NO2S (M+H
+
): 344.1684, found: 344.1683 
 TLC: Rf 0.51 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
  Analysis: C20H25NO2S (343.48) 
  Calcd:  C, 69.93;  H, 7.34% N, 4.08% 
   Found:  C, 69.98;  H, 7.40% N, 4.28% 
 
Preparation of (E)-N-(4-Toluenesulfonyl)-5-phenylpent-4-enamide (100)
54
 [HMC2082] 
 
An oven-dried, 25-mL Schlenk flask equipped with a magnetic stir bar, a septum, and a 
argon inlet were charged with a solution of carboxylic acid 168
132
 (352 mg, 2.0 mmol, 1 equiv) 
in THF (7 mL), and Et3N (558 L, 4.0 mmol, 2 equiv). After stirring 5 min at room temperature, 
155 
 
to the flask was added p-toluenesulfonyl isocyanate (321 L, 2.1 mmol, 1.05 equiv) dropwise via 
syringe with observation of gas evolution. After stirring for 16 h at room temperature, the 
reaction was complete monitored by TLC. The reaction mixture was cooled to 0 
o
C (internal 
temperature) and was added 2 M HCl (7 mL) to quench the reaction. Resulting biphasic mixture 
was extracted with Et2O (7 mL x 3). The combined organic extracts were dried over Na2SO4, 
filtered, and concentrated in vacuo (50 
o
C, 10 mmHg) to afford the crude product. Purification 
via silica gel flash column chromatography (SiO2, 15 g, 20 mm Ø , toluene/EtOAc, 3:1) afforded 
593 mg (90%) of 100 as white solid. 
 
Data for 100: 
 mp:  113-114 °C 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 8.42 (brs, 1 H, HN), 7.93 (d, J = 8.0 Hz, 2 H, HC(12)), 7.33 – 7.20 (m, 7 H, 
HC(7,8,9,13)), 6.33 (d, J = 16.0 Hz, 1 H, HC(5)), 6.07 (dt, J = 16.0, and 6.5 Hz, 1 
H, HC(4)), 2.51 – 2.42 (m, 4 H, HC(2,3)), 2.42 (s, 3 H, HC(15)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 170.3 (C(1)), 145.1 (C(11)), 137.0 (C(6)), 135.4 (C(14)), 131.5 (C(5)), 129.6 
(C(13)), 128.4 (C(8)), 128.2 (C(12)), 127.3 (C(4)), 127.2 (C(9)), 126.1 (C(7)), 35.9 
(C(2)), 27.6 (C(3)), 21.6 (C(15)). 
 IR: (Neat) 
  3290 (w), 1719 (s), 1594 (w), 1433 (m), 1415 (m), 1373 (w), 1335 (m), 1187 (w), 
1169 (s), 1118 (m), 1082 (s), 1042 (w), 1019 (w), 959 (m), 859 (s), 848 (m), 815 (s), 
774 (w). 
 
 MS: (ESI) 
158 (22), 330 (M+H, 100), 331 (24), 347 (20), 352 (21) 
 HRMS: (ESI) calcd for C18H20NO3S (M+H
+
): 330.1164, found: 330.1166 
 TLC: Rf 0.27 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
  Analysis: C18H19NO3S (329.41) 
  Calcd:  C, 65.63;  H, 5.81% N, 4.25% 
   Found:  C, 65.33;  H, 5.84% N, 4.30% 
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Preparation of (E)-N-(4-Toluenesulfonyl)-6-phenylpent-5-enylamine (96) [HMC5060, 
HMC5061, HMC5062, HMC5063] 
 Following General Procedure VII, an oven-dried, 250-mL Schlenk flask equipped with a 
magnetic stir bar, a septum, and a argon inlet were charged with a solution of alcohol 2
120
 (2.43 g, 
15.0 mmol, 1 equiv) in CH2Cl2 (150 mL), and Et3N (7.32 mL, 52.5 mmol, 3.5 equiv). The 
solution was cooled to 0 
o
C, to the flask was added methanesulfonyl chloride (1.74 mL, 22.5 
mmol, 1.5 equiv). After stirring for 1 h at 0 
o
C, the reaction was quenched. Purification via silica 
gel flash column chromatography (SiO2, 30 g, 30 mm Ø , hexanes/EtOAc, 9:1) afforded 3.16 g 
(88%) of mesylate as a colorless oil. Then to an oven-dried, 250-mL round-bottomed-flask were 
added a solution of the resulted mesylate (3.16 g, 13.1 mmol, 1 equiv) in DMF (44 mL) and 
NaCN (9.67 g, 197 mmol, 15 equiv) as a solid in one portion. The flask was equipped with a 
reflux condenser and heated to 80 
o
C and stirred for 4 h. Upon reaction completion the reaction 
was quenched. Purification via silica gel flash column chromatography (SiO2, 30 g, 30 mm Ø , 
hexanes/EtOAc, 19:1) afforded 1.92 g (86%) of nitrile 164 as a colorless oil. The 
1
H NMR 
spectroscopic data matched those reported in the literature.
133 
 
Data for 164: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.42 – 7.25 (m, 5 H), 6.49 (d, J = 16.0 Hz, 1 H), 6.15 (dt, J = 16.0, and 7.0 Hz, 1 
H), 2.45 – 2.37 (m, 4 H), 1.86 (qt, J = 7.0 Hz, 2 H). 
 
An oven-dried, 100-mL Schlenk flask equipped with a magnetic stir bar was charged 
with LiAlH4 (569 mg, 15.0 mmol, 1.5 equiv) and capped with a septum under argon. The flask 
was immersed in an ice-bath and was added Et2O (26 mL). To the resulting suspension was 
added a solution of nitrile 164
133
 (1.71 g, 10.0 mmol, 1 equiv) in Et2O (7 mL). The suspension 
was warmed to room temperature and stirred for 2 h. The reaction was quenched upon 
completion, and acidified to afford the corresponding amine∙HCl salt. Then an oven-dried, 50-
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mL Schlenk flask equipped with a magnetic stir bar was charged with amine∙HCl salt (1.47 g, 
approx. 8.39 mmol, 1 equiv), CH2Cl2 (21 mL), and Et3N (3.51 mL, 25.2 mmol, 3 equiv). To the 
solution was added a solution of p-toluenesulfonyl chloride (1.68 g, 8.81 mmol, 1.05 equiv) in 
CH2Cl2 (7 mL) at 0 
o
C. The solution was warmed to room temperature and was stirred for 8 h. 
The reaction was quenched upon completion. Purification via silica gel flash column 
chromatography (SiO2, 30 g, 30 mm Ø , hexanes/EtOAc, 9:1 to 4:1) afforded 2.63 g (80% over 
two steps from 164) of the homologated tosylamine 96 as white solid. The 
1
H NMR 
spectroscopic data matched those reported in the literature.
42a
 
  
Data for 96: 
 mp:  61-62 °C 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.76 (d, J = 8.5 Hz, 2 H, HC(12)), 7.34 – 7.28 (m, 6 H, HC(8,9,13)), 7.23 – 7.19 
(m, 1 H, HC(10)), 6.34 (d, J = 16.0 Hz, 1 H, HC(6)), 6.13 (dt, J = 16.0, and 7.0 Hz, 
1 H, HC(5)), 4.61 (brt, J = 5.5 Hz, 1 H, HN), 2.97 (q, J = 6.5 Hz, 2 H, HC(1)), 2.42 
(s, 3 H, HC(15)), 2.17 (q, J = 7.0 Hz, 2 H, HC(4)), 1.56 – 1.42 (m, 4 H, HC(2,3)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.3 (C(11)), 137.5 (C(7)), 136.9 (C(14)), 130.3 (C(5)), 129.9 (C(4)), 129.6 
(C(13)), 128.4 (C(9)), 127.0 (C(12)), 126.9 (C(10)), 125.9 (C(8)), 43.0 (C(1)), 32.3 
(C(4)), 29.0 (C(2)), 26.1 (C(3)), 21.5 (C(15)). 
 IR: (Neat) 
  3255 (w), 2944 (w), 1495 (w), 1421 (w), 1321 (s), 1290 (w), 1159 (s), 1094 (m), 
1067 (w), 968 (m), 911 (w), 872 (w), 820 (m), 741 (m). 
 MS: (ESI)  
330 (M+H, 100), 331 (23), 347 (12), 352 (17) 
 HRMS: (ESI) calcd for C19H24NO2S (M+H
+
): 330.1528, found: 330.1525 
 TLC: Rf 0.48 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
  Analysis: C19H23NO2S (329.46) 
  Calcd:  C, 69.27;  H, 7.04% N, 4.25% 
   Found:  C, 69.38;  H, 7.16% N, 4.48% 
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Preparation of (E)-N-(4-Toluenesulfonyl)-6-phenylpent-5-enylamine (97) [HMC4021, 
HMC4022, HMC4023, HMC4024] 
 
Following General Procedure VII, an oven-dried, 250-mL Schlenk flask equipped with a 
magnetic stir bar, a septum, and a argon inlet were charged with a solution of alcohol 163
25
 (1.28 
g, 10.0 mmol, 1 equiv) in CH2Cl2 (100 mL), and Et3N (4.88 mL, 35.0 mmol, 3.5 equiv). The 
solution was cooled to 0 
o
C, to the flask was added methanesulfonyl chloride (1.16 mL, 15.0 
mmol, 1.5 equiv). After stirring for 1 h at 0 
o
C, the reaction was quenched. Purification via silica 
gel flash column chromatography (SiO2, 30 g, 30 mm Ø , hexanes/EtOAc, 9:1) afforded 1.90 g 
(92%) of mesylate as a colorless oil. Then to an oven-dried, 250-mL round-bottomed-flask were 
added a solution of the resulted mesylate (1.90 g, 9.20 mmol, 1 equiv) in DMF (100 mL) and 
NaCN (1.35 g, 27.6 mmol, 3 equiv) as a solid in one portion. The flask was equipped with a 
reflux condenser and heated to 90 
o
C and stirred for 24 h. Upon reaction completion the reaction 
was quenched. Purification via silica gel flash column chromatography (SiO2, 30 g, 30 mm Ø , 
hexanes/EtOAc, 19:1) afforded 1.09 g (86%) of nitrile 165 as a colorless oil. The 
1
H NMR 
spectroscopic data matched those reported in the literature.
121
 
 
Data for 165: 
 
1
H NMR:  (500 MHz, CDCl3) 
  δ 5.49 (ddt, J = 15.5, 6.5, and 1.5 Hz, 1 H, HC(6)), 5.28 (dtd, J = 15.5, 6.5, and 1.5 
Hz, 1 H, HC(5)), 2.33 (t, J = 7.0 Hz, 2 H, HC(1)), 2.30 – 2.22 (m, 1 H, HC(7)), 2.15 
(q, J = 7.0 Hz, 2 H, HC(4)), 1.73 (p, J = 7.0 Hz, 2 H, HC(3)), 0.98 (d, J = 6.5 Hz, 6 
H, HC(8)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 140.2 (C(6)), 124.1 (C(5)), 119.3 (C(1)), 31.2 (C(4)), 31.0 (C(7)), 25.1 (C(3)), 
22.5 (C(8)), 16.2 (C(2)).  
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An oven-dried, 100-mL Schlenk flask equipped with a magnetic stir bar was charged 
with LiAlH4 (285 mg, 7.5 mmol, 1.5 equiv) and capped with a septum under argon. The flask 
was immersed in an ice-bath and was added Et2O (10 mL). To the resulting suspension was 
added a solution of nitrile 165
121
 (686 mg, 5.0 mmol, 1 equiv) in Et2O (7 mL). The suspension 
was warmed to room temperature and stirred for 2 h. The reaction was quenched upon 
completion, and acidified to afford the corresponding amine∙HCl salt. Then an oven-dried, 50-
mL Schlenk flask equipped with a magnetic stir bar was charged with amine∙HCl salt (5.0 mmol, 
1 equiv), CH2Cl2 (10 mL), and Et3N (2.09 mL, 15.0 mmol, 3 equiv). To the solution was added a 
solution of p-toluenesulfonyl chloride (1.00 g, 5.25 mmol, 1.05 equiv) in CH2Cl2 (7 mL) at 0 
o
C. 
The solution was warmed to room temperature and was stirred for 4 h. The reaction was 
quenched upon completion. Purification via silica gel flash column chromatography (SiO2, 30 g, 
30 mm Ø , hexanes/EtOAc, 9:1 to 4:1) afforded 1.02 g (69% over two steps from 165) of the 
homologated tosylamine 97 as a colorless oil.  
  
Data for 97: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.76 (d, J = 8.5 Hz, 2 H, HC(10)), 7.29 (d, J = 8.0 Hz, 2 H, HC(11)), 5.31 (dd, J = 
15.5, and 6.5 Hz, 1 H, HC(6)), 5.23 (dt, J = 15.5, and 6.5 Hz, 1 H, HC(5)), 5.02 (t, J 
= 6.0 Hz, 1 H, HN), 2.90 (q, J = 7.0 Hz, 2 H, HC(1)), 2.41 (s, 3 H, HC(13)), 2.18 
(hept, J = 6.5 Hz, 1 H, HC(7)), 1.89 (q, J = 7.0 Hz, 2 H, HC(4)), 1.44 (dt, J = 15.0, 
and 7.0 Hz, 2 H, HC(2)), 1.30 (p, J = 7.44 Hz, 2 H, HC(3)), 0.92 (d, J = 7.0 Hz, 6 H, 
HC(8)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.1 (C(9)), 138.1 (C(6)), 136.9 (C(12)), 129.5 (C(11)), 127.0 (C(10)), 126.2 
(C(5)), 43.0 (C(1)), 31.8 (C(4)), 30.8 (C(7)), 28.8 (C(2)), 26.4 (C(3)), 22.5 (C(8)), 
21.4 (C(13)). 
 IR: 3283 (m), 2933 (m), 2868 (w), 1598 (w), 1456 (m), 1325 (s), 1158 (s), 1093 (m), 
971 (w), 937 (w), 815 (m). 
 MS: (ESI)  
252 (31), 294 (100), 296 (M+H, 49), 310 (32), 350 (17) 
 HRMS: (ESI) calcd for C16H26NO2S (M+H
+
): 296.1677, found: 296.1684 
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 TLC: Rf 0.56 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
  Analysis: C16H25NO2S (295.44) 
  Calcd:  C, 65.05;  H, 8.53% N, 4.74% 
   Found:  C, 64.98;  H, 8.34% N, 4.65% 
 
Preparation of (E)-N-(4-Toluenesulfonyl)-8-phenylpent-5-enylamine (98) [HMC4031, 
HMC4033, HMC4037, HMC4039] 
 
Following General Procedure VII, an oven-dried, 250-mL Schlenk flask equipped with a 
magnetic stir bar, a septum, and a argon inlet were charged with a solution of alcohol 162
38
 (1.90 
g, 10.0 mmol, 1 equiv) in CH2Cl2 (100 mL), and Et3N (4.88 mL, 35.0 mmol, 3.5 equiv). The 
solution was cooled to 0 
o
C, to the flask was added methanesulfonyl chloride (1.16 mL, 15.0 
mmol, 1.5 equiv). After stirring for 1 h at 0 
o
C, the reaction was quenched. Purification via silica 
gel flash column chromatography (SiO2, 30 g, 30 mm Ø , hexanes/EtOAc, 9:1) afforded 2.47 g 
(92%) of mesylate as a colorless oil. Then to an oven-dried, 250-mL round-bottomed-flask were 
added a solution of the resulted mesylate (2.47 g, 9.23 mmol, 1 equiv) in DMF (100 mL) and 
NaCN (1.35 g, 27.6 mmol, 3 equiv) as a solid in one portion. The flask was equipped with a 
reflux condenser and heated to 90 
o
C and stirred for 24 h. Upon reaction completion the reaction 
was quenched. Purification via silica gel flash column chromatography (SiO2, 30 g, 30 mm Ø , 
hexanes/EtOAc, 19:1) afforded 1.65 g (90%) of nitrile 166 as a colorless oil.  
 
Data for 166: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.29 (t, J = 7.5 Hz, 2 H, HC(11)), 7.21 – 7.15 (m, 3 H, HC(12,10)), 5.52 (dt, J = 
15.0, and 7.0 Hz, 1 H, HC(6)), 5.30 (dt, J = 15.0, and 7.0 Hz, 1 H, HC(5)), 2.69 (t, J 
= 7.5 Hz, 2 H, HC(8)), 2.34 (q, J = 7.5 Hz, 2 H, HC(7)), 2.20 (t, J = 7.5 Hz, 2 H, 
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HC(2)), 2.13 (q, J = 7.0 Hz, 2 H, HC(4)), 1.67 (p, J = 7.0 Hz, 2 H, HC(3)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 141.7 (C(9)), 132.0 (C(6)), 128.5 (C(10)), 128.2 (HC(11)), 128.2 (HC(5)), 125.8 
(C(12)), 119.7 (C(1)), 35.7 (C(8)), 34.2 (C(7)), 31.1 (C(4)), 24.9 (C(3)), 16.1 (C(2)). 
 IR: 3026 (m), 2933 (s), 2851 (m), 2245 (m), 1496 (s), 1454 (s), 1079 (w), 1030 (w), 
970 (s), 747 (s). 
 MS: (ESI) 
200 (M+H, 100), 201 (18), 219 (33), 224 (32), 227 (46), 231 (34), 232 (20) 
 HRMS: (ESI) calcd for C14H18N (M+H
+
): 200.1439, found: 200.1436 
 TLC: Rf 0.61 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
  Analysis: C14H17N (199.29) 
  Calcd:  C, 84.37;  H, 8.60% N, 7.03% 
   Found:  C, 84.58;  H, 8.58% N, 7.11% 
 
An oven-dried, 100-mL Schlenk flask equipped with a magnetic stir bar was charged 
with LiAlH4 (285 mg, 7.5 mmol, 1.5 equiv) and capped with a septum under argon. The flask 
was immersed in an ice-bath and was added Et2O (10 mL). To the resulting suspension was 
added a solution of nitrile 166 (996 mg, 5.0 mmol, 1 equiv) in Et2O (7 mL). The suspension was 
warmed to room temperature and stirred for 2 h. The reaction was quenched upon completion, 
and acidified to afford the corresponding amine∙HCl salt. Then an oven-dried, 50-mL Schlenk 
flask equipped with a magnetic stir bar was charged with amine∙HCl salt (5.0 mmol, 1 equiv), 
CH2Cl2 (10 mL), and Et3N (2.09 mL, 15.0 mmol, 3 equiv). To the solution was added a solution 
of p-toluenesulfonyl chloride (1.00 g, 5.25 mmol, 1.05 equiv) in CH2Cl2 (7 mL) at 0 
o
C. The 
solution was warmed to room temperature and was stirred for 4 h. The reaction was quenched 
upon completion. Purification via silica gel flash column chromatography (SiO2, 15 g, 20 mm Ø , 
hexanes/EtOAc, 9:1 to 4:1) afforded 1.22 g (66% over two steps from 166) of the homologated 
tosylamine 98 as a white solid.  
  
Data for 98: 
 mp:  68-69 °C 
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 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.75 (d, J = 8.5 Hz, 2 H, HC(14)), 7.31 (d, J = 8.0 Hz, 2 H, HC(15)), 7.27 (t, J = 
7.5 Hz, 2 H, HC(11)), 7.20 – 7.14 (m, 3 H, HC(12,10)), 5.43 – 5.35 (m, 1 H, 
HC(6)), 5.35 – 5.27 (m, 1 H, HC(5)), 4.47 (brs, 1 H, HN), 2.90 (q, J = 6.5 Hz, 2 H, 
HC(1)), 2.65 (t, J = 8.0 Hz, 2 H, HC(8)), 2.43 (s, 3 H, HC(17)), 2.28 (q, J = 7.0 H, 2 
H, HC(7)), 1.91 (q, J = 7.0 Hz, 2 H, HC(4)), 1.43 – 1.35 (m, 2 H, HC(2)), 1.33 – 
1.24 (m, 2 H, HC(3)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.3 (C(13)), 142.0 (C(9)), 136.9 (C(16)), 130.1 (C(6)), 130.0 (C(5)), 129.6 
(C(15)), 128.4 (C(10)), 128.2 (11)), 127.1 (C(14)), 125.7 (C(12)), 43.0 (C(1)), 35.9 
(C(8)), 34.3 (C(7)), 31.8 (C(4)), 28.8 (C(2)), 26.2 (C(3)), 21.5 (C(17)). 
 IR: 3244 (m), 2924 (w), 2857 (w), 1596 (w), 1449 (2), 1424 (w), 1322 (s), 1307 (m), 
1163 (s), 1153 (s), 1093 (m), 1074 (m), 1027 (w), 973 (m), 906 (w), 813 (m), 750 
(m). 
 MS: (ESI) 
358 (M+H, 100), 359 (28), 375 (22), 380 (22), 396 (10) 
 HRMS: (ESI) calcd for C21H28NO2S (M+H
+
): 358.1841, found: 358.1829 
 TLC: Rf 0.53 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
  Analysis: C21H27NO2S (357.51) 
  Calcd:  C, 70.55;  H, 7.61% N, 3.92% 
   Found:  C, 70.55;  H, 7.57% N, 3.98% 
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General Procedure VIII: Cyclization 
An oven-dried, 25-mL Schlenk flask equipped with a stir bar was charged with substrate 
(1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.10 M) and capped with a rubber septum. The flask was 
placed into a isopropyl alcohol bath, and the bath was cooled to 0 
o
C via a Cryocool unit. The 
temperature of the mixture was monitored via a thermocouple digital temperature probe. After 
the temperature stabilized, MsOH (32.5 µL, 0.5 mmol, 0.5 equiv) was added and the mixture was 
allowed to stir for the indicated time. The reaction was quenched while cold by addition of pre-
cooled sat. NaHCO3 aq. solution upon vigorous stirring. The resulting mixture was extracted 
with CH2Cl2 (10 mL x 3). The combined organic extracts were dried over Na2SO4, filtered 
through glass wool and then concentrated in vacuo (23 
o
C, 10 mm Hg) to afford the crude 
product. The product was purified via silica gel flash column chromatography prior to SFC 
analysis. 
 
Sulfenoamination Reactions with (S)-83 (Table 6 – 8 and Scheme 31 – 32) 
Preparation of (2S,3R)-N-(4-Toluenesulfonyl)-2-phenyl-3-(phenylthio)piperidine (69) 
(Table 6 Entry 1) [HMC5087] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 56 (315 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 0.2 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 0.1 
equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH (32.5 
µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 24 h. The reaction was worked up following 
the general procedure. The product 69 was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 393 mg (93%) of a 69 as a white solid.   
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Data for 69: 
 mp:  51-53 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.80 (d, J = 8.0 Hz, 2 H, HC(18)), 7.47 (d, J = 8.5 Hz, 2 H, HC(13)), 7.31 (t, J = 
8.0 Hz, 2 H, HC(14)), 7.29 – 7.16 (m, 8 H, HC(aryl)), 5.41 (s, 1 H, HC(2)), 3.91 (d, 
J = 2.0 Hz, 1H, HC(3)), 3.75 (dd, J = 13.0, and 3.0 Hz, 1 H, HC(6)), 3.21 (td, J = 
12.0, and 3.0 Hz, 1 H, HC(6)), 2.39 (s, 3 H, HC(21)), 1.91 – 1.70 (m, 3 H, HC(4,5)), 
1.38 (dt, J = 13.5, and 3.0 Hz, 1 H, HC(5)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.9 (C(20)), 138.8 (C(7)), 137.7 (C(17)), 135.0 (C(12)), 132.2 (C(13)), 129.2 
(C(19)), 129.1 (C(14)), 128.6 (C(9)), 127.6 (C(18)), 127.4 (C(15)), 127.0 (C(10)), 
126.8 (C(8)), 60.0 (C(2)), 49.7 (C(3)), 41.7 (C(6)), 24.1 (C(4)), 21.5 (C(21)), 19.9 
(C(5)). 
 IR: 3025 (w), 2947 (w), 2869 (w), 1598 (w), 1495 (w), 1479 (w), 1438 (m), 1377 (w), 
1337 (s), 1304 (m), 1287 (m), 1214 (m), 1182 (w), 1157 (s), 1107 (m), 1090 (s), 
1068 (w), 1049 (m), 1003 (w), 942 (s), 915 (w), 882 (w), 859 (w), 827 (w), 814 (w), 
760 (s) 
 MS: (ESI)  
314 (98), 315 (27), 316 (10), 424 (M+H, 100), 425 (27), 426 (13), 441 (19), 446 
(21), 462 (12) 
 HRMS: calcd for C24H26NO2S2: 424.1405, found: 424.1408 
 TLC: Rf 0.54 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 73.0 (c = 1.00, CHCl3) 
 SFC: (2S,3R)-69, tR 13.6 min (93.6%); (2R,3S)-69, tR 15.2 min (6.4%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 Analysis:  C24H25NO2S2 (423.59) 
  Calcd:  C, 68.05;  H, 5.95% N, 3.31% 
   Found:  C, 67.93;  H, 6.11% N, 3.02% 
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Preparation of (2S,3R)-N-(4-Toluenesulfonyl)-2-(4-methoxyphenyl)-3-
(phenylthio)piperidine (101) (Table 6 Entry 2) [HMC5088] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 88 (345 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 24 h. The reaction was worked up 
following the general procedure. The product 101 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 414 mg (91%) of 101 as a white solid.   
 
Data for 101: 
 mp:  53-54 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.84 (d, J = 8.5 Hz, 2 H, HC(20)), 7.48 (d, J = 7.5 Hz, 2 H, HC(15)), 7.36 (t, J = 
7.5 Hz, 2 H, HC(16)), 7.32 – 7.26 (m, 3 H, HC(17,21)), 7.18 (d, J = 9.0 Hz, 2 H, 
HC(8)), 6.84 (d, J = 9.0 Hz, 2 H, HC(9)), 5.38 (s, 1 H, HC(2)), 3.90 (brd, J = 2.5 Hz, 
1 H, HC(3)), 3.80 (s, 3 H, HC(12)), 3.75 (d, J = 13.5 Hz, 1 H, HC(6)), 3.27 – 3.19 
(m, 1 H, HC(6)), 2.45 (s, 3 H, HC(23)), 1.93 – 1.78 (m, 3 H, HC(4,5)), 1.47 – 1.40 
(m, 1 H, HC(5)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 158.6 (C(10)), 142.9 (C(19)), 137.8 (C(22)), 135.2 (C(14)), 132.2 (C(15)), 130.8 
(C(7)), 129.2 (C(21)), 129.2 (C(16)), 128.1 (C(8)), 127.1 (C(20)), 127.4 (C(17)), 
114.0 (C(9)), 59.7 (C(2)), 55.3 (C(12)), 49.6 (C(3)), 41.7 (C(6)), 24.1 (C(4)), 21.5 
(C(23)), 20.1 (C(5)).  
 IR: 3026 (w), 2948 (w), 2869 (w), 1610 (w), 1582 (w), 1512 (m), 1459 (w), 1438 (w), 
1374 (w), 1336 (m), 1304 (m), 1285 (w), 1252 (m), 1212 (w), 1181 (m), 1157 (s), 
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1107 (w), 1089 (m), 1069 (w), 1048 (w), 1034 (w), 1003 (w), 944 (m), 929 (m), 
886 (w), 863 (w), 839 (w), 814 (w), 751 (m) 
 MS: (ESI)  
344 (M+H, 100), 345 (24), 346 (14), 454 (15), 476 (22) 
 HRMS: calcd for C25H28NO3S2: 454.1511, found: 454.1513 
 TLC: Rf 0.53 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 41.3 (c = 1.00, CHCl3) 
 SFC: (2S,3R)-101, tR 18.0 min (91.8%); (2R,3S)-101, tR 22.0 min (8.2%) (Chiralpak AD, 
10% MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 Analysis:  C25H27NO3S2 (453.62) 
  Calcd:  C, 66.19;  H, 6.00% N, 3.09% 
   Found:  C, 66.26;  H, 5.82% N, 2.99% 
 
Preparation of (2S,3R)-N-(4-Toluenesulfonyl)-2-(4-trifluoromethylphenyl)-3-
(phenylthio)piperidine (102) (Table 6 Entry 3) [HMC5089] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 89 (383 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 48 h. The reaction was worked up 
following the general procedure. The product 102 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 191 mg (39%) of 102 as a white solid.   
 
Data for 102: 
 mp:  107-108 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
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  δ 7.82 (d, J = 8.5 Hz, 2 H, HC(19)), 7.54 (d, J = 8.5 Hz, 2 H, HC(9)), 7.49 (d, J = 
7.0 Hz, 2 H, HC(14)), 7.39 – 7.30 (m, 5 H, HC(8,15,16)), 7.28 (d, J = 8.0 Hz, 2 H, 
HC(20)), 5.40 (s, 1 H, HC(2)), 3.88 (q, J = 3.5 Hz, 1 H, HC(3)), 3.79 (m, 1 H, 
HC(6)), 3.25 (ddd, J = 13.5, 12.5, and 3.5 Hz, 1 H, HC(6)), 2.44 (s, 3 H, HC(22)), 
1.95 – 1.81 (m, 2 H, HC(4,5)), 1.79 – 1.70 (m, 1 H, HC(4)), 1.51 – 1.43 (m, 1 H, 
HC(5)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.3 (C(21)), 143.2 (C(7)), 137.4 (C(18)), 134.6 (C(13)), 132.6 (C(14)), 129.4 (q, 
J = 32 Hz, C(10)), 129.3 (C(20)), 129.3 (C(15)), 127.8 (C(16)), 127.6 (C(19)), 
127.3 (C(8)), 125.6 (q, J = 3.8 Hz, C(9)), 123.9 (q, J = 272 Hz, C(11)), 60.0 (C(2)), 
50.0 (C(3)), 42.0 (C(6)), 24.3 (C(4)), 21.5 (C(21)), 19.9 (C(5)).  
19
F NMR:  (470 MHz, CDCl3) 
  δ -63.05.  
 IR: 3025 (w), 2948 (m), 2872 (w), 1918 (w), 1619 (m), 1598 (w), 1984 (w), 1493 (w), 
1479 (w), 1438 (m), 1411 (m), 1336 (s), 1286 (m), 1212 (m), 1132 (s), 1090 (m), 
1069 (s), 1050 (m), 1015 (m), 938 (s), 889 (w), 863 (w), 845 (m), 814 (m), 747 (s) 
 MS: (ESI)  
382 (50), 383 (12), 492 (M+H, 100), 493 (31), 494 (15), 514 (15) 
 HRMS: calcd for C25H25NO2S2F3: 492.1279, found: 492.1276 
 TLC: Rf 0.60 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 46.5 (c = 1.00, CHCl3) 
 SFC: (2R,3S)-102, tR 16.9 min (8.1%); (2S,3R)-102, tR 17.9 min (91.9%) (Chiralcel OD, 
Gradient 3% MeOH in CO2 to 5% MeOH in CO2 over 30 min, 2.0 mL/min, 220 nm, 
40 
o
C) 
 Analysis:  C25H24F3NO2S2 (491.59) 
  Calcd:  C, 61.08;  H, 4.92 % N, 2.85% 
   Found:  C, 61.13;  H, 4.70% N, 2.58% 
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Preparation of (2S,6R)-N-(4-Toluenesulfonyl)-2-(3-phenyl-1-(phenylthio)propyl)pyrrolidine 
(103a) and (2S,3R)-N-(4-Toluenesulfonyl)-2-phenethyl-3-(phenylthio)piperidine (103b) 
(Table 7 Entry 1) [HMC6012] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 90 (343 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 24 h. The reaction was worked up 
following the general procedure. The product 103 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1) to afford 411 mg (91%) of a 3.3:1 mixture of 103a:103b 
as a white solid.   
 
Data for 103a+103b: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.84 (d, J = 7.5 Hz, 2 H, HC(20‟)), 7.65 (d, J = 7.5 Hz, 2 H, HC(20)), 7.50 (d, J = 
8.0 Hz, 2 H, HC(9)), 7.38 (d, J = 8.0 Hz, 2 H, HC(aryl‟)), 7.35 – 7.17 (m, 10 H+8 
H(‟), HC(aryl, aryl‟)), 7.10 (d, J = 8.0 Hz, 2 H, HC(aryl‟)), 4.29 (t, J = 7.0 Hz, 1 H, 
HC(2‟)), 3.93 (dt, J = 9.0, and 5.0 Hz, 1 H, HC(2)), 3.70 (dt, J = 9.0, and 4.5 Hz, 1 
H, HC(6)), 3.63 (d, J = 11.0 Hz, 1 H, HC(6‟)), 3.42 – 3.31 (m, 2 H+1 H(‟), 
HC(5,3‟)), 3.10 – 2.97 (m, 1 H+1 H(‟), HC(13,6‟)), 2.75 (ddd, J = 13.5, 10.0, and 
6.0 Hz, 1 H, HC(13)), 2.63 (t, J = 8.0 Hz, 2 H, HC(8‟)), 2.45 (s, 3 H, HC(23‟)), 2.43 
(s, 3 H, HC(23)), 2.07 (ddt, J = 14.0, 10.0, and 5.5 Hz, 1 H, HC(12)), 2.00 – 1.79 
(m, 3 H+5 H(‟), HC(3,4,12,4‟,5‟,7‟)), 1.68 (dt, J = 13.5, and 7.0 Hz, 1 H, (3)), 1.44 
( d, J = 13.5 Hz, 1 H, HC(5‟)), 1.38 – 1.27 (m, 1 H, HC(4)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.3 (C(19)), 142.9 (C(19‟)), 141.6 (C(14)), 141.1 (C(9‟)), 135.8 (C(8)), 135.1 
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(C(22)), 132.2 (C(aryl‟)), 131.5 (C(9)), 129.6 (C(21)), 129.4(C(21‟)), 129.1 
(C(aryl‟)), 128.9 (C(10)), 128.5 (C(aryl)), 128.4 (C(aryl‟)), 128.4 (C(aryl)), 128.3 
(C(aryl‟)), 127.7 (C(20‟)), 127.5 (C(20)), 127.2 (C(aryl‟)), 126.6 (C(11)), 126.0 
(C(aryl‟)), 125.9 (C(aryl)), 63.8 (C(2)), 57.0 (C(2‟)), 55.3 (C(6)), 49.7 (C(5)), 47.6 
(C(3‟)), 40.3 (C(6‟)), 35.9 (C(12)), 33.7 (C(13)), 32.9 (C(8‟)), 32.6 (C(4‟)), 28.0 
(C(3)), 24.8 (C(4)), 23.9 (C(7‟)), 21.5 (C(23,23‟)), 20.1 (C(5‟)).  
 IR: 3025 (m), 2946 (w), 1598 (w), 1495 (w), 1479 (w), 1452 (w), 1438 (w), 1343 (m), 
1302 (w), 1216 (m), 1157 (s), 1091 (m), 1019 (w), 989 (w), 927 (w), 815 (w), 755 
(s) 
 MS: (ESI)  
342 (24), 452 (M+H, 100), 453 (18), 474 (19) 
 HRMS: calcd for C26H30NO2S2: 452.1718, found: 452.1716 
 TLC: Rf 0.58 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 -46.9 (c = 1.00, CHCl3) 
 SFC: (2S,6R)-103a, tR 23.5 min (95.9% (73.6%)); (2S,3R)-103b, tR 24.9 min (95.8% 
(22.3%); (2R,6S)-103a, tR 27.8 min (4.1% (3.1%)); (2R,6S)-103b, tR 29.7 min (4.2% 
(1.0%)) (Welk, 5% MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C);  
 Analysis:  C26H29NO2S2 (451.64) 
  Calcd:  C, 69.14;  H, 6.47 % N, 3.10% 
   Found:  C, 68.65;  H, 6.44% N, 3.43% 
 
Preparation of (2S,6R)-N-(4-Toluenesulfonyl)-2-(2-methyl-1-
(phenylthio)propyl)pyrrolidine (104) (Table 7 Entry 2) [HMC5097] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 91 (281 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 48 h. The reaction was worked up 
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following the general procedure. The product 104 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 346 mg (89%) of 104 as a white solid.   
Data for 104: 
 mp:  140-141 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.66 (d, J = 8.0 Hz, 2 H, HC(16)), 7.53 (dd, J = 8.5, and 1.0 Hz, 2 H, HC(9)), 7.32 
– 7.25 (m, 4 H, HC(10,17)), 7.19 (t, J = 7.5 Hz, 1 H, HC(11)), 4.01 (ddd, J = 8.5, 
5.5, and 4.0 Hz, 1 H, HC(2)), 3.60 (dd, J = 6.5, and 4.0 Hz, 1 H, HC(6)), 3.36 (ddd, 
J = 8.0, 5.5, and 2.5 Hz, 2 H, HC(5)), 2.42 (s, 3 H, HC(19)), 2.01 (sept, 1 H, 
HC(12)), 1.89 (dtd, J = 13.0, 7.5, and 5.5 Hz, 1 H, HC(3)), 1.79 (dtt, J = 12.0, 5.5, 
and 5.5 Hz, 1 H, HC(4)), 1.67 (dtd, J = 13.0, 8.0, and 5.5 Hz, 1 H, HC(3)), 1.24 (dtt, 
J = 12.0, 8.0, and 8.0 Hz, 1 H, HC(4)), 1.12 (d, J = 6.5 Hz, 3 H, HC(13)), 1.10 (d, J 
= 6.5 Hz, 3 H, HC(13)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.3 (C(15)), 137.4 (C(8)), 134.9 (C(18)), 130.8 (C(9)), 129.7 (C(17)), 128.8 
(C(10)), 127.5 (C(16)), 126.2 (C(11)), 63.3 (C(6)), 62.2 (C(2)), 49.6 (C(5)), 32.1 
(C(12)), 28.6 (C(3)), 24.9 (C(4)), 21.5 (C(19)), 21.0 (C(13)), 20.4 (C(13)).  
 IR: (neat) 
  2960 (w), 1583 (w), 1482 (w), 1332 (s), 1309 (w), 1201 (w), 1155 (s), 1111 (w), 
1088 (m), 1027 (m), 993 (m), 867 (w), 826 (s), 743 (s) 
 MS: (ESI)  
184 (13), 219 (16), 224 (16), 280 (100), 281 (17), 390 (M+H, 71), 391 (21), 392 
(10), 412 (95), 413 (24), 414 (12), 428 (60), 429(17), 430 (10) 
 HRMS: calcd for C21H28NO2S2: 390.1561, found: 390.1574 
 TLC: Rf 0.60 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 -20.8 (c = 1.00, CHCl3) 
 SFC:  (2S,6R)-104, tR 7.9 min (96.8%); (2R,6S)-104, tR 10.3 min (3.2%) (Chiralpak AD, 
10% MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 Analysis:  C21H27NO2S2 (389.57) 
  Calcd:  C, 64.74;  H, 6.99 % N, 3.60% 
   Found:  C, 64.57;  H, 6.95% N, 3.86% 
171 
 
Preparation of (2S,3R)-N-(4-Toluenesulfonyl)-5,5-dimethyl-2-phenyl-3-
(phenylthio)piperidine (23) (Table 7 Entry 3) [HMC5090] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 99 (343 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 24 h. The reaction was worked up 
following the general procedure. The product 105 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 410 mg (91%) of 105 as a white solid.   
 
Data for 105: 
 mp:  100-101 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.50 (d, J = 8.0 Hz, 2 H, HC(19)), 7.37 (dd, J = 8.0, and 1.5 Hz, 2 H, HC(13)), 
7.32 – 7.25 (m, 3 H, HC(14,15)), 7.22 – 7.12 (m, 7 H, HC(8,9,10,20)), 4.94 (d, J = 
6.0 Hz, 1 H, HC(2)), 3.67 (ddd, J = 7.5, 6.0, and 4.5 Hz, 1 H, HC(3)), 3.30 (d, J = 
13.5 Hz, 1 H, HC(6)), 3.20 (d, J = 13.5 Hz, 1 H, HC(6)), 2.39 (s, 3 H, HC(22)), 
1.85 (dd, J = 14.0, and 4.5 Hz, 1 H, HC(4)), 1.67 (dd, J = 14.0, 7.5 Hz, 1 H, HC(4)), 
1.03 (s, 3 H, HC(16)), 0.96 (s, 3 H, HC(16)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.6 (C(21)), 138.5 (C(7)), 137.4 (C(18)), 134.8 (C(12)), 132.6 (C(13)), 129.0 
(C(20)), 128.9 (C(14)), 128.1 (C(9)), 127.7 (C(8)), 127.5 (C(15)), 127.4 (C(10)), 
127.3 (C(19)), 62.6 (C(2)), 53.3 (C(6)), 49.7 (C(3)), 40.9 (C(4)), 31.5 (C(5)), 27.7 
(C(16)), 27.6 (C(16)), 21.4 (C(22)). 
 IR: (neat) 
  2957 (w), 2868 (w), 1581 (w), 1494 (w), 1476 (w), 1454 (m), 1441 (w), 1393 (w), 
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1337 (m), 1313 (s), 1287 (m), 1183 (w), 1148 (s), 1092 (m), 1037 (m), 1026 (m), 
1000 (m), 956 (w), 905 (m), 844 (m), 809 (m), 776 (s), 741 (s) 
 MS: (ESI)  
342 (100), 343 (24), 452 (M+H, 38), 453 (12), 469 (12), 474 (33), 490 (15) 
 HRMS: calcd for C26H30NO2S2: 452.1718, found: 452.1717 
 TLC: Rf 0.58 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 43.4 (c = 1.00, CHCl3) 
 SFC: (2R,3S)-105, tR 37.0 min (3.7%); (2S,3R)-105, tR 38.6 min (96.3%) (Chiralcel OD, 
Gradient 1% MeOH in CO2 to 5% MeOH in CO2 over 60 min, 2.0 mL/min, 220 nm, 
40 
o
C) 
 Analysis:  C26H29NO2S2 (451.64) 
  Calcd:  C, 69.14;  H, 6.47% N, 3.10% 
   Found:  C, 68.79;  H, 6.08% N, 2.80% 
 
Preparation of (5R,6S)-N-(4-Toluenesulfonyl)-2,2-dimethyl-6-phenyl-5-
(phenylthio)piperidine (106) (Table 7 Entry 4) [HMC5092] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 95 (343 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 24 h. The reaction was worked up 
following the general procedure. The product 106 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 421 mg (93%) of 106 as a white solid.   
 
Data for 106: 
 mp:  137-138 
o
C (sealed tube) 
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 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.87 (d, J = 8.5 Hz, 2 H, HC(19)), 7.53 (d, J = 7.5 Hz, 2 H, HC(14)), 7.32 (t, J = 
7.5 Hz, 2 H, HC(15)), 7.23 (t, J = 7.5 Hz, 1 H, HC(16)), 7.13 – 7.03 (m, 5 H, 
HC(11,12,20)), 6.97 (d, J = 7.0 Hz, 2 H, HC(10)), 4.82 (d, J = 3.0 Hz, 1 H, HC(6)), 
4.38 (ddd, J = 9.5, 3.0, and 1.5 Hz, 1 H, HC(5)), 2.36 (td, J = 12.5, and 7.5 Hz, 1 H, 
HC(3)), 2.29 (s, 3 H, HC(22)), 2.00 (dd, J = 13.5, and 8.0 Hz, 1 H, HC(4)), 1.86 – 
1.77 (m, 1 H, HC(4)), 1.77 (s, 3 H, HC(7)), 1.714 (dd, J = 12.5, and 6.5 Hz, 1 H, 
HC(3)), 1.49 (s, 3 H, HC(7)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.7 (C(18)), 139.8 (C(13)), 139.3 (C(21)), 135.6 (C(9)), 129.2 (C(20)), 128.9 
(C(10)), 128.5 (C(15)), 128.4 (C(11)), 128.3 (C(14)), 127.3 (C(19)), 127.2 (C(16)), 
125.5 (C(12)), 67.9 (C(2)), 66.6 (C(5)), 56.7 (C(6)), 41.5 (C(3)), 28.8 (C(7)), 27.1 
(C(7)), 23.9 (C(4)), 21.3 (C(22)).  
 IR: 2993 (w), 2963 (m), 1595 (w), 1579 (w), 1491 (m), 1475 (m), 1446 (m), 1393 (w), 
1351 (w), 1328 (s), 1309 (m), 1286 (w), 1253 (w), 1234 (m), 1205 (m), 1182 (w), 
1153 (s), 1117 (m), 1084 (s), 1014 (s), 980 (s), 941 (w), 905 (w) 862 (w), 846 (w), 
814 (m), 761 (s) 
 MS: (ESI)  
181 (41), 281 (57), 282 (14), 342 (95), 343 (24), 452 (M+H, 100), 453 (30), 474 
(44), 475 (14), 490 (18) 
 HRMS: calcd for C26H30NO2S2: 452.1718, found: 452.1715 
 TLC: Rf 0.64 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 -38.1 (c = 1.00, CHCl3) 
 SFC: (5R,6S)-106, tR 18.4 min (91.8%); (5S,6R)-106, tR 20.3 min (8.2%) (Chiralcel OD, 
Gradient 3% MeOH in CO2 to 5% MeOH in CO2 over 30 min, 2.0 mL/min, 220 nm, 
40 
o
C) 
 Analysis:  C26H29NO2S2 (451.64) 
  Calcd:  C, 69.14;  H, 6.47% N, 3.10% 
   Found:  C, 69.06;  H, 6.38% N, 2.89% 
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Preparation of (2R,3R)-N-(4-Toluenesulfonyl)-2-phenyl-3-(phenylthio)piperidine (107) 
(Scheme 31 Entry 1) [HMC6013] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 92 (315 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 48 h. The reaction was worked up 
following the general procedure. The product 107 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 288 mg (68%) of 107 as a white solid.   
 
Data for 107: 
 mp:  54-55 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.42 – 7.37 (m, 4 H, HC(8,18)), 7.34 – 7.22 (m, 8 H, HC(aryl)), 7.09 (d, J = 8.5 
Hz, 2 H, HC(19)), 5.36 (d, J = 5.5 Hz, 1 H, HC(2)), 3.85 (dd, J = 13.5, and 4.0 Hz, 
1 H, HC(6)), 3.50 (dt, J = 13.0, and 5.0 Hz, 1 H, HC(3)), 3.06 (td, J = 13.5, and 3.0 
Hz, 1 H, HC(6)), 2.37 (s, 3 H, HC(21)), 2.10 (qd, J = 13.0, and 4.0 Hz, 1 H, HC(4)), 
2.00 (dd, J = 13.5, and 3.5 Hz, 1 H, HC(4)), 1.83 (brd, J = 13.5 Hz, 1 H, HC(5)), 
1.70 (qt, J = 13.5, and 5.0 Hz, 1 H, HC(5)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.8 (C(17)), 137.0 (C(20)), 136.6 (C(7)), 134.4 (C(12)), 131.9 (C(13/14)), 
129.7 (C(8)), 129.3 (C(19)), 129.0 (C(14/13)), 128.0 (C(9)), 127.8 (C(15)), 127.3 
(C(10)), 127.0 (C(18)), 59.2 (C(2)), 48.7 (C(3)), 40.8 (C(6)), 26.3 (C(4)), 25.5 
(C(5)), 21.4 (C(21)).  
 IR: 3058 (w), 3027 (m), 2949 (w), 2869 (w), 1598 (w), 1583 (w), 1495 (w), 1479 (w), 
1454 (w), 1438 (m), 1334 (s), 1304 (w), 1286 (w), 1216 (s), 1175 (m), 1159 (s), 
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1133 (m), 1095 (s), 1037 (w), 1022 (w), 1000 (m), 946 (s), 887 (w), 872 (w), 814 
(m), 748 (s) 
 MS: (ESI)  
314 (100), 315 (22), 424 (M+H, 53), 425 (14), 446 (16) 
 HRMS: calcd for C24H26NO2S2: 424.1405, found: 424.1398 
 TLC: Rf 0.53 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 -14.9 (c = 1.00, CHCl3) 
 SFC: (2R,3R)-107, tR 10.9 min (62.8%); (2S,3S)-107, tR 12.4 min (37.2%) (Chiralcel OD, 
10% MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 Analysis:  C24H25NO2S2 (423.59) 
  Calcd:  C, 68.05;  H, 5.95% N, 3.31% 
   Found:  C, 67.80;  H, 5.89% N, 3.27% 
  
Preparation of (2S)-N-(4-Toluenesulfonyl)-2-((phenylthio)methyl)pyrrolidine (108) 
(Scheme 31 Entry 2) [HMC6014] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 93 (239 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 36 h. The reaction was worked up 
following the general procedure. The product 108 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 323 mg (93%) of 108 as a white solid.   
 
Data for 108: 
 mp:  85-86 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.58 (d, J = 8.0 Hz, 2 H, HC(14)), 7.49 (d, J =7.5 Hz, 2 H, HC(9)), 7.37 (t, J = 7.5 
Hz, 2 H, HC(10)), 7.28 – 7.21 (m, 3 H, HC(11,15)), 3.71 (ddd, J = 13.5, and 3.0 Hz, 
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1 H, HC(6)), 3.65 (ddt, J = 11.0, 7.0, and 3.0 Hz, 1 H, HC(2)), 3.51 (ddd, J = 10.5, 
6.5, and 4.5 Hz, 1 H, HC(5)), 3.12 (ddd, J = 10.0, 8.0, and 6.5 Hz, 1 H, HC(5)), 
2.79 (dd, J = 13.5, and 11.0 Hz, 1 H, HC(6)), 2.42 (s, 3 H, HC(17)), 1.94 – 1.86 (m, 
1 H, HC(3)), 1.86 – 1.77 (m, 1 H, HC(4)), 1.70 – 1.60 (m, 1 H, HC(3)), 1.58 – 1.50 
(m, 1 H, HC(4)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.4 (C(13)), 135.3 (C(8)), 133.7 (C(16)), 129.6 (C(15)), 129.0 (C(10)), 128.9 
(C(9)), 127.4 (C(14)), 126.0 (C(11)), 58.8 (C(2)), 49.7 (C(5)), 38.3 (C(6)), 30.2 
(C(3)), 23.7 (C(4)), 21.5 (C(17)).  
 IR: 2975 (w), 2869 (w), 1597 (w), 1481 (m), 1439 (m), 1345 (s), 1197 (m), 1159 (s), 
1092 (m), 1062 (w), 1027 (m), 986 (w), 910 (s), 815 (m), 734 (s) 
 MS: (ESI)  
238 (31), 348 (M+H, 100), 349 (24), 350 (14), 370 (20), 386 (11) 
 HRMS: calcd for C18H22NO2S2: 348.1092, found: 348.1086 
 TLC: Rf 0.51 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 -228.7 (c = 1.00, CHCl3) 
 SFC: (2S)-108, tR 13.8 min (92.5%); (2R)-108, tR 15.0 min (7.5%) (Chiralcel OD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 Analysis:  C24H25NO2S2 (347.49) 
  Calcd:  C, 62.21;  H, 6.09% N, 4.03% 
   Found:  C, 62.06;  H, 5.69% N, 3.96% 
 
Preparation of (5R,6S)-N-(4-Toluenesulfonyl)-6-phenyl-5-(phenylthio)piperidin-2-one (109) 
(Scheme 32) [HMC6011] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 100 (329 mg, 
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1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 48 h. The reaction was worked up 
following the general procedure. The product 109 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 372 mg (85%) of 109 as a white solid.   
Data for 109: 
 mp:  73-74 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.77 (d, J = 8.5 Hz, 2 H, HC(18)), 7.55 (d, J = 7.0 Hz, 2 H, HC(13)), 7.44 – 7.28 
(m, 6 H, HC(14,15,9,10)), 7.25 (d, J = 8.0 Hz, 2 H, HC(19)), 7.12 (d, J = 7.5 Hz, 2 
H, HC(8)), 5.75 (s, 1 H, HC(6)), 3.76 (q, J = 3.0 Hz, 1 H, HC(5)), 2.75 (ddd, J = 
19.5, 12.0, and 8.0 Hz, 1 H, HC(3)), 2.52 (dd, J = 19.5, and 6.5 Hz, 1 H, HC(3)), 
2.43 (s, 3 H, HC(21)), 2.07 – 1.98 (m, 1 H, HC(4)), 1.79 – 1.70 (m, 1 H, HC(4)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 169.4 (C(2)), 144.7 (C(17)), 139.8 (C(7)), 135.7 (C(20)), 133.0 (C(13)), 132.7 
(C(12)), 129.5 (C(14,18)), 128.9 (C(9,19)), 128.4 (C(15)), 128.1 (C(10)), 126.0 
(C(8)), 63.8 (C(6)), 49.7 (C(5)), 29.6 (C(3)), 21.7 (C(21)), 20.2 (C(4)).  
 IR: 3028 (w), 2941 (w), 1731 (m), 1694 (s), 1597 (w), 1495 (w), 1480 (w), 1454 (m), 
1359 (s), 1295 (m), 1263 (m), 1218 (m), 1169 (s), 1130 (m), 1088 (m), 1024 (w), 
963 (m), 822 (m), 751 (s) 
 MS: (ESI)  
328 (100), 329 (25), 438 (M+H, 91), 439 (27), 440 (14), 460 (32), 476 (14) 
 HRMS: calcd for C24H24NO3S2: 438.1198, found: 438.1189 
 TLC: Rf 0.44 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 30.0 (c = 1.00, CHCl3) 
 SFC: (5R,6S)-109, tR 13.8 min (83.7%); (5S,6R)-109, tR 15.7 min (16.3%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 Analysis:  C24H23NO3S2 (437.57) 
  Calcd:  C, 65.88;  H, 5.30% N, 3.20% 
   Found:  C, 66.03;  H, 5.00% N, 3.12% 
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Preparation of (2S,3R)-N-(4-Toluenesulfonyl)-2-phenyl-3-(phenylthio)pyrrolidine (110) 
(Table 8 Entry 1) [HMC5093] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 94 (301 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 36 h. The reaction was worked up 
following the general procedure. The product 110 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 352 mg (86%) of 110 as a white solid.   
 
Data for 110: 
 mp:  72-73 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.74 (d, J = 8.0 Hz, 2 H, HC(17)), 7.36 (d, J = 8.5 Hz, 2 H, HC(18)), 7.34 – 7.16 
(m, 10 H, HC(aryl)), 4.67 (s, 1 H, HC(2)), 3.82 (ddd, J = 9.0, 8.0, 2.5 Hz, 1 H, 
HC(5)), 3.68 – 3.59 (m, 2 H, HC(5(left),3(right))), 2.50 (s, 3 H, HC(20)), 2.38 – 
2.28 (m, 1 H, HC(4)), 1.86 – 1.78 (m, 1 H, HC(4)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.4 (C(16)), 141.6 (C(6)), 134.6 (C(19)), 133.6 (C(11)), 132.2 (C(13)), 129.5 
(C(18)), 129.0 (C(12)), 128.4 (C(8)), 127.8 (C(17)), 127.6 (C(14)), 127.4 (C(9)), 
126.0 (C(7)), 68.7 (C(2)), 55.5 (C(3)), 47.8 (C(5)), 29.2 (C(4)), 21.6 (C(20)).  
 IR: 3026 (w), 2947 (w), 2882 (w), 1598 (w), 1494 (w), 1479 (w), 1439 (w), 1347 (s), 
1305 (w), 1216 (m), 1182 (m), 1160 (s), 1096 (s), 1055 (w), 1022 (w), 1009 (m), 
814 (m), 752 (s) 
 MS: (EI)  
91 (12), 118 (100), 135 (18), 151 (25), 155 (12), 253 (10), 254 (44), 299 (88), 300 
(18), 409 (M+, 81), 410 (18) 
 HRMS: calcd for C23H23NO2S2: 409.1170, found: 409.1162 
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 TLC: Rf 0.54 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 103.4 (c = 1.00, CHCl3) 
 SFC: (2R,3S)-110, tR 12.9 min (8.7%); (2S,3R)-110, tR 15.3 min (91.3%) (Chiralpak AD, 
10% MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 Analysis:  C23H23NO2S2 (409.56) 
  Calcd:  C, 67.45;  H, 5.66% N, 3.42% 
   Found:  C, 67.73;  H, 5.49% N, 3.65% 
 
Preparation of (2S,3R)-N-(4-Toluenesulfonyl)-2-phenyl-3-(phenylthio)azepane (111) (Table 
8 Entry 2) [HMC5095] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 96 (329 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 36 h. The reaction was worked up 
following the general procedure. The product 111 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 368 mg (84%) of 111 as a white solid.   
 
Data for 111: 
 mp:  129-130 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.33 – 7.18 (m, 12 H, HC(aryl)), 7.50 (d, J = 8.0 Hz, 2 H, HC(20)), 5.04 (d, J = 
10.5 Hz, 1 H, HC(2)), 3.69 (d, J = 15.5 Hz, 1 H, HC(7)), 3.48 (t, J = 9.5 Hz, 1 H, 
HC(3)), 2.45 (ddd, J = 15.0, 11.5, and 1.5 Hz, 1 H, HC(7)), 2.33 (s, 3 H, HC(22)), 
2.27 (dd, J = 15.0, and 6.0 Hz, 1 H, HC(4)), 2.03 – 1.89 (m, 2 H, HC(4,5)), 1.88 – 
1.77 (m, 1 H, HC(6)), 1.74 – 1.66 (m, 1 H, HC(6)), 1.48 – 1.35 (m, 1 H, HC(5)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.5 (C(21)), 140.2 (C(8)), 137.6 (C(18)), 134.4 (C(13)), 132.2 (C(14)), 129.0 
180 
 
(C(20)), 128.9 (C(10)), 128.3 (C(15)), 127.7 (C(11)), 127.6 (C(9)), 127.2 (C(16)), 
127.2 (C(19)), 64.3 (C(2)), 54.2 (C(3)), 45.7 (C(7)), 34.4 (C(4)), 29.4 (C(6)), 28.6 
(C(5)), 21.4 (C(22)).  
 IR: (neat) 
  2922 (w), 2854 (w), 1598 (w), 1494 (w), 1476 (w), 1460 (w), 1437 (w), 1378 (w), 
1332 (s), 1306 (w), 1252 (w), 1184 (w), 1157 (s), 1138 (m), 1101 (m), 1088 (m), 
1067 (w), 1027 (m), 982 (w), 933 (s), 850 (m), 811 (m), 781 (s) 
 MS: (ESI)  
328 (100), 329 (25), 438 (M+H, 38), 439 (10), 455 (20), 460 (37), 461 (11), 476 (18) 
 HRMS: calcd for C25H28NO2S2: 438.1561, found: 438.1563 
 TLC: Rf 0.58 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 45.5 (c = 1.00, CHCl3) 
 SFC: (2S,3R)-111, tR 6.0 min (92.7%); (2R,3S)-111, tR 10.4 min (7.3%) (Chiralcel OB, 15% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 Analysis:  C25H27NO2S2 (437.62) 
  Calcd:  C, 68.61;  H, 6.22% N, 3.20% 
   Found:  C, 68.60;  H, 5.97% N, 3.28% 
 
Preparation of (2S,7R)-N-(4-Toluenesulfonyl)-2-(2-methyl-1-(phenylthio)propyl)piperidine 
(112) (Table 8 Entry 3) [HMC6015] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 97 (295 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 48 h. The reaction was worked up 
following the general procedure. The product 112 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 351 mg (87%) of 112 as a white solid.   
Data for 112: 
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 mp:  36-37 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.75 (d, J = 8.0 Hz, 2 H, HC(17)), 7.44 (d, J = 7.5 Hz, 2 H, HC(10)), 7.29 (d, J = 
8.0 Hz, 2 H, HC(18)), 7.25 (t, J = 8.0 Hz, 2 H, HC(11)), 7.18 (t, J = 7.5 Hz, 1 H, 
HC(12)), 4.19 (dd, J = 11.0, and 5.0 Hz, 1 H, HC(2)), 3.75 (dd, J = 15.0, and 3.5 Hz, 
1 H, HC(6)), 3.33 (dd, J = 11.0, and 2.0 Hz, 1 H, HC(7)), 2.86 (ddd, J = 15.0, 13.5, 
and 3.0 Hz, 1 H, HC(6)), 2.42 (s, 3 H, HC(20)), 2.35 (heptd, J = 6.5, and 2.5 Hz, 1 
H, HC(13)), 2.17 (d, J = 14.0 Hz, 1 H, HC(3)), 1.31 – 1.21 (m, 1 H, HC(3)), 1.25 (d, 
J = 7.0 Hz, 3 H, HC(14)), 1.16 (d, J = 13.5 Hz, 1 H, HC(5)), 1.07 – 1.01 (m, 1 H, 
HC(4)), 1.03 (d, J = 6.5 Hz, 3 H, HC(14)), 1.01 – 0.92 (m, 1 H, HC(5)), 0.79 (qt, J 
= 13.0, and 4.0 Hz, 1 H, HC(4)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.0 (C(19)), 138.7 (C(16)), 137.4 (C(9)), 131.4 (C(10)), 129.6 (C(18)), 128.9 
(C(11)), 127.1 (C(17)), 126.6 (C(12)), 57.7 (C(7)), 56.3 (C(2)), 41.0 (C(6)), 27.3 
(C(13)), 24.6 (C(3)), 22.6 (C(5)), 22.4 (C(14)), 21.4 (C(20)), 18.2 (C(4)), 16.2 
(C(14)). 
 IR: 3024 (w), 2957 (m), 2870 (w), 1598 (w), 1581 (w), 1478 (w), 1464 (w), 1446 (w), 
1353 (m), 1336 (s), 1304 (w), 1290 (w), 1216 (w), 1191 (m), 1157 (s), 1116 (w), 
1091 (s), 1067 (w), 1042 (w), 1025 (w), 1001 (w), 930 (s), 880 (w), 840 (w), 815 
(m), 755 (s) 
 MS: (ESI)  
123 (22), 233 (43), 238 (19), 294 (80), 295 (18), 348 (34), 404 (M+H, 100), 405 
(28), 406 (14), 426 (32), 442 (14) 
 HRMS: calcd for C22H30NO2S2: 404.1718, found: 404.1719 
 TLC: Rf 0.63 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 21.6 (c = 1.00, CHCl3) 
 SFC: (2S,7R)-112, tR 7.4 min (95.4%); (2R,7S)-112, tR 9.1 min (4.6%) (Chiralpak AD, 10% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 Analysis:  C22H29NO2S2 (402.60) 
  Calcd:  C, 65.47;  H, 7.24% N, 3.47% 
   Found:  C, 65.20;  H, 7.04% N, 3.62% 
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Preparation of (2S,7R)-N-(4-Toluenesulfonyl)-2-(3-phenyl-1-(phenylthio)propyl)piperidine 
(113) (Table 8 Entry 4) [HMC5096] 
 
Following General Procedure VIII, a 25-mL Schlenk flask was charged with 98 (358 mg, 
1.0 mmol, 1.0 equiv), PhthSPh 6 (255 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 mmol, 
0.10 equiv), and CH2Cl2 (10.0 mL, 0.1 M). After cooled to 0 
o
C, the mixture was added MsOH 
(32.5 µL, 0.5 mmol, 0.5 equiv) and was allowed to stir for 48 h. The reaction was worked up 
following the general procedure. The product 113 was purified by flash chromatography (SiO2, 
25 g, 30 mm Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 423 mg (91%) of 113 as a sticky white 
solid.   
 
Data for 113: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.68 (d, J = 8.0 Hz, 2 H, HC(21)), 7.44 (d, J = 7.0 Hz, 2 H, HC(10)), 7.35 – 7.28 
(m, 5 H, HC(11,12,17)), 7.26 – 7.18 (m, 5 H, HC(16,18,22)), 4.03 (dd, J = 10.5, 
and 4.0 Hz, 1 H, HC(2)), 3.80 (d, J = 14.5 Hz, 1 H, HC(6)), 3.25 (td, J = 10.5, and 
3.0 Hz, 1 H, HC(7)), 3.14 (ddd, J = 13.5, 9.0, and 4.0 Hz, 1 H, HC(14)), 2.88 (dt, J 
= 14.0, and 8.5 Hz, 1 H, HC(14)), 2.67 (td, J = 15.0, and 2.5 Hz, 1 H, HC(6)), 2.42 
(s, 3 H, HC(24)), 2.28 (d, J = 13.0 Hz, 1 H, HC(3)), 2.17 (dtd, J = 14.5, 8.5, and 3.0 
Hz, 1 H, HC(13)), 1.73 (dtt, J = 14.0, 9.5, and 4.5 Hz, 1 H, HC(13)), 1.33 – 1.22 (m, 
3 H, HC(3,4,5)), 1.18 – 1.02 (m, 2 H, HC(4,5)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.8 (C(20)), 141.6 (C(15)), 138.6 (C(23)), 134.2 (C(9)), 132.8 (C(10)), 129.5 
(C(22)), 128.9 (C(11)), 128.6 (C(16)), 128.2 (C(17)), 127.4 (C(12)), 126.9 (C(21)), 
125.7 (C(18)). 
 IR: 3025 (w), 2941 (m), 2856 (w), 1599 (w), 1494 (w), 1453 (m), 1336 (s), 1302 (m), 
1216 (m), 1182 (w), 1154 (s), 1120 (m), 1091 (m), 1012 (w), 983 (w), 928 (s), 815 
(m), 752 (s) 
183 
 
 MS: (ESI)  
185 (12), 356 (41), 357 (23), 358 (11), 466 (M+H, 100), 467 (55), 468 (26), 483 
(45), 484 (17), 488 (12) 
 HRMS: calcd for C27H32NO2S2: 466.1874, found: 466.1871 
 TLC: Rf 0.60 (hexanes/EtOAc, 3:2) [UV/KMnO4] 
 Opt Rot: [α] D
24
 -17.6 (c = 1.00, CHCl3) 
 SFC: (2S,7R)-113, tR 11.6 min (97.4%); (2R,7S)-113, tR 17.1 min (2.6%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
 Analysis:  C27H31NO2S2 (465.67) 
  Calcd:  C, 69.64;  H, 6.71% N, 3.01% 
   Found:  C, 69.68;  H, 6.78% N, 2.88% 
 
NMR Study on the Catalytically Active Complex i
12,69
 (Section 2.3.4.1) [HMC4063] 
 To an oven-dried, 5-mm NMR tube was charged with (S)-83 (10 mg, 0.02 mmol), 
PhthSPh 6 (51 mg, 0.2 mmol, 10 equiv), and CDCl3 (500 L). The resulting solution was 
monitored with 
31
P NMR spectroscopy. 
Data for [(S)-83+PhthSPh(6)]: 
 
31
P NMR: (202 MHz, CDCl3) 
  δ 81.19 (br). 
 
 To an oven-dried, 5-mm NMR tube was charged with (S)-83 (10 mg, 0.02 mmol), 
PhthSPh 6 (51 mg, 0.2 mmol, 10 equiv), CDCl3 (500 L) and MsOH (13 L, 0.2 mmol, 10 
equiv). The resulting solution of catalytically active complex i was monitored immediately with 
31
P NMR spectroscopy. 
Data for [(S)-83+PhthSPh(6)+MsOH] (i): 
 
31
P NMR: (202 MHz, CDCl3) 
  δ 59.77 (sharp). 
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Impact of the Purity of MsOH on Reaction (Section 2.3.5) 
The following experiments were performed to investigate the impact of the purity of MsOH: 
Experiment 1: Using bottle A of MsOH (non-distilled “old & wet” MsOH) [HMC4062] 
Following General Procedure IV, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M). To the NMR tube was 
added MsOH (4.1 µL, 0.063 mmol, 1.0 equiv) at 0 
o
C. Conversion to product was measured by 
the appearance of the diagnostic 
1
H NMR resonance for the piperidine 69 at 5.41 ppm and the 
pyrrolidine 70 at 4.07 ppm with respect to the substrate peaks at 6.34 ppm and 6.09 ppm. 
Interestingly, pyrrolidine 13 was not observed throughout the reaction. Conversion monitored by 
1
H NMR spectroscopy was 20% (6 h), 44% (12 h), 63% (24 h), and 80% (48 h), whereupon only 
69 was observed. Purification via silica gel flash column chromatography (SiO2, 5 g, 10 mm Ø , 
hexanes/EtOAc, 9:1) afforded 21 mg (77%) of 69.  
 SFC: (2S,3R)-69, tR 14.8 min (92.0%); (2R,3S)-69, tR 16.5 min (8.0%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
Experiment 2: Using bottle B of MsOH (distilled MsOH
69
) [HMC4069] 
Following General Procedure IV, an oven-dried, 5-mm NMR tube was charged with 56 
(20 mg, 0.063 mmol), PhthSPh 6 (16.2 mg, 0.063 mmol, 1.0 equiv), chiral Lewis base catalyst 
(S)-83 (3.3 mg, 6.3 mol, 0.10 equiv), and CDCl3 (500 L, 0.13 M). To the NMR tube was 
added distilled MsOH
34
 (4.1 µL, 0.063 mmol, 1.0 equiv) at 0 
o
C. Conversion to product was 
measured by the appearance of the diagnostic 
1
H NMR resonance for the piperidine 69 and the 
pyrrolidine 70 with respect to the substrate peaks. The ratio of 69 to 70 of the reaction mixture 
were 97:3 (76% conversion, 6 h), 94:6 (93% conversion, 12 h), 86:14 (full conversion at 24 h), 
and of the crude product was 86:14. Purification via silica gel flash column chromatography 
(SiO2, 5 g, 10 mm Ø , hexanes/EtOAc, 9:1) afforded 22 mg (82%) of 69.  
 SFC: (2S,3R)-69, tR 14.8 min (91.6%); (2R,3S)-69, tR 16.5 min (8.4%) (Chiralcel OJ, 
Gradient 3% MeOH in CO2 to 8% MeOH in CO2 over 30 min, 2.5 mL/min, 220 nm, 
40 
o
C) 
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X-Ray Crystal Structure of 111 
 
 
 
Figure 21. ORTEP images of X-ray crystal structure of 111. 
 
 Recrystallization of 111 in THF/pentane resulted a white crystal. The crystallographic 
coordinates of 111 have been deposited with the Cambridge Crystallographic Data Centre 
(CCDC); deposition no. 981943. These data can be obtained free of charge via from the 
Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 
1223-336-033; via www.ccdc.cam.ac.uk/conts/retrieving.html or deposit@ccdc.cam.ac.uk). 
 
Table A. Crystal data and structure refinement for cd24gsa. 
Identification code  cd24gsa 
Empirical formula  C25 H27 N O2 S2 
Formula weight  437.59 
Temperature  100(2) K 
Wavelength  0.71073 Å  
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 6.0841(5) Å  = 90°. 
 b = 15.6924(12) Å  = 90°. 
 c = 22.5997(18) Å   = 90°. 
Volume 2157.7(3) Å 3 
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Table A. (cont.) 
Z 4 
Density (calculated) 1.347 Mg/m3 
Absorption coefficient 0.269 mm-1 
F(000) 928 
Crystal size 0.565 x 0.183 x 0.124 mm3 
Theta range for data collection 2.596 to 29.186°. 
Index ranges -8<=h<=8, -21<=k<=21, -28<=l<=30 
Reflections collected 40407 
Independent reflections 5825 [R(int) = 0.0374] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Integration 
Max. and min. transmission 0.97430 and 0.91819 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5825 / 0 / 272 
Goodness-of-fit on F2 1.059 
Final R indices [I>2sigma(I)] R1 = 0.0253, wR2 = 0.0625 
R indices (all data) R1 = 0.0272, wR2 = 0.0634 
Absolute structure parameter -0.034(15) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.289 and -0.255 e.Å -3 
 
Table B. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å 2x 103) for cd24gsa. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________  
S(1) 428(1) 9470(1) 167(1) 10(1) 
S(2) 3564(1) 7888(1) 2124(1) 16(1) 
O(1) -624(2) 9070(1) -331(1) 14(1) 
O(2) 2754(2) 9628(1) 152(1) 14(1) 
N(1) -11(2) 8878(1) 747(1) 10(1) 
C(1) 1659(3) 8834(1) 1227(1) 11(1) 
C(2) 1270(3) 8028(1) 1602(1) 12(1) 
C(3) 1080(3) 7211(1) 1225(1) 16(1) 
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Table B. (cont.) 
C(4) -1296(3) 6990(1) 1058(1) 18(1) 
C(5) -2419(3) 7608(1) 635(1) 16(1) 
C(6) -2259(3) 8542(1) 820(1) 12(1) 
C(7) -971(3) 10444(1) 285(1) 11(1) 
C(8) -3025(3) 10553(1) 31(1) 13(1) 
C(9) -4263(3) 11272(1) 169(1) 14(1) 
C(10) -3470(3) 11882(1) 565(1) 14(1) 
C(11) -1359(3) 11775(1) 797(1) 15(1) 
C(12) -103(3) 11064(1) 662(1) 14(1) 
C(13) -4864(3) 12633(1) 744(1) 19(1) 
C(14) 1813(3) 9650(1) 1591(1) 11(1) 
C(15) 3741(3) 10128(1) 1576(1) 14(1) 
C(16) 3928(3) 10880(1) 1905(1) 18(1) 
C(17) 2177(3) 11155(1) 2246(1) 20(1) 
C(18) 239(3) 10688(1) 2261(1) 18(1) 
C(19) 56(3) 9936(1) 1935(1) 14(1) 
C(20) 2828(3) 8545(1) 2737(1) 14(1) 
C(21) 4336(3) 9147(1) 2942(1) 17(1) 
C(22) 3832(3) 9644(1) 3434(1) 20(1) 
C(23) 1816(3) 9553(1) 3714(1) 20(1) 
C(24) 312(3) 8957(1) 3510(1) 18(1) 
C(25) 822(3) 8446(1) 3024(1) 16(1) 
________________________________________________________________________________  
 
Table C. Bond lengths [Å ] and angles [°] for cd24gsa. 
_____________________________________________________  
S(1)-O(2)  1.4370(12) 
S(1)-O(1)  1.4379(12) 
S(1)-N(1)  1.6294(13) 
S(1)-C(7)  1.7702(16) 
S(2)-C(20)  1.7827(17) 
S(2)-C(2)  1.8407(17) 
N(1)-C(6)  1.475(2) 
N(1)-C(1)  1.486(2) 
C(1)-C(14)  1.524(2) 
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Table C. (cont.) 
C(1)-C(2)  1.542(2) 
C(1)-H(1A)  1.0000 
C(2)-C(3)  1.545(2) 
C(2)-H(2A)  1.0000 
C(3)-C(4)  1.534(3) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.524(2) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(6)  1.528(2) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(7)-C(8)  1.386(2) 
C(7)-C(12)  1.397(2) 
C(8)-C(9)  1.393(2) 
C(8)-H(8A)  0.9500 
C(9)-C(10)  1.395(2) 
C(9)-H(9A)  0.9500 
C(10)-C(11)  1.397(2) 
C(10)-C(13)  1.508(2) 
C(11)-C(12)  1.386(2) 
C(11)-H(11A)  0.9500 
C(12)-H(12A)  0.9500 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-C(15)  1.393(2) 
C(14)-C(19)  1.396(2) 
C(15)-C(16)  1.398(2) 
C(15)-H(15A)  0.9500 
C(16)-C(17)  1.384(3) 
C(16)-H(16A)  0.9500 
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Table C. (cont.) 
C(17)-C(18)  1.388(3) 
C(17)-H(17A)  0.9500 
C(18)-C(19)  1.396(2) 
C(18)-H(18A)  0.9500 
C(19)-H(19A)  0.9500 
C(20)-C(25)  1.392(2) 
C(20)-C(21)  1.396(2) 
C(21)-C(22)  1.392(2) 
C(21)-H(21A)  0.9500 
C(22)-C(23)  1.388(3) 
C(22)-H(22A)  0.9500 
C(23)-C(24)  1.388(3) 
C(23)-H(23A)  0.9500 
C(24)-C(25)  1.394(2) 
C(24)-H(24A)  0.9500 
C(25)-H(25A)  0.9500 
 
O(2)-S(1)-O(1) 119.74(8) 
O(2)-S(1)-N(1) 106.13(7) 
O(1)-S(1)-N(1) 107.96(7) 
O(2)-S(1)-C(7) 109.13(7) 
O(1)-S(1)-C(7) 106.30(7) 
N(1)-S(1)-C(7) 106.97(7) 
C(20)-S(2)-C(2) 103.75(8) 
C(6)-N(1)-C(1) 122.46(12) 
C(6)-N(1)-S(1) 116.39(11) 
C(1)-N(1)-S(1) 120.07(10) 
N(1)-C(1)-C(14) 113.43(12) 
N(1)-C(1)-C(2) 109.53(13) 
C(14)-C(1)-C(2) 113.58(13) 
N(1)-C(1)-H(1A) 106.6 
C(14)-C(1)-H(1A) 106.6 
C(2)-C(1)-H(1A) 106.6 
C(1)-C(2)-C(3) 112.84(13) 
C(1)-C(2)-S(2) 109.55(11) 
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Table C. (cont.) 
C(3)-C(2)-S(2) 108.18(11) 
C(1)-C(2)-H(2A) 108.7 
C(3)-C(2)-H(2A) 108.7 
S(2)-C(2)-H(2A) 108.7 
C(4)-C(3)-C(2) 113.19(14) 
C(4)-C(3)-H(3A) 108.9 
C(2)-C(3)-H(3A) 108.9 
C(4)-C(3)-H(3B) 108.9 
C(2)-C(3)-H(3B) 108.9 
H(3A)-C(3)-H(3B) 107.8 
C(5)-C(4)-C(3) 115.67(14) 
C(5)-C(4)-H(4A) 108.4 
C(3)-C(4)-H(4A) 108.4 
C(5)-C(4)-H(4B) 108.4 
C(3)-C(4)-H(4B) 108.4 
H(4A)-C(4)-H(4B) 107.4 
C(4)-C(5)-C(6) 114.22(14) 
C(4)-C(5)-H(5A) 108.7 
C(6)-C(5)-H(5A) 108.7 
C(4)-C(5)-H(5B) 108.7 
C(6)-C(5)-H(5B) 108.7 
H(5A)-C(5)-H(5B) 107.6 
N(1)-C(6)-C(5) 111.81(14) 
N(1)-C(6)-H(6A) 109.3 
C(5)-C(6)-H(6A) 109.3 
N(1)-C(6)-H(6B) 109.3 
C(5)-C(6)-H(6B) 109.3 
H(6A)-C(6)-H(6B) 107.9 
C(8)-C(7)-C(12) 120.51(15) 
C(8)-C(7)-S(1) 118.50(12) 
C(12)-C(7)-S(1) 120.82(12) 
C(7)-C(8)-C(9) 119.61(15) 
C(7)-C(8)-H(8A) 120.2 
C(9)-C(8)-H(8A) 120.2 
C(8)-C(9)-C(10) 120.85(15) 
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Table C. (cont.) 
C(8)-C(9)-H(9A) 119.6 
C(10)-C(9)-H(9A) 119.6 
C(9)-C(10)-C(11) 118.47(15) 
C(9)-C(10)-C(13) 120.92(16) 
C(11)-C(10)-C(13) 120.61(15) 
C(12)-C(11)-C(10) 121.33(15) 
C(12)-C(11)-H(11A) 119.3 
C(10)-C(11)-H(11A) 119.3 
C(11)-C(12)-C(7) 119.12(16) 
C(11)-C(12)-H(12A) 120.4 
C(7)-C(12)-H(12A) 120.4 
C(10)-C(13)-H(13A) 109.5 
C(10)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B) 109.5 
C(10)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C) 109.5 
H(13B)-C(13)-H(13C) 109.5 
C(15)-C(14)-C(19) 119.00(15) 
C(15)-C(14)-C(1) 119.42(14) 
C(19)-C(14)-C(1) 121.58(15) 
C(14)-C(15)-C(16) 120.70(16) 
C(14)-C(15)-H(15A) 119.6 
C(16)-C(15)-H(15A) 119.6 
C(17)-C(16)-C(15) 119.72(17) 
C(17)-C(16)-H(16A) 120.1 
C(15)-C(16)-H(16A) 120.1 
C(16)-C(17)-C(18) 120.22(16) 
C(16)-C(17)-H(17A) 119.9 
C(18)-C(17)-H(17A) 119.9 
C(17)-C(18)-C(19) 120.05(17) 
C(17)-C(18)-H(18A) 120.0 
C(19)-C(18)-H(18A) 120.0 
C(14)-C(19)-C(18) 120.31(16) 
C(14)-C(19)-H(19A) 119.8 
C(18)-C(19)-H(19A) 119.8 
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Table C. (cont.) 
C(25)-C(20)-C(21) 119.80(15) 
C(25)-C(20)-S(2) 121.23(13) 
C(21)-C(20)-S(2) 118.93(13) 
C(22)-C(21)-C(20) 119.95(17) 
C(22)-C(21)-H(21A) 120.0 
C(20)-C(21)-H(21A) 120.0 
C(23)-C(22)-C(21) 120.16(17) 
C(23)-C(22)-H(22A) 119.9 
C(21)-C(22)-H(22A) 119.9 
C(24)-C(23)-C(22) 119.95(16) 
C(24)-C(23)-H(23A) 120.0 
C(22)-C(23)-H(23A) 120.0 
C(23)-C(24)-C(25) 120.22(17) 
C(23)-C(24)-H(24A) 119.9 
C(25)-C(24)-H(24A) 119.9 
C(20)-C(25)-C(24) 119.90(16) 
C(20)-C(25)-H(25A) 120.1 
C(24)-C(25)-H(25A) 120.1 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table D. Anisotropic displacement parameters (Å 2x 103) for cd24gsa. The anisotropic 
displacement factor exponent takes the form: -22[ h2 a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
S(1) 11(1)  9(1) 9(1)  0(1) 1(1)  0(1) 
S(2) 18(1)  17(1) 12(1)  -1(1) -2(1)  7(1) 
O(1) 17(1)  13(1) 10(1)  -2(1) -1(1)  1(1) 
O(2) 11(1)  15(1) 15(1)  2(1) 3(1)  -1(1) 
N(1) 10(1)  10(1) 10(1)  2(1) 0(1)  -2(1) 
C(1) 10(1)  12(1) 10(1)  0(1) -1(1)  1(1) 
C(2) 14(1)  11(1) 10(1)  0(1) -1(1)  2(1) 
C(3) 24(1)  10(1) 14(1)  -2(1) -2(1)  2(1) 
C(4) 26(1)  12(1) 17(1)  0(1) -2(1)  -5(1) 
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Table D. (cont.) 
C(5) 17(1)  14(1) 17(1)  0(1) -2(1)  -6(1) 
C(6) 10(1)  13(1) 13(1)  1(1) 1(1)  -2(1) 
C(7) 14(1)  9(1) 10(1)  1(1) 1(1)  0(1) 
C(8) 14(1)  12(1) 13(1)  1(1) -1(1)  -2(1) 
C(9) 12(1)  13(1) 16(1)  2(1) -2(1)  -1(1) 
C(10) 17(1)  11(1) 14(1)  3(1) 2(1)  1(1) 
C(11) 21(1)  12(1) 14(1)  -1(1) -5(1)  0(1) 
C(12) 15(1)  13(1) 14(1)  1(1) -4(1)  0(1) 
C(13) 22(1)  14(1) 21(1)  -3(1) -1(1)  5(1) 
C(14) 14(1)  11(1) 10(1)  1(1) -2(1)  2(1) 
C(15) 14(1)  14(1) 13(1)  0(1) -3(1)  0(1) 
C(16) 21(1)  14(1) 18(1)  1(1) -7(1)  -3(1) 
C(17) 31(1)  13(1) 16(1)  -4(1) -7(1)  2(1) 
C(18) 24(1)  17(1) 14(1)  -4(1) 0(1)  6(1) 
C(19) 16(1)  14(1) 14(1)  -1(1) 0(1)  0(1) 
C(20) 19(1)  14(1) 9(1)  1(1) -2(1)  3(1) 
C(21) 18(1)  20(1) 13(1)  3(1) -1(1)  -2(1) 
C(22) 27(1)  17(1) 16(1)  0(1) -4(1)  -5(1) 
C(23) 31(1)  16(1) 13(1)  -2(1) 1(1)  1(1) 
C(24) 22(1)  20(1) 13(1)  2(1) 2(1)  1(1) 
C(25) 20(1)  15(1) 12(1)  2(1) -2(1)  -2(1) 
______________________________________________________________________________  
 
Table E. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å 2x 10 3) 
for cd24gsa. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) 3116 8760 1029 13 
H(2A) -120 8102 1833 14 
H(3A) 1949 7285 858 19 
H(3B) 1723 6728 1447 19 
H(4A) -1310 6416 876 22 
H(4B) -2177 6960 1426 22 
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Table E. (cont.) 
H(5A) -3991 7451 603 19 
H(5B) -1754 7543 237 19 
H(6A) -3286 8885 577 15 
H(6B) -2708 8599 1239 15 
H(8A) -3586 10139 -236 15 
H(9A) -5664 11349 -8 17 
H(11A) -773 12199 1053 18 
H(12A) 1329 11000 823 17 
H(13A) -6391 12533 625 29 
H(13B) -4313 13149 550 29 
H(13C) -4795 12705 1175 29 
H(15A) 4941 9942 1340 17 
H(16A) 5252 11201 1894 21 
H(17A) 2301 11665 2470 24 
H(18A) -962 10880 2494 22 
H(19A) -1271 9617 1947 17 
H(21A) 5706 9217 2746 20 
H(22A) 4870 10045 3578 24 
H(23A) 1466 9899 4046 24 
H(24A) -1070 8898 3701 22 
H(25A) -198 8030 2890 19 
________________________________________________________________________________  
 
Table F. Torsion angles [°] for cd24gsa. 
________________________________________________________________  
O(2)-S(1)-N(1)-C(6) -172.93(11) 
O(1)-S(1)-N(1)-C(6) -43.39(13) 
C(7)-S(1)-N(1)-C(6) 70.65(12) 
O(2)-S(1)-N(1)-C(1) 18.65(13) 
O(1)-S(1)-N(1)-C(1) 148.19(11) 
C(7)-S(1)-N(1)-C(1) -97.77(12) 
C(6)-N(1)-C(1)-C(14) -96.20(16) 
S(1)-N(1)-C(1)-C(14) 71.50(16) 
C(6)-N(1)-C(1)-C(2) 31.85(19) 
S(1)-N(1)-C(1)-C(2) -160.45(11) 
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Table F. (cont.) 
N(1)-C(1)-C(2)-C(3) 51.09(18) 
C(14)-C(1)-C(2)-C(3) 179.05(14) 
N(1)-C(1)-C(2)-S(2) 171.67(10) 
C(14)-C(1)-C(2)-S(2) -60.37(16) 
C(20)-S(2)-C(2)-C(1) 84.47(12) 
C(20)-S(2)-C(2)-C(3) -152.15(11) 
C(1)-C(2)-C(3)-C(4) -92.82(17) 
S(2)-C(2)-C(3)-C(4) 145.81(12) 
C(2)-C(3)-C(4)-C(5) 67.42(19) 
C(3)-C(4)-C(5)-C(6) -50.6(2) 
C(1)-N(1)-C(6)-C(5) -89.95(17) 
S(1)-N(1)-C(6)-C(5) 101.93(13) 
C(4)-C(5)-C(6)-N(1) 71.27(18) 
O(2)-S(1)-C(7)-C(8) 147.58(12) 
O(1)-S(1)-C(7)-C(8) 17.16(14) 
N(1)-S(1)-C(7)-C(8) -98.00(13) 
O(2)-S(1)-C(7)-C(12) -37.18(15) 
O(1)-S(1)-C(7)-C(12) -167.61(13) 
N(1)-S(1)-C(7)-C(12) 77.23(14) 
C(12)-C(7)-C(8)-C(9) -2.3(2) 
S(1)-C(7)-C(8)-C(9) 172.98(12) 
C(7)-C(8)-C(9)-C(10) -0.6(2) 
C(8)-C(9)-C(10)-C(11) 3.1(2) 
C(8)-C(9)-C(10)-C(13) -176.18(15) 
C(9)-C(10)-C(11)-C(12) -2.9(2) 
C(13)-C(10)-C(11)-C(12) 176.42(16) 
C(10)-C(11)-C(12)-C(7) 0.1(2) 
C(8)-C(7)-C(12)-C(11) 2.5(2) 
S(1)-C(7)-C(12)-C(11) -172.63(13) 
N(1)-C(1)-C(14)-C(15) -114.96(16) 
C(2)-C(1)-C(14)-C(15) 119.12(16) 
N(1)-C(1)-C(14)-C(19) 64.1(2) 
C(2)-C(1)-C(14)-C(19) -61.8(2) 
C(19)-C(14)-C(15)-C(16) 0.7(2) 
C(1)-C(14)-C(15)-C(16) 179.81(15) 
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Table F. (cont.) 
C(14)-C(15)-C(16)-C(17) -0.4(2) 
C(15)-C(16)-C(17)-C(18) -0.1(3) 
C(16)-C(17)-C(18)-C(19) 0.4(3) 
C(15)-C(14)-C(19)-C(18) -0.4(2) 
C(1)-C(14)-C(19)-C(18) -179.54(15) 
C(17)-C(18)-C(19)-C(14) -0.1(3) 
C(2)-S(2)-C(20)-C(25) 55.09(15) 
C(2)-S(2)-C(20)-C(21) -127.34(13) 
C(25)-C(20)-C(21)-C(22) 0.1(2) 
S(2)-C(20)-C(21)-C(22) -177.48(13) 
C(20)-C(21)-C(22)-C(23) -1.2(3) 
C(21)-C(22)-C(23)-C(24) 1.0(3) 
C(22)-C(23)-C(24)-C(25) 0.3(3) 
C(21)-C(20)-C(25)-C(24) 1.1(2) 
S(2)-C(20)-C(25)-C(24) 178.66(13) 
C(23)-C(24)-C(25)-C(20) -1.3(3) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
 
 
 
 
 
 
 
 
 
 
 
197 
 
5.5 Experimental Procedures for Chapter 3 
Purification and Specification of Sulfonic Acids 
Specification of the Methanesulfonic Acid [HMC4064] 
Following the established procedure,
134a
 an oven-dried 100-mL round-bottomed-flask 
was charged with methanesulfonic acid (MsOH, 50 mL, 770 mmol, 1 equiv) and P2O5 (2.00 g, 
14.0 mmol, 0.018 equiv). The mixture was stirred for 30 min at 100 
o
C (external temperature). 
Then the mixture was cooled to room temperature and purified via short path distillation (120 
o
C 
at 0.075 mmHg) gave 68.5 g (93% recovery) of MsOH as a pale yellow liquid. 
 
Data for MsOH: 
 1
H NMR:  (500 MHz, 0.1 M in CDCl3) 
   10.52 (s, 1 H, HO), 3.19 (s, 3 H, H3C) 
  Integration ratio: 1.02 (HO): 3.00 (H3C) 
Specification of the Ethanesulfonic Acid [HMC5014] 
Wet EtSO3H can be dried to the specification provided by the azeotropic removal of 
water with benzene.
134b
 An oven-dried 100-mL round-bottomed-flask was charged with EtSO3H 
(8.2 mL, 100 mmol) and anhydrous benzene (60 mL). Simple distillation (80 
o
C, 1 atm) of this 
solution gave turbid liquid. This process was repeated until 
1
H NMR spectrum of the pink 
residue showed no significant change in integration of the OH signal. This residue was then 
connected to high vacuum (0.010 mmHg) for 3 h to remove residual benzene. Purification of the 
acid by short path distillation (83-84 
o
C at 0.010 mmHg) gave 9.3 g (84% recovery) of EtSO3H 
as a pale yellow liquid. In our experience, the azeotropic water removal process was repeated as 
many as six times to ensure that the EtSO3H was dry. 
 
Data for EtSO3H: 
 1
H NMR:  (500 MHz, 0.1 M in CDCl3) 
   10.61 (s, 1 H, HO), 3.25 (t, J = 7.0 Hz, 2 H, H2C), 1.48 (t, J = 7.5 Hz, 3 H, H3C) 
  Integration ratio: 1.15 (HO) : 2.00 (H2C) : 3.02 (H3C) 
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Experimental Procedures 
Optimization of Brønsted Acid (Figures 9 and 10) 
General Procedure IX: Effect of Acid Loading on Catalyzed Reactions at 0.2 M 
Concentration 
 
For experiments with a Lewis base catalyst, an oven-dried 5-mm NMR tube was charged 
with starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 
1.0 equiv), chiral Lewis base catalyst (S)-53 (6.6 mg, 12.0 mol, 0.1 equiv), 1,1,1,2-
tetrachloroethane (CH2ClCCl3, 12.6 L, 120 mol, 1.0 equiv, internal standard) and CDCl3 (600 
L) and capped with a septum cap. After shaking the mixture well making a homogeneous 
solution, the NMR tube was cooled to 20 °C in a cryocool unit. After reaching equilibrium, the 
indicated amount of EtSO3H or MsOH was added via syringe to the upper wall of the NMR tube. 
After 5 min of equilibrium in the cryocool unit, the tube was shaken to dissolve acid into the 
solution. The reaction progress was monitored by the appearance of the diagnostic 
1
H NMR 
resonance for the sulfenylated product 54 at 4.09 ppm (doublet, 1 H), and disappearance of 
starting alkene 52 at 6.37 ppm (doublet, 1 H) with respect to the internal standard at 4.30 ppm 
(singlet, 2 H). 
1
H NMR spectra were obtained at 0.5 h, 1.5 h, 3 h, 6 h, 12 h, 24 h, and 48 h, by 
freezing the NMR tube in a dewar flask with dry-ice/acetone bath (78 °C) while transferring to 
a pre-cooled (20 °C) NMR instrument. After 48 h, the reaction mixture was quenched by 
rapidly pouring into 1 mL of sat. NaHCO3 aq solution and the biphasic mixture was extracted 
with CH2Cl2 (1 mL × 3). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated in vacuo (30 °C, 10 mmHg) to afford the crude product. The product was purified 
via Combiflash®  column chromatography (SiO2, 4 g, RediSep®  column, hexanes/Et2O, 100:0 to 
96:4 (hexane/Et2O=19:1 solution was substituted with neat Et2O with gradient to 80% to make 
96:4)) prior to SFC analysis. 
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General Procedure X: Effect of Acid Loading on Uncatalyzed Reactions at 0.2 M 
Concentration 
 
For background experiments, an oven-dried 5-mm NMR tube was charged with starting 
alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 equiv), 
1,1,1,2-tetrachloroethane (CH2ClCCl3, 12.6 L, 120 mol, 1.0 equiv, internal standard) and 
CDCl3 (600 L) and capped with a septum cap. After shaking the mixture well making a 
homogeneous solution, the NMR tube was cooled to 20 °C in a cryocool unit. After reaching 
equilibrium, the indicated amount of EtSO3H or MsOH was added via syringe to the upper wall 
of the NMR tube. After 5 min of equilibrium in the cryocool unit, the tube was shaken to 
dissolve acid into the solution. The reaction progress was monitored by the appearance of the 
diagnostic 
1
H NMR resonance for the sulfenylated product 54 at 4.09 ppm (doublet, 1 H), and 
proton-initiated cyclization product 123 at 4.00 ppm (triplet, 1 H), and disappearance of starting 
alkene 52 at 6.37 ppm (doublet, 1 H) with respect to the internal standard at 4.30 ppm (singlet, 2 
H). 
1
H NMR spectra were obtained at 0.5 h, 1.5 h, 3 h, 6 h, 12 h, 24 h, and 48 h, by freezing the 
NMR tube in a dewar flask with dry-ice/acetone bath (78 °C) while transferring to a pre-cooled 
(20 °C) NMR instrument. 
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Acid Loading Study with MsOH 
Figure 9a (1.00 equiv, catalyzed) [HMC5036] 
Following General Procedure IX, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), chiral Lewis base catalyst (S)-53 (6.6 mg, 12.0 mol, 0.1 equiv), 1,1,1,2-
tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and capped. The NMR 
tube was cooled to 20 °C in a cryocool unit and MsOH (7.8 µL, 1.00 equiv) was added via 
syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. After 48 h, the reaction 
mixture was quenched. Purification of the crude product via Combiflash®  column 
chromatography (SiO2, 4 g, RediSep®  column, hexanes/Et2O, 100:0 to 96:4) gave 42 mg (93%) 
of 54. 
 SFC: (5S,6S)-54, tR 14.5 min (21%); (5R,6R)-54, tR 16.4 min (79%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
(a) (b)  
 
Figure 22. (a) Catalyzed reaction with 1.00 equiv MsOH. (b) First order kinetic plot.  
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Figure 9b (1.00 equiv, uncatalyzed) [HMC5031] 
Following General Procedure X, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), 1,1,1,2-tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and 
capped. The NMR tube was cooled to 20 °C in a cryocool unit and MsOH (7.8 µL, 1.00 equiv) 
was added via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
Figure 23. Uncatalyzed reaction with 1.00 equiv MsOH. 
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Acid Loadings Study with EtSO3H 
Figure 10a (1.00 equiv, catalyzed) [HMC5037] 
Following General Procedure IX, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), chiral Lewis base catalyst (S)-53 (6.6 mg, 12.0 mol, 0.1 equiv), 1,1,1,2-
tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and capped. The NMR 
tube was cooled to 20 °C in a cryocool unit and EtSO3H (9.8 µL, 1.00 equiv) was added via 
syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. After 48 h, the reaction 
mixture was quenched. Purification of the crude product via Combiflash®  column 
chromatography (SiO2, 4 g, RediSep®  column, hexanes/Et2O, 100:0 to 96:4) gave 41 mg (92%) 
of 54. 
 SFC: (5S,6S)-54, tR 14.7 min (13%); (5R,6R)-54, tR 16.5 min (87%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 
Figure 24. Catalyzed reaction with 1.00 equiv EtSO3H. 
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Figure 10a (0.75 equiv, catalyzed) [HMC5038] 
Following General Procedure IX, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), chiral Lewis base catalyst (S)-53 (6.6 mg, 12.0 mol, 0.1 equiv), 1,1,1,2-
tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and capped. The NMR 
tube was cooled to 20 °C in a cryocool unit and EtSO3H (7.3 µL, 0.75 equiv) was added via 
syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. After 48 h, the reaction 
mixture was quenched. Purification of the crude product via Combiflash®  column 
chromatography (SiO2, 4 g, RediSep®  column, hexanes/Et2O, 100:0 to 96:4) gave 41 mg (91%) 
of 54. 
 SFC: (5S,6S)-54, tR 14.8 min (10%); (5R,6R)-54, tR 16.5 min (90%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 
 
Figure 25. Catalyzed reaction with 0.75 equiv EtSO3H. 
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Figure 10a (0.50 equiv catalyzed) [HMC5039] 
Following General Procedure IX, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), chiral Lewis base catalyst (S)-53 (6.6 mg, 12.0 mol, 0.1 equiv), 1,1,1,2-
tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and capped. The NMR 
tube was cooled to 20 °C in a cryocool unit and EtSO3H (4.9 µL, 0.50 equiv) was added via 
syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. After 48 h, the reaction 
mixture was quenched. Purification of the crude product via Combiflash®  column 
chromatography (SiO2, 4 g, RediSep®  column, hexanes/Et2O, 100:0 to 96:4) gave 40 mg (89%) 
of 54. 
 SFC: (5S,6S)-54, tR 14.8 min (7%); (5R,6R)-54, tR 16.5 min (93%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 
 
Figure 26. Catalyzed reaction with 0.50 equiv EtSO3H. 
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Figure 10a (0.25 equiv, catalyzed) [HMC5040] 
Following General Procedure IX, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), chiral Lewis base catalyst (S)-53 (6.6 mg, 12.0 mol, 0.1 equiv), 1,1,1,2-
tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and capped. The NMR 
tube was cooled to 20 °C in a cryocool unit and EtSO3H (2.4 µL, 0.25 equiv) was added via 
syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. After 48 h, the reaction 
mixture was quenched. Purification of the crude product via Combiflash®  column 
chromatography (SiO2, 4 g, RediSep®  column, hexanes/Et2O, 100:0 to 96:4) gave 39 mg (87%) 
of 54. 
 SFC: (5S,6S)-54, tR 14.8 min (7%); (5R,6R)-54, tR 16.5 min (93%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
(a) (b)  
 
Figure 27. (a) Catalyzed reaction with 0.25 equiv EtSO3H. (b) First order kinetic plot. 
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Figure 10b (1.00 equiv, uncatalyzed) [HMC5032] 
Following General Procedure X, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), 1,1,1,2-tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and 
capped. The NMR tube was cooled to 20 °C in a cryocool unit and EtSO3H (9.8 µL, 1.00 equiv) 
was added via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
 
 
Figure 28. Uncatalyzed reaction with 1.00 equiv EtSO3H. 
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Figure 10b (0.75 equiv, uncatalyzed) [HMC5033] 
Following General Procedure X, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), 1,1,1,2-tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and 
capped. The NMR tube was cooled to 20 °C in a cryocool unit and EtSO3H (7.3 µL, 0.75 equiv) 
was added via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
 
Figure 29. Uncatalyzed reaction with 0.75 equiv EtSO3H. 
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Figure 10b (0.50 equiv, uncatalyzed) [HMC5034] 
Following General Procedure X, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), 1,1,1,2-tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and 
capped. The NMR tube was cooled to 20 °C in a cryocool unit and EtSO3H (4.9 µL, 0.50 equiv) 
was added via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
 
Figure 30. Uncatalyzed reaction with 0.50 equiv EtSO3H. 
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Figure 10b (0.25 equiv, uncatalyzed) [HMC5035] 
Following General Procedure X, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 
equiv), 1,1,1,2-tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and CDCl3 (600 L) and 
capped. The NMR tube was cooled to 20 °C in a cryocool unit and EtSO3H (2.4 µL, 0.25 equiv) 
was added via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
 
Figure 31. Uncatalyzed reaction with 0.25 equiv EtSO3H. 
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General Procedure XI: Effect of Acid Loading on Catalyzed Reactions at 0.1 M 
Concentration 
 
For experiments with a Lewis base catalyst, an oven-dried 5-mm NMR tube was charged 
with starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 
equiv), chiral Lewis base catalyst (S)-53 (2.7 mg, 5.0 mol, 0.1 equiv), 1,1,1,2-tetrachloroethane 
(CH2ClCCl3, 5.0 L, 48 mol, 0.95 equiv, internal standard) and CDCl3 (500 L) and capped 
with a septum cap. After shaking the mixture well making a homogeneous solution, the NMR 
tube was cooled to 20 °C in a cryocool unit. After reaching equilibrium, the indicated amount 
of EtSO3H or MsOH was added via syringe to the upper wall of the NMR tube. After 5 min of 
equilibrium in the cryocool unit, the tube was shaken to dissolve acid into the solution. The 
reaction progress was monitored by the appearance of the diagnostic 
1
H NMR resonance for the 
sulfenylated product 54 at 4.09 ppm (doublet, 1 H), and disappearance of starting alkene 52 at 
6.37 ppm (doublet, 1 H) with respect to the internal standard at 4.30 ppm (singlet, 2 H). 
1
H NMR 
spectra were obtained at 1 h, 3 h, 6 h, 12 h, 24 h, and 48 h, by freezing the NMR tube in a dewar 
flask with dry-ice/acetone bath (78 °C) while transferring to a pre-cooled (20 °C) NMR 
instrument. After 48 h, the reaction mixture was quenched by rapidly pouring into 1 mL of sat. 
NaHCO3 aq solution and the biphasic mixture was extracted with CH2Cl2 (1 mL × 3). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo (30 °C, 
10 mmHg) to afford the crude product. The product was purified via Combiflash®  column 
chromatography (SiO2, 4 g, RediSep®  column, hexanes/Et2O, 100:0 to 96:4 (hexane/Et2O, 19:1 
solution was substituted with neat Et2O with gradient to 80% to make 96:4)) prior to SFC 
analysis. 
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General Procedure XII: Effect of Acid Loading on Uncatalyzed Reactions at 0.1 M 
Concentration 
 
For background experiments, an oven-dried 5-mm NMR tube was charged with starting 
alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
1,1,1,2-tetrachloroethane (CH2ClCCl3, 5.0 L, 48 mol, 0.95 equiv, internal standard) and 
CDCl3 (500 L) and capped with a septum cap. After shaking the mixture well making a 
homogeneous solution, the NMR tube was cooled to 20 °C in a cryocool unit. After reaching 
equilibrium, the indicated amount of EtSO3H or MsOH was added via syringe to the upper wall 
of the NMR tube. After 5 min of equilibrium in the cryocool unit, the tube was shaken to 
dissolve acid into the solution. The reaction progress was monitored by the appearance of the 
diagnostic 
1
H NMR resonance for the sulfenylated product 54 at 4.09 ppm (doublet, 1 H), and 
proton-initiated cyclization product 123 at 4.00 ppm (triplet, 1 H), and disappearance of starting 
alkene 52 at 6.37 ppm (doublet, 1 H) with respect to the internal standard at 4.30 ppm (singlet, 2 
H). 
1
H NMR spectra were obtained at 1 h, 3 h, 6 h, 12 h, 24 h, and 48 h, by freezing the NMR 
tube in a dewar flask with dry-ice/acetone bath (78 °C) while transferring to a pre-cooled 
(20 °C) NMR instrument.  
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Acid Loading Study with MsOH 
(1.00 equiv, catalyzed) [HMC4097] 
Following General Procedure XI, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
chiral Lewis base catalyst (S)-53 (2.7 mg, 5.0 mol, 0.1 equiv), 1,1,1,2-tetrachloroethane (5.0 L, 
48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The NMR tube was cooled to 20 °C in a 
cryocool unit and MsOH (3.2 µL, 1.00 equiv) was added via syringe. The reaction progress was 
monitored by 
1
H NMR spectroscopy. After 48 h, the reaction mixture was quenched. Purification 
of the crude product via Combiflash®  column chromatography (SiO2, 4 g, RediSep®  column, 
hexanes/Et2O, 100:0 to 96:4) gave 17 mg (92%) of 54. 
 SFC: (5S,6S)-54 tR 14.3 min (25%); (5R,6R)-54, tR 16.2 min (75%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 
 
Figure 32. Catalyzed reaction with 1.00 equiv MsOH. 
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Acid Loading Study with MsOH 
 (1.00 equiv, uncatalyzed) [HMC4098] 
Following General Procedure XII, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
1,1,1,2-tetrachloroethane (5.0 L, 48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The 
NMR tube was cooled to 20 °C in a cryocool unit and MsOH (3.2 µL, 1.00 equiv) was added 
via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
 
Figure 33. Uncatalyzed reaction with 1.00 equiv MsOH. 
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Acid Loadings Study with EtSO3H 
(1.00 equiv, catalyzed) [HMC4099] 
Following General Procedure XI, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
chiral Lewis base catalyst (S)-53 (2.7 mg, 5.0 mol, 0.1 equiv), 1,1,1,2-tetrachloroethane (5.0 L, 
48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The NMR tube was cooled to 20 °C in a 
cryocool unit and EtSO3H (4.1 µL, 1.00 equiv) was added via syringe. The reaction progress was 
monitored by 
1
H NMR spectroscopy. After 48 h, the reaction mixture was quenched. Purification 
of the crude product via Combiflash®  column chromatography (SiO2, 4 g, RediSep®  column, 
hexanes/Et2O, 100:0 to 96:4) gave 17 mg (89%) of 54. 
 SFC: (5S,6S)-54, tR 14.3 min (8%); (5R,6R)-54, tR 16.2 min (92%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 
 
Figure 34. Uncatalyzed reaction with 1.00 equiv EtSO3H. 
 
 
 
 
 
215 
 
Acid Loading Study with EtSO3H 
 (0.75 equiv, catalyzed) [HMC5017] 
Following General Procedure XI, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
chiral Lewis base catalyst (S)-53 (2.7 mg, 5.0 mol, 0.1 equiv), 1,1,1,2-tetrachloroethane (5.0 L, 
48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The NMR tube was cooled to 20 °C in a 
cryocool unit and EtSO3H (3.1 µL, 0.75 equiv) was added via syringe. The reaction progress was 
monitored by 
1
H NMR spectroscopy. After 48 h, the reaction mixture was quenched. Purification 
of the crude product via Combiflash®  column chromatography (SiO2, 4 g, RediSep®  column, 
hexanes/Et2O, 100:0 to 96:4) gave 17 mg (91%) of 54. 
 SFC: (5S,6S)-54, tR 14.2 min (7%); (5R,6R)-54, tR 16.1 min (93%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 
Figure 35. Uncatalyzed reaction with 0.75 equiv EtSO3H. 
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Acid Loading Study with EtSO3H 
(0.50 equiv catalyzed) [HMC5019] 
Following General Procedure XI, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
chiral Lewis base catalyst (S)-53 (2.7 mg, 5.0 mol, 0.1 equiv), 1,1,1,2-tetrachloroethane (5.0 L, 
48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The NMR tube was cooled to 20 °C in a 
cryocool unit and EtSO3H (2.0 µL, 0.50 equiv) was added via syringe. The reaction progress was 
monitored by 
1
H NMR spectroscopy. After 48 h, the reaction mixture was quenched. Purification 
of the crude product via Combiflash®  column chromatography (SiO2, 4 g, RediSep®  column, 
hexanes/Et2O, 100:0 to 96:4) gave 16 mg (86%) of 54. 
 SFC: (5S,6S)-54, tR 14.3 min (7%); (5R,6R)-54, tR 16.4 min (93%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 
 
Figure 36. Uncatalyzed reaction with 0.50 equiv EtSO3H. 
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Acid Loading Study with EtSO3H 
(0.25 equiv, catalyzed) [HMC5011] 
Following General Procedure XI, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
chiral Lewis base catalyst (S)-53 (2.7 mg, 5.0 mol, 0.1 equiv), 1,1,1,2-tetrachloroethane (5.0 L, 
48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The NMR tube was cooled to 20 °C in a 
cryocool unit and EtSO3H (1.0 µL, 0.25 equiv) was added via syringe. The reaction progress was 
monitored by 
1
H NMR spectroscopy. After 48 h, the reaction mixture was quenched. Purification 
of the crude product via Combiflash®  column chromatography (SiO2, 4 g, RediSep®  column, 
hexanes/Et2O, 100:0 to 96:4) gave 6 mg (31%) of 54. 
 SFC: (5S,6S)-54, tR 14.4 min (8%); (5R,6R)-54, tR 16.5 min (92%) (Chiralpak AD, 5% 
MeOH in CO2, 2.0 mL/min, 220 nm, 40 
o
C) 
 
Figure 37. Uncatalyzed reaction with 0.25 equiv EtSO3H. 
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Acid Loading Study with EtSO3H 
(1.00 equiv, uncatalyzed) [HMC4100] 
Following General Procedure XII, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
1,1,1,2-tetrachloroethane (5.0 L, 48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The 
NMR tube was cooled to 20 °C in a cryocool unit and EtSO3H (4.1 µL, 1.00 equiv) was added 
via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
 
Figure 38. Uncatalyzed reaction with 1.00 equiv EtSO3H. 
 
 
 
 
 
 
 
 
 
 
 
 
 
219 
 
Acid Loading Study with EtSO3H 
(0.75 equiv, uncatalyzed) [HMC5018] 
Following General Procedure XII, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
1,1,1,2-tetrachloroethane (5.0 L, 48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The 
NMR tube was cooled to 20 °C in a cryocool unit and EtSO3H (3.1 µL, 0.75 equiv) was added 
via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
 
Figure 39. Uncatalyzed reaction with 0.75 equiv EtSO3H. 
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Acid Loading Study with EtSO3H 
(0.50 equiv, uncatalyzed) [HMC5020] 
Following General Procedure XII, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
1,1,1,2-tetrachloroethane (5.0 L, 48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The 
NMR tube was cooled to 20 °C in a cryocool unit and EtSO3H (2.0 µL, 0.50 equiv) was added 
via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
 
Figure 40. Uncatalyzed reaction with 0.50 equiv EtSO3H. 
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Acid Loading Study with EtSO3H 
(0.25 equiv, uncatalyzed) [HMC5012] 
Following General Procedure XII, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (13.3 mg, 50 mol), N-phenylthiophthalimide 6 (12.8 mg, 50 mol, 1.0 equiv), 
1,1,1,2-tetrachloroethane (5.0 L, 48 mol, 0.95 equiv) and CDCl3 (500 L) and capped. The 
NMR tube was cooled to 20 °C in a cryocool unit and EtSO3H (1.0 µL, 0.25 equiv) was added 
via syringe. The reaction progress was monitored by 
1
H NMR spectroscopy. 
 
 
Figure 41. Uncatalyzed reaction with 0.25 equiv EtSO3H. 
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Effect of TBAOMs as Additive 
General Procedure XIII: Effect of Acid Loading on Uncatalyzed Reactions with Additional 
Sulfonate at 0.2 M Concentration 
 
An oven-dried 5-mm NMR tube was charged with starting alkene 52 (32.0 mg, 120 
mol), N-phenylthiophthalimide 6 (30.7 mg, 120 mol, 1.0 equiv), and brought into a glovebox. 
In the glovebox, to the NMR tube was added indicated amount of tetrabutylammonium 
methanesulfonate (TBAOMs, highly hygroscopic) and capped with a septum cap. The NMR tube 
was brought back out from the glovebox and 1,1,1,2-tetrachloroethane (CH2ClCCl3, 12.6 L, 
120 mol, 1.0 equiv, internal standard) and CDCl3 (600 L) were added via syringe. After 
shaking the mixture well making a homogeneous solution, the NMR tube was cooled to 20 °C 
in a cryocool unit. After reaching equilibrium, the indicated amount of MsOH was added via 
syringe to the upper wall of the NMR tube. After 5 min of equilibrium in the cryocool unit, the 
tube was shaken to dissolve acid into the solution. The reaction progress was monitored by the 
appearance of the diagnostic 
1
H NMR resonance for the sulfenylated product 54 at 4.09 ppm 
(doublet, 1 H), and proton-initicated cyclization product 123 at 4.00 ppm (triplet, 1 H), and 
disappearance of starting alkene 52 at 6.37 ppm (doublet, 1 H) with respect to the internal 
standard at 4.30 ppm (singlet, 2 H). 
1
H NMR spectra were obtained at 0.5 h, 1.5 h, 3 h, 6 h, 12 h, 
24 h, and 48 h, by freezing the NMR tube in a dewar flask with dry-ice/acetone bath (78 °C) 
while transferring to a pre-cooled (20 °C) NMR instrument. 
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Figure 14 (1.0 equiv MsOH + 0.1 equiv TBAOMs, uncatalyzed) [HMC5041] 
Following General Procedure XIII, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), PhthSPh 6 (30.7 mg, 120 mol, 1.0 equiv), TBAOMs 
(4.1 mg, 12 mol, 0.1 equiv), 1,1,1,2-tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and 
CDCl3 (600 L). The NMR tube was cooled to 20 °C in a cryocool unit and MsOH (7.8 µL, 
1.00 equiv) was added via syringe. The reaction progress was monitored by 
1
H NMR 
spectroscopy. 
 
 
Figure 42. Uncatalyzed reaction with 1.00 equiv MsOH, 0.1 equiv TBAOMs. 
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Figure 14 (1.0 equiv MsOH + 0.2 equiv TBAOMs, uncatalyzed) [HMC5042] 
Following General Procedure XIII, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), PhthSPh 6 (30.7 mg, 120 mol, 1.0 equiv), TBAOMs 
(8.1 mg, 24 mol, 0.2 equiv), 1,1,1,2-tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and 
CDCl3 (600 L). The NMR tube was cooled to 20 °C in a cryocool unit and MsOH (7.8 µL, 
1.00 equiv) was added via syringe. The reaction progress was monitored by 
1
H NMR 
spectroscopy. 
 
 
Figure 43. Uncatalyzed reaction with 1.00 equiv MsOH, 0.2 equiv TBAOMs. 
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Figure 14 (1.0 equiv MsOH + 0.4 equiv TBAOMs, uncatalyzed) [HMC5043] 
Following General Procedure XIII, an oven-dried, 5-mm NMR tube was charged with 
starting alkene 52 (32.0 mg, 120 mol), PhthSPh 6 (30.7 mg, 120 mol, 1.0 equiv), TBAOMs 
(16.2 mg, 48 mol, 0.1 equiv), 1,1,1,2-tetrachloroethane (12.6 L, 120 mol, 1.0 equiv) and 
CDCl3 (600 L). The NMR tube was cooled to 20 °C in a cryocool unit and MsOH (7.8 µL, 
1.00 equiv) was added via syringe. The reaction progress was monitored by 
1
H NMR 
spectroscopy. 
 
Figure 44. Uncatalyzed reaction with 1.00 equiv MsOH, 0.4 equiv TBAOMs. 
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Figure 15a and 15b (0.9 equiv MsOH + 0.1 equiv TBAOMs + 0 or 0.1 equiv PhthH) 
[HMC5057, HMC5058] 
The experiments for Figure 15a and 15b were set up as „twin batch‟ to minimize error 
from weighing, following a slightly modified version of General Procedure XIII. An oven-dried, 
4-mL vial was charged with starting alkene 52 (63.9 mg, 240 μmol), N-phenylthiophthalimide 6 
(55.1 mg, 108 μmol, 0.9 equiv), and brought into a glovebox. In the glovebox, to the vial was 
added TBAOMs (8.1 mg, 24 μmol, 0.1 equiv) and capped with a cap with a silicon septum. The 
vial was brought back out from the glovebox and 1,1,1,2-tetrachloroethane (CH2ClCCl3, 25.2 μL, 
240 μmol, 1.0 equiv, internal standard) and CDCl3 (1.2 mL) were added via syringe. After 
shaking the mixture well making a homogeneous solution, the solution was equally distributed to 
two oven-dried, 5-mm NMR tubes capped with a septum via syringe. One NMR tube 
(experiment for Figure 15b) was pre-charged with PhthH (1.8 mg, 12 μmol, 0.1 equiv) before the 
distribution of the solution. Both NMR tubes with homogeneous solution were cooled to −20 °C 
in a cryocool unit and MsOH (7.0 μL, 0.90 equiv) was added via syringe. The reaction progress 
was monitored by 
1
H NMR spectroscopy. 
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Figure 45. Uncatalyzed reaction with 0.9 equiv MsOH + 0.1 equiv TBAOMs. 
 
 
Figure 46. Uncatalyzed reaction with 0.9 equiv MsOH + 0.1 equiv TBAOMs + 0.1 equiv 
phthalimide. 
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Preparation of an Authentic Sample of Proton-Initiated Cyclization Product (123) 
[HMC4096] 
 
An oven-dried 5-mm NMR tube were charged with starting alkene 52 (50 mg, 0.19 
mmol), and CDCl3 (940 L) and capped with a septum cap. After shaking the mixture well 
making a homogeneous solution, EtSO3H (30.6 L, 0.38 mmol, 2.0 equiv) was added to the 
solution via syringe at room temperature. The reaction was monitored by 
1
H NMR spectroscopy, 
which was shown to be complete by 1 h. The reaction mixture was quenched by pouring into 5 
mL of sat. aq. NaHCO3 solution and the biphasic mixture was extracted with CH2Cl2 (3 × 5 mL). 
The combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo 
(30 °C, 10 mmHg) to afford the crude product. The product was purified via Combiflash®  
column chromatography (SiO2, 4 g, RediSep®  column, hexanes/EtOAc, 100:0 to 95:5) affording 
48 mg (95%) of 123 as a colorless oil.  
 
Data for 123: 
 1
H NMR:  (500 MHz, CDCl3) 
7.09 (d, J = 8.0 Hz, 2 H, HC(13)), 6.98 (d, J = 8.0 Hz, 2 H, HC(12)), 6.59 (s, 1 H, 
HC(6)), 6.30 (s, 1 H, HC(9)), 5.86 – 5.82 (m, 2 H, OCH2O)), 3.97 (t, J = 6.5 Hz, 1 
H, HC(1)), 2.85 – 2.68 (m, 2 H, HC(4)), 2.32 (s, 3 H, HC(15)), 2.14 – 2.06 (m, 1 H, 
HC(2)), 1.88 – 1.76 (m, 2 H, HC(3,2)), 1.73 – 1.64 (m, 1 H, HC(3)) 
13
C NMR:  (125 MHz, CDCl3) 
  145.7 (C(7)), 145.6 (C(8)), 144.5 (C(14)), 135.4 (C(11)), 132.4 (C(10)), 130.6 
(C(5)), 128.9 (C(13)), 128.6 (C(12)), 109.7 (C(9)), 108.3 (C(6)), 100.5 (OCH2O), 
45.2 (C(1)), 33.3 (C(2)), 29.9 (C(4)), 21.0 (C(3)), 20.9 (C(15)) 
 MS: (EI
+
, 70 eV) 
  267.1 (20.2), 266.1 (100.0), 251.1 (12.6), 251.0 (12.3), 238.1 (34.4), 238.1 (32.5), 
223.0 (38.7), 175.1 (22.4), 174.0 (20.0), 165.0 (19.4), 117.0 (11.8), 115.0 (20.4), 
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109.1 (12.6), 105.0 (17.2), 97.1 (12.3), 95.1 (15.4), 91.1 (17.8), 91.0 (17.4), 89.0 
(12.1), 83.1 (13.5), 83.1 (11.7), 81.1 (14.4), 77.0 (12.5), 69.1 (19.7), 67.1 (13.8), 
57.1 (16.9), 55.1 (25.3) 
 HRMS: calcd for C18H18O2: 266.1307, found: 266.1316 
 TLC: Rf 0.56 (hexanes/Et2O, 96:4) [KMnO4] 
 
 
Catalyst Resting State and Titration Studies.  
Experiment 1 (8.3 M in (S)-53) [HMC5013] 
An oven-dried 5-mm NMR tube was charged with isobutyl-substituted 
selenophosphoramide Lewis base catalyst (S)-53 (2.7 mg, 5.0 mol), N-phenylthiophthalimide 6 
(PhthSPh, 12.8 mg, 50 mol, 10.0 equiv) and CDCl3 (600 L) and the NMR tube was capped 
with a septum. After the NMR tube was shaken thoroughly, the resulting homogeneous solution 
was monitored by 
31
P NMR spectroscopy at 20 °C. To this solution, neat amounts of EtSO3H 
were added to provide solutions with the equivalents shown in Table 1. 
31
P NMR spectra at 20 
and 50 °C were obtained for each solution. 
Table 14. Catalyst Resting State at –20 and –50 °C. 
 
          
31
P NMR at -50 °C 
 
   
   
    
   
   
               
Reagents 31P NMR  ppm 
i-Bu cat 
(equiv) 
PhthSPh 
(equiv) 
EtSO3H 
(equiv) 
at -20 °C at -50 °C 
1.0 10.0 0.0 94.99  
1.0 10.0 1.0 94.94 (br) 95.18 (br) 
1.0 10.0 2.5 
94.28 (br) 
64.26 (br) 
95.35 (br), 63.93 (br) 
(ratio=1.00:0.91) 
1.0 10.0 5.0 63.70 (br) 64.01 
1.0 10.0 7.5 63.67 63.98 
1.0 10.0 10.0 63.60 63.92 
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Experiment 2 (25 M in (S)-1) [HMC5015] 
An oven-dried 5-mm NMR tube was charged with isobutyl-substituted 
selenophosphoramide Lewis base catalyst (S)-53 (8.2 mg, 15.0 mol), N-phenyltihophthalimide 
6 (38.4 mg, 150 mol, 10.0 equiv) and CDCl3 (600 L) and the NMR tube was capped with a 
septum. After the NMR tube was shaken thoroughly, the resulting homogeneous solution was 
monitored by 
31
P NMR spectroscopy at -50 °C. To this solution, neat amounts of EtSO3H were 
added to provide solutions with the equivalents shown in Table 2. 
31
P NMR spectra at -57 °C 
were obtained for each solution. 
Table 15. Catalyst Resting State at –57 ˚C. 
  
          
31
P NMR at -57 °C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reagents Ratio of 
31
P NMR signals 
at 95 ppm and 64 ppm (-57 °C) iBu cat 
(equiv) 
PhthSPh 
(equiv) 
EtSO3H 
(equiv) 
1.0 10.0 0.0 
N/A 
(only 95 ppm signal was observed) 
1.0 10.0 1.0 3.12 : 1.00 
1.0 10.0 2.5 1.00 : 1.86 
1.0 10.0 3.0 1.00 : 4.07 
1.0 10.0 3.5 1.00 : 24.88 
1.0 10.0 4.0 1.00 : 54.49 
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Calculation of Equilibrium Constants (Keq) [HMC5013, HMC5015] 
Equilibrium constants were calculated for above two experiments both at 2.5 equivalent data 
points. The calculation indicated that the catalytically active species exist as tight ionic pair 
under the given reaction conditions. 
 
 
 
 
 
Method 1: Separate ion pair
Catalyst (5 mmol) : PhthSPh : EtSO3H  = 1.0 : 10.0 : 2.5
31P NMR 95 ppm : 64 ppm
ratio: 1.00 : 1.86
ratio: 1.00 : 0.91
Catalyst PhthHPhth SPh EtSO3H catalyst SPh[ ] [ ]
8.3 mM 83.3 mM 20.8 M 0 mM 0 mM
Keq =
8.3 - X mM 83.3 - X 20.8 - X mM
(8.3 - X)(83.3 - X)(20.8 - X)
(8.3 - X) : X = 1.00 : 0.91
X = 3.97
1.08 x 10 -2=
Catalyst PhthHPhth SPh EtSO3H catalyst SPh[ ] [ ]
25 mM 250 mM 62.5 mM 0 mM 0 mM
Keq =
25 - X mM 250 - X mM 62.5 - X mM
(25 - X)(250 - X)(62.5 - X)
(25 - X) : X = 1.00 : 1.86
X = 16.3
4.55 x 10 -2=
X mM
X mM X mM
X3
X3
X mM
(600 mL CDCl3, -50 
oC)
31P NMR 95 ppm : 64 ppm
0 mM
0 mM
X mM
X mM
Catalyst (15 mmol) : PhthSPh : EtSO3H  = 1.0 : 10.0 : 2.5 (600 mL CDCl3, -57 
oC)
EtSO3
EtSO3
Method 2: Tight ion pair
Catalyst (5 mmol) : PhthSPh : EtSO3H  = 1.0 : 10.0 : 2.5
31P NMR 95 ppm : 64 ppm
ratio 1.00 : 1.86
ratio 1.00 : 0.91
Catalyst PhthHPhth SPh EtSO3H catalyst SPh[ ] [ ]
8.3 mM 83.3 mM 20.8 mM 0 mM 0 mM
Keq =
8.3 - X mM 83.3 - X 20.8 - X mM
(8.3 - X)(83.3 - X)(20.8 - X)
(8.3 - X) : X = 1.00 : 0.91
X = 3.97
2.73 x 10 -3=
Catalyst PhthHPhth SPh EtSO3H catalyst SPh[ ] [ ]
25 mM 250 mM 62.5 mM 0 mM 0 mM
Keq =
25 - X mM 250 - X mM 62.5 - X mM
(25 - X)(250 - X)(62.5 - X)
(25 - X) : X = 1.00 : 1.86
X = 16.3
2.80 x 10 -3=
Same Keq!
X mM
X mM X mM
X2
X2
X mM
(600 mL CDCl3, -50 
oC)
31P NMR 95 ppm : 64 ppm
Catalyst (15 mmol) : PhthSPh : EtSO3H  = 1.0 : 10.0 : 2.5 (600 mL CDCl3, -57 
oC)
EtSO3
EtSO3
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Protonation Equilibrium for N-Phenylthiophthalimide 6 [HMC5016, HMC5024] 
 
An oven-dried 5-mm NMR tube was charged with N-phenylthiophthalimide 6 (25.5 mg, 
0.10 mmol) and CDCl3 (600 L) and the NMR tube was capped with a septum. After the NMR 
tube was shaken thoroughly, the resulting homogeneous solution was monitored by 
13
C NMR 
spectroscopy at 20 °C. To the solution was added EtSO3H (2.0 L, 25 mol, 0.25 equiv) and 
monitored the change of chemical shifts at 20 °C. Addition of 0.25 equivalent of EtSO3H was 
repeated 3 more times for 0.50, 0.75, and 1.00 equivalents. To the solution was then added 
EtSO3H (8.2 L, 0.10 mmol, 1.0 equiv) and monitored at 20 °C. Addition of 1.0 equivalent of 
EtSO3H was repeated 5 more times for 3.0, 4.0, 5.0, 6.0, and 7.0 equivalents. To the solution was 
then added EtSO3H (24.5 L, 0.30 mmol, 3.0 equiv) and monitored the result for 10.0 equiv at 
20 °C. Lastly, to the solution was then added EtSO3H (40.8 L, 0.50 mmol, 5.0 equiv) and 
monitored the result for 15.0 equiv at 20 °C. 
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Table 16. Protonation of 6 with EtSO3H. 
13C NMR at −20 °C 
 
 
  
 
 
 
 
An oven-dried 5-mm NMR tube was charged with N-phenylthiophthalimide 6 (25.5 mg, 
0.10 mmol) and CDCl3 (600 L) and the NMR tube was capped with a septum. After the NMR 
tube was shaken thoroughly, the resulting homogeneous solution was monitored by 
13
C NMR 
spectroscopy at 20 °C. To the solution was added MsOH (1.6 L, 25 mol, 0.25 equiv) and the 
change of chemical shifts at 20 °C was monitored. Addition of 0.25 equivalent of MsOH was 
Amount of  
EtSO3H 
(equiv) 
13
C NMR  
of carbonyl 
carbon (ppm) 
0.0 167.8 
0.25 167.9 
0.50 168.0 
0.75 168.1 
1.00 168.1 
2.00 168.3 
3.00 168.4 
4.00 168.5 
5.00 168.6 
6.00 168.7 
7.00 168.7 
10.00 168.8 
15.00 168.9 
234 
 
repeated 3 more times for 0.50, 0.75, and 1.00 equivalents. To the solution was then added 
MsOH (6.5 L, 0.10 mmol, 1.0 equiv) and monitored at 20 °C. Addition of 1.0 equiv of MsOH 
was repeated 1 more time for 3.0 equiv. To the solution was then added MsOH (13.0 L, 0.20 
mmol, 2.0 equiv) for 5.0 equiv at 20 °C. Lastly, to the solution was then added MsOH (32.5 L, 
0.50 mmol, 5.0 equiv) for 10.0 equiv at 20 °C. 
 
Table 17. Protonation of 6 with EtSO3H. 
 13
C NMR at 20 °C 
 
 
Amount of  
MsOH 
(equiv) 
13
C NMR  
of carbonyl 
carbon (ppm 
0.0 167.8 
0.25 168.0 
0.50 168.2 
0.75 168.3 
1.00 168.4 
2.00 168.6 
3.00 168.7 
4.00 168.8 
5.00 168.9 
6.00 168.9 
7.00 168.9 
10.00 168.9 
15.00 169.0 
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Figure 47. Protonation position of 6 by 
13
C chemical shift. 
 
Figure 48. Protonation equilibrium calculation of 6 with MsOH and EtSO3H. 
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5.6 Experimental Procedures for Chapter 4 
Substrate Preparations 
General Scheme for Preparation of Substrate 129-133
123
 (Scheme 45) 
 
Compound 132 was prepared by following a reported procedure.
124
 
 
Preparation of 4-Methoxy-N-(1-phenylallyl)-aniline (129c)
99
 (Scheme 45) [ZY-DW7237] 
 
To a flame-dried 100 mL Schlenk flask was added a solution of vinylmagnesium chloride 
in THF (18.8 mL, 1.6 M, 30 mmol, 2 equiv) and a solution of ZnCl2 in THF (3 mL, 1.0 M, 3 
mmol, 0.2 equiv). After stirring the solution for 20 min at rt, imine 129b
123a
 (3.17 g, 15 mmol) 
was added under positive argon pressure. The solution was stirred at room temperature for 16 h. 
The reaction was quenched with saturated NH4Cl aqueous solution (30 mL) and extracted with 
EtOAc (30 x 3 mL). The organic layers were combined, washed with brine (30 mL) and dried 
over MgSO4. The filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to afford a 
dark brown oil. Purification via silica gel flash column chromatography (SiO2, 18 cm x 5 cm; 
1000 mL of 93:5:2, hexane/EtOAc/Et3N, 500 mL of 95:5 hexane/EtOAc, 300 mL of 93:7 
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hexane/EtOAc, 300 mL of 90:10 hexane/EtOAc) afforded 2.93 g (82%) of 129c as a brown 
liquid. The spectroscopic data matched those reported in the literature.
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Data for 129c: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.42 – 7.32 (m, 4 H, HC(10,11), 7.31 – 7.24 (m, 1 H, HC(12)), 6.78 – 6.72 (m, 2 
H, HC(7)), 6.61 – 6.54 (m, 2 H, HC(6)), 6.04 (ddd, J = 17.2, 10.2, 6.0 Hz, 1 H, 
HC(4)), 5.32 – 5.19 (m, 2 H, HC(5)), 4.87 (d, J = 6.1 Hz, 1 H, HC(3)), 3.82 (s, 1 H, 
HN(2)), 3.73 (s, 3 H, HC(13)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 170.6 (C(8)), 152.4 (C(1)), 142.3 (C(9)), 141.7 (C(4)), 139.7 (C(4)), 128.9 
(C(11)), 127.6 (C(12)), 127.4 (C(10)), 116.1 (C(6)), 115.1 (C(5)), 114.9 (C(7)), 
61.0 (C(3)), 55.9 (C(13)). 
 FTIR: (neat) 
  3394 (w), 3027 (w), 2831 (w), 1617 (w), 1508 (s), 1463 (m), 1451 (m), 1442 (w), 
1406 (w), 1308 (w), 1290 (w), 1240 (s), 1229 (s), 1178 (m), 1156 (w), 1139 (w), 
1114 (w), 1094 (w), 1034 (m), 991 (w), 923 (m), 817 (s), 764 (m), 746 (m) 
 MS: (ESI)  
117 (33), 217 (25), 240 ([M+H]
+
, 75), 241 (13), 262 (22), 270 (21), 328 (100), 329 
(29), 371 (96), 372 (31), 479 (23) 
 HRMS: calcd for C16H18NO ([M+H]
+
): 240.1388, found: 240.1393 
 TLC: Rf 0.44 (Hexanes/Ethylacetate, 4:1) [UV] 
  
Preparation of 4-Fluoro-N-(1-phenylallyl)-aniline (130c)
99
 (Scheme 45) [ZY-DW7236] 
 
To a flame-dried 50 mL Schlenk flask was added a solution of vinylmagnesium chloride 
in THF (18.8 mL, 1.6 M, 30 mmol, 2 equiv) and a solution of ZnCl2 in THF (3 mL, 1.0 M, 3 
mmol, 0.2 equiv). After stirring the solution for 20 min at rt, imine 130b
123b
 (2.99 g, 15 mmol) 
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was added under positive argon pressure. The solution was stirred at room temperature for 16 h. 
The reaction was quenched with saturated NH4Cl aqueous solution (30 mL) and extracted with 
EtOAc (40 x 3 mL). The organic layers were combined, washed with brine (30 mL) and dried 
over MgSO4. The filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to afford 
3.05 g of dark brown oil. Purification via silica gel flash column chromatography (SiO2, 16 cm x 
5 cm; 800 mL of 93:5:2, hexane/EtOAc/Et3N, 200 mL of 90:10 hexane/EtOAc, 200 mL of 85:15 
hexane/EtOAc, 200 mL of 80:20 hexane/EtOAc) afforded 2.84 g (83%) of 130c as a brown 
liquid. The spectroscopic data matched those reported in the literature.
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Data for 130c: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.46 – 7.38 (m, 4 H, HC(10,11)), 7.34 (tt, J = 6.5, 1.5 Hz, 1 H, HC(12)), 6.93 – 
6.87 (m, 2 H, HC(7)), 6.61 – 6.55 (m, 2 H, HC(6)), 6.09 (ddd, J = 16.5, 10.0, and 
6.0 Hz, 1 H, HC(4)), 5.37 – 5.26 (m, 2 H, HC(5)), 4.93 (d, J = 6.0 Hz, 1 H, HC(3)), 
3.99 (s, 1 H, HN(2)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 155.8 (d, J = 235.2 Hz, C1), 143.5 (C1), 141.7 (C9), 139.0 (C4), 128.7 (C10), 
127.5 (C12), 127.0 (C11), 116.1 (C5), 115.5 (C7), 114.4 (C6), 61.5 (C3). 
 19
F NMR: (470 MHz, CDCl3) 
  δ -128.15 Hz 
 FTIR: (neat) 
  3413 (w), 3029 (w), 1612 (w), 1506 (s), 1452 (m), 1401 (w), 1312 (m), 1217 (s), 
1156 (m), 1139 (w), 1108 (w), 1066 (w), 1028 (w), 991 (w), 817 (s), 779 (m), 748 
(m) 
 MS: (ESI)  
117 (27), 145 (24), 183 (16), 200 (18), 228 ([M+H]
+
, 12), 280 (15), 290 (100), 291 
(32), 317 (24), 342 (15), 370 (21), 404 (19) 
 HRMS: calcd for C15H15FN ([M+H]
+
): 228.1189, found: 228.1197 
 TLC: Rf 0.54 (hexanes/EtOAc, 9:1) [UV] 
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Preparation of N-(1-Phenylallyl)-naphthalen-2-amine (131c)
99
 (Scheme 45) [ZY-DW7242] 
 
To a flame-dried 50 mL Schlenk flask was added a solution of vinylmagnesium chloride 
in THF (18.8 mL, 1.6 M, 30 mmol, 2 equiv) and a solution of ZnCl2 in THF (3 mL, 1.0 M, 3 
mmol, 0.2 equiv). After stirring the solution for 20 min at rt, imine 131b
123c
 (3.47 g, 15 mmol) 
was added under positive argon pressure. The solution was stirred at room temperature for 16 h. 
The reaction was quenched with saturated NH4Cl aqueous solution (30 mL) and extracted with 
EtOAc (40 x 3 mL). The organic layers were combined, washed with brine (30 mL) and dried 
over MgSO4. The filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to afford 
3.05 g of dark brown oil. Purification via silica gel flash column chromatography (SiO2, 16 cm x 
5 cm; 800 mL of 93:5:2, hexane/EtOAc/Et3N, 200 mL of 90:10 hexane/EtOAc, 200 mL of 85:15 
hexane/EtOAc, 200 mL of 80:20 hexane/EtOAc) afforded 3.70 g (95%) of 131c as a brown 
liquid. The spectroscopic data matched those reported in the literature.
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 Data for 131c: 
 1
H NMR:  (400 MHz, CDCl3) 
  δ 7.65 (d, J = 8.1 Hz, 1 H, HC(11)), 7.62 (d, J = 8.8 Hz, 1 H, HC(13)), 7.54 (dd, J = 
8.3, 1.1 Hz, 1 H, HC(8)), 7.54 (d, J = 8.2 Hz, 1 H, HC(16)), 7.45 – 7.41 (m, 2 H, 
HC(17)), 7.37 (t, J = 7.6 Hz, 2 H, HC(9)), 7.34 – 7.27 (m, 2 H, HC(18)), 7.18 (ddd, 
J = 8.1, 6.8, 1.2 Hz, 1 H, HC(10)), 6.92 (dd, J = 8.8, 2.4 Hz, 1 H, HC(14)), 6.77 (d, 
J = 2.4 Hz, 1 H, HC(6)), 6.10 (ddd, J = 17.1, 10.2, 5.8 Hz, 1 H, HC(4)), 5.33 (dt, J 
= 17.1, 1.4 Hz, 1 H, HC(5)), 5.27 (dt, J = 10.2, 1.3 Hz, 1 H, HC(5)), 5.08 (t, J = 5.5 
Hz, 1 H, (C(3)), 4.22 (d, J = 5.2 Hz, 1 H, HN(2)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 144.7 (C1), 141.6 (C15), 138.7 (C4), 134.9 (C7), 128.8 (C13,17), 127.6 (C11), 
127.5 (C18), 127.5 (C12), 127.2 (C16), 126.2 (C9), 126.0 (C8), 122.1 (C10), 118.1 
(C14), 116.2 (C5), 105.9 (C6), 60.8 (C3). 
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 FTIR: (neat) 
  3409 (w), 3056 (w), 3026 (w), 2847 (w), 1627 (s), 1601 (m), 1519 (s), 1478 (m), 
1451 (m), 1424 (w), 1396 (m), 1358 (m), 1301 (w), 1265 (w), 1223 (m), 1188 (m), 
1157 (w), 1145 (w), 1125 (w), 1094 (w), 1066 (w), 1028 (w), 1018 (w), 990 (w), 
967 (w), 954 (w), 924 (m), 909 (m), 865 (w), 827 (s), 806 (s), 743 (s) 
 MS: (ESI)  
117 (100), 156 (63), 234 (48), 260 ([M+H]
+
, 60), 274 (31, 400 (20), 415 (19), 517 
(34),  
 HRMS: calcd for C19H18N ([M+H]
+
): 260.1439, found: 260.1445 
 TLC: Rf 0.35 (hexanes/EtOAc, 4:1) [UV] 
 
Preparation of (E)-2-Cinnamyl-4-methoxy-aniline (129d)
98
 (Scheme 45) [ZY-DW7252] 
 
To a flame dried, 100-mL Schlenk flask equipped with a magnetic stir bar were added 4-
methoxy-N-(1-phenylallyl)aniline (129c) (239 mg, 1 mmol), p-toluenesulfonic acid monohydrate 
(39 mg, 0.2 mmol, 0.2 equiv), and a mixed solution of acetonitrile (10 mL) and water (1 mL). 
The solution was heated to 65°C in an oil bath while the reaction was monitored by NMR (the 
reaction stalled after 36 hours). Volatiles were removed under reduced pressure and the residue 
was extracted with diethyl ether (10 mL x 3). Combined organic layer was washed with 1 M 
NaOH (10 mL) and H2O (10 mL), dried over MgSO4 and concentrated under reduced pressure 
(30 
o
C, 10 mmHg). The residue was purified by flash chromatography (SiO2, 16 cm x 2 cm; 500 
mL of 95:5:2, hexane/EtOAc/Et3N, 200 mL of 90:10 hexane/EtOAc, 200 mL of 50:50 
hexane/EtOAc), to afford 195 mg of brown liquid. Recrystallization of the brown liquid was 
done by dissolving in boiling ether (0.5 mL) followed by slow addition of pentane (3 mL). The 
solution was cooled to rt and then to -20 °C in a freezer. Filtration over a glass wool afforded 
170 mg (71%) of 129d as white needle-like crystals. 
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Data for 129d: 
 mp:  63-64 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.35 (d, J = 7.0 Hz, 2H, HC(11)), 7.31 – 7.27 (m, 2H, HC(12)), 7.24 – 7.17 (m, 
1H, HC(13)), 6.72 (d, J = 2.8 Hz, 1H, HC(6)), 6.67 (dd, J = 8.4, 2.9 Hz, 1H, HC(2)), 
6.65 (d, J = 8.5 Hz, 1H, HC(3)), 6.45 (dt, J = 16.0, 1.4 Hz, 1H, HC(9)), 6.33 (dt, J = 
15.8, 6.2 Hz, 1H, HC(8)), 3.75 (s, 3H, HC(14)), 3.45 (d, J = 7.3 Hz, 4H, HC(7) and 
HN(15)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.2 (C(1)), 138.5 (C(4)), 137.4 (C(5)), 131.6 (C(9)), 128.8 (C(12)), 127.7 
(C(8)), 127.5 (C(13)), 126.4 (C(11)), 126.2 (C(10)), 117.3 (C(3)), 116.3 (C(6)), 
113.0 (C(2)), 56.0 (C(14)), 36.0 (C(7)).  
 FTIR: (neat) 
  3358 (w), 3024 (w), 2998 (w), 2936 (w), 2906 (w), 2831 (w), 1607 (w), 1500 (s), 
1465 (m), 1448 (m), 1432 (m), 1323 (w), 1286 (w), 1242 (s), 1211 (w), 1189 (w), 
1154 (m), 1075 (w), 1040 (m), 969 (m) 940 (w), 870 (w), 854 (w), 811 (m), 747 
(m), 732 (m), 692 (s), 566 (m), 498 (w), 475 (m) 
 MS: (ESI)  
136 ([M-Styrene]
+
, 51), 239 (12), 240 ([M+H]
+
, 100), 241 (17) 
 HRMS: calcd for C16H18NO ([M+H]
+
): 240.1383, found: 240.1391 
 TLC: Rf 0.25 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C16H17NO (239.31) 
  Calcd:  C, 80.30;  H, 7.16% N, 5.85% 
   Found:  C, 80.25;  H, 7.05% N, 5.93% 
 
Preparation of (E)-4-Fluoro-N-(1-phenylallyl)-aniline (130d)
98
 (Scheme 45) [ZY-DW7243] 
 
To a flame dried, 500-mL Schlenk flask equipped with a magnetic stir bar were added 4-
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fluoro-N-(1-phenylallyl)aniline (130c) (2.05 g, 9.0 mmol), p-toluenesulfonic acid monohydrate 
(352 mg, 1.8 mmol, 0.2 equiv), and a mixed solution of acetonitrile (90 mL) and water (10 mL). 
The solution was heated to 65°C in an oil bath while the reaction was monitored by NMR (the 
reaction stalled after 36 hours). Volatiles were removed under reduced pressure and the residue 
was extracted with diethyl ether (30 mL x 3). Combined organic layer was washed with 1 M 
NaOH (30 mL) and H2O (30 mL), dried over Na2SO4 and concentrated under reduced pressure 
(30 
o
C, 10 mmHg). The residue was purified by flash chromatography (SiO2, 9.5 cm x 5 cm; 500 
mL of 88:10:2, hexane/EtOAc/Triethylamine, 200 mL of 90:10 hexane/EtOAc, 200 mL of 80:20 
hexane/EtOAc, 250 mL of 50:50 hexane/EtOAc), to afford 1.45 g (71%) of 130d as a brown 
liquid. The spectroscopic data matched those reported in the literature.
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Data for 130d: 
 mp:  63-64 
o
C (sealed tube) 
 1
H NMR:  (400 MHz, CDCl3) 
  δ 7.45 – 7.23 (m, 5 H, (C(11,12,13)), 6.88 (ddt, J = 19.9, 8.5, 2.7 Hz, 2 H, HC(2,6)), 
6.65 (dd, J = 8.7, 4.9 Hz, 1 H, HC(3)), 6.50 (d, J = 15.9 Hz, 1 H, HC(9)), 6.35 (dtd, 
J = 15.8, 6.3, 1.8 Hz, 1 H, HC(8)), 3.59 (s, 2 H, HN(14)), 3.45 (d, J = 6.3 Hz, 2 H, 
HC(7)). 
13
C NMR:  (101 MHz, CDCl3) 
  δ 156.7 (d, J = 235.9 Hz, C(1)), 141.1 (C(4)), 137.3 (C(10)), 132.0 (C(13)), 128.9 
(C(12)), 127.8 (C(9 or 11)), 127.0 (C(9 or 11)), 126.5 (C(8)), 126.2 (d, J = 6.6 Hz, 
C(5)), 116.9 (d, J = 5.7 Hz, C(3)), 116.7 (d, J = 20.4 Hz, C(6)), 114.1 (d, J = 22.1 
Hz, C(2)), 35.6 (C(7)). 
 FTIR: (neat) 
  3444 (w), 3367 (w), 3032 (w), 1624 (m), 1610 (w), 1596 (w), 1577 (w), 1494 (s), 
1448 (w), 1436 (s), 1420 (m), 1352 (w), 1332 (w), 1277 (w), 1261 (m), 1197 (m), 
1144 (m), 1081 (w), 1070 (w), 1055 (w), 1028 (w), 990 (m), 983 (m), 972 (w), 951 
(s), 859 (s), 822 (m), 807 (s), 751 (s) 
 MS: (ESI)  
124 (41), 228 ([M+H]
+
, 100), 229 (29)  
 HRMS: calcd for C15H15NF ([M+H]
+
): 228.1189, found: 228.1192 
 TLC: Rf 0.26 (hexanes/EtOAc, 4:1) [UV] 
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Preparation of (E)-1-Cinnamyl-naphthalen-2-amine (131d)
98
 (Scheme 45) [ZY-DW7249] 
 
To a flame dried, 50-mL Schlenk flask equipped with a magnetic stir bar were added N-
(1-phenylallyl)naphthalen-2-amine (131c) (259 mg, 1.0 mmol), p-toluenesulfonic acid 
monohydrate (39 mg, 0.2 mmol, 0.2 equiv), and a mixed solution of acetonitrile (10 mL) and 
water (1 mL). The solution was heated to 65°C in an oil bath for 6 h. The solution was cooled to 
rt at which point a solid started to form. To this suspension was added 2 M NaOH (10 mL) and 
ether (20 mL). The organic layer was separated, washed with brine (10 mL), dried over MgSO4, 
and then concentrated under reduced pressure (30 
o
C, 10 mmHg). The residue was purified by 
flash chromatography (SiO2, 16 cm x 2 cm; 300 mL of 95:5 hexane/EtOAc, 200 mL of 90:10 
hexane/EtOAc, 250 mL of 50:50 hexane/EtOAc), to afford 210 mg of brown liquid. 
Recrystallization of the brown liquid was done by dissolving in boiling ether (0.5 mL) followed 
by slow addition of pentane (2 mL). The solution was cooled to rt and then to -20 °C in a freezer. 
Filtration over a glass wool afforded 192 mg (74%) of 131d as white crystals. 
 
Data for 131d: 
 mp:  66-68 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ, 7.88 (d, J = 8.6 Hz, 1 H, HC(10)), 7.75 (dt, J = 8.1, 0.7 Hz, 1 H, HC(13)), 7.64 (d, 
J = 8.7 Hz, 1 H, HC(2)), 7.45 (ddd, J = 8.5, 6.8, 1.4 Hz, 1 H, HC(11)), 7.28 (tt, J = 
5.4, 1.5 Hz, 3 H, HC(12,15)), 7.26 – 7.22 (m, 2 H, HC(16)), 7.17 (tt, J = 7.2, 2.2 Hz, 
1 H, HC(17)), 6.99 (d, J = 8.7 Hz, 1 H, HC(3)), 6.44 – 6.34 (m, 2 H, HC(8,9)), 3.86 
(d, J = 4.5 Hz, 4 H, HC(7) and HN(18)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 142.3 (C(4)), 137.4 (C(14)), 133.6 (C(6)), 130.7 (C(9)), 128.9 (C(13)), 128.8 
(C(1)), 128.7 (C(16)), 128.3 (C(2)), 127.4 (C(17)), 127.3 (C(8)), 126.8 (C(11)), 
126.3 (C(12)), 122.5 (C(10)), 122.4 (C(15)), 119.1 (C(3)), 114.7 (C(5)), 29.9 (C(7)).  
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FTIR:(neat) 
  3023 (w), 1622 (s), 1600 (m), 1496 (m), 1473 (m), 1446 (m), 1435 (m), 1393 (m), 
1356 (w), 1282 (m), 1259 (m), 1222 (w), 1164 (w), 964 (s), 908 (m), 857 (w), 811 
(s), 782 (m), 731 (s), 691 (s), 672 (m), 648 (m), 617 (m), 599 (m), 586 (m), 545 (m), 
518 (m), 500 (m), 477 (m). 
 MS: (ESI)  
156 ([M-Styrene]
+
, 100), 157 (11), 260 ([M+H]
+
), 261 (10) 
 HRMS: calcd for C19H18N ([M+H]
+
): 260.1434, found: 260.1441 
 Analysis: C19H17N (259.35) 
  Calcd:  C, 87.99;  H, 6.61% N, 5.40% 
   Found:  C, 87.76;  H, 6.44% N, 5.50% 
 TLC: Rf 0.40 (hexanes/EtOAc, 4:1) [UV] 
 
Preparation of (E)-N-(2-Cinnamyl-4-methoxyphenyl)-4-methyl-benzenesulfonamide (129) 
(Scheme 45)
101
 [ZY-DW7248] 
 
To a flame-dried, 25-mL Schlenk flask equipped with a magnetic stir bar, purged with 
positive pressure of argon, were added aniline 129d (1.17 g, 4.9 mmol) and CH2Cl2 (15 mL, 0.3 
M). The solution was cooled to 0 
o
C and added pyridine (1.97 mL, 24.5 mmol, 5.0 equiv) and 4-
toluenesulfonyl chloride (1.4 g, 7.35, mmol, 1.5 equiv). The reaction mixture was warmed to rt 
and stirred for 12 h. After 12 h, brine (30 mL) was added to the solution and extracted with 
CH2Cl2 (30 mL x 3). Organic layers were combined, dried over MgSO4, filtered, and 
concentrated in vacuo (30 
o
C, 10 mmHg). The crude solid was purified via recrystallization by 
dissolving in boiling EtOAc (10 mL). The solution was cooled to rt and then to 20 oC in a 
freezer. Collected 1
st
 crop by filtration and mother liquor was concentrated and recrystallized 
again in boiling EtOAc (5 mL). After cooling again at 20 oC and filtration, combined yield of 
1.6 g (83%) of 129 was obtained as white solid. 
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Data for 129: 
 mp:  114-115 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.58 (d, J = 8.2 Hz, 2 H, HC(16)), 7.31 – 7.27 (m, 4 H, HC(11,12)), 7.24 – 7.20 
(m, 3 H, HC(17,13)), 7.19 (d, J = 8.7 Hz, 1 H, HC(3)), 6.72 (dd, J = 8.7, 3.0 Hz, 1 
H, HC(2)), 6.69 (d, J = 2.9 Hz, 1 H, HC(6)), 6.31 (s, 1 H, HN(14)), 6.26 (dt, J = 
15.8, 1.7 Hz, 1 H, HC(9)), 6.06 (dt, J = 15.9, 6.5 Hz, 1 H, HC(8)), 3.77 (s, 3 H, 
HC(20)), 3.17 (dd, J = 6.5, 1.6 Hz, 2 H, HC(7)), 2.39 (s, 3 H, HC(19)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 158.68 (C(1)), 143.92 (C(18)), 137.02 (C(10)), 136.99 (C(5)), 132.03 (C(9)), 
129.85 (C(17)), 128.79 (C(12)), 128.50 (C(3)), 127.73 (C(13)), 127.69 (C(10) or 
C(15)), 127.49 (C(16)), 127.41 (C(10) or C(15)), 127.30 (C(8)), 126.46 (C(11)), 
116.04 (C(6)), 112.59 (C(2)), 55.63 (C(20)), 35.36 (C(7)), 21.82 (C(19). 
 FTIR: (neat) 
  3271 (w), 3027 (w), 2957 (w), 2837 (w), 1599 (m), 1581 (w), 1496 (s), 1464 (w), 
1448 (w), 1433 (w), 1399 (m), 1327 (m), 1304 (m), 1290 (m), 1215 (m), 1185 (w), 
1159 (s), 1092 (m), 1038 (m), 968 (m), 945 (w), 899 (m), 814 (m), 753 (m), 731 
(m), 693 (m), 665 (m), 596 (w), 550 (m) 
 MS: (ESI)  
239 ([M-Ts]
+
, 100), 240 (18), 394 ([M+H]
+
, 45), 395 (12), 411 (10) 
 HRMS: calcd for C23H24NO3S ([M+H]
+
): 394.1471, found: 394.1479 
 Analysis: C23H23NO3S (393.50) 
  Calcd:  C, 70.20;  H, 5.89% N, 3.56% 
   Found:  C, 69.85;  H, 5.81% N, 3.59% 
 TLC: Rf 0.30 (hexanes/EtOAc, 4:1) [UV] 
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Preparation of (E)-N-(2-Cinnamyl-4-fluorophenyl)-4-methyl-benzenesulfonamide (130) 
(Scheme 45)
101
 [ZY-DW7245] 
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar, purged with 
positive pressure of argon, were added aniline 130d (1.13 g, 5.0 mmol) and CH2Cl2 (15 mL, 0.3 
M). The solution was cooled to 0 
o
C and added pyridine (2.0 mL, 25.0 mmol, 5.0 equiv) and 4-
toluenesulfonyl chloride (1.43 g, 7.5, mmol, 1.5 equiv). The reaction mixture was warmed to rt 
and stirred for 12 h. After 12 h, brine (30 mL) was added to the solution and extracted with 
CH2Cl2 (30 mL x 3). Organic layers were combined, dried over MgSO4, filtered, and 
concentrated in vacuo (30 
o
C, 10 mmHg). The crude solid was purified via flash chromatography 
(SiO2, 8 cm x 5 cm; 500 mL of 90:10 hexane/EtOAc, 200 mL of 85:15 hexane/EtOAc, 200 mL 
of 80:20 hexane/EtOAc, 200 mL of 75:25 hexane/EtOAc, 200 mL of 50:50 hexane/EtOAc), to 
afford 1.88 g of brown liquid. Recrystallization of the brown liquid was done by dissolving in 
boiling EtOAc (10 mL). The solution was cooled to rt and then to -20 
o
C in a freezer. Collected 
1
st
 crop by filtration and mother liquor was concentrated and recrystallized again in boiling 
EtOAc (5 mL). After cooling again at -20 
o
C and filtration, combined yield of 1.63 g (86%) of 
130 was obtained as a fluffy solid. 
 
Data for 130: 
 mp:  128-129 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ, 7.57 (d, J = 8.3 Hz, 2 H, HC(16)), 7.31 – 7.26 (m, 6 H, HC(3,11,12,13)), 7.21 (d, 
J = 8.1 Hz, 2 H, HC(17)), 6.89 (ddd, J = 19.0, 8.6, 3.0 Hz, 2 H, HC(2 and 6)), 6.32 
(s, 1 H, HN(14)), 6.27 (dt, J = 16.2, 0.9 Hz, 1 H, HC(9)), 6.04 (dt, J = 15.9, 6.5 Hz, 
1 H, HC(8)), 3.18 (d, J = 6.01Hz, 2 H, HC(7)), 2.39 (s, 3 H, HC(19). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 162.3 (C(1)), 144.2 (C(18)), 136.7 (C(15)), 136.6 (C(4)), 132.7 (C(9)), 130.6 (C(5) 
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or C(10)), 130.5 (C(5) or C(10)), 129.9 (C(17)), 128.8 (C(6)), 128.0 (d, J = 6.0 Hz, 
C(3)), 127.9 (C(12)), 127.8 (C13)), 127.4 (C(16)), 126.5 (C11)), 126.4 (C(8)), 
117.3 (d, J = 22.7 Hz, C(6)), 114.6 (d, J = 22.2 Hz, C(2)), 35.2 (C(7)), 21.8 (C(19)). 
 19
F NMR: (470 MHz, CDCl3) 
  δ -115.22 
 FTIR: (neat) 
  3270 (w), 3028 (w), 2924 (w), 1614 (w), 1598 (w), 1494 (m), 1448 (w), 1435, (w), 
1392 (w), 1328 (w), 1305 (w), 1273 (w), 1200 (w), 1184 (w), 1157 (s), 1120 (w), 
1092 (w), 1019 (w), 963 (w), 904 (w), 814 (w), 754 (w), 730 (w), 706 (w), 692 (w), 
664 (m), 595 (w), 548 (m), 527 (m), 493 (w) 
 MS: (ESI)  
226 (21), 227 ([M-Ts]
+
, 100), 228 (18), 382 ([M+H]
+
, 72), 399 (36), 404 (17) 
 HRMS: calcd for C22H21FNO2S ([M+H]
+
): 382.1271, found: 382.1273 
 Analysis: C22H20FNO2S (381.46) 
  Calcd:  C, 69.27;  H, 5.28% N, 3.67% 
   Found:  C, 69.36;  H, 5.20% N, 3.70% 
 TLC: Rf 0.32 (hexanes/EtOAc, 4:1) [UV] 
 
Preparation of (E)-N-(1-Cinnamyl-2-naphthyl)-4-methyl-benzenesulfonamide (131) 
(Scheme 45)
101
 [ZY-DW7251] 
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar, purged with 
positive pressure of argon, were added aniline 131d (1.43 g, 5.5 mmol) and CH2Cl2 (17 mL, 0.3 
M). The solution was cooled to 0 
o
C and added pyridine (2.2 mL, 27.5 mmol, 5.0 equiv) and 4-
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toluenesulfonyl chloride (1.57 g, 8.25, mmol, 1.5 equiv). The reaction mixture was warmed to rt 
and stirred for 12 h. After 12 h, brine (30 mL) was added to the solution and extracted with 
CH2Cl2 (30 mL x 3). Organic layers were combined, dried over MgSO4, filtered, and 
concentrated in vacuo (30 
o
C, 10 mmHg) to afford dark brown oil. The crude product was 
dissolved in ether and yellow solid precipitated immediately. Recrystallization was done by 
dissolving the yellow solid in boiling EtOAc (10 mL), and then the solution was cooled to rt and 
subsequently to -20 
o
C in a freezer. Collected 1
st
 crop by filtration and mother liquor was 
concentrated and recrystallized again in boiling EtOAc (5 mL). After cooling again at -20 
o
C and 
filtration, combined yield of 1.9 g (83%) of 131 was obtained as a yellow solid. 
 
Data for 131: 
 mp:  148-149 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.92 (d, J = 8.5 Hz, 1 H, HC(10)), 7.84 (d, J = 8.1 Hz, 1 H, HC(2)), 7.75 (d, J = 
8.8 Hz, 1 H, HC(13)), 7.66 (d, J = 8.8 Hz, 1 H, HC(12)), 7.61 (d, J = 8.1 Hz, 2 H, 
HC(20)), 7.53 – 7.42 (m, 2 H, HC(11,3)), 7.24 (dd, J = 7.2, 1.2 Hz, 2 H, HC(16)), 
7.22 – 7.17 (m, 3 H, HC(15,17)), 7.13 (d, J = 7.9 Hz, 2 H, HC(21)), 6.64 (s, 1 H, 
HN(18)), 6.19 (dtd, J = 16.1, 5.1, 1.1 Hz, 1 H, (HC(8)), 6.13 (d, J = 16.1 Hz, 1 H, 
HC(9)), 3.65 (dd, J = 5.4, 1.3 Hz, 2 H, HC(7)), 2.31 (s, 3 H, HC(23)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 144.1 (C(22)), 136.9 (C(14)), 136.8 (C(19)), 132.7 (C(6)), 132.6(C(1)), 132.4 
(C(5)), 131.6 (C(9)), 129.9 (C(21)), 129.8 (C(4)), 128.9 (C(2)), 128.7 (C(16)), 
128.4 (C(13)), 127.7 (C(17)), 127.5 (C(5)), 127.4 (C(20)), 127.0 (C(11)), 126.8 
(C(8)), 126.4 (C(15)), 125.8 (C(3)), 124.5 (C(10)), 123.6 (C(12)), 30.0 (C(7)), 21.8 
(C(23)). 
 FTIR: (neat) 
  3283 (w), 1598 (m), 1512 (w), 1496 (w), 1468 (w), 1447 (w), 1407 (m), 1367 (m), 
1320 (m), 1304 (m), 1234 (w), 1185 (w), 1159 (s), 1092 (m), 1067 (w), 1019 (w), 
966 (m), 907 (m), 864 (w), 847 (w), 813 (m), 763 (m), 733 (s), 706 (m), 691 (m), 
669 (s), 598 (m), 552 (s), 532 (m), 494 (w). 
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MS: (ESI)  
258 (22), 259 ([M-Ts]
+
, 100), 260 (18), 436 ([M+Na]
+
, 25) 
 HRMS: calcd for C26H23NO2SNa ([M+Na]
+
): 436.1342, found: 436.1347 
 Analysis: C26H23NO2S (413.53) 
  Calcd:  C, 75.52;  H, 5.61% N, 3.39% 
   Found:  C, 75.19;  H, 5.63% N, 3.51% 
 TLC: Rf 0.38 (hexanes/EtOAc, 4:1) [UV] 
 
Preparation of N-[1-(1-Methylethyl)-2-propen-1-yl]-benzenamine (133c)
100
 (Scheme 45) 
[HMC11054] 
 
By adopting the described procedure,
100
 to an oven-dried 100-mL round-bottomed flask 
equipped with a magnetic stir bar were added imine 133b
123d
 (736 mg, 5 mmol) and toluene (30 
mL, 0.17 M). After installing a condenser, the flask was purged with argon and was added 
trimethylsilylbenzotriazole (957 mg, 5 mmol, 1 equiv) via syringe. After stirring for 30 min at rt, 
the reaction mixture was cooled to 0 
o
C in an ice bath and was added a solution of 
vinylmagnesium chloride in THF (6.25 mL, 1.6 M, 10 mmol, 2 equiv) via syringe. To the 
resulting yellow turbid mixture was added 10 mL of ether. The reaction mixture was refluxed 
under heat (bath temperature 90 
o
C) for 20 h. After cooling the reaction mixture to rt, it was 
quenched by pouring to ice water (30 mL) and extracted with ether (60 x 3 mL). The organic 
layers were combined and washed with 2 M NaOH aqueous solution (20 mL x 2) and water (30 
mL x 2). Resulting organic layer was dried over Na2SO4, filtered and concentrated under reduced 
pressure (30 
o
C, 10 mmHg). Purification via silica gel flash column chromatography (SiO2, 40 g, 
25 mm Ø , hexanes to hexanes/EtOAc, 19:1) afforded 595 mg (68%) of 133c, as pale yellow oil. 
An analytically pure sample was obtained by Kugelrohr distillation (60 
o
C at 0.01 mmHg) 
affording 550 mg (63%) of 133c as a colorless oil. The spectroscopic data matched those 
reported in the literature.
135 
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Data for 133c: 
 bp:  60 
o
C (at 0.01 mmHg) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.18 (t, J = 8.0 Hz, 2 H, HC(3), 6.69 (t, J = 7.5 Hz, 1 H, HC(4)), 6.63 (d, J = 8.5 
Hz, 2 H, HC(2)), 5.76 (ddd, J = 17.0, 10.5, and 6.0 Hz, 1 H, HC(6)), 5.27 – 5.16 (m, 
2 H, HC(7)), 3.75 – 3.63 (brs+m, 2 H, HN+HC(5)), 1.90 (dq, J = 13.5, 6.5 Hz, 1 H, 
HN(8)), 1.01 (dd, J = 15.0, 7.0 Hz, 6 H, HC(9)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 147.8 (C(1)), 137.9 (C(6)), 129.1 (C(3)), 117.0 (C(4)), 116.0 (C(7)), 113.3 (C(2)), 
61.4 (C(5)), 32.4 (C(8)), 18.8 (C(9)), 18.5 (C(9)). 
 MS: (ESI)  
94 (20), 97 (22), 98 (15), 106 (14), 114 (56), 118 (28), 138 (16), 140 (13), 142 (26), 
148 (34), 150 (28), 176 (M+H, 78), 188 (50), 202 (43), 219 (100), 220 (17), 230 
(16), 235 (69), 248 (16), 251 (19), 258 (25), 262 (14), 274 (40). 
 HRMS: calcd for C12H18N ([M+Na]
+
): 176.1439, found: 176.1440 
 TLC: Rf 0.58 (Hexanes/Ethyl acetate, 4:1) [UV] 
 
Preparation of (E)-2-(4-Methyl-2-penten-1-yl)-benzenamine (133d) (Scheme 45)
98
 
[HMC11056] 
 
By adopting the described procedure,
101
 to an oven-dried, 38-mL pressure tube with side 
arm in the neck equipped with a magnetic stir bar were added allylaniline 133c (350 mg, 2.0 
mmol) and xylenes (4 mL, 0.5 M). The tube was capped with a septum and purged with positive 
pressure of argon. The solution was cooled to 40 oC in MeCN/dri-ice bath under positive 
pressure of argon. To the tube was added BF3•OEt2 (48% solution, 0.3 mL, 2.4 mmol, 1.2 equiv). 
The reaction mixture was warmed to rt and replaced septum with pressure screw cap under 
positive stream of argon. Then it was heated to 180 
o
C and stirred for 17 h. After completion, the 
reaction mixture was cooled to 0 
o
C with continuous vigorous stirring and quenched with 2 M 
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NaOH (15 mL) at 0 
o
C. Resulting biphasic layer was extracted with ether (15 mL x 3). Organic 
layers were combined, filtered over celite, and concentrated in vacuo (30 
o
C, 10 mmHg). The 
crude solid was purified via flash chromatography (SiO2, 30 g, 20 mm Ø , hexanes to 
hexanes/EtOAc, 6:1) afforded 199 mg (57%) of 133d, as yellow oil. An analytically pure sample 
was obtained by Kugelrohr distillation (80 
o
C at 0.01 mmHg) affording 179 mg (51%) of 133d 
as a colorless oil. 
 
Data for 133d: 
 bp:  80 
o
C (at 0.01 mmHg) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.14 – 7.07 (m, 2 H, HC(3,5)), 6.80 (tt, J = 7.5, 1.5 Hz, 1 H, HC(4)), 6.72 (dd, J = 
7.5, 1.5 Hz, 1 H, HC(6)), 5.63 – 5.50 (m, 2 H, HC(8,9)), 3.75 (brs, 2 H, H2N), 3.30 
(d, J = 5.5 Hz, 2 H, HC(7)), 2.35 (heptd, J = 6.5, 2.0 Hz, 1 H, HC(10)), 1.04 (dd, J 
= 7.0, 2.0 Hz, 6 H, HC(11)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 144.9 (C1), 139.5 (C9), 129.9 (C5), 127.3 (C3), 125.1 (C2), 124.3 (C8), 118.7 
(C4), 115.7 (C6), 35.4 (C7), 31.0, (C10) 22.5 (C11). 
 MS: (ESI)  
106 (100), 114 (27), 176 ([M+H]
+
, 13), 177 (13) 
 HRMS: calcd for C12H18N ([M+H]
+
): 176.1439, found: 176.1443 
 TLC: Rf 0.43 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C12H17N (175.27) 
  Calcd:  C, 82.23;  H, 9.78% N, 7.99% 
   Found:  C, 82.25;  H, 10.00% N, 7.80% 
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Preparation of (E)-N-[2-(4-Methyl-2-penten-1-yl)-phenyl]-4-methyl-bezenesulfonamide 
(133) (Scheme 45)
101
 [HMC10081] 
 
To a oven-dried, 50-mL round-bottomed flask equipped with a magnetic stir bar were 
added aniline 133d (876 mg, 5.0 mmol) and CH2Cl2 (10 mL, 0.5 M) under positive pressure of 
argon. The solution was cooled to 0 
o
C and added pyridine (1.21 mL, 15.0 mmol, 3.0 equiv) and 
4-toluenesulfonyl chloride (1.05 g, 5.5, mmol, 1.1 equiv). The reaction mixture was warmed to rt 
and stirred for 24 h. To quench the reaction, water (20 mL) was added to the solution and 
extracted with CH2Cl2 (20 mL x 3). Organic layers were combined, dried over Na2SO4, filtered, 
and concentrated in vacuo (30 
o
C, 10 mmHg). The crude solid was purified via flash 
chromatography (SiO2, 40 g, 25 mm Ø , hexanes to hexanes/EtOAc, 6:1) afforded 1.48 g (90%) 
of 133, as yellow solid. An analytically pure sample was obtained by recrystallization in boiling 
pentane (50 mL). The solution was cooled to rt and then to -20 
o
C in a freezer. After collecting 
1
st
 crop by filtration, mother liquor was concentrated and recrystallized again in boiling pentane 
(10 mL). After cooling again at -20 
o
C and filtration, combined yield of 1.34 g (82%) of 133 was 
obtained as a white crystalline solid. 
 
Data for 133: 
 mp:  128-129 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.60 (d, J = 8.0 Hz, 2 H, HC(8)), 7.43 (d, J = 8.0 Hz, 1 H, HC(6)), 7.22 (d, J = 8.0 
Hz, 2 H, HC(9)), 7.19 (t, J = 7.5 Hz, 1 H, HC(5)), 7.09 (t, J = 7.5 Hz, 1 H, HC(4)), 
7.04 (d, J = 7.5 Hz, 1 H, HC(3)), 6.69 (s, 1 H, HN), 5.44 (dd, J = 15.5, 6.5 Hz, 1 H, 
HC(14)), 5.31 (dt, J = 15.5, 6.0 Hz, 1 H, HC(13)), 2.93 (d, J = 6.0 Hz, 1 H, HC(12)), 
2.39, (s, 3 H, HC(11)), 2.34 – 2.22 (m, 1 H, HC(15)), 0.99 (d, J = 7.0 Hz, 6 H, 
HC(16)) 
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13
C NMR:  (126 MHz, CDCl3) 
  δ 143.7 (C10), 140.7 (C14), 136.9 (C7), 135.3 (C1), 132.2 (C2), 130.3 (C3), 129.6 
(C9), 127.6 (C5), 127.0 (C8), 125.9 (C4), 124.0 (C13), 123.9 (C6), 35.5 (C12), 31.0 
(C15), 22.3 (C16), 21.5 (C11) 
 FTIR: (neat) 
  3286 (m), 2963 (w), 1489 (m), 1458 (w), 1391 (m), 1334 (s), 1307 (w), 1291 (w), 
1275 (w), 1187 (w), 1166 (s), 1119 (w), 1090 (s), 1045 (w), 1021 (w), 969 (m), 901 
(m), 834 (w), 810 (m), 762 (s). 
 MS: (ESI)  
118 (52), 132 (22), 146 (13), 160 (39), 174 (17), 175 (100), 176 (14), 330 (M+H, 
36), 352 (42) 
 HRMS: calcd for C19H24NO2S ([M+H]
+
): 330.1528, found: 330.1526 
 TLC: Rf 0.32 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C19H23N (329.46) 
  Calcd:  C, 69.27;  H, 7.04% N, 4.25% 
   Found:  C, 69.42;  H, 7.23% N, 4.26% 
 
Preparation of Substrate 131-134 via Olefin Metathesis (Scheme 47) 
Preparation of (E)-4-Methyl-N-[2-(3-phenyl-2-propen-1-yl)phenyl]benzenesulfonamide 
(136) (Scheme 47) [HMC10070] 
 
An oven-dried 50 mL Schlenk flask was equipped with a stir bar was introduced into a 
glove box. Grubbs 1
st
 generation indenylidene catalyst (CAS #250220-36-1, 111 mg, 0.12 mmol, 
0.03 equiv) was loaded into the flask, sealed with a septum and exited the glove box. The 
Schlenk flask was hooked up to a Schlenk manifold and was purged thoroughly with argon. To a 
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separate 50 mL round-bottomed flask was added sulfonamide 134 (1.15 g, 4.0 mmol, 1 equiv), 
styrene (4.60 mL, 40.0 mmol, 10 equiv), and CH2Cl2 (20 mL, 0.2 M, degassed with Ar), then 
sealed with a septum. The mixture turned into a solution while the mixture was degassed for 
additional 30 min with Ar (needle and a bubbler outlet attached). Premixed, degassed solution of 
two olefin substrates was transferred to the Schlenk flask via syringe. The top area of the 
Schlenk flask including the needle-punctured septum was thoroughly sealed with parafilm. The 
black mixture was allowed to stir for 48 h at rt. The the mixture was filtered through a plug of 
silica, then rinsed with CH2Cl2 (25 mL x 2), and EtOAc (25 mL x 2) to afford a dark solution. 
The filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to afford a black solid. 
Purification via silica gel flash column chromatography (SiO2, 40 g, 25 mm Ø , hexanes to 
hexanes/EtOAc, 9:1) afforded 685 mg (47%) of 136, as a white solid. Recrystallization of the 
solid with hot pentane (36 
o
C, 30 mL) afforded 630 mg (43%) of 136 as white crystals. The 
spectroscopic data matched those reported in the literature.
137 
Data for 136: 
 mp:  159-160 
o
C (sealed tube) 
 1
H NMR: (500 MHz, CDCl3) 
  δ 7.60 (d, J = 8.0 Hz, 2 H, HC(8)), 7.43 (d, J = 8.0 Hz, 1 H, HC(6)), 7.35 – 7.21 (m, 
6 H, HC(aryl)), 7.21 – 7.13 (m, 4 H, HC(aryl)), 6.52 (brs, 1 H, HN), 6.29 (dt, J = 
16.0, 1.5 Hz, 1 H, HC(14)), 6.11 (dt, J = 16.0, 6.5 Hz, 1 H, HC(13)), 3.25 (dd, J = 
6.5, 1.5 Hz, 2 H, HC(12)), 2.39 (s, 3 H, HC(11)). 
 13
C NMR: (126 MHz, CDCl3) 
  δ 143.8 (C10), 136.6 (C7), 136.6 (C15), 134.9 (C1), 132.2 (C2), 131.9 (C14), 130.5 
(C3), 129.6 (C9), 128.6 (C17), 127.8, 127.6, 127.2 (C8), 127.0 (C13), 126.2 (C16), 
126.2, 124.2 (C6), 35.2 (C12), 21.5 (C11). 
 FTIR: (neat) 
  3281 (m), 1596 (w), 1584 (w), 1492 (m), 1448 (w), 1402 (m), 1333 (s), 1304 (w), 
1291 (w), 1278 (w), 1184 (w), 1165(s), 1119 (w), 1090 (s), 1053 (w), 1040 (w), 
1018 (w), 969 (m), 954 (w), 906 (s), 810 (m), 756 (m). 
 MS: (ESI)  
208 (15), 209 (100), 210 (24), 364 (M+H, 28), 381 (44), 382 (13), 386 (17) 
 HRMS: calcd for C22H22NO2S ([M+H]
+
): 364.1371, found: 364.1373 
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Preparation of (E)-4-Methyl-N-{2-[3-(4-anisyl)-2-propen-1-yl]-phenyl}-benzenesulfonamide 
(137) (Scheme 47) [HMC10063] 
 
An oven-dried 25 mL Schlenk flask was equipped with a stir bar was introduced into a 
glove box. Grubbs 1
st
 generation indenylidene catalyst (CAS #250220-36-1, 55 mg, 0.06 mmol, 
0.03 equiv) was loaded into the flask, sealed with a septum and exited the glove box. The 
Schlenk flask was hooked up to a Schlenk manifold and was purged thoroughly with argon. To a 
separate 25 mL round-bottomed flask was added sulfonamide 134 (575 mg, 2.0 mmol, 1 equiv), 
4-vinylanisole (2.66 mL, 20.0 mmol, 10 equiv), and CH2Cl2 (10 mL, 0.2 M, degassed with Ar), 
then sealed with a septum. The mixture turned into a solution while the mixture was degassed for 
additional 30 min with Ar (needle and a bubbler outlet attached). Premixed, degassed solution of 
two olefin substrates was transferred to the Schlenk flask via syringe. The top area of the 
Schlenk flask including the needle-punctured septum was thoroughly sealed with parafilm. The 
black mixture was allowed to stir for 48 h at rt. The the mixture was filtered through a plug of 
silica, then rinsed with CH2Cl2 (15 mL x 2), and EtOAc (15 mL x 2) to afford a dark solution. 
The filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to afford a black solid. 
Purification via silica gel flash column chromatography (SiO2, 25 g, 20 mm Ø , hexanes to 
hexanes/EtOAc, 9:1) afforded 425 mg (54%) of 137, as a white solid. Recrystallization of the 
solid with hot pentane (36 
o
C, 30 mL) afforded 396 mg (50%) of 137 as white crystals.
 
 
Data for 137: 
 mp:  117-118 
o
C (sealed tube) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.58 (d, J = 8.5 Hz, 2 H, HC(8)), 7.42 (d, J = 8.0 Hz, 1 H, HC(6)), 7.25 – 7.13 (m, 
7 H), 6.84 (d, J = 8.5 Hz, 2 H, HC(17)), 6.56 (brs, HN), 6.22 (d, J = 16.0 Hz, 1 H, 
HC(14)), 5.94 (dt, J = 16.0, 6.5 Hz, 1 H, HC(13)), 3.81 (s, 3 H, HC(19)), 3.19 (dd, J 
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= 6.5, 2.0 Hz, HC(12)), 2.37 (s, 3 H, HC(11)). 
 13
C NMR: (126 MHz, CDCl3) 
  δ 159.1 (C18), 143.7 (C10), 136.6 (C7), 134.9 (C1), 132.3 (C2), 131.3 (C14), 130.5 
(C3), 129.6 (C9), 129.4, 127.6, 127.4 (C8), 127.1 (C16), 126.1, 124.7 (C13), 124.0 
(C6), 113.9 (C17), 55.3 (C19), 35.1 (C12), 21.5 (C11). 
 FTIR: (neat) 
  3271 (m), 3005 (w), 2965 (w), 1739 (w), 1606 (m), 1578 (w), 1510 (m), 1488 (m), 
1469 (w), 1456 (w), 1437 (w), 1406 (m), 1332 (m), 1308 (w), 1292 (m), 1275 (w), 
1251 (s), 1177 (w), 1160 (s), 1121 (w), 1109 (w), 1089 (m), 1066 (w), 1032 (m), 
1018 (w), 969 (m), 908 (m), 862 (w), 820 (m), 812 (m), 778 (w), 761 (m), 754 (m). 
 MS: (ESI)  
238 (17), 239 (100), 240 (37), 297 (34), 394 (M+H, 52), 395 (16), 411 (79), 412 (25) 
 HRMS: calcd for C23H24NO3S ([M+H]
+
): 394.1477, found: 394.1484 
 TLC: Rf 0.20 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C23H23NO3S (393.50) 
  Calcd:  C, 70.20;  H, 5.89% N, 3.56% 
   Found:  C, 70.05;  H, 5.81% N, 3.55% 
 
Preparation of (E)-4-Methyl-N-{2-[3-(4-bromophenyl)-2-propen-1-yl]-phenyl}-
benzenesulfonamide (138) (Scheme 47) [HMC10064] 
 
An oven-dried 25 mL Schlenk flask was equipped with a stir bar was introduced into a 
glove box. Grubbs 1
st
 generation indenylidene catalyst (CAS #250220-36-1, 55 mg, 0.06 mmol, 
0.03 equiv) was loaded into the flask, sealed with a septum and exited the glove box. The 
Schlenk flask was hooked up to a Schlenk manifold and was purged thoroughly with argon. To a 
separate 25 mL round-bottomed flask was added sulfonamide 134 (575 mg, 2.0 mmol, 1 equiv), 
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4-bromostyrene (2.62 mL, 20.0 mmol, 10 equiv), and CH2Cl2 (10 mL, 0.2 M, degassed with Ar), 
then sealed with a septum. The mixture turned into a solution while the mixture was degassed for 
additional 30 min with Ar (needle and a bubbler outlet attached). Premixed, degassed solution of 
two olefin substrates was transferred to the Schlenk flask via syringe. The top area of the 
Schlenk flask including the needle-punctured septum was thoroughly sealed with parafilm. The 
black mixture was allowed to stir for 48 h at rt. The the mixture was filtered through a plug of 
silica, then rinsed with CH2Cl2 (15 mL x 2), and EtOAc (15 mL x 2) to afford a dark solution. 
The filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to afford a black solid. 
Purification via silica gel flash column chromatography (SiO2, 25 g, 20 mm Ø , hexanes to 
hexanes/EtOAc, 5:1) afforded 440 mg (50%) of 138, as a white solid. Recrystallization of the 
solid with hot pentane (36 
o
C, 30 mL) afforded 404 mg (46%) of 138 as white crystals.
 
Data for 138: 
 mp:  141-142 
o
C (sealed tube) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.62 (d, J = 8.5 Hz, 2 H, HC(8)), 7.45 (d, J = 8.5 Hz, 2 H, HC(17)), 7.41 (dd, J = 
8.0, 1.0 Hz, 1 H, HC(6)), 7.25 (ddd, J = 8.5, 6.0, and 3.0 Hz, 1 H, HC(aryl)), 7.22 
(dd, J = 8.0, 1.0 Hz, 2 H, HC(9)), 7.20 – 7.15 (m, 4 H, HC(aryl)), 6.5 (brs, 1H, HN), 
6.23 (d, J = 16.0 Hz, 1 H, HC(14)), 6.15 (dt, J = 16.0, 6.0 Hz, 1 H, HC(13)), 3.29 
(dd, J =6.0, 1.5 Hz, 2 H, HC(12)), 2.41 (s, 3 H, HC(11)). 
 13
C NMR: (126 MHz, CDCl3) 
  δ 144.1 (C10), 136.8 (C7), 135.8 (C15), 135.0 (C1), 132.5 (C2), 131.9 (C17), 130.9 
(C14), 130.8 (C3), 129.9 (C9), 128.2 (C13), 128.1 (C5), 128.0 (C16), 127.4 (C8), 
126.7 (C4), 124.6 (C6), 121.6 (C18), 35.3 (C12), 21.8 (C11).  
 MS: (ESI)  
440 ([M]
+
, 95), 441 (22), 442 (100), 443 (23), 456 (13) 
 HRMS: calcd for C22H19NO2SBr ([M]
+
): 440.0320, found: 440.0318 
 TLC: Rf 0.22 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C22H20BrNO2S (442.37) 
  Calcd:  C, 59.73;  H, 4.56% N, 3.17% 
   Found:  C, 59.93;  H, 4.39% N, 3.13% 
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Preparation of (E)-4-Methyl-N-[2-(4-phenyl-3-buten-1-yl)-phenyl]-benzenesulfonamide 
(139) (Scheme 47) [HMC10078] 
 
An oven-dried 50 mL Schlenk flask was equipped with a stir bar was introduced into a 
glove box. Grubbs 1
st
 generation indenylidene catalyst (CAS #250220-36-1, 110 mg, 0.12 mmol, 
0.03 equiv) was loaded into the flask, sealed with a septum and exited the glove box. The 
Schlenk flask was hooked up to a Schlenk manifold and was purged thoroughly with argon. To a 
separate 25 mL round-bottomed flask was added sulfonamide 135 (1.21 g, 4.0 mmol, 1 equiv), 
styrene (4.60 mL, 40.0 mmol, 10 equiv), and CH2Cl2 (16 mL, 0.25 M, degassed with argon), 
then sealed with a septum. The mixture turned into a solution while the mixture was degassed for 
additional 30 min with argon (needle and a bubbler outlet attached). Premixed, degassed solution 
of two olefin substrates was transferred to the Schlenk flask via syringe. The top area of the 
Schlenk flask including the needle-punctured septum was thoroughly sealed with parafilm. The 
black mixture was allowed to stir for 48 h at rt. The the mixture was filtered through a plug of 
silica, then rinsed with CH2Cl2 (30 mL x 2), and EtOAc (30 mL x 2) to afford a dark solution. 
The filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to afford a black solid. 
Purification via silica gel flash column chromatography (SiO2, 40 g, 25 mm Ø , hexanes to 
hexanes/EtOAc, 5:1) afforded 740 mg (49%) of 139, as a grey solid. Recrystallization of the 
solid with boiling EtOAc/pentane (1:10 mixture, 20 mL) afforded 649 mg (43%) of 139 as white 
crystals.
 
 
Data for 139: 
 mp:  110-111 
o
C (sealed tube) 
 1
H NMR: (500 MHz, CDCl3) 
  δ 7.64 (d, J = 8.5 Hz, 2 H, HC(8)), 7.36 – 7.30 (m, 5 H, HC(17,18,aryl)), 7.28 – 
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7.22 (m, 3 H, HC(aryl,9)), 7.20 – 7.15 (m, 1 H, (HC(aryl)), 6.33 (d+brs, J = 16.0 Hz, 
2 H, HC(15)+HN), 6.13 (dt, J = 16.0, 7.0 Hz, 1 H, HC(14)), 2.57 (dd, J = 9.0, 6.5 
Hz, 2 H, HC(12)), 2.40 (s, 3 H, HC(11)), 2.33 (qd, J = 7.5, 7.0 Hz, 2 H, HC(13)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.8 (C10), 137.3 (C16), 136.7 (C7), 135.1 (C2), 134.0 (C1), 131.0 (C14), 129.9 
(C3), 129.6 (C9), 128.9 (C15), 128.5 (C18), 127.2 (C8), 127.2, 127.1, 126.5, 126.0 
(C17), 124.8 (C6), 33.2 (C13), 30.7 (C12), 21.5 (C11). 
 FTIR: (neat) 
  3222 (m), 1597 (w), 1493 (w), 1456 (w), 1448 (w), 1411 (w), 1324 (s), 1305 (w), 
1294 (w), 1269 (w), 1185 (w), 1155 (s), 1120 (w), 1090 (s), 985 (w), 964 (m), 913 
(m), 812 (m), 795 (w), 766 (s). 
 MS: (ESI)  
194 (13), 222 (22), 223 (100), 224 (16), 378 (M+H, 49), 379 (13), 400 (32). 
 HRMS: calcd for C23H24NO2S ([M+H]
+
): 378.1528, found: 378.1525 
 TLC: Rf 0.25 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C23H23NO2S (377.50) 
  Calcd:  C, 73.18;  H, 6.14% N, 3.71% 
   Found:  C, 72.99;  H, 6.29% N, 3.62% 
 
Preparation of Substrates 140, 141 via C-N Cross-coupling (Scheme 48) 
Preparation of (E)-6-(2-Chlorophenyl)-4-hexenenitrile (140d) (Scheme 48) [HMC11089, 
HMC11090] 
 
To an oven-dried 200-mL round-bottomed flask was equipped with a magnetic stir bar 
were added homoallylic alcohol 140c
125
 (787 mg, 4.0 mmol), CH2Cl2 (40 mL, 0.1 M), and then 
the flask was connected to an argon inlet. The solution was cooled to 0 
o
C in ice bath, and were 
added Et3N (1.95 mL, 14.0 mmol, 3.5 equiv), and methanesulfonic chloride (0.46 mL, 6.0 mmol, 
1.5 equiv) via syringe. The reaction mixture was stirred for 1 h at 0 
o
C. The reaction was 
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quenched by adding water (20 mL) and the resulting biphasic solution was separated. The 
aqueous layer was further extracted with CH2Cl2 (30 mL x 2). Combined organic layer was dried 
over Na2SO4, and filtered over a glass wool. The filtrate was concentrated under reduced 
pressure (30 
o
C, 10 mmHg) to afford a brown oil. Purification via silica gel plug filtration (SiO2, 
10 g, 30 mm Ø , hexanes/EtOAc, 7:3) afforded 1.04 g (95%) of mesylate as a pale yellow oil. 
(The mesylate intermediate slowly turned into a dark oil upon standing.) To an oven-dried 100-
mL round-bottomed flask with a magnetic stir bar were added mesylate (1.04 g, 3.79 mmol), 
DMF (30 mL, 0.125 M), and sodium cyanide (557 mg, 11.4 mmol, 3 equiv). A condenser was 
installed to the flask, and connected to an argon inlet. The flask was purged with argon and the 
solution was stirred for 12 h at 40 
o
C. After 12 h, the flask was cooled to room temperature and 
the reaction was quenched by pouring into an ice-water (30 mL). The aqueous layer was 
extracted with CH2Cl2 (30 mL x 3), and each layer was washed with brine (20 mL x 2). The 
organic layers were combined and dried over Na2SO4, and evaporated under reduced pressure 
(25 
o
C, 10 mmHg). Residual DMF was additionally removed by passing through a silica plug (10 
g), rinsed with 4:1 hexanes:EtOAc. Collected organic layer was concentrated, and was purified 
by silica gel flash chromatography (SiO2, 40 g, 25 mm Ø , hexanes to hexanes/EtOAc, 4:1) 
afforded 701 mg (90%) of 140d, as a colorless oil. An analytically pure sample was obtained by 
Kugelrohr distillation (80 
o
C at 0.1 mmHg) affording 670 mg (86%) of 140d as a colorless oil. 
 
Data for 140d: 
 bp:  80 
o
C (at 0.1 mmHg) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.39 (dd, J = 8.0, 1.5 Hz, 1 H, HC(9)), 7.28 – 7.16 (m, 3 H, HC(aryl)), 5.79 (dtd, J 
= 15.0, 6.5, and 1.5 Hz, 1 H, HC(5)), 5.54 (dddt, J = 15.0, 6.5, 5.0, and 1.5 Hz, 1 H, 
HC(4)), 3.52 (dd, J = 6.5, 1.5 Hz, 2 H, HC(6)), 2.47 – 2.36 (m, 4 H, HC(2,3)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 137.6 (C7), 133.9 (C8), 130.6 (C5), 130.3 (C12), 129.4 (C9), 127.8 (C4), 127.6 
(C11), 126.9 (C10), 119.2 (C1), 36.3 (C6), 28.3 (C3), 17.5 (C2). 
 MS: (EI)  
89 (11), 115 (30), 116 (25), 125 (30), 128 (25), 129 (100), 130 (26), 151 (64), 153 
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(20), 164 (14), 170 (50), 205 (M, 45), 207 (14.6). 
 HRMS: calcd for C15H12NCl: 205.0658, found: 205.0662 
 TLC: Rf 0.53 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C15H12NCl (205.68) 
  Calcd:  C, 70.07;  H, 5.88% N, 6.81% 
   Found:  C, 69.99;  H, 5.81% N, 6.76% 
 
Preparation of (E)-6-(2-Aminophenyl)-4-hexenenitrile (140e) (Scheme 48) [HMC11093] 
 
Following the procedure procedure developed by Hartwig,
105
 to an oven-dried, 38-mL 
pressure tube equipped with a magnetic stir bar were added aryl bromide 140d (737 mg, 3.6 
mmol) and ammonium sulfate (710 mg, 5.4 mmol, 1.5 equiv) and then introduced into a glove 
box. In the glove box, a separate oven-dried 20-mL vial with a magnetic stir bar were added 
Pd[P(o-tolyl)3]2
138
 (12.8 mg, 0.018 mmol, 0.005 equiv), Josiphos (CAS#158923-11-6, 9.9 mg, 
0.018 mmol, 0.005 equiv), and dioxane (1 mL) and stirred for 5 min. To the pressure tube were 
added NaOt-Bu (1.55 g, 16.1 mmol, 4.5 equiv), dioxane (18 mL, 0.2 M) and the Pd/Josiphos 
solution (1 mL). The pressure tube was tightly sealed with the screw cap and exited the glove 
box. The reaction mixture was heated to 100 
o
C and stirred for 12 h. After 12 h, the reaction 
mixture was cooled to rt and was diluted with EtOAc (10 mL). Resulting dark mixture was 
filtered through a pad of Celite and the filtrate was concentrated under reduced pressure (30 
o
C, 
10 mmHg) to yield a brown oil. Purification via silica gel flash column chromatography (SiO2, 
40 g, 25 mm Ø , hexanes to hexanes/EtOAc, 9:1) afforded 274 mg (41%) of 140e, as a pale 
yellow oil. An analytically pure sample was obtained by Kugelrohr distillation (90 
o
C at 0.01 
mmHg) affording 236 mg (35%) of 140e as a colorless oil. 
 
Data for 140e: 
 bp: 90 
o
C (at 0.01 mmHg)  
 
1
H NMR: (500 MHz, CDCl3) 
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  δ 7.11 – 7.02 (m, 2 H, HC(10,12)), 6.77 (t, J = 7.5 Hz, 1 H, HC(11)), 6.69 (d, J = 
7.5 Hz, 1 H, HC(9)), 5.71 (dtd, J = 15.0, 6.5, and 1.5 Hz, 1 H, HC(5)), 5.53 (ddd, J 
= 15.0, 6.5,  and 4.5 Hz, 1 H, HC(4)), 3.63 (brs, 2 H, HN), 3.21 (dd, J = 6.5, 1.5 Hz, 
2 H, HC(6)), 2.46 – 2.35 (m, 4 H, HC(2,3)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 139.5 (C7), 136.7 (C8), 130.4 (C5), 129.3 (C12), 128.1 (C4), 126.4 (C10), 119.1 
(C11), 119.1 (C1), 115.1 (C9), 33.6 (C6), 28.4 (C3), 17.5 (C2). 
 MS: (ESI)  
103 (17), 187 (M+H, 100), 209 (26). 
 HRMS: calcd for C12H15N2: 187.1235, found: 187.1232 
 TLC: Rf 0.41 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C12H14N2 (186.12) 
  Calcd:  C, 77.38;  H, 7.58% N, 15.04% 
   Found:  C, 77.24;  H, 7.41% N, 14.92% 
 
Preparation of (E)-N-[2-(5-Cyano-2-pentenyl)-phenyl]-4-methylbenzenesulfonamide
101
 (140) 
(Scheme 48) [HMC11096] 
 
To an oven-dried, 25-mL round-bottomed flask equipped with a magnetic stir bar were 
added aniline 140e (236 mg, 1.27 mmol), CH2Cl2 (2.5 mL, 0.5 M), pyridine (133 L, 1.65 mmol, 
1.3 equiv), and 4-toluenesulfonyl chloride (266 mg, 1.39 mmol, 1.1 equiv) in order at rt. After 
stirring for 24 h, the reaction mixture was washed with 1 M HCl solution (3 mL) and brine (3 mL 
x 2). Resulting organic layer was dried over Na2SO4, filtered, and concentrated reduced pressure 
(30 
o
C, 10 mmHg) to yield an yellow oil. The crude product was purified via flash 
chromatography (SiO2, 25 g, 30 mm Ø , hexanes to hexanes/EtOAc, 4:1) afforded 372 mg (86%) 
of 140, as a yellow solid. An analytically pure sample was obtained by recrystallization of the 
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solid with boiling EtOAc/pentane (1:10 mixture, 15 mL), affording 341 mg (79%) of 140 as pale 
yellow crystals.  
 
Data for 140: 
 mp:  91-92 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.65 (d, J = 8.0 Hz, 2 H, HC(8)) 7.39 (d, J = 7.5 Hz, 1 H, HC(3)), 7.22 (d, J = 7.5 
Hz, 2 H, HC(9)) 7.19 – 7.09 (m, 3 H, HC(aryl), 6.47 (brs, 1 H, HN), 5.75 (dt, J = 
15.0, 6.0 Hz, 1 H, HC(13)), 5.59 (ddd, J = 15.0, 6.0, and 4.5 Hz, 1 H, HC(14)), 3.23 
(dd, J = 6.5, 1.5 Hz, 2 H, HC(12)), 2.42 (s, 3 H, HC(11)), 2.50 – 2.35 (m, 4 H, 
HC(15,16)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.6 (C10), 136.5 (C7), 135.9 (C2), 134.1 (C1), 131.6 (C14), 130.5 (C13), 129.8 
(C6), 129.6 (C9), 127.1 (C4), 127.1 (C3), 127.0 (C8), 126.9 (C5), 119.0 (C17), 35.9 
(C12), 28.4 (C15), 21.5 (C11), 17.4 (C16). 
 MS: (ESI)  
105 (23), 118 (67), 130 (20), 184 (27), 185 (40), 186 (100), 272 (15), 340 (M+H, 
52), 357 (10), 363 (11). 
 HRMS: calcd for C19H21N2O2S: 340.1245, found: 340.1248 
 TLC: Rf 0.35 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C19H20N2O2S (340.44) 
  Calcd:  C, 67.03;  H, 5.92% N, 8.23% 
   Found:  C, 67.17;  H, 6.10% N, 8.31% 
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Preparation of (E)-N-{2-[6-(4-Methylbenzenesulfonamido)-2-hexenyl]phenyl}-4-
methylbenzenesulfonamide (141) (Scheme 48) [HMC10056, HMC10057] 
 
An oven-dried, 100-mL Schlenk flask equipped with a magnetic stir bar was charged 
with LiAlH4 (223 mg, 5.87 mmol, 2.0 equiv) and capped with a septum under argon. The flask 
was immersed in an ice-bath and was added THF (10 mL). To the resulting suspension was 
added a solution of nitrile 140 (1.0 g, 2.94 mmol, 1 equiv) in THF (10 mL). The suspension was 
stirred for 2 h at 0 
o
C and gradually warmed to room temperature over 1 h. The reaction was 
cooled to 0 
o
C and slowly quenched with aqueous 1 M NaOH solution (0.4 mL) upon completion. 
The resulting emulsion was filtered through a short pad of Celite and rinsed with ether (15 mL x 
3). Evaporation of the filtrate at reduced pressure (25 
o
C, 10 mmHg) gave 799 mg (79%) of 
amine. Then an oven-dried, 25-mL Schlenk flask equipped with a magnetic stir bar was charged 
with the crude amine (689 mg, approx. 2.0 mmol, 1 equiv), CH2Cl2 (4 mL), and pyridine (210 
L, 2.6 mmol, 1.3 equiv). To the solution was added p-toluenesulfonyl chloride (419 mg, 2.2 
mmol, 1.1 equiv) portionwise at 0 
o
C under positive stream of argon. The solution was warmed 
to room temperature and was stirred for 4 h. The reaction mixture was washed with aqueous 1 M 
HCl (4 mL), then brine (4 mL x 2). Resulting organic layer was dried over Na2SO4 and 
evaporated under reduced pressure (25 
o
C, 10 mmHg). Purification via silica gel flash column 
chromatography (SiO2, 40 g, 25 mm Ø , hexanes only to hexanes/EtOAc, 4:1) afforded 858 mg 
(59% over two steps from 140) of the homologated tosylamine 141 as white solid. An 
analytically pure sample was obtained by recrystallization of the solid with boiling 
EtOAc/pentane (1:10 mixture, 30 mL), affording 756 mg (52%) of 141 as white crystals. 
 
 
Data for 141: 
 mp:  104-105 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
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  δ 7.74 (d, J = 8.0 Hz, 2 H, HC(19)), 7.65 (d, J = 8.0 Hz, 2 H, HC(8)) 7.39 (d, J = 
7.5 Hz, 1 H, HC(3)), 7.33 (d, J = 8.0 Hz, 2 H, HC(20)), 7.22 (d, J = 7.5 Hz, 2 H, 
HC(9)) 7.19 – 7.09 (m, 3 H, HC(aryl), 6.47 (brs, 1 H, HN), 5.69 (dt, J = 15.0, 6.5 
Hz, 1 H, HC(13)), 5.54 (dd, J = 15.0, 7.0 Hz, 1 H, HC(14)), 4.65 (brs, 1 H, HN), 
3.24 (dd, J = 6.5, 1.5 Hz, 2 H, HC(12)), 2.92 (appq, J = 7.0 Hz, 2 H, HC(17)), 2.43 
(s, 3 H, HC(22)), 2.41 (s, 3 H, HC(11)), 1.98 (appq, J = 7.0 Hz, 2 H, HC(15)), 1.52 
(appp, J = 7.0 Hz, 2 H, HC(16)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.6 (C10), 143.3 (C21), 137.0 (C18), 136.5 (C7), 135.9 (C2), 134.1 (C1), 130.7 
(C13), 129.9 (C14), 129.8 (C6), 129.7 (C20), 129.6 (C9), 127.1 (C4), 127.1 (C3), 
127.1 (C19), 127.0 (C8), 126.9 (C5), 42.6 (C17), 35.8 (C12), 29.3 (C15), 29.2 
(C16), 21.5 (C11), 21.5 (C22). 
 MS: (ESI) 
118 (21), 273 (13), 344 (36), 499 (M+H, 100), 521 (53), 537 (24). 
 HRMS: (ESI) calcd for C26H31N2O4S2: 499.1725, found: 499.1728 
 TLC: Rf 0.28 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C26H30N2O4S2 (498.66) 
  Calcd:  C, 62.62;  H, 6.06% N, 5.62% 
   Found:  C, 62.85;  H, 6.23% N, 5.69% 
 
Preparation of Substrates 142 via C-N Cross-coupling (Scheme 49) 
Preparation of (E)-1-Bromo-2-(3-hepten-1-yl)-benzene (142e) (Scheme 49) [HMC10028, 
HMC10029] 
 
To an oven-dried 250-mL round-bottomed flask was equipped with a magnetic stir bar 
were added bromoalcohol 142d
126
 (3.21 g, 11.9 mmol), CH2Cl2 (120 mL, 0.1 M), and then the 
flask was connected to an argon inlet. The solution was cooled to 0 
o
C in ice bath, and were 
added Et3N (5.83 mL, 41.8 mmol, 3.5 equiv), and methanesulfonic chloride (1.38 mL, 17.9 
mmol, 1.5 equiv) via syringe. The reaction mixture was stirred for 1 h at 0 
o
C. The reaction was 
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quenched by adding water (30 mL) and the resulting biphasic solution was separated. The 
aqueous layer was further extracted with CH2Cl2 (30 mL x 2). Combined organic layer was dried 
over Na2SO4, and filtered over a glass wool. The filtrate was concentrated under reduced 
pressure (30 
o
C, 10 mmHg) to afford a brown oil. Purification via silica gel plug filtration (SiO2, 
10 g, 30 mm Ø , hexanes/EtOAc, 7:3) afforded 3.52 g (85%) of mesylate as a pale yellow oil. 
(The mesylate intermediate slowly turned into a dark oil upon standing.) To an oven-dried 200-
mL round-bottomed flask with a magnetic stir bar were added mesylate (2.5 g, 7.2 mmol), and 
THF (80 mL, 0.09 M). The flask was connected to an argon inlet and capped with a septum. The 
solution was cooled to 0 
o
C in an ice bath and was added a suspension of LiAlH4 (273 mg, 7.2 
mmol, 1 equiv in 10 mL of THF) via cannula dropwise. The resulting reaction mixture was 
stirred for 4 h at 0 
o
C. Fieser & Fieser workup method was used to quench the reaction, adding 
water (0.3 mL), 15% NaOH (0.3 mL), water (0.9 mL) in order, dropwise via syringe at 0 
o
C. The 
resulting white slurry was filtered through celite and rinsed with ether (20 mL x 2). The colorless 
filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to afford a colorless oil. 
Purification via silica gel flash chromatography (SiO2, 120 g, 35 mm Ø , hexanes to 
hexanes/EtOAc, 19:1) afforded 1.68 g (92%) of 142e, as a colorless oil. An analytically pure 
sample was obtained by Kugelrohr distillation (80 
o
C at 0.1 mmHg) affording 1.62 g (89%) of 
142e as a colorless oil. 
 
Data for 142e: 
 bp:  80 
o
C (at 0.1 mmHg) 
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.53 (d, J = 8.0 Hz, 1 H, HC(6)), 7.25 – 7.17 (m, 2 H, HC(3,4)), 7.07 – 7.02 (m, 1 
H, HC(5)), 5.46 (q, J = 5.0 Hz, 2 H, HC(9,10)), 2.83 – 2.76 (m, 2 H, HC(7)), 2.35 – 
2.27 (m, 2 H, HC(8)), 1.97 (q, J = 7.0, 6.5 Hz, 2 H, HC(11)), 1.36 (app. sext, J = 7.5 
Hz, 2 H, HC(12)), 0.88 (t, J = 7.5 Hz, 3 H, HC(13)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 141.3 (C(1)), 132.7 (C(6)), 131.2 (C(10)), 130.4 (C(3)), 129.0 (C(9)), 127.4 
(C(5)), 127.2 (C(4)), 124.4 (C(2)), 36.4 (C(7)), 34.7 (C(11)), 32.8 (C(8)), 22.6 
(C(12)), 12.7 (C(13)). 
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 MS: (EI)  
55 (92), 67 (15), 82 (48), 83 (70), 89 (20), 90 (33), 91 (17), 117 (34), 169 (100), 
171 (98), 173 (43), 182 (18), 184 (17), 252 (M, 20), 254 (20). 
 HRMS: calcd for C13H17Br: 252.0514, found: 252.0507 
 TLC: Rf 0.67 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C13H17Br (253.18) 
  Calcd:  C, 61.67;  H, 6.77% 
   Found:  C, 62.01;  H, 6.69% 
 
 
Preparation of (E)-2-(3-Hepten-1-yl)-benzenamine (142f) (Scheme 49) [HMC10030] 
 
Following the procedure procedure developed by Hartwig,
105
 to an oven-dried, 200-mL 
pressure tube equipped with a magnetic stir bar were added aryl bromide 142e (1.52 g, 6.0 mmol) 
and ammonium sulfate (1.19 g, 9.0 mmol, 1.5 equiv) and then introduced into a glove box. In the 
glove box, a separate oven-dried 20-mL vial with a magnetic stir bar were added Pd[P(o-tolyl)3]2 
138
 (21.5 mg, 0.03 mmol, 0.005 equiv), Josiphos (CAS#158923-11-6, 16.6 mg, 0.03 mmol, 0.005 
equiv), and dioxane (1 mL) and stirred for 5 min. To the pressure tube were added NaOt-Bu 
(2.60 g, 27.0 mmol, 4.5 equiv), dioxane (60 mL) and the Pd/Josiphos solution (1 mL). The 
pressure tube was tightly sealed with the screw cap and exited the glove box. The reaction 
mixture was heated to 100 
o
C and stirred for 12 h. After 12 h, the reaction mixture was cooled to 
rt and was diluted with EtOAc (30 mL). Resulting dark mixture was filtered through a pad of 
Celite and the filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to yield a 
brown oil. Purification via silica gel flash column chromatography (SiO2, 120 g, 35 mm Ø , 
hexanes to hexanes/EtOAc, 9:1) afforded 738 mg (65%) of 142f, as a pale yellow oil. An 
analytically pure sample was obtained by Kugelrohr distillation (110 
o
C at 0.1 mmHg) affording 
701 mg (62%) of 142f as a colorless oil. 
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Data for 142f: 
 bp: 110 
o
C (at 0.1 mmHg)  
 
1
H NMR: (500 MHz, CDCl3) 
  δ 7.08 – 7.01 (m, 2 H, HC(3,5)), 6.74 (t, J = 7.5 Hz, 1 H, HC(4)), 6.68 (d, J = 8.0 
Hz, 1 H, HC(6)), 5.50 (m, 2 H, HC(9,10)), 3.62 (brs, 2 H, NH2), 2.55 (dd, J = 9.0, 
6.5 Hz, 2 H, HC(7)), 2.32 (m, 2 H, HC(8)), 1.98 (m, 2 H, HC(11)), 1.38 (tq, J = 7.5, 
7.5 Hz, 2 H, HC(12)), 0.89 (t, J = 7.5 Hz, 3 H, HC(13)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 144.1 (C(1)), 131.1 (C(10)), 129.4 (C(3)) 129.4 (C(9)), 126.9 (C(5)), 126.3 (C(2)), 
118.7 (C(4)), 115.5 (C(6)), 34.7 (C(11)), 31.8 (C(8)), 31.5 (C(7)), 22.6 (C(12)), 
13.7 (C(13)). 
 MS: (ESI)  
106 (13), 190 (M+H, 100), 191 (32). 
 HRMS: calcd for C13H20N: 190.1596, found: 190.1595 
 TLC: Rf 0.43 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C13H19N (189.30) 
  Calcd:  C, 82.48;  H, 10.12% N, 7.40% 
   Found:  C, 82.48;  H, 9.95% N, 7.69% 
 
Preparation of (E)-N-[2-(3-Hepten-1-yl)-phenyl]-4-methyl-bezenesulfonamide
101
 (142) 
(Scheme 49) [HMC10031] 
 
To an oven-dried, 25-mL round-bottomed flask equipped with a magnetic stir bar were 
added aniline 142f (568 mg, 3.0 mmol), CH2Cl2 (6 mL, 0.5 M), pyridine (315 L, 3.9 mmol, 1.3 
equiv), and 4-toluenesulfonyl chloride (686 mg, 3.6 mmol, 1.2 equiv) in order at rt. After stirring 
for 12 h, the reaction mixture was washed with 1 M HCl solution (5 mL) and brine (5 mL x 2). 
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Resulting organic layer was dried over Na2SO4, filtered, and concentrated reduced pressure (30 
o
C, 10 mmHg) to yield an yellow oil. The crude product was purified via flash chromatography 
(SiO2, 80 g, 30 mm Ø , hexanes to hexanes/EtOAc, 5:1) afforded 896 mg (87%) of 142, as an 
yellow oil which crystallized upon standing. An analytically pure sample was obtained by 
recrystallization of the solid with boiling EtOAc/pentane (1:10 mixture, 20 mL), affording 841 
mg (82%) of 142 as pale yellow crystals. 
 
 
Data for 142: 
 mp:  58-59 
o
C (sealed tube) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.64 (d, J = 8.5 Hz, 2 H, HC(8)) 7.38 (d, J = 7.5 Hz, 1 H, HC()), 7.25 (d, J = 7.5 
Hz, 2 H, HC(9)) 7.20 – 7.10 (m, 3 H, HC(aryl), 6.51 (brs, 1 H, HN), 5.41 – 5.29 (m, 
2 H, HC(14,15)), 2.42 (s, 3 H, HC(11)), 2.41 – 2.35 (m, 2 H, HC(12)), 2.10 (q, J = 
7.0 Hz, 2 H, HC(13)), 1.97 (q, J = 6.5 Hz, 2 H, HC(16)), 1.38 (septd, J =7.5, 1.0 Hz, 
2 H, HC(17)), 0.90 (td, J = 7.5, 1.0 Hz, 3 H, HC(18)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.7 (C10), 136.6 (C7), 135.1 (C2), 134.0 (C1), 132.1 (C15), 129.9 (C6), 129.6 
(C9), 128.5 (C14), 127.1 (C8), 126.9 (C5), 126.2 (C4), 124.5 (C3), 34.6 (C16), 32.8 
(C13), 30.9 (C12), 22.5 (C17), 21.5 (C11), 13.7 (C18). 
 MS: (ESI)  
118 (25), 130 (19), 132 (76), 146 (17), 187 (29), 188 (37), 189 (100), 190 (13), 205 
(13), 286 (13), 342 (13), 344 (M+H, 38), 360 (12), 366 (12). 
 HRMS: calcd for C20H26NO2S ([M+H]
+
): 344.1684, found: 344.1680 
 TLC: Rf 0.35 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C20H25NO2S (343.48) 
  Calcd:  C, 69.93;  H, 7.34% N, 4.08% 
   Found:  C, 69.89;  H, 7.56% N, 4.05% 
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Preparation of Substrate 138 via C-N Cross-coupling (Scheme 50) 
Preparation of 2-(4-Penten-1-yl)-benzenamine (143c) (Scheme 50) [HMC10011] 
 
Adopting the C-N amination procedure,
105
 to an oven-dried, 250-mL pressure tube 
equipped with a magnetic stir bar were added aryl bromide 143b
108
 (2.45 g, 10.9 mmol) and 
ammonium sulfate (2.16 g, 16.3 mmol, 1.5 equiv) and then introduced into a glove box. In the 
glove box, a separate oven-dried 20-mL vial with a magnetic stir bar were added Pd[P(o-
tolyl)3]2
138
 (38.9 mg, 0.054 mmol, 0.005 equiv), Josiphos (CAS#158923-11-6, 30.2 mg, 0.054 
mmol, 0.005 equiv), and dioxane (1 mL) and stirred for 5 min. To the pressure tube were added 
NaOt-Bu (4.71 g, 49.0 mmol, 4.5 equiv), dioxane (110 mL), and the Pd/Josiphos solution (1 mL). 
The pressure tube was tightly sealed with the screw cap and exited the glove box. The reaction 
mixture was heated to 100 
o
C and stirred for 12 h. After 12 h, the reaction mixture was cooled to 
rt and was diluted with EtOAc (50 mL). Resulting dark mixture was filtered through a pad of 
Celite and the filtrate was concentrated under reduced pressure (30 
o
C, 10 mmHg) to yield a 
brown oil. Purification via silica gel flash column chromatography (SiO2, 120 g, 35 mm Ø , 
hexanes to hexanes/EtOAc, 6:1) afforded 1.07 g (61%) of 143c, as a pale yellow oil. An 
analytically pure sample was obtained by Kugelrohr distillation (70 
o
C at 0.1 mmHg) affording 
1.01 g (57%) of 143c as a colorless oil. 
 
Data for 143c: 
 bp:  70 
o
C (at 0.1 mmHg) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.07 (td, J = 7.5, 1.5 Hz, 2 H, HC(3,5)), 6.76 (tt, J = 7.5, 1.5 Hz, 1 H, HC(4)), 
6.70 (d, J = 8.0 Hz, 1 H, HC(6)), 5.89 (ddtd, J = 17.0, 10.0, 6.5, and 1.5 Hz, 1 H, 
HC(10)), 5.09 (dp, J = 17.0, 1.5 Hz, 1 H, HC(11)), 5.04 (dt, J = 10.0, 1.5 Hz, 1 H, 
HC(11)), 3.62 (brs, 2 H, H2N), 2.53 (t, J = 8.0 Hz, 2 H, HC(7)), 2.18 (q, J = 6.5, 1.5 
Hz, 2 H, HC(9)), 1.76 (qdd, J = 8.5, 7.0, and 1.5 Hz, 2 H, HC(8)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.9 (C1), 138.4 (C10), 129.5 (C3), 126.9 (C5), 126.5 (C2), 118.8 (C4), 115.6 
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(C6), 114.9 (C11), 33.5 (C9), 30.5 (C7), 27.8 (C8). 
 MS: (ESI)  
106 (10), 162 (M+H, 100), 163 (15), 174 (10), 216 (25). 
 HRMS: calcd for C11H16N ([M+H]
+
): 162.1283, found: 162.1288 
 TLC: Rf 0.34 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C11H15N (161.24) 
  Calcd:  C, 81.94;  H, 9.38% N, 8.69% 
   Found:  C, 81.97;  H, 9.13% N, 8.63% 
 
Preparation of 4-Methyl-N-[2-(4-penten-1-yl)-phenyl]-bezenesulfonamide (143) (Scheme 
50)
101
 [HMC10012] 
 
To an oven-dried, 25-mL round-bottomed flask equipped with a magnetic stir bar were 
added aniline 143c (806 mg, 5.0 mmol), CH2Cl2 (10 mL, 0.5 M), pyridine (526 L, 6.5 mmol, 
1.3 equiv), and 4-toluenesulfonyl chloride (1.14 g, 6.0 mmol, 1.2 equiv) in order at rt. A 
condenser was installed on top of the flask and refluxed for 12 h. The reaction mixture was 
cooled to rt and washed with 1 M HCl solution (10 mL) and brine (5 mL x 3). Resulting organic 
layer was dried over Na2SO4, filtered, and concentrated reduced pressure (30 
o
C, 10 mmHg) to 
yield an yellow oil. The crude product was purified via flash chromatography (SiO2, 120 g, 35 
mm Ø , hexanes to hexanes/EtOAc, 5:1) afforded 1.34 g (85%) of 143, as an white crystalline 
solid. An analytically pure sample was obtained by recrystallization of the solid with boiling 
pentane (50 mL), affording 1.23 g (78%) of 143 as white crystals. 
 
 
Data for 143: 
 mp:  70-71 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
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  δ 7.64 (d, J = 8.0 Hz, 2 H, HC(8)), 7.40 (d, J = 8.0 Hz, 1 H, HC(6)), 7.25 (d, J = 8.0 
Hz, 2 H, HC(9)), 7.21 – 7.11 (m, 3 H, HC(3,4,5)), 6.36 (brs, 1 H, HN), 5.78 (ddt, J 
= 17.0, 10.5, and 6.5 Hz, 1 H, HC(15)), 5.09 – 5.01 (m, 2 H, HC(16)), 2.43 (s, 3 H, 
HC(11)), 2.34 (appt, J = 7.5 Hz, 2 H, HC(12)), 2.01 (appq, J = 7.0 Hz, 2 H, 
HC(14)), 1.49 (appp, J = 7.5 Hz, 2 H, HC(13)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 143.8 (C10), 138.0 (C15), 136.6 (C7), 135.2 (C1), 134.0 (C2), 129.7 (C3), 129.6 
(C9), 127.2 (C8), 126.9 (C4), 126.2 (C5), 124.5 (C6), 115.4 (C16), 33.1 (C14), 29.8 
(C12), 29.0 (C13), 21.5 (C11). 
 FTIR: (neat) 
  3280 (m), 1490 (m), 1392 (m), 1335 (s), 1305 (w), 1291 (w), 1274 (w), 1185 (w), 
1160 (s), 1120 (m), 1092 (s), 1019 (w), 993 (w), 951 (w), 910 (s), 886 (w), 875 (w), 
832 (w), 814 (m), 762 (m). 
 MS: (ESI)  
160 (15), 161 (93), 162 (16), 316 (M+H, 100), 317 (20), 333 (34), 335 (38), 338 
(95), 339 (22), 492 (72), 493 (47).  
 HRMS: calcd for C18H22NO2S ([M+H]
+
): 316.1371, found: 316.1376 
 TLC: Rf 0.30 (hexanes/EtOAc, 4:1) [UV] 
 Analysis: C18H21NO2S (315.43) 
  Calcd:  C, 68.54;  H, 6.71% N, 4.44% 
   Found:  C, 68.43;  H, 6.92% N, 4.31% 
 
Optimization of the Sulfenoamination Reaction (Table 11) 
Table 11 Entry 1-4 [HMC9073] 
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 An oven-dried, 5-mm NMR tube was charged with anisidine 129 (39.4 mg, 0.1 mmol), 
N-(2,6-diisopropyl)thiophthalimide 124 (33.9 mg, 0.1 mmol, 1 equiv), catalyst (S)-83 (5.2 mg, 
0.01 mmol, 0.1 equiv), and CDCl3 (1 mL, 0.1 M). The tube was capped with a septum and 
shaken thoroughly. Subsequently, MsOH (3.2 mL, 0.05 mmol, 0.5 equiv) was added via syringe 
at 20 
o
C, and the resulting mixture was shaken again. The NMR tube was kept in a water bath 
(20 
o
C), and taken out for NMR spectroscopy at 6, 12, 24, and 48 h. Conversion to product was 
measure by the apprearance of the diagnostic 
1
H NMR resonance for the product at 5.14 pp, with 
respect  to the substrate peaks at 6.11, 6.31, and 3.80 ppm. No other products were observed in 
the 
1
H NMR spectra. Formation of phthalimide byproduct was visually confirmed by the 
precipitation. After 48 h, the reaction mixture was quenched by addition of saturated NaHCO3 
aqueous solution (1 mL) and extracted with CH2Cl2 (1 mL x 3). Combined organic layer was 
dried over Na2SO4, filtered, and evaporated. Purification by flash column chromatography (SiO2, 
5 g, 20 mm Ø , hexanes/EtOAc = 19:1) gave 48 mg (82%) of 144 as white solid.  
 
Data for 144: 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.62 (d, J = 8.5 Hz, 1 H, HC(8)), 7.54 (d, J = 8.0 Hz, 2 H, HC(12)) 7.39 – 7.27 (m, 
8 H, HC(aryl)), 7.10 (d, J = 7.5 Hz, 2 H, HC(22)), 6.87 (dd, J = 9.0, 3.0 Hz, 1 H, 
HC(7)), 6.40 (d, J = 3.0 Hz, 1 H, HC(5)), 5.15 (d, J = 9.0 Hz, 1 H, HC(2)), 3.79 (s, 
3 H, HC(26)), 3.35 (brs, 2 H, HC(24)), 2.83 (ddd, J = 12.5, 9, and 4.0 Hz, 1 H, 
HC(3)), 2.48 (s, 3 H, HC(15)), 2.18 (dd, J = 14.0, 4.0 Hz, 1 H, HC(4)), 1.52 (t, J = 
13.0 Hz, 1 H, HC(4)), 1.06 (d, J = 7.0 Hz, 6 H, HC(25)), 0.98 (d, J = 7.0 Hz, 6 H, 
HC(25)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 158.0 (C6), 153.7 (C20), 143.5 (C11), 142.5 (C16), 136.3 (C14), 135.7 (C10), 
129.5 (C19), 129.5 (C13), 129.2 (C9), 128.9 (C8), 128.8 (C21), 128.3 (C17), 127.5 
(C23), 127.2 (C12), 127.0 (C18), 123.6 (C22), 112.9 (C7), 112.6 (C5), 64.6 (C2), 
55.5 (C26), 55.4 (C3), 33.8 (C4), 31.2 (C24), 24.5 (C25), 23.8 (C25), 21.6 (C15). 
 
HPLC: (2R,3S)-144, tR 7.1 min (9.9%); (2S,3R)-144, tR 8.2 min (90.1%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
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Table 11 Entry 5 (Background reaction) [HMC9057] 
 An oven-dried, 5-mm NMR tube was charged with anisidine 129 (19.7 mg, 0.05 mmol), 
N-(2,6-diisopropyl)thiophthalimide 124 (17.0 mg, 0.05 mmol, 1 equiv), and CDCl3 (0.5 mL, 0.1 
M). The tube was capped with a septum and shaken thoroughly. Subsequently, MsOH (1.6 mL, 
0.025 mmol, 0.5 equiv) was added via syringe at 20 
o
C, and the resulting mixture was shaken 
again. The NMR tube was kept in a water bath (20 
o
C), and taken out for NMR spectroscopy at 6, 
12, 24, and 48 h. No conversion to product was observed by 
1
H NMR spectroscopy. 
 
Table 11 Entry 6 [HMC9085] 
 An oven-dried, 4-mL vial with a magnetic stir bar was charged with anisidine 129 (39.4 
mg, 0.1 mmol), N-(2,6-diisopropyl)thiophthalimide 124 (33.9 mg, 0.1 mmol, 1 equiv), catalyst 
(S)-83 (5.2 mg, 0.01 mmol, 0.1 equiv), and CH2Cl2 (1 mL, 0.1 M). The vial was capped with a 
septum and stirred thoroughly for 10 min at 0 
o
C bath. Subsequently, MsOH (3.2 mL, 0.05 mmol, 
0.5 equiv) was added via syringe at 0 
o
C (be aware of MsOH freezing), and the resulting mixture 
was stirred again for 48 h at 0 
o
C. The reaction mixture was quenched by adding saturated 
NaHCO3 aqueous solution (1 mL) and extracted with CH2Cl2 (1 mL x 3). Combined organic 
layer was dried over Na2SO4, filtered, and evaporated. 
1
H NMR spectroscopy of the crude 
product mixture showed 80% conversion after 48 h. Conversion to product was measure by the 
apprearance of the diagnostic 
1
H NMR resonance for the product at 5.14 pp, with respect to the 
substrate peaks at 6.11, 6.31, and 3.80 ppm. Purification by flash column chromatography (SiO2, 
5 g, 20 mm Ø , hexanes/EtOAc = 19:1) gave 37 mg (64%) of 144 as white solid.  
Data for 144: 
 
HPLC: (2R,3S)-144, tR 7.2 min (6.1%); (2S,3R)-144, tR 8.2 min (93.9%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 
Table 11 Entry 7 [HMC9093] 
 An oven-dried, 4-mL vial with a magnetic stir bar was charged with anisidine 129 (39.4 
mg, 0.1 mmol), N-(2,6-diisopropyl)thiophthalimide 124 (33.9 mg, 0.1 mmol, 1 equiv), catalyst 
(S)-83 (5.2 mg, 0.01 mmol, 0.1 equiv), and CDCl3 (0.25 mL, 0.4 M). The vial was capped with a 
septum and stirred thoroughly for 10 min at 0 
o
C bath. Subsequently, MsOH (3.2 mL, 0.05 mmol, 
0.5 equiv) was added via syringe at 0 
o
C (be aware of MsOH freezing), and the resulting mixture 
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was stirred again for 48 h at 0 
o
C. The reaction mixture was quenched by adding saturated 
NaHCO3 aqueous solution (1 mL) and extracted with CH2Cl2 (1 mL x 3). Combined organic 
layer was dried over Na2SO4, filtered, and evaporated. 
1
H NMR spectroscopy of the crude 
product mixture showed full conversion after 48 h. Conversion to product was measure by the 
apprearance of the diagnostic 
1
H NMR resonance for the product at 5.14 pp, with respect to the 
substrate peaks at 6.11, 6.31, and 3.80 ppm. Purification by flash column chromatography (SiO2, 
5 g, 20 mm Ø , hexanes/EtOAc = 19:1) gave 47 mg (80%) of 144 as white solid.  
 
Data for 144: 
 
HPLC: (2R,3S)-144, tR 7.1 min (6.6%); (2S,3R)-144, tR 8.2 min (93.4%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 
Survey of Substrate Scope (Table 12) 
General Procedure XIII: Sulfenoamination of Anilines 
An oven-dried, 10-mL Schlenk flask equipped with a stir bar was charged with substrate 
(1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.10 equiv), and CH2Cl2 (2.5 mL, 0.4 M) then capped with a rubber septum followed by 
argon purge. The flask was placed in 0 
o
C isopropyl alcohol bath cooled via a Cryocool unit. The 
temperature of the mixture was monitored via a thermocouple digital temperature probe. After 
the temperature stabilized, MsOH (32.5 µL, 0.5 mmol, 0.5 equiv) was added slowly via syringe 
(internal temperature was maintained below 4 
o
C while addition of MsOH, and MsOH was 
dropped carefully far from the top to prevent freezing in the syringe) and the mixture was 
allowed to stir for the indicated time. The reaction was quenched while cold by addition of pre-
cooled sat. NaHCO3 aq. solution (5 mL) upon vigorous stirring. The biphasic resulting mixture 
was extracted with CH2Cl2 (5 mL x 3). The combined organic extracts were dried over Na2SO4, 
filtered through glass wool and then concentrated in vacuo (23 
o
C, 10 mm Hg) to afford the 
crude solid product. The product was purified via silica gel flash column chromatography. 
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Preparation of (2S,3R)-3-[(2,6-Diisopropyl)phenylthio]-6-methoxy-2-phenyl-1-tosyl-1,2,3,4-
tetrahydroquinoline (144) (Table 12 Entry 1) [HMC11030] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 129 (393.5 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 510 mg (87%) of a 144 as a white solid.   
 
Data for 144: 
 mp: 157-158 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.62 (d, J = 8.5 Hz, 1 H, HC(8)), 7.54 (d, J = 8.0 Hz, 2 H, HC(12)) 7.39 – 7.27 (m, 
8 H, HC(aryl)), 7.10 (d, J = 7.5 Hz, 2 H, HC(22)), 6.87 (dd, J = 9.0, 3.0 Hz, 1 H, 
HC(7)), 6.40 (d, J = 3.0 Hz, 1 H, HC(5)), 5.15 (d, J = 9.0 Hz, 1 H, HC(2)), 3.79 (s, 
3 H, HC(26)), 3.35 (brs, 2 H, HC(24)), 2.83 (ddd, J = 12.5, 9, and 4.0 Hz, 1 H, 
HC(3)), 2.48 (s, 3 H, HC(15)), 2.18 (dd, J = 14.0, 4.0 Hz, 1 H, HC(4)), 1.52 (t, J = 
13.0 Hz, 1 H, HC(4)), 1.06 (d, J = 7.0 Hz, 6 H, HC(25)), 0.98 (d, J = 7.0 Hz, 6 H, 
HC(25)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 158.0 (C6), 153.7 (C20), 143.5 (C11), 142.5 (C16), 136.3 (C14), 135.7 (C10), 
129.5 (C19), 129.5 (C13), 129.2 (C9), 128.9 (C8), 128.8 (C21), 128.3 (C17), 127.5 
(C23), 127.2 (C12), 127.0 (C18), 123.6 (C22), 112.9 (C7), 112.6 (C5), 64.6 (C2), 
55.5 (C26), 55.4 (C3), 33.8 (C4), 31.2 (C24), 24.5 (C25), 23.8 (C25), 21.6 (C15). 
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 MS: (ESI)  
148 (13), 236 (11), 431 (100), 432 (31), 586 (M+H, 11), 608 (22) 
 HRMS: calcd for C35H40NO3S2: 586.2450, found: 586.2440 
 TLC: Rf 0.34 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2965 (w), 1495 (m), 1457 (w), 1354 (m), 1343 (w), 1222 (m), 1164 (s), 1089 (w), 
1053 (m), 1032 (w), 960 (w), 868 (m), 811 (w), 802 (m), 750 (w) 
 Opt Rot: [α] D
24
 -35.7 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-144, tR 7.1 min (6.3%); (2S,3R)-144, tR 8.2 min (93.7%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C35H39NO3S2 (585.82) 
  Calcd:  C, 71.76;  H, 6.71% N, 2.39% 
   Found:  C, 71.63;  H, 6.59% N, 2.26% 
 
Preparation of (2S,3R)-3-[(2,6-Diisopropyl)phenylthio]-2-phenyl-1-tosyl-1,2,3,4-
tetrahydroquinoline (145) (Table 12 Entry 2) [HMC11029] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 136 (363.5 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 510 mg (92%) of a 145 as a white solid.   
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Data for 145: 
 mp: 172-173 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.72 (d, J = 8.0 Hz, 1 H, HC(8)), 7.56 (d, J = 8.0 Hz, 2 H, HC(12)) 7.37 – 7.25 (m, 
9 H, HC(aryl)), 7.14 (td, J = 7.5, 1.0 Hz, 1 H, HC(6)), 7.10 (d, J = 7.5 Hz, 2 H, 
HC(22)), 6.88 (d, J = 7.5 Hz, 1 H, HC(5)), 5.26 (d, J = 8.5 Hz, 1 H, HC(2)), 3.37 
(brs, 2 H, HC(24)), 2.89 (ddd, J = 11.5, 8.5, and 4.0 Hz, 1 H, HC(3)), 2.46 (s, 3 H, 
HC(15)), 2.31 (dd, J = 14.0, 4.0 Hz, 1 H, HC(4)), 1.71 (dd, J = 14.0, 12.0 Hz, 1 H, 
HC(4)), 1.07 (d, J = 7.0 Hz, 6 H, HC(25)), 0.99 (d, J = 7.0 Hz, 6 H, HC(25)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 159.0 (C6), 153.7 (C20), 143.7 (C11), 142.2 (C16), 136.3 (C14), 135.8 (C10), 
131.0 (C9), 129.6 (C19), 129.5 (C13), 129.0 (C8), 128.7 (C21), 128.3 (C17), 127.6 
(C23), 127.2 (C12), 127.0 (C18), 123.7 (C22), 113.4 (C7), 113.4 (C5), 64.6 (C2), 
55.3 (C3), 33.6 (C4), 31.2 (C24), 24.5 (C25), 23.8 (C25), 21.6 (C15). 
 MS: (ESI)  
169 (17), 259 (22), 286 (28), 440 (95), 442 (100), 522 (41), 556 (M+H, 10), 636 
(40) 
 HRMS: calcd for C34H38NO2S2: 556.2344, found: 556.2340 
 TLC: Rf 0.43 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2965 (w), 1487 (w), 1461 (w), 1356 (m), 1169 (s), 1093 (w), 1054 (w), 1005 (w), 
960 (m), 817 (m), 807 (m), 761 (w), 753 (w) 
 Opt Rot: [α] D
24
 -43.0 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-145, tR 8.5 min (5.2%); (2S,3R)-145, tR 10.1 min (94.8%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C34H37NO2S2 (555.79) 
  Calcd:  C, 73.47;  H, 6.71% N, 2.52% 
   Found:  C, 73.23;  H, 6.53% N, 2.30% 
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Preparation of (2S,3R)-3-[(2,6-Diisopropyl)phenylthio]-6-fluoro-2-phenyl-1-tosyl-1,2,3,4-
tetrahydroquinoline (146) (Table 12 Entry 3) [HMC11031] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 130 (381.5 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 6 d. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 493 mg (86%) of a 146 as a white solid.   
 
Data for 146: 
 mp: 198-199 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.69 (ddd, J = 9.0, 5.0, and 2.0 Hz, 1 H, HC(8)), 7.56 (d, J = 8.0 Hz, 2 H, HC(12)) 
7.38 – 7.28 (m, 8 H, HC(aryl)), 7.11 (d, J = 7.5 Hz, 2 H, HC(22)), 7.03 (td, J = 8.5, 
3.0 Hz, 1 H, HC(7)), 6.62 (dd, J = 8.5, 3.0 Hz, 1 H, HC(5)), 5.21 (dd, J = 9.0, 2.5 
Hz, 1 H, HC(2)), 3.35 (brs, 2 H, HC(24)), 2.90 – 2.83 (m, 1 H, HC(3)), 2.49 (s, 3 H, 
HC(15)), 2.28 – 2.21 (m, 1 H, HC(4)), 1.60 (d, J = 14.0, 12.0 Hz, 1 H, HC(4)), 1.07 
(d, J = 6.5 Hz, 6 H, HC(25)), 0.99 (d, J = 7.0 Hz, 6 H, HC(25)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 160.7 (d, J = 248.3 Hz, C6), 153.6 (C20), 143.8 (C11), 142.1 (C16), 136.2 (C14), 
136.0 (d, J = 7.4 Hz, C10), 132.4 (d, J = 2.8 Hz, C9), 129.7 (C19), 129.6 (C13), 
129.0 (d, J = 8.3 Hz, C8), 128.6 (C21), 128.4 (C17), 127.7 (C23), 127.2 (C12), 
126.9 (C18), 123.7 (C22), 114.6 (d, J = 22.6 Hz, C7), 114.2 (d, J = 22.8 Hz, C5), 
64.5 (C2), 55.1 (C3), 33.4 (C4), 31.2 (C24), 24.5 (C25), 23.8 (C25), 21.6 (C15). 
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 19
F NMR: δ -115.42 (app q, J = 7.2 Hz) 
 MS: (ESI)  
181 (19), 224 (35), 380 (100), 381 (25), 574 (M+H, 42), 596 (M+Na, 36) 
 HRMS: calcd for C34H37NO2S2F: 574.2250, found: 574.2245 
 TLC: Rf 0.45 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2965 (w), 1490 (m), 1356 (m), 1347 (m), 1184 (w), 1168 (s), 1141 (m), 1042 (m), 
940 (w), 872 (m), 818 (w), 799 (m), 747 (m) 
 Opt Rot: [α] D
24
 -17.9 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-146, tR 6.9 min (4.4%); (2S,3R)-146, tR 8.5 min (95.6%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C34H36NO2S2F (573.78) 
  Calcd:  C, 71.17;  H, 6.32% N, 2.44% 
   Found:  C, 71.17;  H, 6.30% N, 2.36% 
 
Preparation of (2S,3R)-3-[(2,6-Diisopropyl)phenylthio]-2-phenyl-1-tosyl-1,2,3,4-
tetrahydrobenzo[f]quinoline (147) (Table 12 Entry 4) [HMC11034] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 131 (413.5 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 563 mg (93%) of a 147 as a white solid.   
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Data for 147: 
 mp: 214-215 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.91 (d, J = 9.0 Hz, 1 H, HC(9)), 7.86 (d, J = 8.0 Hz, 1 H, HC(5)) 7.81 (d, J = 9.0 
Hz, 1 H, HC(10)), 7.59 (d, J = 8.5 Hz, 2 H, HC(16)), 7.50 (d, J = 8.5 Hz, 1 H, 
HC(8)), 7.45 (t, J = 7.0 Hz, 1 H, HC(6)), 7.40 (t, J = 7.0 Hz, 1 H, HC(7)), 7.35 – 
7.27 (m, 6 H, HC(aryl)), 7.22 (d, J = 8.0 Hz, 2 H, HC(17)), 7.11 (d, J = 7.5 Hz, 1 H, 
HC(26)), 5.41 (d, J = 7.5 Hz, 1 H, HC(2)), 3.44 (brs, 2 H, HC(28)), 3.05 – 2.96 (m, 
2 H, HC(3,4)), 2.43 (s, 3 H, HC(19)), 1.84 (td, J = 12.0, 4.0 Hz, 1 H, HC(4)), 1.07 
(d, J = 7.0 Hz, 6 H, HC(29)), 0.97 (d, J = 7.0 Hz, 6 H, HC(29)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.7 (C24), 143.7 (C15), 142.1 (C20), 136.5 (C18), 134.4 (C12), 131.7 (C14), 
130.5 (C13), 129.7 (C23), 129.5 (C17), 128.9 (C25), 128.6 (C5), 128.4 (C21), 
127.9 (C11), 127.6 (C10), 127.5 (C27), 127.3 (C16), 126.9 (C22), 126.3 (C7), 
125.5 (C6), 125.1 (C9), 123.7 (C26), 122.4 (C8), 64.3 (C2), 55.2 (C3), 31.3 (C28), 
27.6 (C4), 24.4 (C29), 23.9 (C29), 21.6 (C19). 
 MS: (ESI)  
167 (34), 168 (59), 256 (48), 257 (25), 412 (58), 413 (17), 451 (100), 452 (34), 606 
(M+H, 91), 607 (41), 628 (M+Na, 68), 629 (29). 
 HRMS: calcd for C38H40NO2S2: 606.2500, found: 606.2501 
 TLC: Rf 0.40 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2965 (w), 1455 (w), 1358 (s), 1239 (w), 1170 (s), 1091 (w), 1048 (w), 1025 (w), 
990 (m), 807 (m), 762 (w), 747 (m) 
 Opt Rot: [α] D
24
 -92.5 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-147, tR 9.5 min (2.3%); (2S,3R)-147, tR 13.3 min (97.7%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C38H39NO2S2 (605.85) 
  Calcd:  C, 75.33;  H, 6.49% N, 2.31% 
   Found:  C, 74.93;  H, 6.37% N, 2.41% 
 
282 
 
Preparation of (2S,3R)-3-[(2,6-Diisopropyl)phenylthio]-2-(4-methoxy)phenyl-1-tosyl-
1,2,3,4-tetrahydroquinoline (148) (Table 12 Entry 5) [HMC11032] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 137 (393.5 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 546 mg (93%) of a 148 as a white solid.   
Data for 148: 
 mp: 161-162 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.69 (d, J = 8.0 Hz, 1 H, HC(8)), 7.55 (d, J = 8.0 Hz, 2 H, HC(12)) 7.33 – 7.23 (m, 
6 H, HC(aryl)), 7.15 – 7.08 (m, 3 H, HC(aryl)), 6.89 – 6.85 (m, 3 H, HC(aryl)), 
5.22 (d, J = 8.5 Hz, 1 H, HC(2)), 3.84 (s, 3 H, HC(20)), 3.41 (brs, 2 H, HC(25)), 
2.89 (ddd, J = 11.5, 8.5, and 4.0 Hz, 1 H, HC(3)), 2.45 (s, 3 H, HC(15)), 2.29 (dd, J 
= 14.0, 4.0 Hz, 1 H, HC(4)), 1.68 (dd, J = 14.0, 11.5 Hz, 1 H, HC(4)), 1.08 (d, J = 
7.0 Hz, 6 H, HC(26)), 1.00 (d, J = 7.0 Hz, 6 H, HC(26)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 159.0 (C19), 153.6 (C21), 143.5 (C11), 136.5 (C14), 136.4 (C16), 134.6 (C10), 
133.4 (C9), 129.5 (C7), 129.4 (C13), 128.9 (C22), 128.1 (C17), 127.7 (C24), 127.5 
(C5), 127.2 (C12), 126.7 (C8), 126.1 (C6), 123.6 (C23), 113.7 (C18), 64.2 (C2), 
55.3 (C3), 55.3 (C20), 33.2 (C4), 31.2 (C25), 24.5 (C26), 23.9 (C26), 21.6 (C15). 
 MS: (ESI)  
114 (44), 121 (100), 142 (17), 150 (28), 236 (64), 392 (70), 608 (M+Na, 78), 609 
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(31), 624 (20). 
 HRMS: calcd for C35H39NO3S2Na: 608.2269, found: 608.2257 
 TLC: Rf 0.35 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2965 (w), 1497 (m), 1455 (w), 1347 (m), 1341 (w), 1225 (w), 1163 (s), 1090 (w), 
1053 (m), 1030 (w), 958 (w), 853 (m), 812 (w), 800 (m), 749 (w) 
 Opt Rot: [α] D
24
 -27.6 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-148, tR 10.5 min (3.9%); (2S,3R)-148, tR 14.6 min (96.1%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C35H39NO3S2 (585.82) 
  Calcd:  C, 71.76;  H, 6.71% N, 2.39% 
  Found:  C, 71.68;  H, 6.89% N, 2.41% 
 
 
 
Preparation of (2S,3R)-2-(4-Bromo)phenyl-3-[(2,6-diisopropyl)phenylthio]-1-tosyl-1,2,3,4-
tetrahydroquinoline (149) (Table 12 Entry 6) [HMC11033] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 138 (442.4 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 557 mg (88%) of a 149 as a white solid.   
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Data for 149: 
 mp: 183-184 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.72 (d, J = 8.0 Hz, 1 H, HC(8)), 7.53 (d, J = 8.5 Hz, 2 H, HC(12)), 7.47 (d, J = 
8.5 Hz, 2 H, HC(18)), 7.35 – 7.22 (m, 6 H, HC(7,13,17,23)), 7.14 (td, J = 7.5, 1.0 
Hz, 1 H, HC(6), 7.11 (d, J = 7.5 Hz, 2 H, HC(22)), 6.87 (d, J = 7.5 Hz, 1 H, HC(5)), 
5.16 (d, J = 9.0 Hz, 1 H, HC(2)), 3.34 (brs, 2 H, HC(24)), 2.79 (ddd, J = 11.5, 9.0, 
and 4.0 Hz, 1 H, HC(3)), 2.46 (s, 3 H, HC(15)), 2.30 (dd, J = 14.0, 4.0 Hz, 1 H, 
HC(4)), 1.66 (dd, J = 14.0, 11.5 Hz, 1 H, HC(4)), 1.08 (d, J = 7.0 Hz, 6 H, HC(25)), 
0.99 (d, J = 7.0 Hz, 6 H, HC(25)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.6 (C20), 143.8 (C11), 141.5 (C16), 136.2 (C14), 136.1 (C10), 133.4 (C9), 
131.4 (C18), 129.7 (C7), 129.5 (C13), 128.7 (C17), 128.5 (C21), 127.9 (C23), 
127.5 (C5), 127.2 (C12), 126.8 (C8), 126.4 (C6), 123.7 (C22), 121.5 (C19), 64.2 
(C2), 55.2 (C3), 33.3 (C4), 31.2 (C21), 24.5 (C25), 23.9 (C25), 21.6 (C15). 
 MS: (ESI)  
169 (14), 171 (16), 259 (22), 261 (21), 284 (27), 286 (28), 287 (10), 440 (96), 441 
(24), 442 (100), 443 (24), 634 (M+H, 39), 635 (17), 636 (45), 637 (17), 656 (M+Na, 
30), 657 (12), 658 (34), 659 (13). 
 HRMS: calcd for C34H37NO2S2Br: 634.1449, found: 634.1448 
 TLC: Rf 0.43 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2963 (w), 1488 (w), 1350 (m), 1342 (m), 1180 (m), 1167 (s), 1139 (m), 1047 (m), 
1041 (m), 960 (w), 940 (w), 867 (m), 815 (w), 799 (m), 746 (m) 
 Opt Rot: [α] D
24
 -51.2 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-149, tR 6.5 min (3.3%); (2S,3R)-149, tR 8.8 min (96.7%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C35H39NO3S2 (634.69) 
  Calcd:  C, 64.34;  H, 5.72% N, 2.21% 
  Found:  C, 64.53;  H, 5.58% N, 2.17% 
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Preparation of (2S,15R)-2-{3-[1-(2,6-Diisopropyl)phenylthio]cyanopropyl}-1-tosylindoline 
(150) (Table 12 Entry 7) [HMC11050] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 140 (340.4 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 457 mg (86%) of a 150 as a white solid.   
 
Data for 150: 
 mp: 144-145 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.71 (d, J = 8.0 Hz, 1 H, HC(7)), 7.39 (t, J = 7.5 Hz, 1 H, HC(22)), 7.33 (d, J = 
8.5 Hz, 2 H, HC(11)), 7.27 – 7.21 (m, 3 H, HC(6,21)), 7.18 – 7.05 (m, 4 H, 
HC(4,5,12)), 4.03 (dd, J = 11.0, 9.5 Hz, 1 H, HC(2)), 3.93 (sept, J = 7.0 Hz, 2 H, 
HC(23)), 3.39 (dd, J = 13.5, 3.0 Hz, 1 H, HC(15)), 2.95 (dd, J = 16.0, 3.0 Hz, 1 H, 
HC(3)), 2.94 (dd, J = 16.0, 9.0 Hz, 1 H, HC(3)), 2.47 – 2.33 (m, 4 H, HC(16,17)), 
2.38 (s, 3 H, HC(14)), 1.30 (d, J = 7.0 Hz, 6 H, HC(24)), 1.22 (d, J = 7.0 Hz, 6 H, 
HC(24)).  
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.2 (C19), 144.0 (C10), 141.5 (C8), 134.2 (C13), 130.7 (C9), 129.8 (C20), 
129.2 (C12), 129.1 (C22), 127.6 (C6), 126.8 (C11), 125.0 (C4), 124.8 (C5), 123.8 
(C21), 119.1 (C18), 117.4 (C7), 61.5 (C2), 43.1 (C15), 33.9 (C3), 31.5 (C23), 28.3 
(C16), 24.3 (C24), 24.2 (C24), 21.4 (C14), 17.5 (C17). 
 MS: (ESI)  
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169 (14), 171 (16), 259 (22), 261 (21), 284 (27), 286 (28), 287 (10), 440 (96), 441 
(24), 442 (100), 443 (24), 634 (M+H, 39), 635 (17), 636 (45), 637 (17), 656 (M+Na, 
30), 657 (12), 658 (34), 659 (13). 
 HRMS: calcd for C31H37N2O2S2: 533.2296, found: 533.2293 
 TLC: Rf 0.49 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2965 (w), 2249 (s), 1456 (w), 1323 (m), 1159 (s), 1089 (w), 1054 (m), 1029 (m), 
961 (m), 921 (w), 816 (w), 807 (m), 755 (w), 749 (w) 
 Opt Rot: [α] D
24
 -21.4 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,15S)-150, tR 7.3 min (13.6%); (2S,15R)-150, tR 9.1 min (86.4%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C31H36N2O2S2 (532.76) 
  Calcd:  C, 69.89;  H, 6.81% N, 5.26% 
  Found:  C, 69.71;  H, 6.64% N, 5.21% 
 
Preparation of (2S,15R)-2-{2-[(2,6-Diisopropyl)phenylthio]isobutyl}-1-tosylindoline (151) 
(Table 12 Entry 8) [HMC11044] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 133 (329.5 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 443 mg (85%) of a 151 as a white solid.   
 
 
287 
 
Data for 151: 
 mp: 131-132 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.65 (d, J = 7.5 Hz, 1 H, HC(7)), 7.44 (t, J = 8.0 Hz, 1 H, HC(21)), 7.31 (d, J = 
8.5 Hz, 2 H, HC(11)), 7.29 – 7.05 (m, 7 H, HC(4,5,6,12,20)), 4.06 (ddt, J = 11.5, 
9.5, and 2.0 Hz, 1 H, HC(2)), 3.95 (sept, J = 7.0 Hz, 2 H, HC(22)), 3.53 (m, 1 H, 
HC(15)), 2.99 (dd, J = 16.5, 3.5 Hz, 1 H, HC(3)), 2.91 (dd, J = 16.5, 9.0 Hz, 1 H, 
HC(3)), 2.36 (s, 3 H, HC(14)), 2.10 (sept, 1 H, HC(16)), 1.30 (d, J = 7.0 Hz, 6 H, 
HC(23)), 1.23 (d, J = 7.0 Hz, 6 H, HC(23)), 1.11 (d, J = 6.5 Hz, 3 H, HC(17)), 1.09 
(d, J = 6.5 Hz, 3 H, HC(17)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.0 (C18), 144.1 (C10), 141.5 (C8), 134.2 (C13), 130.1 (C19), 129.9 (C9), 
129.5 (C12), 129.4 (C21), 127.7 (C6), 126.5 (C11), 125.4 (C4), 124.7 (C5), 123.6 
(C20), 117.0 (C7), 61.3 (C2), 60.0 (C15), 33.9 (C3), 32.1 (C16), 31.4 (C22), 24.4 
(C23), 24.1 (C23), 21.5 (C14), 21.1 (C17), 20.5 (C17). 
 MS: (ESI)  
169 (14), 171 (16), 259 (22), 261 (21), 284 (27), 286 (28), 287 (10), 440 (96), 441 
(24), 442 (100), 443 (24), 634 (M+H, 39), 635 (17), 636 (45), 637 (17), 656 (M+Na, 
30), 657 (12), 658 (34), 659 (13). 
 HRMS: calcd for C31H40NO2S2: 522.2500, found: 522.2504 
 TLC: Rf 0.47 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2964 (w), 1486 (w), 1356 (m), 1160 (s), 1093 (w), 1076 (w), 1054 (m), 1029 (m), 
1002 (w), 961 (m), 813 (m), 805 (m), 761 (w), 751 (m) 
 Opt Rot: [α] D
24
 -31.2 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,15S)-151, tR 7.8 min (2.2%); (2S,15R)-151, tR 10.4 min (97.8%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C31H39NO2S2 (521.78) 
  Calcd:  C, 71.36;  H, 7.53% N, 2.68% 
  Found:  C, 71.51;  H, 7.72% N, 2.70% 
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Preparation of (2S)-2-{[(2,6-Diisopropyl)phenylthio]methyl}-1-tosylindoline (152) (Table 12 
Entry 9) [HMC11077] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 134 (287.4 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 432 mg (90%) of a 152 as a white solid.  
 
 
Data for 152: 
 mp: 127-128 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.69 (d, J = 8.0 Hz, 1 H, HC(7)), 7.42 (t, J = 7.5 Hz, 1 H, HC(19)), 7.30 (d, J = 
8.5 Hz, 2 H, HC(11)), 7.28 – 7.20 (m, 3 H, HC(6,18)), 7.16 – 7.04 (m, 4 H, 
HC(4,5,12)), 4.06 (ddt, J = 11.0, 9.5, and 2.5 Hz, 1 H, HC(2)), 3.95 (sept, J = 7.0 
Hz, 2 H, HC(20)), 3.28 (dd, J = 13.0, 3.5 Hz, 1 H, HC(15)), 3.00 (dd, J = 16.5, 3.5 
Hz, 1 H, HC(3)), 2.92 (dd, J = 16.5, 9.0 Hz, 1 H, HC(3)), 2.80 (dd, J = 12.5, 11.0 
Hz, 1 H, HC(15)), 2.38 (s, 3 H, HC(14)), 1.31 (d, J = 7.0 Hz, 6 H, HC(21)), 1.24 (d, 
J = 7.0 Hz, 6 H, HC(21)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.4 (C16), 143.8 (C10), 141.4 (C8), 134.4 (C13), 130.9 (C9), 129.8 (C17), 
129.5 (C12), 129.4 (C19), 127.8 (C6), 126.9 (C11), 125.2 (C4), 124.7 (C5), 123.8 
(C18), 117.1 (C7), 61.1 (C2), 43.0 (C15), 33.8 (C3), 31.5 (C20), 24.4 (C21), 24.2 
(C21), 21.5 (C14). 
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 MS: (ESI)  
272 (15), 318 (40), 325 (46), 326 (11), 480 (M+H, 100), 481 (31), 482 (14), 502 
(M+Na, 55), 503 (18), 518 (12). 
 HRMS: calcd for C28H34NO2S2: 480.2031, found: 480.2027 
 TLC: Rf 0.46 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2965 (w), 1480 (w), 1458 (w), 1358 (s), 1331 (w), 1169 (s), 1104 (m), 1091 (w), 
1021 (m), 997 (w), 955 (m), 811 (m), 803 (s), 763 (m), 752 (s) 
 Opt Rot: [α] D
24
 +34.6 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,15S)-152, tR 8.1 min (1.8%); (2S,15R)-152, tR 9.6 min (98.2%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C28H33NO2S2 (479.70) 
  Calcd:  C, 70.11;  H, 6.93% N, 2.92% 
  Found:  C, 69.90;  H, 6.95% N, 2.83% 
  
 
Preparation of (3R)-3-[(2,6-Diisopropyl)phenylthio]-2,2-dimethyl-1-tosyl-1,2,3,4-
tetrahydroquinoline (153) (Table 12 Entry 10) [HMC11043] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 132 (315.4 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 451 mg (89%) of a 153 as a white solid.   
290 
 
 
Data for 153: 
 mp: 167-168 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.63 (d, J = 8.0 Hz, 1 H, HC(8)), 7.37 (d, J = 8.5 Hz, 2 H, HC(12)), 7.34 (t, J = 
8.0 Hz, 1 H, HC(20)), 7.22 (t, J = 7.5 Hz, 1 H, HC(7)), 7.18 (d, J = 7.5 Hz, 2 H, 
HC(19)), 7.11 (d, J = 8.0 Hz, 2 H, HC(13)), 7.07 (t, J = 7.5 Hz, 1 H, HC(6)), 7.05 
(d, J = 6.5 Hz, 1 H, HC(5)), 4.36 (dd, J = 9.0, 1.5 Hz, 1 H, HC(3)), 3.97 (sept, J = 
7.0 Hz, 2 H, HC(21)), 3.20 (dd, J = 16.5, 1.5 Hz, 1 H, HC(4)), 2.63 (dd, J = 17.0, 
9.0 Hz, 1 H, HC(4)), 2.35 (s, 3 H, HC(15)), 1.31 (brd, J = 47.0 Hz, 6 H, HC(22)), 
1.31 (s, 3 H, HC(16)), 1.07 (brd, J = 32.5 Hz, 6 H, HC(22)), 0.90 (s, 3 H, HC(16)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 155.4 (C17, broadened due to slow rotation), 143.8 (C14), 142.8 (C9), 134.8 
(C10), 134.7 (C11), 129.8 (C20), 129.3 (C13), 127.7 (C18), 127.5 (C7), 127.3 
(C12), 125.8 (C6), 124.1 (C5), 123.5 (C19), 119.3 (C8), 70.2 (C3), 55.3 (C2), 32.0 
(C21), 31.7 (C4), 26.5 (C16), 26.0 (C22), 23.7 (C16), 22.7 (C22), 22.3 (C22), 21.5 
(C15). 
 MS: (ESI)  
158 (16), 272 (11), 314 (100), 315 (20), 353 (11), 508 (M+H, 17), 530 (M+Na, 30), 
531 (10). 
 HRMS: calcd for C30H38NO2S2: 508.2344, found: 508.2339 
 TLC: Rf 0.48 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2964 (w), 1458 (w), 1356 (s), 1168 (s), 1131 (w), 1115 (w), 1090 (m), 998 (m), 956 
(m), 812 (m), 804 (m), 767 (s), 757 (w), 747 (m) 
 Opt Rot: [α] D
24
 -87.1 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-153, tR 7.5 min (11.8%); (2S,3R)-153, tR 9.9 min (88.2%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C30H37NO2S2 (507.75) 
  Calcd:  C, 70.96;  H, 7.34% N, 2.76% 
  Found:  C, 70.87;  H, 7.25% N, 2.71% 
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Preparation of (13R,14S)-N-(2-{2-[(2,6-Diisopropylphenyl)thio]-2-(1-tosylpyrrolidin-2-
yl)ethyl}phenyl)-4-toluenesulfonamide (154) (Table 12 Entry 11) [HMC11053] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 141 (498.7 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 451 mg (89%) of a 154 as a white solid.   
 
Data for 154: 
 mp: 184-185 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.66 (d, J = 8.0 Hz, 2 H, HC(19)), 7.64 (d, J = 8.5 Hz, 2 H, HC(8)), 7.38 (d, J = 
7.5 Hz, 1 H, HC(6)), 7.33 – 7.23 (m, 5 H, HC(9,20,26)), 7.20 – 7.09 (m, 5 H, 
HC(3,4,5,25)), 6.39 (brs, 1 H, HN), 4.08 (sept, J = 7.0 Hz, 2 H, HC(27)), 4.01 (ddd, 
J = 8.5, 5.5, and 4.0 Hz, 1 H, HC(14)), 3.41 – 3.30 (m, 3 H, HC(13,17)), 2.43 (s, 3 
H, HC(22)), 2.42 (s, 3 H, HC(11)), 2.41 – 2.35 (m, 2 H, HC(12)), 1.89 (dtd, J = 
13.0, 7.5, and 5.5 Hz, 1 H, HC(15)), 1.79 (dtt, J = 12.0, 5.5, and 5.5 Hz, 1 H, 
HC(16)), 1.67 (dtd, J = 13.0, 8.0, and 5.5 Hz, 1 H, HC(15)), 1.24 (m, 1 H, HC(16)), 
1.25 (d, J = 7.0 Hz, 6 H, HC(28)), 1.24 (d, J = 7.0 Hz, 6 H, HC(28)). 
13
C NMR:  (126 MHz, CDCl3) 
  153.9 (C23), 143.7 (C10), 143.3 (C(18)), 136.6 (C7), 135.1 (C2), 134.9 (C(21)), 
134.0 (C1), 130.3 (C24), 129.9 (C6), 129.7 (C(20)), 129.6 (C9), 128.9 (C26), 127.5 
(C(19)), 127.1 (C8), 126.9 (C5), 126.2 (C4), 124.5 (C3), 123.6 (C25), 62.2 (C(14)), 
57.5 (C13), 49.6 (C(17)), 31.2 (C27), 30.9 (C12), 28.6 (C(15)), 24.9 (C(16)), 24.6 
(C28), 24.2 (C28), 21.5 (C(22)), 21.5 (C11). 
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 MS: (ESI)  
342 (25), 691 (M+H, 100), 692 (18), 713 (19), 729 (11). 
 HRMS: calcd for C38H47N2O4S3: 691.2698, found: 691.2694 
 TLC: Rf 0.32 (hexanes/EtOAc, 4:1) [UV] 
 IR: 3025 (m), 2946 (w), 1598 (w), 1475 (w), 1451 (w), 1343 (m), 1303 (w), 1216 (m), 
1157 (s), 1091 (m), 1028 (m), 990 (w), 927 (w), 813 (w), 745 (m) 
 Opt Rot: [α] D
24
 -45.9 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (13S,14R)-154, tR 9.6 min (5.5%); (13R,14S)-154, tR 12.0 min (94.5%) (Chiralpak 
AD, 220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C38H46N2O4S3 (690.98) 
  Calcd:  C, 66.05;  H, 6.71% N, 4.05% 
  Found:  C, 65.91;  H, 6.55% N, 3.98% 
 
Preparation of (2S,16R)-2-{1-[(2,6-Diisopropyl)phenylthio]butyl}-1-tosyl-1,2,3,4-
tetrahydroquinoline (155) (Table 13 Entry 1) [HMC11035] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 142 (343.5 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 499 mg (93%) of a 155 as a white solid.   
 
Data for 155: 
 mp: 158-159 
o
C (pentane) 
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 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.80 (d, J = 8.0 Hz, 1 H, HC(8)), 7.33 – 7.26 (m, 4 H, HC(7,12,23)), 7.19 – 7.13 
(m, 5 H, HC(6,13,22)), 6.94 (d, J = 7.5 Hz, 1 H, HC(5)), 4.41 – 4.36 (m, 1 H, 
HC(2)), 4.08 (sept, J = 7.0 Hz, 2 H, HC(24)), 3.35 (dt, J = 9.5, 5.0 Hz, 1 H, 
HC(16)), 2.39 (s, 3 H, HC(15)), 2.19 (dt, J = 15.0, 4.5 Hz, 1 H, HC(4)), 2.01 – 1.93 
(m, 1 H, HC(3)), 1.83 – 1.74 (m, 1 H, HC(3)), 1.67 – 1.51 (m, 2 H, HC(17)), 1.49 – 
1.35 (m, 2 H, HC(17)), 1.35 – 1.27 (m, 1 H, HC(4)), 1.25 (d, J = 7.0 Hz, 6 H, 
HC(25)), 1.24 (d, J = 7.0 Hz, 6 H, HC(25)), 0.85 (t, J = 7.0 Hz, 3 H, HC(19)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.9 (C20), 143.3 (C14), 136.5 (C11), 135.7 (C9), 135.5 (C10), 130.3 (C21), 
129.3 (C13), 128.9 (C23), 128.5 (C8), 127.1 (C5), 127.0 (C12), 126.9 (C7), 126.1 
(C6), 123.6 (C22), 58.8 (C2), 57.5 (C16), 36.0 (C17), 31.2 (C24), 25.3 (C4), 25.2 
(C3), 24.6 (C25), 24.2 (C25), 21.5 (C15), 20.1 (C18), 14.0 (C19). 
  
MS: (ESI)  
132 (22), 342 (17), 381 (54), 382 (15), 536 (M+H, 100), 537 (37), 538 (16), 558 
(51), 559 (19). 
 HRMS: calcd for C32H42NO2S2: 536.2657, found: 536.2657 
 TLC: Rf 0.48 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2966 (w), 1463 (w), 1350 (m), 1163 (s), 1092 (w), 1054 (w), 1025 (w), 966 (m), 
817 (w), 805 (m), 759 (w), 748 (m) 
 Opt Rot: [α] D
24
 +57.9 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-155, tR 6.1 min (1.7%); (2S,3R)-155, tR 8.7 min (98.3%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C32H41NO2S2 (535.80) 
  Calcd:  C, 71.73;  H, 7.71% N, 2.61% 
  Found:  C, 71.61;  H, 7.84% N, 2.47% 
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Preparation of (2S,3R)-3-[(2,6-Diisopropyl)phenylthio]-2-phenyl-1-tosyl-2,3,4,5-
tetrahydrobenzazepine (156) (Table 13 Entry 2) [HMC11049] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 139 (377.5 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 516 mg (91%) of a 156 as a white solid.   
 
Data for 156: 
 mp: 143-144 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.36 (d, J = 7.5 Hz, 2 H, HC(13), 7.32 – 7.27 (m, 3 H, HC(19,20)), 7.25 – 7.18 (m, 
2 H, HC(7,24)), 7.22 – 7.16 (m, 2 H, HC(18)), 7.12 – 7.00 (m, 6 H, HC(6,8,14,23), 
6.73 (d, J = 7.0 Hz, 1 H, HC(9)), 5.43 (d, J = 10.5 Hz, HC(2)), 3.51 (brs, 2 H, 
HC(25)), 3.02 – 2.89 (m, 2 H, HC(3,5)), 2.43 – 2.36 (m, 1 H, HC(5)), 2.36 (s, 3 H, 
HC(16)), 2.09 – 1.98 (m, 1 H, HC(4)), 1.80 – 1.69 (brs, 1 H, HC(4)), 1.05 (brs, 6 H, 
HC(26)), 0.93 (d, J = 5.0 Hz, 6 H, HC(26)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.5 (C21), 143.0 (C15), 140.3 (C11), 140.2 (C17), 138.8 (C12), 135.0 (C10), 
131.3 (C9), 129.7 (C6,22), 129.1 (C14), 129.0 (C24), 128.9 (C7), 128.1 (C19), 
128.0 (C20), 127.7 (C18), 127.3 (C13), 126.8 (C8), 123.6 (C23), 65.4 (C2), 50.2 
(C3), 31.2 (C25), 29.4 (C5), 28.4 (C4), 24.5 (C26), 23.7 (C26), 21.5 (C16). 
 MS: (ESI)  
220 (15), 376 (100), 377 (26), 570 (M+H, 22), 571 (9), 592 (21). 
 HRMS: calcd for C35H40NO2S2: 570.2500, found: 570.2495 
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 TLC: Rf 0.41 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2965 (w), 1455 (w), 1345 (m), 1153 (s), 1117 (w), 1091 (m), 1054 (w), 1042 (w), 
1026 (m), 980 (w), 960 (w), 815 (w), 800 (w), 749 (m) 
 Opt Rot: [α] D
24
 +41.2 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-156, tR 8.1 min (5.3%); (2S,3R)-156, tR 10.3 min (94.7%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C35H39NO2S2 (569.82) 
  Calcd:  C, 73.77;  H, 6.90% N, 2.46% 
  Found:  C, 73.79;  H, 6.35% N, 2.58% 
 
Preparation of (2S)-3-[(2,6-Diisopropyl)phenylthio]-2,2-dimethyl-1-tosyl-1,2,3,4-
tetrahydroquinoline (157) (Table 13 Entry 3) [HMC11028] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 135 (301.4 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 459 mg (93%) of a 157 as a white solid.   
 
Data for 157: 
 mp: 129-130 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.71 (d, J = 8.0 Hz, 1 H, HC(8)), 7.31 (d, J = 8.5 Hz, 2 H, HC(12)), 7.30 (t, J = 
8.0 Hz, 1 H, HC(20)), 7.23 (t, J = 7.5 Hz, 1 H, HC(7)), 7.16 (d, J = 7.5 Hz, 2 H, 
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HC(19)), 7.15 (d, J = 8.0 Hz, 2 H, HC(13)), 7.12 (t, J = 7.5 Hz, 1 H, HC(6)), 6.98 
(d, J = 7.5 Hz, 1 H, HC(5)), 4.39 – 4.31 (m, 1 H, HC(2)), 3.88 (sept, J = 7.0, 2 H, 
HC(21)), 2.98 (dd, J = 12.0, 5.0 Hz, 1 H, HC(16)), 2.77 (dd, J = 12.0, 8.5 Hz, 1 H, 
HC(16)), 2.43 – 2.34 (m, 1 H, HC(4)), 2.38 (s, 3 H, HC(15)), 2.11 – 2.02 (m, 1 H, 
HC(3)), 1.83 – 1.75 (m, 1 H, HC(4)), 1.68 – 1.59 (m, 1 H, HC(3)), 1.22 (d, J = 7.0 
Hz, 6 H, HC(22)), 1.20 (d, J = 7.0 Hz, 6 H, HC(22)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.1 (C18), 143.0 (C15), 142.5 (C11), 138.6 (C12), 135.4 (C10), 131.3 (C9), 
131.1 (C19), 129.8 (C6), 129.4 (C14), 129.1 (C21), 128.4 (C8), 127.2 (C13), 126.6 
(C7), 123.7 (C20), 56.4 (C2), 40.0 (C17), 33.7 (C5), 32.9 (C3), 31.4 (C22), 24.4 
(C23), 24.3 (C23), 21.5 (C16), 20.8 (C4). 
 MS: (ESI)  
132 (37), 339 (91), 340 (23), 494 (M+H, 100), 495 (34), 496 (15), 516 (72), 517 
(24), 518 (11), 532 (13). 
 HRMS: calcd for C29H36NO2S2: 494.2187, found: 494.2183 
 TLC: Rf 0.44 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2965 (w), 1347 (s), 1161 (s), 1089 (m), 1053 (m), 966 (m), 818 (m), 801 (m), 767 
(m), 760 (m), 748 (m) 
 Opt Rot: [α] D
24
 +71.2 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R,3S)-157, tR 5.4 min (2.0%); (2S,3R)-157, tR 7.7 min (98.0%) (Chiralpak AD, 
220 nm, 90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C29H35NO2S2 (493.72) 
  Calcd:  C, 70.55;  H, 7.15% N, 2.84% 
  Found:  C, 70.55;  H, 7.03% N, 3.05% 
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Preparation of (2S)-2-{[(2,6-Diisopropyl)phenylthio]methyl}-1-tosyl-2,3,4,5-
tetrahydrobenzazepine (158) (Table 13 Entry 4) [HMC11036] 
 
Following General Procedure XIII, a 10-mL Schlenk flask was charged with 143 (315.4 
mg, 1.0 mmol, 1.0 equiv), PhthSAryl 124 (339.5 mg, 1.0 mmol, 1.0 equiv), (S)-83 (52.1 mg, 0.1 
mmol, 0.1 equiv), and CH2Cl2 (2.5 mL, 0.4 M). To the mixture was added MsOH (32.5 µL, 0.5 
mmol, 0.5 equiv) at 0 
o
C and the stirred for 48 h. The reaction was worked up following the 
general procedure. The crude product was purified by flash chromatography (SiO2, 25 g, 30 mm 
Ø , hexanes/EtOAc, 19:1 to 9:1) to afford 450 mg (89%) of a 158 as a white solid.   
 
Data for 158: 
 mp: 60-61 
o
C (pentane) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.55 (d, J = 8.0 Hz, 2 H, HC(13)), 7.29 (t, J = 7.5 Hz, 1 H, HC(21)), 7.22 (d, J = 
8.0 Hz, 1 H, HC(9)), 7.21 (t, J = 8.0, 1 H, HC(8)), 7.20 (d, J = 8.0 Hz, 2 H, HC(14)), 
7.14 (t, J = 8.0 Hz, 1 H, HC(7)), 7.11 (d, J = 7.5 Hz, 2 H, HC(20)), 7.10 (d, J = 8.0 
Hz, 1 H, HC(6)), 4.63 (tt, J = 7.5, 4.0 Hz, 1 H, HC(2)), 3.69 (sept, J = 7.0 Hz, 2 H, 
HC(22)), 2.53 (dd, J = 12.5, 7.5 Hz, 1 H, HC(17)), 2.47 (t, J = 5.0 Hz, 2 H, HC(5)), 
2.41 (s, 3 H, HC(16)), 2.28 (ddd, J = 12.0, 7.5, and 1.0 Hz, 1 H, HC(17)), 2.12 (ddt, 
J = 16.0, 12.5, and 4.0 Hz, 1 H, HC(3)), 1.91 (dd, J = 14.5, 4.5 Hz, 1 H, HC(3)), 
1.71 (dt, J = 14.0, 4.5 Hz, 1 H, HC(4)), 1.35 (dtt, J = 14.0, 5.0, and 2.5 Hz, 1 H, 
HC(4)), 1.14 (d, J = 7.0 Hz, 6 H, HC(23)), 1.13 (d, J = 7.0 Hz, 6 H, HC(23)). 
13
C NMR:  (126 MHz, CDCl3) 
  δ 153.1 (C18), 143.0 (C15), 142.5 (C11), 138.6 (C12), 135.4 (C10), 131.3 (C9), 
131.1 (C19), 129.8 (C6), 129.4 (C14), 129.1 (C21), 128.4 (C8), 127.2 (C13), 126.6 
(C7), 123.7 (C20), 56.4 (C2), 40.0 (C17), 33.7 (C5), 32.9 (C3), 31.4 (C22), 24.4 
(C23), 24.3 (C23), 21.5 (C16), 20.8 (C4). 
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 MS: (ESI)  
314 (20), 353 (15), 508 (M+H, 100), 509 (34), 510 (15), 530 (44), 531 (15). 
 HRMS: calcd for C30H38NO2S2: 508.2344, found: 508.2345 
 TLC: Rf 0.45 (hexanes/EtOAc, 4:1) [UV] 
 IR: 2960 (w), 1455 (w), 1345 (m), 1158 (s), 1092 (m), 1053 (m), 1029 (m), 923 (w), 
813 (w), 801 (m), 763 (m), 744 (m) 
 Opt Rot: [α] D
24
 +27.4 (c = 0.90, CHCl3) 
 CD: (-), Cotton sign, 230-280 nm 
 
HPLC: (2R)-153, tR 8.7 min (6.9%); (2S)-153, tR 10.8 min (93.1%) (Chiralpak AD, 220 nm, 
90:10, hexanes:i-PrOH, 1 mL/min) 
 Analysis:  C30H37NO2S2 (507.75) 
  Calcd:  C, 70.96;  H, 7.34% N, 2.76% 
  Found:  C, 70.69;  H, 7.39% N, 2.99% 
 
Desulfurization of Sulfenoamination Products
110
 [HMC11100] 
 
In a glovebox, an oven-dried, 10-mL Schlenk flask equipped with a stir bar was lithium 
metal (42 mg, 6.0 mmol, 6 equiv, cut into parts smaller than 3 mm), and naphthalene (769 mg, 
6.0 mmol, 6 equiv). The flask was capped with a septum, it was transferred to a Schlenk line 
after exiting the glove box. To the flask was added THF (2 mL) via syringe at 42 oC. The 
resulting mixture was stirred for 30 min at 42 oC with development of green color. To the 
lithium-naphthylide solution was added a solution of sulfenylated product in THF (1.0 mmol in 2 
mL, 0.5 M) via syringe at 42 oC. The color of the reaction mixture gradually turned into yellow 
while stirring for 1 h at 42 oC. The reaction mixture was decanted into a suspension of hexanes, 
water, NH4Cl (10 mL: 5 mL: 5 mL). Residual lithium in Schlenk flask was rinsed with TBME (5 
mL x 2). The biphasic mixture was separated, and the organic layer was washed with 1 M KOH 
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solution (10 mL x 2), and brine (10 mL). Resulting organic layer was dried over Na2SO4 and 
evaporated under reduced pressure (25 
o
C, 10 mmHg) to yield a yellow odorous oil. Purification 
via silica gel flash column chromatography (SiO2, 40 g, 25 mm Ø , hexanes to hexanes/EtOAc, 
9:1) afforded 116 mg (87%) of 154, as a colorless oil. The spectroscopic data matched those 
reported in the literature.
111 
 
Data for 154: 
 bp: 110 
o
C (at 15 mmHg) 
 1
H NMR:  (500 MHz, CDCl3) 
  δ 7.07 (d, J = 7.0 Hz, 1 H), 7.01 (t, J = 7.5 Hz, 1 H), 6.69 (td, J = 7.5, 1.0 Hz, 1 H), 
6.60 (d, J = 7.5 Hz, 1 H), 3.99 (ddq, J = 8.5, 8.0, and 6.0 Hz, 1 H, HC(2)), 3.14 (dd, 
J = 15.5, 8.5 Hz, 1 H, HC(3)), 2.64 (ddt, J = 15.5, 8.0, and 1.0 Hz, 1 H, HC(3)), 
1.29 (d, J = 6.0 Hz, 3 H, HC(10)). 
 Opt Rot: [α] D
24
 6.9 (c = 0.80, C6H6) 
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